The Development of Pd(II)-Catalysed C–H Activation Cascades for the Synthesis of Polyheterocycles by Glaisyer, Beth
                          
This electronic thesis or dissertation has been





The Development of Pd(II)-Catalysed C–H Activation Cascades for the Synthesis of
Polyheterocycles
General rights
Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License.   A
copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode  This license sets out your rights and the
restrictions that apply to your access to the thesis so it is important you read this before proceeding.
Take down policy
Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research.
However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of
a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity,
defamation, libel, then please contact collections-metadata@bristol.ac.uk and include the following information in your message:
•	Your contact details
•	Bibliographic details for the item, including a URL
•	An outline nature of the complaint








The Development of Pd(II)-Catalysed C–H 




Elizabeth Lauren Glaisyer 





A thesis submitted to the University of Bristol in accordance with the requirements of the 


















A novel Pd(II)-catalysed C–H activation/aza-Wacker cascade sequence has been optimised for indoles 
bearing an N-tethered alkene and an N-acyl mesylamide group that serves dual purpose as a directing 
group and a C–N bond precursor. This optimisation was achieved by a combination of Design of 
Experiments and traditional reactant screening. The reaction is tolerant to functionalisation on the 
alkene and tether, as well as substitution at various positions around the indole ring. The methodology 
can also be applied to pyrrole systems. 24 successful examples of this Pd(II)-catalysed C–H activation 
methodology are described. 
 
A number of studies have been carried out in order to probe the mechanism of this cascade sequence. 
As a result of this an oxidative Heck/aza-Wacker mechanism beginning with amide deprotonation can 
be proposed. 
The application of this methodology to non-aromatic substrates, with a view to this being used as a 
potential key step towards the total synthesis of naturally occurring alkaloids and potential drug 
discovery scaffolds, was examined. The synthesis of the substrate necessary for the total synthesis of 
the alkaloid matrine was unsuccessful, so the Pd(II)-catalysed C–H activation of enamine test 
substrates were instead investigated. These substrates were found to be unsuitable for Pd(II)-
catalysed C–H activation due to a lack of aromaticity and a lack of electron density. 
 
Proof of concept for the oxidative Heck/aza-Wacker cascade cyclisation of aniline-derived substrates 
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1. Introduction  
Nitrogen containing polyheterocycles are an important class of compounds and can be found in a wide 
variety of natural products, drug molecules and other biologically active compounds. Their 
pharmacological activity is due to their similarity to structures found within the body, such as in DNA, 
and the ability of nitrogen-containing polyheterocycles to participate in hydrogen bonding 
interactions with structures in the body, such as proteins. Indole-containing compounds are 
particularly prevalent in nature as they can be synthesised from the amino acid tryptophan. Because 
of this, the development of efficient synthesis of nitrogen-containing polyheterocycles is essential in 
order to fully exploit their pharmacological properties. It is not clear whether natural products are 
synthesised in nature because those are the optimum compounds, or because they are easily 
synthesised by nature, so the synthesis and analysis of compounds seen in nature and novel 
compounds are both necessary areas of exploration. Pd(II)-catalysed C–H activation reactions are 
powerful tools in organic synthesis as they can be used to functionalise polyheterocycles, but can also 
be used in ring annulations towards the formation of polyheterocycles. C–H activation reactions are 
particularly useful when used as part of a cascade reaction as these can rapidly transform simple 
starting materials into much more complex products. This thesis investigates the development of 
Pd(II)-catalysed oxidative Heck/aza-Wacker cascade sequences for the generation of novel complex 
polyheterocycles. 
1.1 Pd(0)-Catalysed cross coupling reactions 
Pd(0)-catalysed cross coupling reactions have revolutionised modern synthetic chemistry by allowing 
the efficient formation of C–C and C–N bonds. These reactions have therefore become vital tools in 
both academia and industry, particularly in the pharmaceutical, agrochemical, and fine chemical 
industries. This was highlighted in 2010 when the Nobel Prize was awarded to Heck, Suzuki and Negishi 
for their ground-breaking discoveries regarding Pd(0)-catalysed C–C bond formations. Over the years, 
examples of Pd(0)-catalysed cross-coupling reactions have grown in number and diversity. The most 
notable reactions include the Suzuki,1 Heck,2 Negishi,3 Sonogashira,4 Stille5 and Kumada6 reactions and 





Scheme 1. Common Pd(0)-catalysed cross-coupling reactions 
These reactions all follow a general mechanism based on a Pd(0)/Pd(II) catalytic cycle, involving 
oxidative addition, transmetalation, and reductive elimination (Scheme 2). The active Pd(0) catalyst is 
usually formed in situ by the reduction of a Pd(II) precatalyst such as Pd(OAc)2. The generated Pd(0) 
species undergoes oxidative addition with an aryl halide or pseudo halide, where the Pd(0) species 
inserts itself into the aryl halide R–X bond producing a reactive organopalladium(II) halide complex. 
This complex then undergoes transmetalation with an organometallic coupling partner; it is this 
transmetalation step that distinguishes one cross-coupling reaction from another. While the 
Sonogashira reaction does not initially contain an organometallic reagent, a copper acetylide is formed 
in situ by the reaction of a base and a copper halide salt with the alkyne. The Suzuki reaction is also 
unique in that the addition of a base, such as sodium hydroxide, is necessary for the reaction to occur. 
It was originally thought that the base activates the boronic acid by forming a borate complex 
[B(OR)3R]-. However, it is now believed that the anionic hydroxide does not act as a base, but as a 
ligand for aryl-Pd(II) complexes.8 The boron coupling partner is able to form a much stronger 
interaction with the oxygen of the hydroxyl ligand than it would with a halide ligand, allowing 
transmetalation to occur. The transmetalated species undergoes reductive elimination to form the 





Scheme 2. General Pd(0)-catalysed reaction mechanism 
The Heck reaction differs in mechanism to that of the other Pd(0)-catalysed cross coupling reactions 
as it does not include a transmetalation step. Instead, following oxidative addition, an alkene coupling 
partner coordinates to the Pd(II) centre. This then undergoes migratory insertion followed by syn-
selective β-hydride elimination to form the desired product. The cycle is completed by the reductive 
elimination of the resulting Pd(II)  species, regenerating the active Pd(0) species (Scheme 3).  
 
Scheme 3. General Heck reaction mechanism 
1.2 Pd(II)-Catalysed C–H activation reactions 
While Pd(0)-catalysed cross-coupling reactions are crucial in modern synthetic chemistry, they require 
pre-functionalisation steps to access the aryl halides or pseudohalides. These pre-functionalisation 
steps can be costly with regard to both time and resources. The use of aryl halides also results in the 
generation of stoichiometric amounts of halide waste. C–H bonds are not traditionally reactive due to 
large kinetic barriers associated with C–H bond cleavage and due to the apolar nature of such bonds. 
There can also be selectivity issues due to the ubiquity of C–H bonds in organic molecules. However, 




Pd(0)-catalysed cross-coupling as no pre-functionalisation steps are required and no halide waste is 
produced. Instead of replacing aryl halides, C–H activation can also replace the use of organometallic 
reagents as coupling partners. This avoids the generation of a stoichiometric amount of metal waste 
and, again, avoids costly pre-functionalisation steps. Therefore, in recent years there has been 
significant advancement in this area and there are now a plethora of examples in the literature.9  
1.2.1 Mechanism of C–H activation 
The mechanism of C–H activation bears similarity to that of the Pd(0)-catalysed cross-coupling 
reactions shown above (cf. Scheme 2, page 11). However, C–H activation differs in the fact that the 
reaction is catalysed by a Pd(II) species. An electrophilic Pd(II) catalyst can insert into a C–H bond. This 
C–H activation is followed by reaction with a coupling partner, such as an organometallic reagent or 
alkene, to generate the desired product. In contrast to Pd(0)-catalysed reactions, C–H activation 
requires the presence of an oxidant to reoxidise the resulting Pd(0) species back to the active Pd(II) 
catalyst (Scheme 4). 
 
Scheme 4. General Pd(II)-catalysed CH activation reaction mechanism 
There have been a number of mechanisms proposed for the C–H activation step, including 
electrophilic aromatic substitution (SEAr), concerted metalation deprotonation (CMD), oxidative C–H 





Scheme 5. Common mechanisms of C–H activation 
SEAr proceeds via Pd–C bond formation that results in a temporary loss of aromaticity (Scheme 5A). It 
is the most probable mechanism for the C–H activation of electron-rich, nucleophilic arenes and 
heteroarenes due to their ability to stabilise the intermediate carbocation.10-12 Arylation usually occurs 
at the site most susceptible to electrophilic attack. However, the initial site of electrophilic attack is 
not necessarily where the functional group ends up due to the possibility of migration, for example 
the 2,3-migration of indoles.13 No kinetic isotope effect (KIE) is observed for C–H activation reactions 
which proceed by SEAr due to the rapid nature of the C–H cleavage step.  
An example of SEAr is the arylation of imidazole [1,2,a]pyrimidine 1 (Scheme 6).10 This reaction 
proceeds with complete regioselectivity, with arylation occurring at the 3-position to give 3. This is the 
site most susceptible to electrophilic attack as it gives rise to the most stable arenium ion. Attack at 
the 2-position is also possible but is unfavoured as the intermediate would be much less stable. The 
reaction was tolerant to a range of aryl bromide coupling partners, although those bearing electron-





Scheme 6. Arylation of imidazole [1,2,a]pyrimidines via SEAr 
CMD involves arene metalation and C–H bond cleavage occurring in a concerted manner (Scheme 5B). 
The hydrogen atom is abstracted by a base either in an intermolecular or intramolecular fashion. The 
accessibility of this mechanism is dependent on the acidity of the C–H bond. CMD is usually seen with 
simple and electron-deficient arenes which do not have sufficient electron density to undergo SEAr. 
However, Fagnou has reported that the CMD pathway can also be used to predict the reactivity for a 
diverse set of arenes including some previously proposed to react via SEAr.14  A KIE is observed, 
indicating that C–H bond cleavage is a kinetically significant event.15 
An example of CMD by Fagnou exemplifies the complementary reactivity of CMD to SEAr,16 in which 
the intermolecular direct arylation of electron-deficient perfluorobenzene 7 was demonstrated 
(Scheme 7). Computational studies showed that C–H activation proceeded via a concerted arene 
metalation and C–H bond cleavage process, with the proton being transferred to a carbonate ligand 
bound to the Pd-catalyst (11). This mechanism favours electron-deficient arenes with an acidic C–H 





Scheme 7. Direct arylation of electron-deficient perfluorobenzenes 
Another possible mechanism for electron-deficient arenes is oxidative addition. In this mechanism the 
Pd(II) species inserts itself into the C–H bond, increasing the oxidation state of Pd from II to IV. The 
Pd(IV) species then undergoes reductive elimination to form the common organometallic 
intermediate (Scheme 5C). This mechanism is most likely to occur when the metal catalyst is electron-
rich and low valent, and a when a strong oxidant is present. It is most commonly observed for late 
transition metals due to their ability to accommodate higher oxidation states and changes in 
geometry. Compared with SEAr and CMD, oxidative addition is a fairly uncommon pathway due to the 
instability and high energy of Pd(IV) species. Despite this there are still many examples in the 
literature.17-19 
The Heck-like mechanism can occur in the presence of a pre-functionalised Pd(II) species (Scheme 5D). 
The Pd(II) species can add across the double bond of an alkene or an arene. This intermediate can then 





1.2.2 Directed C–H activation 
A major challenge of C–H activation is achieving the selective functionalisation of a single C–H bond 
within a complex molecule, often containing multiple C–H bonds of similar reactivity. There are several 
strategies for overcoming this including the use of sterics22-24 and intrinsic electronic properties.25 
However, the most successful strategy is the use of directing groups. This involves the use of 
substrates containing coordinating ligands, usually Lewis basic functional groups containing non-
bonding electrons. These ligands bind to the metal centre allowing for the selective delivery of the 
catalyst to a proximal C–H bond. As well as controlling site selectivity, directing groups promote the 
formation of the agostic interaction due to the increase in effective concentration between the metal 
and the C–H bond, and they arrange the pre-transition state geometry in a favourable way for C–H 
cleavage. The key criterion for an effective directing group is to coordinate to a metal in a strong yet 
reversible manner, in order to promote C–H activation and then disassociate at the end of the 
reaction.  
1.2.2.1 Oxygen-based directing groups 
The use of directing groups for C–H activation was first made popular by Murai in the early 1990s.26 It 
was demonstrated that the coupling of aromatic C–H bonds with alkenes could be carried out 
selectively at the ortho-position of the aromatic ring to form alkylarenes 15, using a ruthenium catalyst 
(Scheme 8). This was achieved using a ketone directing group, which coordinated to the low-valent 
ruthenium complex and positioned it for the subsequent cleavage of the aromatic C–H bond. This 
reaction served as a blueprint for the field of directed C–H activation. 
 
Scheme 8. Ketone-directed ortho-alkylation 
Since this work by Murai a wide range of Pd(II)-catalysed C–H activation reactions directed by oxygen-
based directing groups have been reported. As well as ketones27-29, esters30-31, silanols32 and ethers33 
have also been employed as effective directing groups. The use of carboxylic acids as directing groups 
can be challenging as they are weakly coordinating and they can undergo undesired side reactions 
such as hydrodecarboxylation. However, carboxylic acid are desirable directing groups as they are 
naturally occurring, easily installed and can be removed or serve as a handle for subsequent 
transformations. For these reasons there many examples of carboxylic acid directing groups in the 




benzoic acids 16 with aryl iodides 27 was achieved using a mono-protected amino acid (MPAA) ligand 
at ambient temperature to give biaryl products 18 (Scheme 9). A wide functional group tolerance was 
observed including substrates bearing esters and ketones, with the carboxyl group overriding any 
directing group ability of the ester or ketone allowing arylation to occur selectively at the ortho-
position of the carboxyl only.  
 
Scheme 9. ortho-Arylation of benzoic acids 
Aldehydes are not commonly used as directing groups as they are weakly coordinating, susceptible to 
oxidation and prone to metal-insertion. However, they can be applied as part of transient directing 
group systems, in which a more strongly coordinating directing group is formed and cleaved in situ. 
This approach has been demonstrated by a number of groups.36-38 The challenge lies with selecting 
the most appropriate transient directing group, as often the transient Pd(II) species is too stable, 
preventing functionalisation and/or dissociation from occurring. In 2017 Yu reported an example in 
which a catalytic amount of 2-methylalanine was used as a mediator to form the effective directing 
group (Scheme 10).39 The use of an amino acid results in a carboxyl directing group attached to the 
substrate by an imine linkage (21). Carboxyl groups are not strongly coordinating, allowing 
functionalisation to occur. The nature of the amino acid used played a vital role towards the outcome 
of the reaction: α-amino acids performed better than β-amino acids, suggesting that a 5-membered 
palladacycle was more favourable, and the presence of the quaternary carbon centre in 2-
methylalanine was beneficial due to the smaller bit angle helping to form the 5-membered 
palladacycle 22. This transformation could be applied to a wide range of benzaldehydes 19 and was 





Scheme 10. The use of aldehydes as a transient directing group 
The use of unprotected phenol as a directing group has recently been reported by Zhu.40 In this 
reaction phenols 24 undergo highly selective ortho-alkenylation in good yields under mild reaction 
conditions (Scheme 11). It was found that Pd(acac)2 was the most effective catalyst for the reaction 
and K2S2O8 the best oxidant. Addition of a AgOAc additive gave a large increase in yield, and swapping 
from to DMSO to AcOH as the solvent gave a yield of 95% with no by-products for the parent system. 
The reaction had a broad substrate scope including unprotected tyrosine and its derivatives, and the 
drug molecules estrone (26), estradiol and ethinylestradiol. This demonstrated that the 
transformation was suitable for late-stage modifications of complex, biologically active, phenol-
containing compounds and could be used for a tool for diversity-oriented drug discovery.41 
 
Scheme 11. ortho-Alkenylation of phenols 
1.2.2.2 Nitrogen-based directing groups 
Nitrogen-based directing groups represent the largest class of directing groups. Nitrogen possesses 
multiple binding modes and can bind up to 3 substituents, allowing its Lewis basicity to be fine-tuned. 
Nitrogen directing groups are also stable, easily accessible and easily removed.  
There are a plethora of examples of amide-directed Pd(II)-catalysed functionalisation reactions 




amide-directed C–H functionalisation reaction is the Pd(II)-catalysed alkynylation of phenylacetic acid 
derivatives 27 by Chen (Scheme 12).47 Here a polyfluoroaniline auxiliary was used, which greatly 
increased the acidity of the N–H bond as a result of the strongly electron-withdrawing nature of 
fluorine. This was beneficial to N-coordination and allowed the Pd(II) catalyst to be delivered to the 
desired site of C–H activation. The efficiency of this reaction was increased by the addition of pyridine 
ligands. Investigation into the substitution pattern of the methyl groups on the pyridine showed 2,5-
dimethyl pyridine to be the best ligand, allowing the Pd loading to be reduced to just 1 mol%. This 
transformation had a broad substrate scope and proved easy to scale up. 
 
Scheme 12. Amide-directed alkynylation of phenylacetic acid derivatives 
As well as standard amides, N-alkoxy amides have also been shown to act as versatile directing 
groups.48 In 2008, Yu reported the use of N-alkoxyl amides as directing groups in the cross-coupling of 
sp3 C–H bonds with both sp2 and sp3 boronic acids (Scheme 13).49 In initial studies, cross-coupling with 
alkylboronic acids 31 did not result in the formation of desired product 32. It was thought that this 
was due to an undesired β-hydride elimination pathway which would be supressed by the addition of 
sterically hindered ligands. In fact, the addition of such ligands prevented C–H activation. However, 
the use of 2,2,5,5-tetramethyltetrahydrofuran as the solvent did allow the transformation using 
alkylboronic acids to occur. It was also found that, instead of the AgO used in preliminary studies, 
oxygen could be used as the oxidant as an inexpensive and environmentally friendly alternative.   
 
Scheme 13. N-Alkoxy amide-directed sp2-sp3 and sp3-sp3 cross-coupling 
The use of amines as directing groups is challenging as their strong σ-donating ability and their excess 
relative to the transition metal catalyst mean they occupy the vacant coordination sites on the metal 
centre which are vital for C–H activation to occur. Amines also increase the electron density on the 




alkenylation of substrates such as 33 with acrylates 34 (Scheme 14).50 AcOH was used to tune the 
concentration of free amines by an acid/base balance and to assist the dissociation of anionic ligands 
from the catalytic centre. The best solvent system for this transformation was 2,2,2-trifluoroethanol 
and AcOH, but the quantity of acid had to be carefully controlled. Both a decrease and increase in 
AcOH concentration from the range of 16-32 equiv. (relative to tertiary amine) lead to a decrease in 
the reaction yield, likely due to changing the concentration of tertiary amines and the electrophilicity 
of the metal centre. Use of the stronger acid TFA shut down the reaction completely, possibly due to 
the strong acid completely protonating the tertiary amine directing group and preventing binding to 
the metal.  
 
Scheme 14. Amine-directed ortho-alkenylation 
Bidentate directing groups are also an important class of directing groups, with the N,N-bidentate 
group 8-aminoqunoline (AQ) being by far the most common bidentate auxiliary used in directed C–H 
activation. Since the first examples by Daugulis in 200551 there have been numerous examples in the 
literature.52-53 One example is the ortho-C−H alkylation of N-quinolyl benzamides 36 by Chen (Scheme 
15).54 The key challenge for this transformation was to selectively form the monoalkylated product 38 
without formation of the dialkylated derivative 39. It was hoped that a second ortho-C–H alkylation 
would be sterically disfavoured relative to the first, however this disparity proved too small to allow 
for the selective formation of only 38. It was found that the amount of NaHCO3 was the crucial variable 
for achieving selectivity. The use of 1.5 equiv. of NaHCO3 gave 38 in a yield of 81% with only 9% 39. 
The use of a phosphate additive was also necessary to obtain a high yield. Interestingly, it was found 
that increasing the amount of NaHCO3 to 3.5 equiv. and increasing the reaction time gave 39 in a yield 
of 82%. The scope of the reaction was examined, with a range of primary iodides forming the 
corresponding monoalkylated products 38 in good yield under the standard conditions. 
Reoptimisation of the reaction conditions allowed the coupling of secondary iodides. Mechanistic 
studies suggested that the functionalisation of the Pd(II) palladacycle with secondary iodides 





Scheme 15. AQ-directed mono- and dialkylation 
There are also examples of N-acyl sulfonamides as ortho-directing groups for Pd(II)-catalysed 
transformations. Fabis and coworkers demonstrated the N-acyl sulfonamide-directed arylation of 
arenes 40 with aryl iodides 17 as an example of a new entry into biarylcarboxamides 41 (Scheme 16).55 
The reaction was carried out using a Pd(OAc)2 catalyst and a AgOAc additive in an acidic medium. The 
scope of the reaction was investigated, and it was found that both electron-donating and -withdrawing 
substituents were well tolerated at the ortho- and meta-positions, but para-substitution lead to 
formation of the diarylated product, reducing the yield of the desired monoarylated product. The 
versatility of the directing group as a handle for further derivatisation was demonstrated, with 
examples including removal of the sulfonamide, basic hydrolysis of the sulfonamide, and 
intramolecular amination.  
 
Scheme 16. N-Acyl sulfonamide-directed ortho-arylation  
Further examples of N-acyl sulfonamides as directing groups include the use of N-tosylamide as a 
directing group for Pd(II)-catalysed arylation,55 alkoxylation and halogenation.56  
1.2.2.3 Remote C–H activation  
Despite the success and broad utility of ortho-directing groups, the activation of remote C–H bonds is 
also a key goal within C–H activation. The Yu group have developed an approach in which a nitrile-
containing template is able to deliver the Pd(II) catalyst to a meta-C–H bond (Scheme 17).57 This 
facilitates meta-olefination of arene C–H bonds with excellent selectivity. The nitrile group 
coordinates to the Pd(II) in an ‘end-on’ fashion and allows the formation of a macrocyclic cyclophane 




and electronic effects. This strategy has been shown to be effective for two distinct classes of 
substrate: toluene and hydrocinnamic acid derivatives.  
 
Scheme 17. Nitrile-based template-directed meta-olefination 
While the template approach by Yu has been a success, the use of a weakly coordinating nitrile group 
does have limitations: competing coordination of solvents or other functional groups. This has been 
overcome in a more recent example by the Yu group, which employs a more strongly σ-coordinating 
pyridine group to direct C–H activation (Scheme 18).58 The template is attached by an easily removable 
ester linker. This pyridine-based template was successfully used for meta-olefination of 45 to give 46 
and the reaction was tolerant to a wide range of functional groups. Another advantage to this 
template was the ability to direct meta-iodination, using 1,3-diiodo-5,5-dimethylhydantoin (DIH) as 
the iodine source, yielding meta-iodinated products 47. meta-Iodination was a reaction that was 
unsuccessful with the previous nitrile-based template.  
 
Scheme 18. Pyridyl-based template-directed meta-olefination 
Despite being a greater challenge due to the difficulties associated with forming large cyclophane-like 
metallocycles, and the need for optimum chain length in order to deliver the catalyst to the correct 
position, the activation of para-arene C–H bonds can also be realised. Once again, this can be achieved 
using a template-based strategy using a nitrile coordinating group. This has been demonstrated by 
Maiti, who used a silyl biphenyl template to achieve para-functionalisation of phenol derivatives 48 
(Scheme 19).59 The para-selectivity was achieved by the end-on coordination of a nitrile group to the 
Pd catalyst and the formation of a cyclophane 17-membered transition state. Both electron-




withdrawing groups meta-to the hydroxy group which would usually strongly deactivate the para-
position. This ability to override electronic effects illustrates the crucial role of the template. Bulky 
substituents on the phenol derivatives and a range of olefins were also tolerated. The template was 
easily removed following functionalisation using TsOH or TBAF. 
 
Scheme 19. Nitrile-based template-directed para-olefination 
1.3 The Fujiwara–Moritani reaction 
The Fujiwara–Moritani, or oxidative-Heck, reaction involves the coupling of arenes with alkenes 
through Pd(II)-assisted cleavage of a C–H bond. It is analogous to the Heck reaction and is an early 
example of a transition metal catalysed C–H activation reaction. The reaction begins with C–H 
activation of an aryl C–H bond. The alkene coupling partner can then coordinate to the Pd(II) centre, 
before undergoing migratory insertion into the C–Pd(II) bond. The product is formed by a syn-selective 
β-hydride elimination. The resulting Pd(II) species undergoes reductive elimination, forming a Pd(0) 
species, which is re-oxidised to regenerate the active Pd(II) catalyst (Scheme 20). 
 
Scheme 20. The Fujiwara–Moritani reaction mechanism 
The first examples of the Fujiwara–Moritani reaction were reported by Fujiwara and in the late 




stoichiometric amounts of Pd in the presence of acetic acid (Scheme 21A). Later developments 
allowed the reaction to be carried out catalytically using high pressure O2 and Cu(OAc)2 as an oxidant 
(Scheme 21B).62 
 
Scheme 21. Early examples of the Fujiwara–Moritani reaction 
However, these early examples of the Fujiwara-Moritani reaction required harsh conditions including 
high pressures of O2 as an oxidant and high temperatures. In 2003, Ishii reported an example of the 
Fujiwara-Moritani reaction using much milder conditions (Scheme 22).63 They showed that arenes 50 
can be directly coupled to acrylates 34 in the presence of a Pd(II) catalyst using an atmospheric 
pressure of O2 as the terminal oxidant at temperatures less than 100 °C. For atmospheric O2 to be used 
as the oxidant it had to be used in combination with molybdovanadophosphoric acid (HPMoV). It was 
found that the outcome of the reaction was heavily dependent on the Mo and V content. It was also 
found that the use of acetylacetone, either as an additive of in the form of Pd(acac)2, was beneficial.  
 
Scheme 22. Fujuwara-Moritani reaction under mild conditions 
 A later example by Lipshutz demonstrated even milder conditions, where the alkenylation of 
acetanilide substrates 54 with acrylates 34 could occur in water at ambient temperature without the 
need for external acid (Scheme 23).64 Usually the presence of acid accelerates cross-coupling reactions 
as it increases the electrophilicity of the Pd centre, however in this example the use of the dicationic 
Pd catalyst [Pd(MeCN)4][BF4]2 negates this need for acid. The ortho-alkenylation of acetanilides using 
this catalyst was carried out using BQ as the oxidant and AgNO3 as an additive in water with the 




acrylates with varying chain lengths undergoing the transformation in good yields. However, para-
substituted derivatives proved unreactive.  
 
Scheme 23. [Pd]2+-catalysed acid-free Fujiwara-Moritani reaction in water 
Examples of the Fujiwara-Moritani are largely restricted to electronically activated olefins such as 
acrylates and styrenes.62-64 In 2014 Maiti reported the ortho-alkenylation of phenylacetic acid 
derivatives 59 using unactivated aliphatic olefins 60 (Scheme 24).65 This was achieved using the 
bidentate directing group AQ. It was thought that the rigid coordination and resulting 6-membered 
palladacycle helped incorporate unactivated olefins. Initial experiments resulted in the formation of a 
mixture of linear and branched products. In order to reduce the amount of the undesired branched 
product being formed a racemic BINAP ligand was added to saturate the coordination sites on the Pd 
centre. Once the linear product could be obtained selectively the scope of the reaction was analysed, 
with a wide range of olefins, functionalised olefins and substituted phenylacetic acids tolerated.   
 




The scope of the Fujiwara-Moritani reaction is not limited to phenyl derivatives. A recent example by 
Emery showcases the alkenylation of quinoxaline N-oxides 62 with styrene derivatives 51 (Scheme 
25).66 Quinoxaline is a privileged heterocyclic motif that is present in a number of biologically active 
compounds.67 Quinoxaline N-oxides possess increased C–H acidity at the α-position, which gives it 
excellent reactivity and selectivity for Pd(II)-catalysed cross-coupling reactions. The key variable for 
this reaction was the ligand and it was found that the use of the bidentate ligands 1,10-phenanthroline 
(phen) and BBBPY resulted in decreased yields compared to pyridine ligands. The most effective 
ligands proved to be MPAA’s, with Fmoc-Val-OH giving the best result. It is thought that the MPAA 
forms a complex with Pd(II), coordinating both the N–H and COOH. The Pd(II) then coordinates to the 
oxygen of the N-oxide and can undergo reversible ligand exchange. Following CMD, a stable complex 
67 is formed due to hydrogen bonding between the anionic oxygen and the acetate ligand. The 
mechanism continues in an analogous fashion to the general Fujiwara-Moritani mechanism (cf. 
Scheme 20, page 23).  
 
Scheme 25. Fujiwara-Moritani reaction of quinoxaline N-oxide 
1.4 The aza-Wacker reaction  
Pd(II)-catalysed oxidative coupling of alkenes with oxygen nucleophiles, such as water, have been 
known for over half a century.68 An extension of these Wacker-type reactions is the aza-Wacker 
reaction, in which the oxygen nucleophile is replaced with a nitrogen nucleophile.69 This is a powerful 




The reaction begins with aminopalladation of the alkene. The alkylpalladium(II) intermediate then 
undergoes β-hydride elimination to form either an enamine or an allylic amine (Scheme 26). Due to 
the oxidative nature of this process a stoichiometric amount of oxidant is needed.  
 
Scheme 26. Aza-Wacker reaction mechanism 
The aza-Wacker reaction was pioneered by Hegedus.70-73 In 1976, Hegedus demonstrated the 
cyclisation of ortho-allyl anilines 68 to 2-methyl indoles 69 using a stoichiometric amount of 
PdCl2(MeCN)2 and Et3N in THF (Scheme 27A).70 While this reaction proceeded in good yields under 
mild conditions and tolerated a range of functional groups, the use of stoichiometric Pd was 
unfavourable. This was later overcome by the addition of 1 equiv. of BQ, allowing the generated Pd(0) 
species to be re-oxidised to Pd(II), so catalytic amounts of Pd could be used (Scheme 27B).71  
 
Scheme 27. Early examples of the aza-Wacker reaction 
This methodology was also extended to aliphatic nucleophiles 70 (Scheme 27C).73 In this case the 
increased basicity and nucleophilicity of the NH2 group prevented the desired cyclisation from 
occurring and it was therefore necessary for an N-protecting group to be employed. p-




synthetic intermediates. This use of a protecting group allowed the cyclisation to be carried out in 
good yields under catalytic conditions.  
Since their discovery, aza-Wacker-type cyclisations have been utilised in the formation of a wide range 
of nitrogen-containing heterocycles including pyrroles,73 dihydroindoles and dihydroquinolines,74 and 
imidazolidinones.75 A switchable regioselective aza-Wacker cyclisation was developed by Zhang in 
which isoindolinones 73 or isoquinolin-1(2H)-ones 74 could be made from the same starting 
substrates 72 simply by changing the catalytic system (Scheme 28).76 Initial studies focused on the 
formation of isoindolinones. When Pd(OAc)2 with a pyridine ligand in toluene was used a 68% yield of 
73 was obtained. The bidentate ligand phen was then employed to see if this could increase the yield, 
but the Pd-complexes generated were insoluble in toluene and the yield decreased. Switching the 
solvent to MeOH overcame this, resulting in a yield of 85%. Interestingly, in the absence of ligand it 
was found that the corresponding isoquinolin-1(2H)-one 74 was formed instead of the isoindolinone 
73. The conditions for this transformation were optimised by adding a CuCl2 cocatalyst and a catalytic 
amount of triethylamine. Following a number of ligand studies it was concluded that the key to 
regiocontrol was the steric hinderance of the ligands.  
 
Scheme 28. Synthesis of isoindolinones and isoquinolin-1(2H)-ones by the aza-Wacker reaction 
Interest has also turned to the addition of chiral ligands to achieve enantioselective aza-Wacker 
reactions. Zhang employed chiral quinolineoxazoline ligands (Scheme 29, L2) in the aza-Wacker-type 
cyclisation of olefinic tosylamides 75 to afford chiral nitrogen-containing heterocycles 76 in good yield 
with ee’s of up to 74%.77 Another example, also by Zhang, allowed the formation of isoindolines 78, 
which contain a quaternary carbon stereocentre adjacent to the nitrogen. This was achieved by using 





Scheme 29. Enantioselective aza-Wacker reactions using chiral ligands 
All examples discussed so far have been intramolecular, however intermolecular aza-Wacker 
transformations are also possible. The reaction of N-alkylsulfonamides 79 with electron-deficient 
olefins 80 has been reported by Wang (Scheme 30).79 This reaction was carried out under mild 
conditions using a green solvent and gave high levels of (E)-selectivity. It was found that a 
stoichiometric amount of methanesulfonic acid was required for the reaction to succeed. When lower 
quantities of methanesulfonic acid were used longer reaction times were required and lower yields 
were obtained. It was proposed that the reaction proceeds via a Pd(II)/Pd(0) catalytic pathway with 
Selectfluor® acting as a strong oxidant. The electronics of the sulfonyl group proved to have a 
significant effect on the outcome of the reaction, with substrates bearing strongly electron-
withdrawing sulfonyl groups yielding no product. Investigations into the effect of the olefin also gave 
varied results with acrylates being well tolerated but alkenes such as styrene, acrylonitrile and BQ 
yielding no product. 
 
Scheme 30. Intermolecular aza-Wacker reaction 
A recent example by Zhu describes the desymmetrising aza-Wacker reaction of prochiral 3,3-
disubstituted cyclohexa-1,4-dienes 82 to form enantioenriched tetrahydroindoles 83 (Scheme 31).80 
The key to this reaction was the use of a Pd catalyst bearing chiral phosphinic acid (CPA) ligands in 
combination with a chiral pyrox ligand, L4. The enantioselectivity was determined by the pyrox ligand 
and the matched CPA increased both the yield and the ee. The utility of this transformation was 





Scheme 31. Desymmetrising aza-Wacker cyclisation 
1.5 C–H Activation of indoles 
Indoles can be found in a wide range of products, across a diverse set of industries. Crucially, indole is 
seen as a privileged structure in medicinal chemistry due to its ubiquitous presence in both drug 
molecules and natural products (Figure 1).81 Because of this, indole is of key interest in the design of 
new, synthetic molecules that possess biological activity. Consequently, the development of 
methodologies for the synthesis of functionalised indoles is crucial. There are three main routes 
towards the synthesis of functionalised indoles: de novo construction of the indole ring itself by 
reactions such as the Fischer82 or Larock83 indole synthesis, halogenation of the indole followed by 
Pd(0)-catalysed cross-coupling, or direct Pd(II)-catalysed C–H activation. The latter is by far the most 
attractive route due to its step and atom economy. 
 
Figure 1. Important indole-containing molecules 
1.5.1 Intermolecular C–H activation of indoles 
1.5.1.1  C3-Functionalisation of indoles 
The nucleophilic nature of indole at the C3 position means that electrophilic palladation usually occurs 
preferentially at this position in the absence of a directing group. To understand this C3 vs C2 
selectivity the mechanism of electrophilic attack at each position must be examined. Electrophilic 




does not. This means that electrophilic attack at the C3 position is much more thermodynamically 
favourable and C–H activation therefore occurs naturally at C3.  
 
Scheme 32. Nucleophilic reactivity of indoles 
An example of the alkenylation of indoles at the C3 position was reported by Wang in 2012 (Scheme 
33).84 The reaction proceeded with complete regio- and stereoselectivity with only O2 as an oxidant, 
avoiding the generation of reduced oxidant waste. It was found that increasing the electrophilicity of 
the Pd(OAc)2 catalyst by the addition of TFA improved the yield of the reaction. DMSO was the most 
effective solvent, and a temperature of 60 °C was found to be optimal as higher temperatures led to 
the decomposition of both the starting material and product. This transformation tolerated a large 
range of alkenes 85, including mono- and disubstituted activated and unactivated olefins. Substitution 
on the indole ring with both electron-donating and -withdrawing groups was also well tolerated, with 
even the N-unprotected indole forming the desired product. 
 
Scheme 33. C3-Alkenylation of indoles 
Li has demonstrated the use of air stable Pd-phosphinous acid complexes as effective catalysts for 
transition-metal catalysed cross-coupling reactions.85 This work was extended by He with the 
application of these catalysts to the C3-arylation of indoles 87 with aryl bromides 88 (Scheme 34).86 
The best Pd complex for this transformation was found to be Pd[(tBu)2P(OH)2]Cl2 (POPd). A base screen 
revealed weak bases such as K2CO3 to be the most effective. The biggest advantage of this reaction 
was that N-unprotected indoles were used, avoiding the need for N-protection and deprotection. The 
scope of this reaction was limited, with both electron-withdrawing and -donating groups on the 
bromobenzene coupling partner significantly decreasing the yield. Cyano- and nitro groups on the 5-





Scheme 34. C3-Arylation of indoles 
The Pd(II)-catalysed C3-acylation of indoles has also been realised (Scheme 35).87 Initial studies 
focused on the acylation of phenyl boronic acid using nitriles, however it was hypothesised that the 
cationic intermediate may also be trapped with nucleophilic indoles 87 to yield 3-acylated indoles 91. 
Indeed, using Pd(OAc)2, L5, and K2CO3 in dioxane at 70 °C the desired product 91a was formed in a 
yield of 70%. The reaction was successfully applied to a broad range of substrates. This represented a 
versatile, regioselective and non-hazardous (relative to standard acylating reagents) C3-acylation of 
N-unprotected indoles using nitriles.  
 
Scheme 35. C3-Acylation of indoles 
1.5.1.2 C2-Functionalisation of indoles 
In recent years much work has been done on fine-tuning reaction conditions to selectively access the 




coordinates weakly to the Pd-centre and directs metalation to the adjacent position (Figure 2). 
Effective directing groups for the C2 functionalistion of indoles include N-(2-pyridyl)sulfonyl,88-89 N-(2-
pyridyl)methyl,90 and N-2-aminophenyl.91 
 
Figure 2. Directing group strategy for the C2-functionalisation of indole 
The directed Pd(II)-catalysed C2-alkenylation of indoles was exemplified by Capito.90 It was 
demonstrated that when the indole nitrogen bore a benzyl-substituent the sole product was the 3-
alkenylated indole 97. The regioselectivity could be switched to the 2-position using a 2-pyridyl methyl 
substituent, giving the 2-alkenylated indole 98. This selectivity arises because with the N-(2-
pyridyl)methyl group present electrophilic attack of the Pd catalyst can occur reversibly at both the C3 
and C2 positions, but attack at C2 results in the formation of a palladacycle due to ligation of the Pd 
to the directing group. This ligation increases the lifetime of the Pd-C intermediate causing subsequent 
reactivity to occur at this site.  Lability of the cyclopalladated intermediate proved to be crucial as a 
catalytic turnover was only observed when the intermediate could not be isolated.  
 
Scheme 36. N-substituent controlled C3 vs C2 selectivity for the alkenylation of indoles 
An alternative approach to the C2 functionalisation of indoles is the direct 2-alkylation of free N–H 
indoles 87 reported by Bach in 2010 (Scheme 37).92 This was achieved via a norbornene-mediated 
cascade C–H activation process inspired by the norbornene-mediated alkylation of aryl halides 
reported by Lautens.93 During reaction optimisation it was found that while the use of Cs2CO3 as a base 
gave the N-alkylated product, the use of K2CO3 resulted in the formation of the desired C2-alkylated 
product 100. A screen of solvents revealed DMA to be the most effective, however a comparison of 
reagent grade DMA to freshly distilled DMA revealed that the reagent grade gave better yields. This 
led to studies to probe the effect of water, and it was found that the presence of a small amount of 
water accelerated the reaction. The scope of the reaction was assessed with a range of alkyl bromides 




occurs preferentially at the C3 position to give 101. Norbornene then undergoes insertion into the Pd-
indole bond which then allows a second C–H activation of the indole to occur at the 2-position, forming 
the indole-fused palladacycle 102. Oxidative addition of the alkyl halide then occurs, forming Pd(IV) 
species 103. This is followed by reductive elimination, norbornene expulsion, and proto-depalladation, 
generating the desired 2-alkylated indole species 100a.  
 
Scheme 37. Norborne-mediated direct C2-alkylation of indole 
Work by Gaunt has shown that regioselective alkenylation of free N–H indoles 87 can be achieved by 
solvent-switching (Scheme 38).94 It was found that the use of polar solvents resulted exclusively in C3-
alkenylated indoles 106. However, the use of AcOH as a co-solvent with dioxane lead to a complete 
reversal in selectivity, allowing the C2-alkenylated product 107 to be formed. Both reactions occur via 
intermediate 108. For C3-alkenylation, rearomatisation occurs followed by a Heck-type reaction. 
Under these neutral conditions the acetate formed from the attack of indole on Pd(OAc)2 is able to 
remove the C3 proton, allowing rearomatisation to occur. However, under acidic conditions, as in the 
C2-alkenylation reaction, this deprotonation is much slower. This enables migration of the C3–Pd bond 
to the more activated C2 position prior to rearomatisation. This is again followed by a Heck-type 






Scheme 38. Solvent-controlled C3 vs C2 alkenylation of indoles 
1.5.2 Intramolecular C–H activation of indoles 
The first reported example of intramolecular C–H activation of indoles was by Trost in 1978.95 He used 
stoichiometric amounts of PdCl2(MeCN)2 and AgBF4 to activate the C2 position of indole 112, followed 
by a NaBH4 workup. This was used as the key step in the total synthesis of the alkaloid natural product 
ibogamine (Scheme 39). Since then a vast number of examples of intramolecular C–H activation of 
indoles have been reported in the literature.96-100 
 
Scheme 39. Trosts’s synthesis of ibogamine by the intramolecular alkenylation of indole 
A more recent example is that by Ferriera, in which the intramolecular annulation of alkenyl indoles 
113 resulted in the formation of carbocyclic 5-membered ring-fused indoles 114 (Scheme 40).97 A 
correlation between the electronic properties of the pyridine ligands and their ability to facilitate 
cyclisation was observed. It was assumed that electron-poor ligands resulted in a more electrophilic 




ligate to the Pd-catalyst. A compromise between these factors was achieved by using ethyl nicotinate. 
It was also found that more polar solvents were more effective, most likely due to their ability to 
stabilise any charged intermediates. AcOH was also found to be a necessary additive. With these 
conditions in hand a range of substrates were cyclised, with substitutions on both the nitrogen and on 
the tethered alkene tolerated. 
 
Scheme 40. Intramolecular C–H activation of indoles  
Macrocyclisation is traditionally achieved using ring closing olefin metathesis,101 amide coupling102 or 
copper-catalysed azide alkyne ‘click’ reactions.103 The intramolecular Pd(II)-catalysed arylation of 
indoles has been shown to be an additional tool for macrocyclisation.98 This was achieved by the cross-
coupling of tryptophan and phenylanaline derivatives 115 to yield products such as 116. The reaction 
was carried out using a Pd(OAc)2 catalyst with a silver(I) additive. An acid additive was found to be 
beneficial to the reaction, and ortho-NO2C6H4COOH was found to be the most effective compared to 
the weak acids PivOH and para-NO2C6H4COOH. The best solvent was DMA, and under these conditions 
a 90% yield by UV absorption from LC/MS was observed. This Pd(II)-catalysed macrocyclisation was 
applied to a range of substrates to form 15- to 25-membered peptidic rings. Both meta- and para-
iodo-substituted phenylalanine derivatives were tolerated, but no macrocyclisation occurred using 
ortho-iodophenylalanine, likely due to the increased steric hinderance. 
 
Scheme 41. Intramolecular arylation of indoles for macrocyclisation 
Intramolecular Pd(II)-catalysed C–H activation has also been used as they key step in the synthesis of 




antimitotics (Scheme 42).99 Colchicine is a tubulin polymerisation inhibitor used in the treatment of 
acute gout and familial Mediterranean fever. It also has potential as an anticancer agent, but this is 
limited due to its high toxicity. The generation of analogues is therefore a key area of interest. A 
number of tubulin polymerisation inhibitors have been reported that contain indole as the key 
pharmacophore.104 Such structures may be accessed by the intramolecular Pd(II)-catalysed arylation 
of specific indolyl ketones 117. Importantly this cross-coupling reaction gives rise to the seven-
membered ring seen in colchicine.  
 
Scheme 42. Intramolecular arylation of indoles for drug design 
A recent example of intramolecular Pd(II)-catalysed C–H activation of indoles is the synthesis of 
tetrahydroindolones and tetrahydrocarbazolones 120 (Scheme 43).100 With Pd(OAc)2 selected as the 
best catalyst, a variety of bases were trialled. Organic and strong inorganic bases were detrimental to 
the reaction yield, so the weak inorganic base Cs2CO3 was chosen. Using a catalyst loading of 5 mol% 
the reaction did not go to completion, however increasing the loading led to unproductive side 
reactions. The addition of PPh3 overcame this issue, increasing the yield when using a 5 mol% catalyst 
loading. These conditions proved to be general for both indole and pyrrole substrates, although a 
higher temperature was required for indole substrates. It was feared that an absence of the R2 
substituent would lead to the formation of an undesired furan derivative, but pleasingly the desired 
product was isolated in a 30% yield.  
 





1.6 C–H Activation of pyrroles 
Pyrrole is also a privileged heterocycle found in a number of drug molecules and natural products.105 
The synthesis of substituted pyrroles is therefore a key aim within medicinal chemistry. As with 
indoles, there are several key strategies towards the synthesis of substituted pyrroles: de novo 
synthesis of the pyrrole core via methods such as the Paal Knorr,106 Hantzsch107 and Van Leusen pyrrole 
synthesis,108 halogenation followed by Pd(0)-catalysed cross coupling, or direct C–H activation. The 
instability of halopyrroles means that the development of effective direct C–H activation reactions is 
vital. However, the transition metal catalysed functionalisation of pyrroles poses a bigger challenge 
than that of indoles, as pyrroles are much less stable under acidic and oxidative conditions. Despite 
this there are a plethora of examples reported in the literature.109-111  
 
Figure 3. Important pyrrole-containing molecules 
1.6.1.1 C2-Functionalisation of pyrroles 
In contrast with indoles, pyrroles are most reactive towards electrophiles at the 2- and 5- positions. 
Electrophilic attack can easily occur at any position, but reaction at the 2- or 5- positions is slightly 
more favourable. One justification for this can be understood by looking at the intermediates formed 
by electrophilic attack. When attack occurs at C2 the intermediate formed has a linear conjugated 
system whereas attack at C3 gives a ‘cross-conjugated’ system. The linear conjugated system is slightly 
more favourable, thus making the C2 position more reactive. 
 




It is known that N-alkyl and N-aryl pyrrole substrates are effective substrates for C–H activation.112 
However, the formation of products with a free N–H is desirable as it would allow for subsequent 
functionalisation at this position. This has been investigated by Doucet, who compared the reactivity 
of N–H pyrrole with N-tosyl pyrrole in C2-arylation reactions with aryl chlorides.113 The N-tosyl pyrrole 
is an attractive substrate as the tosyl can be easily removed following transition metal-catalysed 
functionalisation. Reaction optimisation studies revealed the N-tosyl substrate to give higher yields. A 
competition experiment was run, in which equal amounts of N–H and N-tosyl substrates were used. 
It was found that the N–H product was formed exclusively, demonstrating that the N–H substrate 
coordinates much faster than the N-tosyl. However, yields were low. It is likely that it is this 
coordination of the N–H that is poisoning the Pd-catalyst and hindering the reaction. Ultimately the 
N-tosyl substrate 121 was chosen to investigate the scope of the reaction, which was found to be 
general for a wide variety of aryl- and heteroaryl chlorides 122 (Scheme 45A). Following arylation, the 
tosyl group could then be removed easily by hydrolysis with NaOH in MeOH to give 124. 
 
Scheme 45. C2-Arylation of pyrrole  
The same group has also developed methodology for the Pd(II)-catalysed symmetric diarylation of 
pyrroles (Scheme 45B).109 For this transformation a PdCl(C3H5)dppb catalyst was chosen over Pd(OAc)2 
as it formed Pd black less rapidly under the reaction conditions, and therefore gave increased yields. 
A broad substrate scope was observed for the 2,5-diarylation of N-methylpyrrole using para-
substituted bromobenzenes, but meta-substituted aryl bromides were less tolerated. N-Phenylpyrrole 




electron-deficient 3,5-bis(trifluoromethyl)bromobenzene 125a was employed: a mixture of di-, tri- 
and tetra-substituted products was formed. When the amount of this aryl bromide was increased to 
4 equiv. the tetra-substituted product 128 was formed as the major product in a yield of 62%. This 
represented a novel strategy for the preparation of tetra-arylated pyrroles.  
The Pd(II)-catalysed C2 alkenylation of pyrroles has also been investigated. Work by Joo describes the 
importance of electronically tailoring the catalytic system to be specific for either electron-rich or 
electron-poor pyrrole substrates (Scheme 46).114  It was hypothesised that an electrophilic catalyst 
would be suitable for electron-rich pyrroles, whereas catalyst bearing basic ligands would be more 
suited to electron-poor pyrroles with acidic C–H bonds. Indeed, the alkenylation of N-methylpyrrole 
125a using Pd(OAc)2 and 4,5-diazafluoren-9-one (DAF) as a ligand in dioxane gave the alkenylated 
product 129 in a yield of 80%, but under the same conditions the electron-poor substrate 2-acetyl-1-
methylpyrrole 130 only resulted in a 19% yield of 131. In contrast, the use of a mono-protected amino 
acid (MPAA) instead of DAF and the addition of KOAc in DMF gave 131 in a yield of 85% but 129 in 
only 14%.  The addition of MPAA’s to the DAF system did not improve the yield of 129, highlighting 
the importance of electronic matching of the heterocycle and the catalytic system. Both systems 
tolerated a range of olefins, and the basic catalyst system was general for pyrroles bearing a range of 
electron-withdrawing groups. 
 
Scheme 46. C2-Alkenylation of pyrroles 
1.6.1.2 C3-Functionalisation of pyrroles 
Gaunt has reported reaction conditions under which either C2 or C3 alkenylation can be achieved 
simply by the selection of a sterically or electronically tuned N-pyrrole protecting group (Scheme 
47).110 Initial work focused on achieving this selectivity via the choice of solvent as had been achieved 
with indoles (cf. Scheme 38, page 35). However, the increased reactivity of pyrroles meant that 
reactions proceeded with low selectivity and were prone to over alkenylation and polymerisation. This 
reactivity was harnessed and allowed for alkenylation to be carried out under much milder conditions. 




alkenylation of N-benzylpyrrole was achieved, but with a disappointing 2:1 ratio of C2:C3. To enhance 
the natural reactivity of the pyrrole substrate an electron-withdrawing group was installed on the 
nitrogen to reduce reactivity and increase selectivity. Indeed, this allowed the selective alkenylation 
at the C2 position. In contrast, the use of a bulky TIPS group on the nitrogen gave selectively the C3-
alkenylation product. Later it was found that the tBuOOBz oxidant could be replaced with the more 
environmentally friendly O2 with little effect on the yield. 
 
Scheme 47. N-Substituent controlled C2 vs C3 alkenylation of pyrroles 
Stereoselective control during the C–H activation of pyrroles is a challenge due to the relatively small 
size of pyrrole resulting in weak steric interactions between it and the chiral catalyst and ligands. The 
Pd(II)-catalysed asymmetric C–H functionalisation of pyrroles using α-aryl-α-diazoacetates 136 has 
been reported (Scheme 48).111 This was achieved using the bipy-derived chiral ligand L6.  The effect of 
the structure of the pyrrole substrate on the enantioselectivity was investigated. It was found that 
increasing the steric bulk of the C2- and C5- substituents decreased the ee, as did switching the benzyl 
N-protecting group to 4-methoxyphenyl. Because of this, 1-benzyl-2,5-dimethyl-1H-pyrrole 135 was 
used as the substrate for all subsequent reactions, but the reaction was tolerant to a wide range of 
diazosubstrates.  
 
Scheme 48. Asymmetric C3 functionalisation of pyrroles 
1.7 C–H Activation of anilide derivatives 
Anilides are an important class of compounds as they serve as ubiquitous structural motifs in a wide 
range of natural products, pharmaceuticals, agrochemicals and dyes. The development of efficient 
routes towards functionalised anilide derivatives is therefore crucial and the C–H functionalisation of 
aromatic compounds is a key goal in industry.115 There are a plethora of Pd(II)-catalysed C–H activation 




substrates for transition metal catalysed C–H activation reactions as the amide moiety can serve as a 
directing group, allowing for selective ortho-functionalisation.  
 
Figure 4. Important anilide-containing molecules 
An early example of the Pd(II)-catalysed C–H functionalisation of anilides was reported by Van 
Leeuwen (Scheme 49).117 This reaction enabled the coupling of acetanilide 54 with butyl acrylate 138 
using cheap oxidants under mild conditions. Interestingly, the yields of 139 obtained were found to 
higher when the reaction was carried out at 20 °C compared with at 80 °C. It was also found that the 
addition of TsOH was beneficial, although use of more than 0.5 equiv. promoted undesired side 
reactions. The transformation displayed excellent ortho-selectivity, with no observation of meta- or 
para-substitution, nor any products derived from the activation of the amide N–H bond, 
demonstrating the importance of the amide directing group. A range of substituted acetanilides were 
tolerated although ortho-substitution was found to hamper the yields. When a methyl group was 
added to the amide nitrogen no product was formed under the standard reaction conditions. 
 
Scheme 49. Alkenylation of acetanilides 
As previously noted, the C–H functionalisation of ortho-substituted anilides proves more of a 
challenge due to steric effects. A serendipitous result from work by Youn resulted in the ortho-
alkenylation of ortho-phenyl-substituted acetanilides 140.118 This reactivity was as a result of the 
unique combination of the TFA:DCM (4:1) solvent system, the high concentration and the use of K2S2O8 
as the oxidant. Under these conditions a variety of 2-alkenyl-6-phenyl acetanilides 141 were formed. 
The only functionality not tolerated was strongly electron-withdrawing groups which required 
elevated heating and then reacted at the 2’ position. The reaction conditions were also suitable for 





Scheme 50. Alkenylation of ortho-substituted acetanilides 
A urea moiety has also been shown to be an effective directing group in the Pd(II)-catalysed ortho-
functionalisation of anilide-derivatives. Booker-Milburn and co-workers have reported the urea-
directed C–H activation of anilides as part of a C–H insertion/carbopalladation cyclisation sequence 
(Scheme 51).119 In this reaction the use of a diene results in the generation of a π-allyl intermediate 
which can then be trapped by the urea nitrogen to generate an indoline. The initial C–H insertion and 
oxidative Heck step is analogous to the reaction reported by Van Leeuwen117 which required acidic 
reaction conditions and a TsOH additive. It was possible the urea or diene may have been sensitive to 
these acidic conditions so in an attempt to improve initial yields the reaction was carried out in the 
absence of acid. Interestingly, the absence of AcOH had no significant effect on the yield but the 
absence of TsOH resulted in no reaction. This suggested that TsOH was vital for the reaction to occur 
and was likely forming an active Pd tosylate species in situ. Another observation was the detrimental 
effect of water, so Ac2O was added as a drying agent. The reaction conditions proved general for 
electron-deficient olefins and electron-donating phenyl substituents. ortho-Methyl substitution was 
not tolerated. It was thought that this was because it was preventing the urea from adopting the 
necessary conformation for Pd-complexation or C–H insertion.  
 
Scheme 51. Urea-directed C–H functionalisation of anilides for the generation of indolines 
The directing group ability of aniline carbamates is an area less explored. A recent publication 
describes the use of aniline carbamates as directing groups for the ortho-acylation of anilides 145 with 
α-oxocarboxylic acids 146 (Scheme 52).120 Pd(OAc)2 was employed as the catalyst and ammonium 
persulfate as the oxidant. Once again, the use of a TsOH additive was necessary for an efficient 
reaction. A broad substrate scope was observed with respect to both coupling partners. Ammonium 




probe the reaction mechanism. Indeed, it was discovered that a free radical process is involved in the 
reaction mechanism. It was proposed that the reaction begins with ortho-palladation, resulting in the 
formation of the 6-membered palladacycle 148. 148 then undergoes oxidative coupling with acyl 
radical 149 which is formed by decarboxylation of oxocarboxylic acid 146a in the presence of 
ammonium persulfate. 150 is then oxidised to Pd(IV) and the product 147a is then expelled by 
reductive elimination, which also regenerates the Pd(II) catalyst.   
 
Scheme 52. ortho-Acylation of aniline carbamates 
All examples described above contain an anilide N–H bond, which is true for the majority of examples 
found in the literature.121 However there are also examples of Pd(II)-catalysed ortho-functionalisation 
of tertiary anilides 152. An examples of this is the alkynylation reaction developed by Chatani (Scheme 
53).122  Silver salts were needed in order to increase the electrophilicity of the Pd species to allow it to 
react with the anilide substrates. The alkyne substituent 153 was found to have a significant effect on 
the outcome of the reaction. When the triisopropyl group was replaced with a TBS group the yield 
decreased by almost half, and groups such as phenyl, hexyl and ester groups shut down the reaction 
completely. The reaction conditions were general for anilides bearing both electron-donating and -





Scheme 53. ortho-Functionalisation of tertiary anilides 
1.8 Cascade reactions  
A cascade reaction is defined as a chemical process in which at least two reactions occur consecutively 
with each subsequent reaction occurring as a result of the functionality formed in the previous 
reaction. In such processes no intermediates are isolated and the reaction conditions do not change 
during the course of the reaction.123 This differs from one-pot reactions, which involve at least two 
consecutive chemical reactions but additional reagents may be added following each step. Cascade 
reactions are powerful tools which can be used to rapidly generate complex, often polycyclic, 
molecules from relatively simple starting materials. Other advantages include high atom economy, 
shorter synthesis times and the generation of much less waste. A number of Pd(II)-catalysed cascade 
reactions are discussed below, with examples chosen to demonstrate the complexity which can be 
achieved. The following examples focus on cascade reactions beginning with a Heck-type reaction, as 
this is what the work in this project involves. The development of Pd(II)-catalysed cascade 
methodology within the KBM group is also discussed. 
Work by Zhu exemplifies the advantages of using an N-acyl sulfonamide as a directing group in the 
tandem olefination/annulation reaction of N-tosylbenzamides 155 with olefins to form isoindolines 
156 or 157 (Scheme 54).124 This reaction was found to be compatible with both aliphatic and activated 
alkenes, with the product formed being dictated by the electronic properties of the alkene. Non-
conjugated alkenes undergo an aza-Wacker type ring annulation followed by β-hydride elimination to 
give 156, while electron-deficient alkenes participate in a Michael addition reaction to give 157. A 
number of alternative directing groups were trialled, but only substrates bearing an N-acyl 
sulfonamide group were able to form any product. It is the acidic nature of the N-acyl sulfonamide N–
H bond which allowed the reaction to occur and allowed the compatibility of a much wider range of 
alkenes than would normally be feasible. This acidity arises from the combined electron-withdrawing 
effect of the carbonyl and tosyl groups. The acidity of the N–H bond enables the formation of a Pd–N 
bond, which in turn promotes the formation of the intermediate palladacycle. The reaction was shown 




considered an eco-friendly transformation as it can be carried out using molecular oxygen or even air 
as the oxidant. 
 
Scheme 54. Tandem olefination/annulation of N-tosylbenzamides 
The utility of cascade reactions was later exploited in the synthesis of tetra-substituted helical alkenes 
160 (Scheme 55).125 The reaction mechanism is norbornene-mediated (cf. Scheme 37, page 34) and 
involves the formation of three new carbon-carbon bonds. Initial reactions gave a mixture of (E)- and 
(Z)-alkenes, likely due to acid-catalysed or light-induced isomerisation. In acid-free conditions in the 
absence of light the desired isomer was formed exclusively. The transformation was tolerant to a 
variety of ortho-substituents on the aryl iodide and substitution of the alkyne ring system. As well as 
the pyrrole used in the test substrate a number of other heterocycles could be used, including indole, 
furan and thiophene. When enantiomerically enriched substrates were employed complete retention 
of stereochemistry was observed, providing a route towards enantiomerically enriched helical 
alkenes.  
 
Scheme 55. Cascade sequence for the synthesis of tetra-substituted helical alkenes 
Another example that showcases the utility of cascade reactions in the formation of complex 
polycyclic molecules from relatively simple starting materials is that reported by Garcia-Lopez in 
2016.126 This reaction relies on the tapping of transient alkyl-Pd(II) species with arynes, and gives rise 




positions, allowing difunctionalisation, and it can be used to generate biaryl systems, a ubiquitous 
motif throughout functional material and medicinal chemistry. The best conditions for the reaction 
were found to be a Pd(OAc)2 catalyst with PPh3 as a ligand, CsF as a base and a 1:1 mixture of MeCN 
and toluene as the solvent. The scope of the reaction was investigated with respect to the tether, the 
presence of aryl substituents and the benzyne precursor and a range of interesting spirocyclic products 
in the form of 163 were generated. The reaction begins with an intramolecular Heck-type mechanism 
of the bromoaniline coupling partner to give 165. The pendant phenyl group the undergoes C–H 
activation with the generated alkyl Pd(II) species to form 166. Coordination followed by migratory 
insertion of the benzyne (generated in situ) to gives 168. The product 163a is formed by reductive 
elimination.    
 
Scheme 56. Cascade reaction for the synthesis of spirocyclic compounds 
The use of Pd(II)-catalysed C–H activation reactions as part of cascade sequences for the generation 
of complex polyheterocycles has long been a theme in the Booker-Milburn group.119, 127-130 In the 
reaction of N-alkoxybenzamide 169 with butyl acrylate, instead of the expected Fujiwara-Moritani 
product, the annulated ring system 170 was formed. Investigation into the oxidant system revealed 




effectively, suggesting that there are two Pd(II) turnovers per reaction. The scope of the reaction was 
assessed, and a variety of olefins 14 were tolerated, with electron-deficient olefins performing the 
best. A range of substituted N-alkoxybenzamides 169 were also tolerated, although in two cases the 
saturated products were formed, a result of a Michael addition rather than the desired Pd(II)-catalysed 
transformation. The reaction displayed complete (E)-selectivity, and complete regioselectivity in the 
case of meta-substituted N-alkoxybenzamides. ortho-Substitution and the use of alternative alkoxy 
groups were not tolerated. The first catalytic cycle for this transformation is a standard Fujiwara-
Moritani mechanism that forms intermediate 174. 174 then undergoes a second Pd(II)-catalysed 
transformation, an aza-Wacker reaction. Following coordination of the Pd(II) catalyst to the N-alkoxy 
directing group, aminopalladation occurs to give intermediate 176. The product is formed by β-
hydride elimination.  
 
Scheme 57. Fujiwara-Moritani/ aza-Wacker cascade sequence of N-alkoxybenzamides 
The Booker-Milburn group has also used the C–H activation of heterocycles as part of cascade 




π-allyl intermediate 179 which could then be trapped by a variety of internal heterocyclic nucleophiles 
to give complex polyheterocyclic products in the form of 180 (Scheme 58A).127 It was found that the 
use of bulky quinone oxidants was necessary in order to prevent conjugate addition of the heterocyclic 
nucleophile to benzoquinone. DMF as a solvent and high temperatures were also found to be crucial 
for a successful reaction. This methodology was extended further by switching the internal 
heterocyclic nucleophile to an internal heteroatomic nucleophile, N-acyl tosylamide, which resulted 
in the formation of products in the form of 183 (Scheme 58B).128 For this reaction Cu(OAc)2 was needed 
as the oxidant and dioxane was used as the solvent. Both reactions are thought to proceed via a similar 
mechanism: C–H activation at the C2 position of the heterocyclic core, migratory insertion of the diene 
to generate the π-allyl intermediate, then trapping by the internal nucleophile to generate structures 
such as 180 and 183.  
 





2. Results and discussion 
2.1 Aims 
As discussed above, the Booker-Milburn group has developed a number examples of Pd(II)-catalysed 
cascade sequences for the synthesis of complex polyheterocycles (cf. Scheme 58, page 49). In the work 
using indole substrates bearing an N-acyl tosylamide nucleophile an unexpected result was observed 
when the tethered diene was replaced by a tethered alkene.131 Without the second alkene of the diene 
a reactive π-allyl intermediate cannot be formed so it was thought that the reaction would stop after 
the oxidative-Heck step to give the oxidative-Heck product 188 (Scheme 59A). This would have been 
consistent with previous findings within the group.132 However, when 187 was exposed to the 
standard reaction conditions, 188 was not formed. Instead, the only product observed was the fully 
cyclised product 189 in a yield of 25% (Scheme 59B). 
 
Scheme 59. Expected and actual outcome of the cyclisation of alkene-tethered substrate 187 
It is thought that 189 was formed by an oxidative Heck reaction followed by an aza-Wacker reaction. 
The aza-Wacker reaction was able to occur due to the presence of the N–H bond of the N-acyl 
tosylamide and the exo alkene of the oxidative Heck product 188. 188 begins this second catalytic 
cycle by coordination of the alkene to the Pd(II) catalyst. The coordinated species 192 then undergoes 
aminopalladation to give 193, which then undergoes β-hydride elimination to give the fully cyclised 





Scheme 60. Proposed mechanism for the formation of 189 (ligands omitted for clarity) 
Initial optimisation studies carried out in the group saw the yield of this reaction increase from 25% 
to 49%.133 The aim of the project described in this thesis was to explore this reaction further with a 
view to applying it to a range of distinct substrates. Reaction optimisation, substrate scope for indole 
and pyrrole systems and mechanistic studies are discussed. Attempts at expanding the methodology 
further for natural product synthesis is then explored, along with the synthesis of additional novel 
polyheterocyclic structures. 
2.2 Reaction optimisation 
The initial aim of the project was to optimise the reaction in order to increase the moderate yield of 
49%. 
2.2.1 Initial optimisation studies 
The alkene-tethered indole substrate bearing an N-acyl tosylamide directing group could be easily 
synthesised in three steps from inexpensive, commercially available starting materials. Alkylation of 
indole 194 using NaH and 5-bromo-1-pentene in DMF gave the alkylated indole 195 in a yield of 85%. 
The methyl ester was then hydrolysed using NaOH in THF and MeOH to afford the free acid 196 in a 
yield of 92%. 196 was coupled with p-toluenesulfonamide in an amide coupling reaction using EDC.HCl 





Scheme 61. Synthesis of substrate 187 
The optimum reported conditions for the diene tethered substrate (cf. Scheme 58B, page 49) were 10 
mol% Pd(OAc)2, 2.5 equiv. Cu(OAc)2 and 1 equiv. K2CO3 in dioxane.128 These conditions gave a 25% 
yield of 189 when applied to the alkene tethered indole 187 (Scheme 59). However, following initial 
optimisation studies, it was found that changing the conditions to 10 mol% Pd(TFA)2, 2.5 equiv. 
Cu(OAc)2, and 2.5 equiv. K2CO3 increased the yield of 189 to 49%.133  
Throughout this work Quantitative 1H NMR analysis was carried out following filtration of the crude 
reaction mixture over celite (to remove any copper species) and evaporation of the dioxane. The crude 
material was dissolved in CDCl3 and a known amount of 1,4-dimethoxybenzene was added as an 
internal standard. 1H NMR yields were calculated by comparing peak integration to that of the internal 
standard.  
The previously optimised conditions were repeated, and gave a 1H NMR yield of 20%, and an isolated 
yield of 49% after purification by flash column chromatography. This disparity between the 1H NMR 
yield and the isolated yield was due to the insolubility of 189 in CDCl3. 189 was also found to be highly 
insoluble in all other common laboratory solvents, so it was also unclear whether the isolated yields 
were accurate, as undissolved material could have been lost during filtration or column 
chromatography. Therefore, to begin the reaction optimisation process, the use of alternative 
directing groups was explored. It was hoped that replacing the N-acyl tosylamide with a group with 
similar electronic properties would allow the reaction to proceed with a similar yield but would 
improve product solubility.  
The first directing group investigated was an N-benzoyl amide. To synthesise substrate 199, indole 
was initially alkylated using NaH and 5-bromo-1-pentene in DMF to give 198 in an excellent yield of 
95%. 198 was then reacted with benzoyl isocyanate to give the desired substrate 199 (Scheme 62). 
The reaction with benzoyl isocyanate proceeded in a poor yield of only 8%, however this generated 





Scheme 62. Synthesis of N-benzoyl amide substrate 199 
The cyclisation reaction was carried out on 199 using the previously optimised conditions (Scheme 
63). Unfortunately, no formation of the desired product 200 was observed. Only unreacted starting 
material was visible by TLC and 1H NMR of the crude material, and on purification by flash column 
chromatography 57% of the unreacted starting material was recovered. 
 
Scheme 63. Cyclisation of N-benzoyl amide substrate 199 
Another directing group investigated was an N-acyl mesylamide. This was a more promising directing 
group as it was expected to have more similar electronic properties to the N-acyl tosylamide. The N-
acyl mesylamide substrate 201 was synthesised in an analogous fashion to the N-acyl tosylamide 
substrate 187. The N-acyl mesylamide group was installed by an amide coupling reaction of acid 196 
with methanesulfonamide using CDI, DMAP and DBU, giving 201 in a yield of 82%. Substrate 201 was 
subjected to the previously optimised cyclisation conditions and the desired cyclisation product 202 
was obtained in a 52% isolated yield (59% yield by 1H NMR) (Scheme 64). As well as this result being a 
slight improvement on the yields obtained using the N-acyl tosylamide substrate, the product was also 
much more soluble in CHCl3. For these reasons an N-mesylamide directing group was used for all 
further studies. 
 
Scheme 64. Synthesis and cyclisation of N-mesylamide substrate 201 
In all cyclisation reactions carried out thus far, complete mass balanced had not been observed (a 59% 




material was unaccounted for). One explanation for this could be that the product was, as a result of 
containing nitrogen, acting like a ligand and coordinating to palladium. This would mean that on 
filtration through Celite® during the workup any palladium-coordinated product would be insoluble in 
organic solvent and would be lost on the Celite® pad. To investigate this, 4 equiv. of the cyclised 
product 202 were heated at 90 °C with 1 equiv. of the Pd(TFA)2 catalyst for 16 hours in dioxane 
(Scheme 65). After filtration through celite® and washing with DCM and CHCl3 all material was 
recovered. This demonstrated that the unaccounted material was not due to loss of material upon 
workup as a result of coordination of the product to palladium. 
 
Scheme 65. Coordination study of cyclised product 202 
Another hypothesis for the low yield was product inhibition. It was possible that cyclised product could 
be ligating to the palladium catalyst during the reaction which would supress the catalyst turnover. 
This effect would increase with the amount of product generated. This theory was investigated by 
adding 20 mol% of the cyclised product 202 at the start of the reaction (Scheme 66). After 16 hours, a 
72% 1H NMR yield of 202 was observed (20% from the product added at the beginning plus ~50% 
formed during the reaction). This suggests that no significant product inhibition is in operation. This 
also supports the previous findings that the product does not coordinate to the catalyst. 
 
Scheme 66. Product inhibition experiment 
At this point, no further improvement on the yield of the reaction had been achieved. For this reason, 
more information on the reaction mechanism was sought. The proposed mechanism of the reaction 
(Scheme 60, page 51) involves two catalytic cycles, each requiring one equivalent of oxidant to re-
oxidise the Pd(0) species to the active Pd(II) in order to allow the catalytic cycle to continue. A reaction 
was carried out using stoichiometric palladium in the absence of oxidant. It was hoped that this would 
give insight into the relative rates of reaction for each catalytic cycle. Using 1 equiv. of palladium it 




intermediate 204 would be observed, whereas if the second cycle was significantly faster 50% of the 
product 202 and 50% unreacted starting material 201 would be observed. It was envisaged that the 
ratio of these two products would shed light on the mechanism, thus allowing further optimisation to 
be more targeted (Scheme 67).  
 
Scheme 67. Expected outcome of the cyclisation of 201 using stoichiometric palladium 
Unfortunately, on carrying out this reaction neither the fully cyclised product, nor the oxidative Heck 
product was observed. Instead, a complex mixture was formed, as observed by TLC analysis (6 spots 
observed). Analysis of the crude reaction mixture by 1H NMR also showed a complex mixture of 
products. Flash column chromatography of the crude mixture lead to the isolation of trace amounts 
of the fully aromatised intermediate 205 and the fully aromatised demesylated intermediate 206 
(Scheme 68). No other products were isolated in yields appreciable enough to be characterised. It is 
thought that most material was lost via a Pd(0)-catalysed decomposition pathway. 
 
Scheme 68. Actual outcome of the cyclisation of 201 using stoichiometric palladium 
A brief solvent screen was then performed (Table 1). Solvents with boiling points with over 90 °C were 
screened to allow the reaction to still be heated to this temperature. The results showed that the only 
solvent to yield a significant amount of the product 202 was dioxane (Table 1, entry 1). When toluene 
was used (Table 1, entry 2), no product was observed by 1H NMR, nor any unreacted starting material 
or appreciable by-products. This suggests that all material polymerised or decomposed. Interestingly, 
when the more polar solvents DMSO and DMF were used (Table 1, entries 3 and 4) the unexpected 
by-product 207 was formed. This fully aromatised by-product suggests that the desired product was 
forming but continued to react further. A possible mechanism for this is Pd-insertion into an aliphatic 
C–H bond followed by β-hydride elimination. 207 was a particularly interesting by-product as it was 
bright yellow in colour, and a bright blue colour under UV. This suggests that it may have interesting 








201 202 207 
1 dioxane >5 59 0 
2 toluene 0 0 0 
3 DMSO 30 0 24 
4 DMF 20 16 20 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
2.2.2 Statistical approach: Design of Experiments (DoE) 
Traditionally, reaction optimisation is carried out in a ‘one variable at a time’ (OVAT) approach. This 
method has many drawbacks. The OVAT approach does not necessarily uncover the optimal 
conditions for a reaction as the outcome is highly dependent on the starting point. It also does not 
distinguish between any inherent run-to-run variations of a system and actual improvements unless a 
significant number of repeats of a reaction using identical reaction conditions are used. Design of 
Experiments (DoE) is a statistical approach to reaction optimisation, which allows the whole ‘reaction 
space’ of a system to be investigated by varying multiple factors simultaneously. A DoE approach 
overcomes the drawbacks faced by an OVAT approach as the whole chemical space is explored, so 
optimal conditions will not be missed unless they fall outside the space covered. DoE also eliminates 
any researcher bias. Another major advantage of a DoE approach is that much more information can 
be gained from a much smaller number of reactions run. For example, in a traditional OVAT approach 
if 3 variables were to be investigated at least 8 reactions would be required. In contrast, for a half-
factorial DoE only 4 experiments would need to be carried out. This efficiency allows a much larger 
number of parameters to be explored in a relatively small number of experiments.134-135 
A DoE was carried out, using the software MODDE, to provide an insight into which parameters most 
affected the yield of the desired product. Seven variables, with minimum and maximum values 
decided for quantitative variables, were chosen: temperature (80, 100 °C); concentration (0.025, 0.1 
M); catalyst (Pd(TFA)2, Pd(OAc)2, [Pd(η3-C3H5)Cl]2; catalyst loading (10, 20 mol%); oxidant (Cu(OAc)2, 
AgOAc); amount of oxidant (2, 4 equiv.); and amount of base (2, 4 equiv.). These variables were input 




point runs. These reactions were carried out and the 1H NMR yields obtained. The results were input 
into MODDE and a coefficient plot was generated to illustrate the findings of the DoE (Figure 5). Each 
purple bar represents a variable and shows the effect of increasing that variable on the yield. A bar 
with a positive value means the yield will increase with an increase of that variable. Similarly, a 
negative value means the yield will decrease with an increase of that variable. However, only variables 
for which the confidence intervals do not include zero can be considered statistically significant 
(confidence intervals of 95% shown). For qualitative variables (catalyst and oxidant), the values show 
the effect of that variable compared with the average for all experiments.  
 
Figure 5. DoE coefficient plot 
From the coefficient plot it could clearly be seen that the most significant factor was the catalyst used, 
with the use of [Pd(η3-C3H5)Cl]2 resulting in a significant decrease in yield compared with the average 
for all experiments. Both Pd(OAc)2 and Pd(TFA)2 give a significant increase in yield. The previously 
optimised conditions used Pd(TFA)2 as a catalyst, however these results showed that the use of 
Pd(OAc)2 results in a better yield.  
While no other factors could be considered statistically significant, due to their confidence intervals 
including zero, more information could be gained from the coefficient plot. Both an increase in 
temperature and an increase in catalyst loading both appeared to have a positive effect on the yield, 
while an increase in concentration and an increase in the amount of base appeared to have a negative 
effect. The oxidant used and the amount of oxidant had no significant impact on the yield, although 




A graph of the experimentally observed results against the results predicted by the computer model 
is shown below (Figure 6). A positive correlation can be seen which validates the accuracy of the 
model. 
 
Figure 6. Observed vs Predicted results from DoE 
The optimum conditions from the DoE were as follows: 20 mol% Pd(OAc)2, 4 equiv. AgOAc, and 2 
equiv. K2CO3 in dioxane (0.025 M) at 100 °C. The cyclisation of 201 was carried out under these 
conditions and pleasingly an 1H NMR yield of 75% and an isolated yield of 67% of the cyclised product 
202 were obtained (Scheme 69). This was a significant improvement on conditions used previously. 
However, limitations were evident; a high catalyst loading (20 mol%) and a large excess of costly 
AgOAc (4 equiv.) were required. A catalyst loading of 20 mol% was deemed too high, so was 
subsequently reduced to 10 mol%, and oxidant returned to 3 equiv. of Cu(OAc)2. This gave an 1H NMR 
yield of 60%. Therefore, although the DoE was a success, further optimisation was required. 
 
Scheme 69. Optimum conditions from the DoE for the cyclisation of 201 
From the DoE studies it was shown that an increase in temperature proved beneficial. This could be 




catalyst. The boiling point of dioxane (101 °C) limited the amount the temperature could be increased 
by, but the reaction was carried out at reflux to determine if this would result in any further 
improvement in yield (Scheme 70). Unfortunately, under these conditions a 1H NMR yield of only 11% 
was obtained. No starting material remained, and no other products were detected.  
 
Scheme 70. Cyclisation of 203 under reflux conditions 
2.2.3 Traditional reactant screening 
The only parameter not investigated thus far was the base, so a base screen was performed. A variety 
of inorganic and organic bases were chosen and were employed at 2 equiv. as this was found to be 
the optimum amount from the DoE. The results are displayed below (Table 2). NaOAc and tBuOK (Table 
2, entries 3 and 4) showed comparable yields to that when using K2CO3. However, no others showed 
any improvement, with the organic bases DBU and DIPEA (Table 2, entries 5 and 6) resulting in poor 
yields. Therefore, K2CO3 remained as the optimum choice of base and was used in all further 
cyclisation reactions. 
Table 2. Base screen for the cyclisation of 201 
 











3 NaOAc 55 
4 tBuOK 59 
5 DBU 5 
6 DIPEA 17 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
MPAA ligands have been used extensively by Yu et al. in C–H activation methodology.33, 136-138 Inspired 




71). At this point it was also decided to swap the AgOAc oxidant back to the cheaper and more 
environmentally friendly Cu(OAc)2 as this had no significant detrimental effect on the yield. Pleasingly, 
this addition of an MPAA ligand resulted in a 1H NMR yield of 202 of 72% and an isolated yield of 63%. 
This was close to the yields achieved by the DoE, but with a significantly lower catalyst loading, and a 
lower amount of the cheaper oxidant Cu(OAc)2. 
  
Scheme 71. Addition of Boc-Gly-OH ligand 
Following this success, the loading of Boc-Gly-OH was investigated (Table 3). It was found that both 
decreasing (Table 3, entries 1 and 2) and increasing the loading (Table 3, entry 4) from the original 20 
mol% resulted in a slight decrease in the yield of 202. Investigations were then carried out to identify 
the optimal amino acid backbone. A range of commercially available Boc-protected amino acids were 
examined (Table 3, entries 5-9). While all ligands performed well, there was no improvement seen on 
the 1H NMR yield of 202 achieved by Boc-Gly-OH. It could be argued that this is due to steric factors 
as the least bulky MPAA’s, such as glycine and alanine, (Table 3, entries 3 and 6) appeared to perform 
better than those with bulkier α-substituents such as valine (Table 3, entry 9). However, no firm 
conclusions can be drawn as the yields are all within 15% of each other, which are within the errors 









Yield of 202 (%)a 
(Isolated yield) 
1 Boc-Gly-OH 10 mol% 60 
2 Boc-Gly-OH 15 mol% 67 
3 Boc-Gly-OH 20 mol% 72 (63) 
4 Boc-Gly-OH 30 mol% 69 
5 Boc-Phe-OH 20 mol% 62 
6 Boc-Ala-OH 20 mol% 71 
7 Boc-Leu-OH 20 mol% 64 
8 Boc-Thr(bzl)-OH 20 mol% 65 
9 Boc-Val-OH 20 mol% 57 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
Following the identification of glycine as the optimal amino acid backbone, optimisation of the N-
protecting group was carried out (Table 4). An initial control reaction was carried out to assess 
whether an N-protecting group was required. In this reaction with a NH2-Gly-OH additive (Table 4, 
entry 2) a 1H NMR yield of 64% was observed. This revealed that N-protection was not necessary for 
the reaction to occur, but it did aid in increasing the yield. A range of N-protected glycine ligands were 
synthesised (Table 4, entries 3-8). Because Boc-protecting groups were found to be beneficial, other 
carbamate groups with different steric properties were trialled (Table 4, entries 3 and 4). However, no 
improvement was observed. Amide protecting groups were also investigated (Table 4, entries 5-8) and 
pleasingly several showed an improvement in yield, with the best being Ac-Gly-OH giving a 1 H NMR 
yield of 202 of 75% and an isolated yield of 69%. An N-tosyl protecting group was also trialled (Table 




Table 4. MPAA N-protecting group screen for the cyclisation of 201 
 
Entry MPAA 
Yield of 202 (%)a 
(Isolated yield) 
1 Boc-Gly-OH 72 (63) 
2 NH2-Gly-OH 64 
3 Cbz-Gly-OH 67 
4 EtO2C-Gly-OH 59 
5 Ac-Gly-OH 75 (69) 
6 Formyl-Gly-OH 63 
7 TFA-Gly-OH 70 
8 Piv-Gly-OH 66 (67) 
9 Ts-Gly-OH 55 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
A mono-N-protected β-amino acid ligand, Boc-β-Ala-OH, was also examined (Scheme 72), thus 
increasing the length of the ligand backbone by one methylene unit. If the MPAA’s were acting as 
bidentate ligands this would increase the chelate from a 5- to a 6-membered ring. It was expected 
that this would have a significant impact on the yield of the reaction. In fact, a 71% 1H NMR yield was 
observed for this reaction, which is comparable to that when using Boc-Gly-OH. This result suggested 
that the MPAA’s may not have been acting as bidentate ligands, but as acids. 
 
Scheme 72. Addition of Boc-β-Ala-OH ligand 
To investigate the role of the additives the reaction was carried out using 30 mol% PivOH, conditions 
with literature precedent for C–H activation methodology.139 Indeed, for this reaction a 1H NMR yield 
of 71% was observed and an isolated yield of 68% was obtained (Table 5, entry 1). This was again 
comparable with that seen for Boc-Gly-OH. The amount of PivOH used was then investigated (Table 




(Table 5, entries 4-6) and they all performed equally well, except for the more electron deficient TFA 
(Table 5, entry 4) for which the 1H NMR yield dropped to 65%.  
Table 5. Acid additive screen for the cyclisation of 201 
 
Entry Acid Loading 
Yield of 202 (%)a 
(Isolated yield) 
1 PivOH 30 mol% 71 (68) 
2 PivOH 20 mol% 65 
3 PivOH 1 equiv. 65 
4 TFA 30 mol% 65 
5 AcOH 30 mol% 70 
6 AdOH 30 mol% 71 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
At this point a decision was made to finish the reaction optimisation as the DoE yields had been 
matched, but with a lower catalyst and using a lower amount of the cheaper oxidant Cu(OAc)2. This 
was achieved by the use of MPAA or acid additives. It was decided that PivOH would be used as an 
additive over Ac-Gly-OH, despite the marginally higher yield resulting from the use of Ac-Gly-OH, 
because it was a more readily available and inexpensive reagent. Therefore, the optimised conditions 
were as follows: 10 mol% Pd(OAc)2, 3 equiv. Cu(OAc)2, 2 equiv. K2CO3, 30 mol% PivOH, dioxane (0.1 





2.3 Substrate scope 
Following the optimisation process an investigation into the scope of the reaction was undertaken, 
starting with modifications of the alkene and tether. Such modifications would have the potential to 
lead to the formation of various sized rings or substituted rings.  
2.3.1 Alkene variation  
The first substrate targeted was one with a methyl group at the internal position of the alkene. This 
substrate was not expected to perform well as the presence of the methyl substituent meant the β-
hydride elimination step in the first cyclisation (cf. Scheme 60, page 51) could not occur. However, 215 
was still a substrate of interest in order to see whether any alternative products would be formed, or 
whether the fully cyclised product would still be formed but via a different mechanism. The synthesis 
of 215 began with the opening of γ-butyrolactone 208 with MeLi to access 5-hydroxypentan-2-one 
which was immediately protected with TBSCl, due to instability of the alcohol in air. This was followed 
by a Wittig reaction to form alkene 210. Subsequent TBS-deprotection and mesylation resulted in the 
formation of tether 212, which was used to alkylate indole 194. The synthesis was completed by 
hydrolysis of the methyl ester followed by amide coupling to afford 215.   
 
Scheme 73. Synthesis of and attempted cyclisation of 215 
Substrate 215 was then subjected to the standard cyclisation conditions. As expected, no formation 
of the desired cyclisation product 216 was observed. The only product formed was a trace amount of 






Scheme 74. Cyclisation of 215 and proposed mechanism 
The tolerance of the reaction to substitution on the terminal position of the alkene was also explored. 
It was envisaged that such substrates could be synthesised in a similar manner to that of 215 but 
starting from aldehyde 224. A Wittig reaction between 224 and a variety of phosphonium salts 225 
would enable access to alkenes bearing a range of terminal substituents (Scheme 75).  
 
Scheme 75. Retrosynthetic analysis of 220 
For this to be realised, an efficient synthesis of 224 needed to be developed. A literature procedure 
was found in which THF could be ring-opened by NaI and TBS-protected to give 227 in one pot.141 This 
reaction was carried out and a good yield of 77% was achieved on a 40 mmol scale. It was then 
envisaged that the iodide could be converted to the desired aldehyde by a Kornblum oxidation. A 
range of conditions were trialled, with limited success (Table 6). Initially, pyridine N-oxide and NaHCO3 
were used in toluene at 110 °C. After 5 hours 1H NMR analysis of the crude mixture showed that only 
an 8% conversion to the product had occurred. This reaction was repeated but left for a prolonged 




after 40 hours analysis by TLC showed a complex mixture of products, and by 1H NMR of the crude 
reaction mixture no product was visible. Instead, DMSO and NaHCO3 were used, as these Kornblum 
oxidation conditions are more commonly found in the literature.142-144 Under these conditions at 150 
°C only the TBS peaks were visible in the 1H NMR, suggesting that the TBS group had been hydrolysed. 
These conditions were repeated at a lower temperature (110 °C) to supress this hydrolysis. Pleasingly, 
a 22% conversion to the product was observed by 1H NMR. An increase in reaction time provided 224 
in a 53% isolated yield. However, on scale-up, this yield dropped to 43%. It was decided that this route 
was not efficient enough to be used for the generation of terminally substituted alkene substrates. 
Table 6. Kornblum oxidation conditions for the synthesis of aldehyde 224 
 
Entry Conditions Solvent Temperature Time Yield of 224 (%) 
1 Pyridine N-oxide, NaHCO3 toluene 110 °C 5 hours 8 
2 Pyridine N-oxide, NaHCO3 toluene 110 °C 40 hours 0 
3 DMSO, NaHCO3 NA 150 °C 2 minutes 0 
4 DMSO, NaHCO3 NA 110 °C 2 minutes 22 
5 DMSO, NaHCO3 NA 110 °C 20 minutes 53 
 
Fortunately, enough of aldehyde 224 was generated to take forward for the synthesis of the methyl 
substituted 220a. This was achieved by a Wittig reaction between 224 and PPh3EtBr to install a methyl 
substituent on the terminal position of the alkene. Alkene 223a was formed as a mixture of 
stereoisomers. The remainder of the synthesis was the same as for substrate 215: TBS deprotection 
followed by mesylation to form tether 221a, then alkylation, hydrolysis, and amide coupling to give 
220a (Scheme 76). 
 




An interesting result arose when 220a was subjected to the standard cyclisation conditions. It was 
expected that the reaction would proceed in the normal manner to form 230, with the usual [6,6] ring 
system but with a methyl substituent adjacent to the N-mesylamide. In fact, the seven-membered ring 
containing product 231 was formed in a moderate yield of 53% (Scheme 77). 
It is thought that the mechanism for this reaction begins with an oxidative Heck reaction with β-
hydride elimination to give intermediate 235 with a terminal alkene. The second catalytic cycle is an 
aza-Wacker type reaction. The presence of the additional methyl substituent on the alkene means 
that aminopalladation should be able to occur 6-exo or 7-endo. Both scenarios are allowed by 
Baldwin’s rules, but it appears that the 7-endo reaction is much more favoured and so occurs 
preferentially, with 231 being form exclusively and no 6-exo product 232 observed. It is not currently 
known why this selectivity occurs. 
 
Scheme 77. Unexpected result from cyclisation of 220a and proposed mechanism 
Subsequent optimisation studies were carried out by another member of the group.145 Initial 
investigation involved the screening of a number of parameters (selected results in Table 7). The initial 
experiment gave 231 in a 1H NMR and isolated yield of 53% using the standard cyclisation conditions. 




but this led only to complete degradation of the starting material. A brief oxidant screen was carried 
out to see if the catalytic turnover could be increased (Table 7, entries 3-5). The use of tBuOOBz 
resulted in degradation of the starting material, AgO gave a lower yield of 31% and BQ gave a 
comparable yield to that using Cu(OAc)2. A base screen was then carried out, but all bases screened 
resulted in a decrease in yield (Table 7, entries 6-9). Inorganic bases proved more effective, with the 
organic base Et3N giving a yield of only 13%. Lastly alternative additives were investigated (Table 7, 
entries 10-13). Unfortunately, still no increase in yield was achieved, so the original conditions were 
used in further studies. 
Table 7. Optimisation studies for the cyclisation of 220a  
 
Entry Oxidant Base Additive Solvent Yield of 231 (%)a 
1 Cu(OAc)2 K2CO3 PivOH dioxane 53 
2b Cu(OAc)2 K2CO3 PivOH dioxane/AcOH 0 
3b AgOAc K2CO3 PivOH dioxane 31 
4b BQ K2CO3 PivOH dioxane 52 
5b tBuOOBz K2CO3 PivOH dioxane 0 
6b Cu(OAc)2 tBuOK PivOH dioxane 37 
7b Cu(OAc)2 Et3N PivOH dioxane 13 
8b Cu(OAc)2 NaOAc PivOH dioxane 50 
9b Cu(OAc)2 KOAc PivOH dioxane 32 
10b Cu(OAc)2 K2CO3 Piv-Gly-OH dioxane 37 
11b Cu(OAc)2 K2CO3 Cbz-Gly-OH dioxane 30 
12b Cu(OAc)2 K2CO3 Ac-Gly-OH dioxane 22 
13b Cu(OAc)2 K2CO3 Boc-β-Ala-OH dioxane 31 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard bExperiment conducted by J. Box 
Further investigation into this reaction was conducted by another member of the group145 to find out 
what would happen if two methyl groups were added to the terminal position of the alkene; whether 
it would go back to forming the [6,6] ring system or if it would still form the [6,7] ring system. When 
the dimethyl substrate 238 was subjected to the standard cyclisation conditions, once again the 
product with the [6,7] ring formation was formed exclusively in a yield of 23%, this time with a methyl 




position of the alkene was also trialled to see whether a [6,6] ring system with an ethyl substituent, a 
[6,7] system with a methyl substituent or a [6,8] ring system would be formed. When 240 was 
subjected to the standard cyclisation conditions only a trace amount of the [6,7] system 241 was 
observed (Scheme 78B). 
 
Scheme 78. Cyclisation of 238 and 240. Work performed (and substrates synthesised) by J. Box 
The addition of a phenyl ring to the terminal position of the alkene was then studied. The synthesis 
began with a Sonogashira reaction between iodobenzene and 4-pentyn-1-ol, followed by reduction of 
the resulting alkyne 243 to give alkene 222b which was formed predominantly as the trans isomer. 
Alcohol 222b was then mesylated to give the tethered alkene 221b which was then suitable for 
alkylation with methyl indole-3-carboxylate. The synthesis was completed by the hydrolysis of the 
methyl ester followed by amide coupling. Substrate 220b was recrystallised to give the trans isomer 
exclusively. When a methyl group was added to the terminal position of the alkene a change in 
mechanism resulted in the unexpected formation of a 7-membered ring (Scheme 77). However, the 
incorporation of a phenyl ring at this position does not allow for this alternative β-hydride elimination 
pathway, so it was expected that the standard [6,6] ring formation would occur. Indeed, when 220b 
was subjected to the standard cyclisation conditions the polyheterocyclic product 246 was formed in 






Scheme 79. Synthesis and cyclisation of 220b 
Functionalisation of the terminal position of the alkene was also achieved using Grubbs olefin 
metathesis. This allowed the alkene to be substituted with an ester group. Unfortunately, when 220c 
was subjected to the standard cyclisation conditions complete decomposition of the starting material 
was observed and no formation of the desired product 247 was evident (Scheme 80). 
 
Scheme 80. Synthesis and attempted cyclisation of 220c 
Another variation explored was the substitution of the alkene with an alkyne. Alkyne substrate 252 
was easily synthesised in four steps from 4-pentyn-1-ol in an analogous fashion to previous examples. 
Unfortunately, when subjected to the standard cyclisation conditions, no formation of the cyclised 





Scheme 81. Synthesis and attempted cyclisation of 252 
2.3.2 Tether variation 
Following exploration of the alkene, an investigation into the N-tether was conducted. Initial 
investigations focused on the addition of substituents on the tether. 
The tolerance to the presence of a methyl group β- to the nitrogen was first trialled. Synthesis of the 
tethered alkene portion 255 was achieved by reduction of the commercially available ester 253 to the 
corresponding alcohol 254 followed by mesylation, with both steps proceeding in excellent yields. 
Indole 194 was then alkylated using 255, followed by hydrolysis of the methyl ester and amide 
coupling with methanesulfonamide to yield the desired substrate 258. Pleasingly, under the standard 
cyclisation conditions, the cyclised product 259 was formed with an isolated yield of 63%. This was 
slightly less than that of the parent substrate, but that was to be expected due to the steric effects of 
the additional methyl group. 
 




Continuing with this theme, substitution on the tether of a methyl group γ- to the indole nitrogen was 
also trialled. Substrate 265 was synthesised in an analogous fashion to 258 but starting from acid 260 
(Scheme 83). Under the standard cyclisation conditions, the cyclised product 266 was formed in an 
isolated yield of 71%; a yield comparable to that of the parent system.  
 
Scheme 83. Synthesis and cyclisation of 265 
A substrate with a gem-dimethyl group adjacent to the alkene was also synthesised. This was achieved 
by reduction of ester 267 to alcohol 268. This was followed by mesylation, alkylation, ester hydrolysis 
and amide coupling as seen previously to give substrate 272 (Scheme 84). It was expected that, when 
subjected to the standard cyclisation conditions, substrate 272 would form a product similar to that 
seen with the parent substrate but with the double bond in a different place (Scheme 84). The gem-
dimethyl group would prevent β-hydride elimination occurring in the usual manner, but there is still a 
β-hydrogen available for elimination. Indeed, cyclised product 273 was formed, albeit in a low yield of 
20%. 
 




The incorporation of an oxygen atom into the tether was investigated. Substrate 278 was easily 
synthesised from ethylene glycol vinyl ether in the usual manner (Scheme 85). This resulted in the 
incorporation of an oxygen atom adjacent to the alkene. Unfortunately, when exposed to the standard 
cyclisation conditions no desired cyclisation product 279 was formed. This is likely due to the instability 
of the vinyl ether under the reaction conditions.  
 
Scheme 85. Synthesis and attempted cyclisation of 278 
The final tether variation explored was the tether length. It was hoped that this would allow access to 
a range of ring sizes of the bottom ring. Substrates 282a and 282b were synthesised in the usual way 
from commercially available bromoalkenes (Scheme 86A).  
 




Indoles 282a and 282b were both subjected to the standard cyclisation conditions. It was expected 
that, based on previous work within the group,132 282a would perform poorly as it would have to go 
via an 8-membered transition state. Surprisingly, the reaction proceeded to give 283 in an isolated 
yield of 38% (Scheme 86B). In contrast, 282b was expected to cyclise, but no formation of the cyclised 
product 284 was observed (Scheme 86C). The completed reaction mixture for 282b was a black mess, 
which suggested that the material had polymerised. 
2.3.3 Cyclic alkenes 
Following the success of the investigation into substitution on the tether and alkene, more complex 
systems were targeted. It was envisaged that the incorporation of a ring in the alkene portion of the 
molecule would result in the formation of more complex polyheterocyclic structures, such as those 
shown below (Scheme 87).  
 
Scheme 87. Predicted formation of more complex polyheterocycles 
First substrates 285a and 285b were synthesised, with the alkenes incorporated into 5- and 6-
membered rings respectively. To begin the synthesis of 285b 3-bromocyclohexene was reacted with 
diethyl malonate to give the corresponding carboxylic acid 290b. For the synthesis of 285a the 
necessary carboxylic acid 290a was commercially available. The carboxylic acids were reduced to give 
alcohols 291a and 291b which were then mesylated to afford 292a and 292b. Indole 3-carboxylate 
194 was then alkylated using the newly formed mesylates to give indoles 293a and 293b, and this was 
followed by hydrolysis of the methyl esters and amide coupling to give the desired substrates 285a 





Scheme 88. Synthesis and expected cyclisation of 285a and 285b 
When 285b was subjected to the standard cyclisation conditions formation of the fully cyclised 
product 286b was not observed, only a 10% conversion to the oxidative Heck product 296 and a trace 
amount of the aromatised oxidative Heck product 297. No starting material remained, so it is assumed 
that the rest of the material was lost to decomposition. Similarly, when 285a was subjected to the 
standard cyclisation conditions, only trace amounts of the oxidative Heck product 295 were observed. 
It is likely that the desired fully cyclised products were not formed as a result of a reduction in 
conformational flexibility due to the additional rings. 
 
Scheme 89. Cyclisation of 285a and 285b 
Substrate 287 was then targeted (Scheme 90). Its synthesis began with reduction of the commercially 
available carboxylic acid 298 to alcohol 299. This alcohol was homologated by bromination followed 
by reaction with diethyl malonate and then reduction to give 302. As seen previously, the alcohol was 
then mesylated to form the desired tether portion of the substrate. Mesylate 303 was used to alkylate 
methyl indole-3-carboxylate 194 to give 304. Hydrolysis of the methyl ester followed by amide 
coupling gave the desired substrate 287. It was envisaged that upon exposure to the standard 




product was formed, nor any other products, with only 22% of unreacted starting material observed 
by 1H NMR analysis. 
 
Scheme 90. Synthesis and expected cyclisation of 287 
2.3.4 Substitution on indole 
The tolerance of the reaction to substitution around the indole ring was then explored.  
For this to be achieved a straightforward and robust method for the synthesis of such substrates 
needed to be developed. It was decided that designing a route from commercially available 
substituted indoles would be the simplest option, as opposed to adding functionality to the indoles at 
a later stage. Initially the route shown below was used (Scheme 91). The substituted indoles could be 
alkylated with 5-bromo-1-pentene using the standard alkylation conditions. The alkylated indoles 307 
could then be brominated at the C3 position using NBS to give 308. This then enabled a lithium-
halogen exchange reaction to be carried out, during which trapping with CO2 furnished the indoles 
with a carboxylic acid group. As seen previously the acid could then be coupled with 
methanesulfonamide to give the desired substrates 310. Using this route two derivatives were 
synthesised; the 5-fluoro-substitued 310a and the 5-cyano-substituted 310b. A number of other 
substituted indoles were also trialled, but it was found that the brominated substrates were often 
very unstable, with some decomposing within minutes of isolation. The results of the lithium-halogen 
exchange reactions were also very variable, with some reactions only yielding the dehalogenated 





Scheme 91. Synthesis of substituted indole substrates 310 
It was found that the desired transformation could be achieved by treatment of the alkylated indole 
with TFAA, followed by hydrolysis with KOH.146 This reaction was found to proceed with good to 
excellent yields of 65% and above, except in the case of indoles substituted at the 4 position (Table 8, 
entries 4 and 5) where the yield dropped significantly, likely due to steric effects. Utilising this new 
route, another eight examples were synthesised from commercially available indoles substituted with 
a variety of functional groups at different positions around the indole ring (Table 8).  
Table 8. Synthesis of substituted indole substrates 310 
 
Entry Label R 
Yield (%) 
307 309 310 
1 c 5-Me 100 73 63 
2 d 5-OMe 90 65 80 
3 e 5-NO2 100 88 76 
4 f 4-Me 73 42 64 
5 g 4-OMe 100 37 61 
6 h 6-Cl 97 75 74 
7 i 7-NO2 75 86 84 





The substituted indole substrates were then subjected to the standard cyclisation conditions. Overall 
the reaction was tolerant of the different functional groups, with the majority of yields ranging from 
good to excellent. The reaction appeared to show a slight preference for electron-donating groups, 
particularly in the C5-substituted substrates, with the electron-donating methyl and ether 
substituents (Table 9, entries 3 and 4) giving rise to higher yields than the electron-withdrawing nitrile 
and halide substituents (Table 9, entries 1 and 2). This preference for more electron-rich substrates 
could be suggestive of an SEAr-type mechanism. The tolerance to halide functionality is particularly 
useful due to its ability to serve as a handle for further functionalisation by cross-coupling reactions. 
The only substituent to perform poorly was the nitro group (Table 9, entries 5 and 9). It is thought that 
this was due to the high insolubility of the nitro substrates. It was expected that the 7-aza indole (Table 
9, entry 10) would perform poorly due to the basic pyridine nitrogen and its ability to act as a ligand, 
which could deactivate the palladium catalyst. Surprisingly, even this example proceeded in a good 
yield of 58%.  
Table 9. Cyclisation of substituted indole substrates 
 
Entry Label R Yield of 312 (%) 
1 a 5-F 61 
2 b 5-CN 64 
3 c 5-Me 75 
4 d 5-OMe 73 
5 e 5-NO2 15 
6 f 4-Me 54 
7 g 4-OMe 67 
8 h 6-Cl 60 
9 i 7-NO2 22 
10 j 7-aza 58 
2.3.5 Pyrrole core 
The next goal of the project was to switch the indole heterocyclic core to a pyrrole core as this would 
allow access to other novel polyheterocyclic structures. This had been successful for other cascade 




The pyrrole moiety of the substrates could be constructed by a Van Leusen pyrrole synthesis, which 
has much literature precedence.128, 147-148 This method was desirable as the ability to incorporate 
different R groups in the starting materials would allow for the synthesis of a variety of substrates with 
varying substitution around the ring. A Van Leusen pyrrole synthesis also generates pyrroles with an 
ester group at the 3-postion; an ideal handle for the synthesis of the N-acyl mesylamide. 
The viability of the route was demonstrated using the parent system 317a (Scheme 92); reaction of 
TosMIC 318 and ethyl acrylate in the presence of NaH gave pyrrole 314a, albeit in a disappointingly 
low yield of 20%. Alkylation and hydrolysis using the standard conditions both proceeded in excellent 
yields to give 316a. The synthesis was completed by the formation of the mesylamide which gave the 
desired substrate 317a in a 47% yield. Two 4-substituted pyrrole substrates were also synthesised 
using this route, albeit in low yields due to challenging purification of the Van Leusen products, and 
the low yields of the amide coupling reactions.  
 
Scheme 92. Synthesis of 4-substituted pyrroles 317 via Van Leusen pyrrole synthesis 
The synthesis of the 5-Me pyrrole substrate 317d was achieved using an analogous sequence, 
following methylation of TosMIC with MeI using phase transfer conditions to give the methylated 





Scheme 93. Van Leusen pyrrole synthesis of 317d 
A number of 3,5-substituted pyrroles bearing electron-withdrawing groups at the 5-position and a 
trichloroacetyl group at the 3-position 323 were available within the group.131 These served as ideal 
starting materials for the synthesis of 5-substituted pyrrole substrates as such pyrroles are known to 
cleanly undergo Mitsunobu alkylation, and the trichloroacetyl groups could be easily hydrolysed to 
give the corresponding acid derivatives 325 ready for amide coupling (Scheme 94). By this route two 
5-susbstituted pyrrole substrates, 317e and 317f, were synthesised. 
 
Scheme 94. Synthesis of 5-substituted pyrroles 
The synthesis of a pyrrole substrate bearing an ester substituent was also attempted. Commercially 
available 2-(trichloroacetyl)pyrrole 326 was alkylated using Mitsunobu conditions to give 327 in an 
excellent yield of 84%. The trichloroacetyl group was then hydrolysed and furnished with a tert-butyl 
ester using oxalyl chloride. It was envisaged that an acid group at the 3-position could be installed in 
an analogous fashion to the indole cores, using TFAA followed by KOH. Unfortunately, no formation 
of the product 329 was observed, with 1H NMR analysis revealing a complex mixture containing no 
tBuO peak. An alternative method for installing functionality at the 3-position was trialled, utilising 
Friedel-Crafts chemistry. This reaction resulted in the degradation of the starting material, so again no 






Scheme 95. Attempted synthesis of ester-substituted pyrrole substrate 
The six successfully synthesised pyrrole substrates were subjected to the same cyclisation conditions 
used for the indole substrates. Pleasingly, all of the pyrrole substrates underwent cyclisation, 
generating a range of novel complex structures 331a-f in moderate yields, demonstrating tolerance 
to substitution at both the 4- and 5-positions of the pyrrole ring (Table 10). 
Table 10. Cyclisation of pyrrole substrates 
 
Entry Label R Yield of 331 (%) 
1 a H 35 
2 b 4-Me 50 
3 c 4-Ph 40 
4 d 5-Me 39 
5 e 5-Ac 35 
6 f 5-Bz 37 
 
Despite all pyrrole substrates undergoing the desired cyclisation, the yields for these systems were 
less than that seen for indoles (Table 9). Factors which may have been contributing to the lower yields 
could be a lower catalytic turnover, or that the pyrrole substrates and products are more sensitive to 
decomposition under the reaction conditions due to their increased electron density.  
Following the lower yields obtained for these pyrrole systems further optimisation was undertaken in 
the hope that the yields could be increased to those of the indoles. A screen of oxidants for the 




11). A variety of organic and inorganic oxidants were chosen. Unfortunately all oxidants other than 
Cu(OAc)2 performed poorly, with the use of tBuOOBz and oxone (Table 11, entries 3 and 5) resulting 
in no formation of the desired  product and BQ and IBX (Table 11, entries 2 and 6) resulting in only 
trace amounts of product formed, indicating no catalytic turnover. The only oxidant other than 
Cu(OAc)2 to give a catalytic turnover was AgBF4 (Table 11, entry 4) but even this only generated a yield 
of 15%. 
Table 11. Oxidant screen for the cyclisation of 321b 
 
Entry Oxidant Yield of 331b (%)a 
1 Cu(OAc)2 50 
2 BQ 5 
3 tBuOOBz 0 
4 AgBF4 15 
5 Oxone 0 
6 IBX Trace 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
It was noted that the mechanism for this cyclisation reaction (Scheme 60, page 51) had marked 
similarity to a reaction previously developed within the group in which alkylidine isoindolines were 
synthesised from N-alkoxybenzamides (Scheme 57, page 48).129 Despite their obvious differences, in 
that the reaction of N-alkoxybenzamides has a different core and is an intermolecular reaction, both 
cascade sequences proceed by a C–H activation/oxidative Heck reaction followed by an aza-Wacker 
reaction and both sequences are directed by an acidic amide directing group. Interestingly, while the 
reaction in this work was carried out under basic conditions, the reaction of N-alkoxybenzamides was 
carried out under acidic conditions. Inspired by this, a variety of new conditions were trialled in the 
hope that the moderate yields obtained for the pyrrole substrates could be improved. 
First, the cyclisation of the pyrrole substrate 317e was carried out using Pd(OAc)2 (10 mol%) and BQ 
(2 equiv.) in AcOH at 100 °C (A), conditions similar to those used in the reaction of N-
alkoxybenzamides. BQ was chosen as the oxidant as O2 was more difficult to obtain and during 
optimisation studies for the reaction of N-alkoxybenzamides BQ was shown to perform equally well. 




was unsurprising as BQ had previously performed poorly for this reaction (Table 11, entry 2), and 
previous investigations into the solvent have shown only dioxane to be an effective solvent (Table 1, 
page 56). For these reasons conditions more similar to those used normally were trialled; Pd(OAc)2 
(10 mol%), Cu(OAc2) (3 equiv.), PivOH (2 equiv.) in 1,4-dioxane at 100 °C (B). Here the oxidant and 
solvent were kept the same as usual, but K2CO3 was replaced with an excess of PivOH, making the 
conditions acidic rather than basic. These conditions produced a yield of 331e of only 10%. 
 
Scheme 96. Pyrrole cyclisation under acidic conditions (*As determined by 1H NMR analysis with 1,4-dimethoxybenzene as a 
standard) 
Use of an N-alkoxyamide directing group was also trialled. Acid 196 was reacted with oxalyl chloride 
to give the corresponding acid chloride, which was then reacted with methylamine hydrochloride to 
afford 332 in a 51% yield over two steps. This N-alkoxyamide substrate 332 was subjected to the 
standard cyclisation conditions but no cyclisation to form the expected product 333 was observed 
(Scheme 97). 
 
Scheme 97. Synthesis and attempted cyclisation of N-alkoxy amide substrate 332 
2.4 Mechanistic studies 
Having explored the scope of the reaction attention was turned to the reaction mechanism. Initially a 
C–H activated oxidative Heck reaction followed by an aza-Wacker reaction was proposed (Scheme 60, 
page 51). It was thought that this began with C–H activation at the C2 position of indole 187 to give 
190, followed by migratory insertion and then β-hydride elimination to give the intermediate 188. It 
was thought that 188 then enters a second Pd(II)-catalysed cycle, with alkene coordination to the 
Pd(II) catalyst, aminopalladation to give 193 and then β-hydride elimination to yield the product 189. 




The proposed mechanism involves two catalytic cycles. In order to test this, 201 was subjected to the 
cyclisation conditions but with only 1 equiv. of Cu(OAc)2. If two catalytic cycles are in operation the 
use of only 1 equiv. of Cu(OAc)2 would only allow for a yield of up to 50%. Indeed, when the reaction 
was carried out a yield of only 23% of 202 was obtained, thus supporting two palladium turnovers per 
cascade sequence.  
 
Scheme 98. Cyclisation of 201 using only 1 equiv. Cu(OAc)2 
The next investigation involved methylating the N-mesylamide of 201. This transformation was easily 
achieved using MeI and K2CO3 to give the methylated substrate 334 in a 91% yield (Scheme 99). It was 
envisaged that subjecting 334 to the cyclisation conditions would reveal the importance of the free 
N–H in the mesylamide directing group. Substrate 334 would not be able to undergo the aza-Wacker 
cyclisation owing to the lack of N-H. It was thought that it would be possible, however, for 334 to 
undergo the oxidative Heck reaction to form 335. In fact, when 334 was subjected to the standard 
cyclisation conditions, 100% of unreacted starting material was recovered. This result demonstrates 
that the mesylamide N-H is required to direct the Pd(II) centre to the C-2 position of the indole and 
indicates that the first step of the mechanism is not C–H activation of the indole as previously thought, 
but deprotonation and metalation of the N-mesylamide. This result also suggests that the role of the 
K2CO3 is to deprotonate the mesylamide in order to facilitate this coordination. 
 
Scheme 99. Methylation of 201 and attempted cyclisation of 334 
As a key piece of mechanistic evidence, the synthesis of the putative intermediate 204 was targeted. 
If this could be achieved, subjection of 204 to the cyclisation conditions would elucidate its 
involvement in the cascade sequence. 
Following a search of the literature a straightforward synthesis of alkene 340 was found. It involved 




the presence of base to give 338. An acidic decarboxylation reaction gave tricyclic ketone 340 which 
could then undergo a Wittig reaction to give the desired alkene moiety. All reactions proceeded in 
excellent yields (Scheme 100). It had been envisaged that a carboxylic acid group could then be 
installed at the C3 position of the indole using TFAA followed by KOH as had been used for the 
substituted indole substrates (cf. Table 8, page 77). When this reaction was carried out a complex 
mixture of products was observed by 1H NMR analysis of the crude material. Unfortunately, no peaks 
were present in the alkene region of the spectrum meaning the mixture did not contain any of the 
desired product 341. 
 
Scheme 100. Attempted synthesis of putative intermediate 204 
A number of other reaction conditions were trialled (Scheme 101), including bromination using NBS 
which would allow for a lithium-halogen exchange reaction followed by trapping with CO2 to afford 
the desired acid 341. Again, for all conditions trialled, only complex mixtures containing no alkene 
peaks were observed by 1H NMR analysis. This decomposition of the alkene was likely due to the 
increased reactivity of the alkene as a result of conjugation to the indole. To circumvent this, 
installation of the acid prior to the formation of the alkene was attempted. Following reaction of 339 
with TFAA it appeared that the formation of a trace amount of the product 343 had occurred, but not 





Scheme 101. Attempted functionalisation at indole C3 
A reaction developed by Williams et al. was found in which aldehydes could be converted to amides 
in a one pot reaction.149 Alkene 340 could easily be functionalised using a Vilsmeier-Haack to give the 
necessary aldehyde. Indole 344 was then treated with methanesulfonamide in the presence of 
NiCl2.6H2O, hydroxylamine hydrochloride and NaOH in p-xylene (Scheme 102). Unfortunately, no 
formation of the desired product 204 was observed. It was also reported that this transformation 
could be carried out in two steps via the formation of the oxime. Generation of the oxime 345 
proceeded in a good yield of 61%, but again formation of the desired mesylamide was unsuccessful. 
 
Scheme 102. Attempted functionalisation at indole C3 via a Vilsmeier Haack reaction 
Following the lack of success in the synthesis of 204 it was decided that, instead of an N-acyl 
mesylamide group, an N-acyl tosylamide group would be used. Both groups have similar electronic 
properties, and it had been shown previously that substrates bearing an N-acyl tosylamide directing 
group also undergo the same cascade sequence (Scheme 59). It was hoped that this would make the 
synthesis more straightforward as an N-acyl tosylamide group can be installed directly by reaction of 
an indole with tosyl isocyante (the mesyl equivalent is not commercially available). Indeed, when 





Scheme 103. Installation of N-acyl tosylamide group 
The putative intermediate 188 was subjected to the standard cyclisation conditions and pleasingly 
gave the cyclised product 189 in a yield of 83%. This result is strong evidence that this intermediate is 
indeed involved in the cascade sequence. As a comparison, the tosylamide substrate 187 was also 
subjected to the optimised reaction conditions and gave 189 in a yield of 51%. This is another piece of 
evidence that supports two catalytic turnovers per cascade sequence. 
 
Scheme 104. Cyclisation of putative intermediate 188 and N-tosylamide substrate 187 






Scheme 105. Revised mechanism for the cyclisation of 203 (ligands omitted for clarity) 
The catalytic cycle begins with coordination of the N-atom of 201 to the Pd(II) centre, which is 
facilitated by K2CO3. This directs C–H activation to the 2-position of the indole. Migratory insertion of 
347 is followed by β-hydride elimination to give intermediate 204. The active Pd(II) species is 
regenerated by oxidation with Cu(II). The intermediate 204 then enters a second catalytic cycle, 
undergoing N-coordination, alkene coordination and aminopalladation to give 351. The product 202 
is then generated by β-hydride elimination, and the resulting Pd(0) centre undergoes a second redox 
cycle with Cu(II). In addition to our observations, the mechanism for the aza-Wacker reaction is also 
supported by work done by Stahl that supports a syn-amino palladation mechanism for such 
processes.150-152 
It must be noted that an alternative mechanism can also be proposed, involving nucleophilic addition 
of the indole to the alkene,153 which does not process via C–H activation. A more comprehensive 
mechanistic study must be carried out in order to confirm which mechanism is in operation. 
Determination of a KIE using an indole substrate deuterated at the C2 position would determine which 
mechanism is occurring. If it is C–H activation by SEAr no KIE would be observed as the C–H cleavage 
step is fast. if it is a nucleophilic addition a KIE would be observed. However, from the experiments 
conducted so far it is more likely that it is the C – H activation mechanism in operation due to the need 




2.5 Natural product synthesis: Matrine alkaloids 
The next aim of the project was to adapt the methodology for use as the key step in the synthesis of 
a natural product.  
Matrine is a quinolizidine alkaloid which has been isolated from a number of plants from the Sophora 
genus, including Sophora flavescens, Sophora tonkinensis,154 and Sophora moorcroftiana.155 Sophora 
flavescens has long been used in traditional medicine in China, Japan and India for the treatment of 
conditions such as eczema, dysentery and pyogenic skin infections.156 Modern analysis has shown that 
this is due to the presence of matrine-type alkaloids and flavonoids, which are the main components 
of this plant.156 Over 40 matrine alkaloids have now been isolated from various Sophora plants. Recent 
pharmacological studies have shown that these alkaloids exhibit strong antiviral activities against 
Coxsackie virus B3 and B5, hepatitis B, and influenza virus A (H3N2).157  Matrine has also displayed 
synergistic effects with several anti-cancer drugs, so could be used to reduce their therapeutic dose.  
This would reduce the side-effects of toxic drugs without compromising their efficacy.158  
 
Figure 7. Matrine alkaloids 
The matrine alkaloids and their derivatives are therefore considered ideal lead compounds in drug 
discovery, so the development of efficient syntheses towards such compounds is vital. Previous total 
syntheses of matrine alkaloids include the synthesis of matrine by Zard using a radical cyclisation 
methodology,159 and the synthesis of (+)-allomatrine by Brown using an imino-aldol reaction and N-
acyliminium cyclisation.160 The matrine alkaloids are ideal targets for this work as they contain a diaza-
tricyclic core that could be accessed using a Pd(II) cascade sequence similar to that described in the 
previous chapter of this thesis. 
Retrosynthetically, the matrine alkaloid cores could be accessed by the hydrogenation of 353. A 
potential route to 353 could be N-acylation of 354 followed by a ring closure with an appropriate 
pendant R group. Structure 354 would be formed from 355 via reduction of the amide and removal of 
the directing group. It is envisaged that the key step in this synthesis would be the Pd(II)-catalysed ring 
annulation of 356 to give 355, similar to the Pd(II)-catalysed methodology described previously. 
Therefore, the initial focus was on developing an efficient and scalable route for the synthesis of 





Scheme 106. Retrosynthetic analysis of matrine alkaloid core 352 
2.5.1 Substrate synthesis: Reduction of pyridine derivatives  
The most obvious route to 361 began with cheap, commercially available methyl nicotinate which 
could be partially hydrogenated to 358 using Pd/C under H2 (10 bar) (Scheme 107). This formation of 
the desired core with a double bond preserved is as a result of the conjugation between the ester 
group and the N-atom which prevents overhydrogenation. Compound 358 was alkylated using the 
standard alkylation conditions to give 359 in a 50% yield over the two steps.  
 
Scheme 107. Attempted synthesis of 361 
From here it was envisaged that the methyl ester could then be hydrolysed to give the corresponding 
acid, which would then be used in an amide coupling reaction with methanesulfonamide to afford the 
desired substrate 361. Unfortunately, when 359 was treated with aqueous NaOH in MeOH and THF 
no formation of product 360 was observed (Table 12, entry 1), even after heating at reflux for several 
days. On increasing the excess of NaOH, decomposition of the starting material was observed (Table 
12, entry 4). This lack of success was likely due to the highly electron rich nature of the ester, so acidic 
conditions were also trialled but again no product was formed (Table 12, entry 7). A variety of other 




Table 12. Screen of conditions for the hydrolysis of 359 
 
Entry Conditions Solvent Temperature Time Yield of 360 (%) Observationsa 
1 NaOH (10 equiv.)b MeOH/THF reflux 4 days 0 No reaction 
2 KOH (10 equiv.)b MeOH/THF reflux 4 days 0 No reaction 
3 LiOH (10 Equiv.)b MeOH/THF reflux 4 days 0 No reaction 
4 NaOH (40 equiv.)b MeOH/THF reflux 3 days 0 Decomposition 
5 LiCl (5 equiv.) DMF 150 °C 18 hours 0 No reaction 
6 LiCl (3 equiv.) DMSO 150 °C 18 hours 0 No reaction 
7 HCl (1.6 equiv.)b THF reflux 18 hours 0 Decomposition 
8 TFA (14 equiv.) Water reflux 3 hours 0 Decomposition 
aAs observed by TLC and 1H NMR analysis bAs a 2 M aqueous solution 
It was though that one way to circumvent this hydrolysis problem would be to perform the reactions 
in a different order (Scheme 108). Alkylation prior to reduction of the pyridine would result in the 
formation of pyridinium salt 362. The electronics of the ester on the pyridinium salt would be very 
different to that of ester 360 so hydrolysis should be more facile. From here it was thought that the 
acid could be transformed to the mesylamide by standard amide coupling conditions and then the 
pyridinium core reduced to the desired 1,4,5,6- tetrahydropyridine core. Reduction using H2 and Pd/C 
could be employed as this would also result in the reduction of the tethered alkene, but there are 
several examples in the literature in which similar systems are reduced using reducing agents such as 
NaBH4.161-162 
Unfortunately, pyridinium salts 362 and 363 proved difficult to work with, particularly during 
purification due to their high polarity and high water solubility. By 1H NMR analysis of the crude 
hydrolysis product the methyl ester peak had disappeared, suggesting the hydrolysis had been 
successful, but there were many inseparable impurities present.  
 




Instead, nicotinic acid was alkylated directly. It was hoped that this would circumvent any purification 
issues as once the reaction has gone to completion any solvent and unreacted bromide could simply 
be evaporated, leaving the pure product without need for aqueous workup or flash column 
chromatography. The only downside to this approach was that nicotinic acid is less nucleophilic than 
the methyl ester, so the alkylation reaction was much slower. After refluxing nicotinic acid with 5-
bromo-1-pentene for 72 hours the reaction had reached only 20% completion. In order to increase 
the rate of reaction the bromide was first converted to the iodide using a Finkelstein reaction. Using 
this iodide, a 90% conversion to the pyridinium salt was observed after 72 hours at reflux. Despite this 
improvement in yield this route was not continued as there was still a significant amount of 
inseparable starting material present. 
  
Scheme 109. Alkylation of nicotinic acid 
There are many examples in the literature of dithionate reductions of pyridinium salts of nicotinamide 
and its derivatives.163-165 Nicotinamide was alkylated by refluxing with 5-bromo-1-pentene in MeCN 
for 3 days, which gave the pyridinium salt 370 in a quantitative yield. Pyridinium salt 370 was then 
reacted with sodium dithionate in the presence of sodium hydrogen carbonate to give the 
corresponding 1,4-dihydropyridine 371 in a yield of 90%. From here it was hoped that this could be 
further reduced to the desired 1,4,5,6-tetrahydropyridine and then the amide transformed to the 





Scheme 110. Attempted synthesis of 361 from nicotinamide 
A variety of conditions were trialled for the reduction of the 1,4-dihydropyridine to the 1,4,5,6-
tetrahydropyridine (Table 13). The use of sodium triacetoxyborohydride (STAB) with AcOH gave a 
complex mixture by TLC and 1H NMR of the crude material (Table 13, entry 1). Following flash column 
chromatography, no product was observed. The amount of STAB and the reaction time were 
decreased (Table 13, entry 2) to see if a simpler reaction mixture could be observed in order to 
determine what reactions were occurring, but still a complex mixture, with no discernible products, 
was seen. Another reducing agent, NaCNBH3, was also trialled (Table 13, entry 3) but once again only 
a complex mixture was formed. Lastly, literature precedent was found for reduction using NaBH4 and 
NiCl2.6H2O.166 Indeed, under these conditions the desired 1,4,5,6-tetrahydropyridine core was formed 
(Table 13), but unfortunately the tethered alkene was also reduced, giving 373 in a yield of 26%. The 
amount of NaBH4 and NiCl2.6H2O were reduced (Table 13, entry 4) in the hope that using only 1 equiv. 
of reducing agent would result only in the selective reduction of the tetrahydropyridine. Again, only 
the over reduced compound 373 was observed. The amount of reducing agent was reduced further 




Table 13. Reduction of 1,4-dihydropyridine 371 
 
Entry Conditions Solvent Temperature Time Yield of 372 (%) Observationsa 
1 
STAB (4 equiv.), 
AcOH (2 equiv.) 
DCM r.t. 48 hours 0 Complex mixture 
2 
STAB (1 equiv.), 
AcOH (2 equiv.) 
DCM r.t. 4 hours 0 Complex mixture 
3 
NaCNBH3 (1.5 
equiv.), AcOH (drop) 
MeOH r.t. 4 hours 0 Complex mixture 
4 
NiCl2.6H2O (1 
equiv.), NaBH4 (4 
equiv.) 
MeOH r.t. 3 hours 0 26% 373 
5 
NiCl2.6H2O (0.3 
equiv.), NaBH4 (1 
equiv.) 
MeOH r.t. 3 hours 0 373 
6 
NiCl2.6H2O (0.05 
equiv.), NaBH4 (0.5 
equiv.) 
MeOH r.t. 3 hours 0 
Complex mixture, 
including 373 
aAs observed by TLC and 1H NMR analysis 
Attention was then turned to the dihydropyridine core. If the sulfonamide directing group could be 
installed then this may itself serve as a suitable substrate for Pd(II)-catalysis, without need for further 
reduction. A range of literature conditions were trialled for the installation of the sulfonamide group 
(Table 14). The use of the literature conditions KOH, TBAHS and K2CO3 followed by MsCl167 were 
employed (Table 14, entry 1), but in the 1H NMR of the crude material no dihydropyridine peaks were 
present, suggesting the starting material had degraded. The use of the stronger base NaH with TsCl 
under heating168 was trialled (Table 14, entry 2), but only TsCl was recovered from the reaction 
mixture. A search of the literature found that 1,4-dihydropyridines are known to degrade at elevated 
temperatures,169 so the reaction was repeated without heating for a much shorter reaction time (Table 
14, entry 3). Still only TsCl was recovered from the reaction mixture. It was thought that NaH as a base 
may be too strong, so the reaction was attempted with the much weaker base Na2CO3 (Table 14, entry 
4). Again, no dihydropyridine peaks were present in the 1H NMR of the crude material. Instead of 
reacting the primary amide directly to form the N-acyl sulfonamide, hydrolysis of amide to the 
corresponding acid using NaOH was attempted (Table 14, entry 6). By 1H NMR of the crude material a 
complex mixture was observed, with no obvious product peaks. From these results it appears that the 




directing group could be successfully installed it is unlikely that it would survive the likely high 
temperature of the Pd(II)-catalysed cyclisation. 
Table 14. Reaction of primary amide 
 
Entry Conditions R Solvent Temperature Time 






NHMs THF 55 °C 20 hours 0 No DHP peaks 
2 NaH, TsCl NHTs THF 55 °C 20 hours 0 
Only TsCl 
recovered 






4 Na2CO3, TsCl NHTs 
water, 
acetone 




NHMs THF r.t. 20 hours 0 
No Ts or DHP 
peaks 
6 KOH OH 
MeOH, 
THF 
reflux 20 hours 0 Mess 
aAs observed by TLC and 1H NMR analysis 
An alternative approach was to construct a substrate around a pyridone core. Such structures were 
easily accessible from 5-hydroxynicotinic acid 375 (Scheme 111). Following esterification to give 376, 
the hydroxypyridine core was alkylated to give the N-alkylated pyridone 377 in an excellent yield of 
80%. Hydrolysis of the methyl ester was then feasible due to the distinct electronic properties of the 
pyridone core compared to the 1,4,5,6-tetrahydropyridine core of 360. Acid 378 was subjected to the 
standard amide coupling conditions to give the N-mesylamide substrate 379. When 379 was subjected 
to the standard cyclisation conditions no cyclised product was observed, only decomposition. This 
result was unsurprising because the C6 position of pyridones is the most electron deficient position, 
and therefore not nucleophilic enough C–H activation.170 While several transition metal catalysed 
Heck reactions have been reported at the C6 position171-172 there are no examples using palladium, 
which prefers to react at the C3 and C5 positions.173-174  
The ideal scenario would have been to reduce the 4,5-carbon-carbon double bond and the pyridine 
carbonyl to give the desired substrate. Unfortunately, following a search of the literature, attainment 






Scheme 111. Synthesis and attempted cyclisation of 2-pyridone substrate 379 
2.5.2      Substrate synthesis: Lactam reduction 
An alternative route to the desired tetrahydropyridine substrate 361 was proposed, starting from δ-
valerolacram (Scheme 112). It was envisaged that the carbonyl group at the 2-position of the ring 
would allow the hydrolysis step to occur, but then would be able to be reduced and then eliminated 
to give the desired double bond formed in a straightforward manner. δ-Valerolacram was alkylated 
using KOH in DMSO to give lactam 382 in a 72% yield. The ester moiety was then installed by treatment 
of 382 with LiHMDS and ethyl chloroformate in THF to give 383 in an excellent yield of 80%. As 
expected, the ethyl ester was hydrolysed successfully using the standard hydrolysis conditions; NaOH 
(as a 2 M aqueous solution) in THF and MeOH. Acid 384 then underwent an amide coupling reaction 
to give N-mesylamide 385. 
  




From here it was hoped that the desired substrate 361 would be formed by reduction of the carbonyl 
followed by elimination of the generated alcohol to give the desired carbon-carbon double bond 
(Scheme 113). Substrate 385 was reacted with NaBH4 in MeOH. Unfortunately, the desired alcohol 
was not formed. In the 1H NMR of the crude material there was no mesyl proton peak, and no obvious 
CH proton peak formed, suggesting that desired reduction had not occurred but the sulfonamide 
group had been removed. Because of this undesired reactivity of the mesylamide future reductions 
were performed on acid 384. Again, NaBH4 was trialled. By TLC no reaction was observed and after 20 
hours the reaction was worked up but only a small mass recovery was obtained, with no appreciable 
peaks in the 1H NMR. DIBAL was then trialled, and while a greater mass was obtained there were still 
no discernible peaks in the 1H NMR. The material was reacted with H2SO4 in Et2O in case it was the 
desired alcohol but following workup no material was recovered. 
 
Scheme 113. Attempted reduction/elimination sequence of 383 
Literature conditions were found in which a benzyl-protected lactam is reduced using lithium 
triethylborohydride and the resulting alcohol eliminated using DMAP, DIPEA and TFAA.175 It was 
thought that these conditions would also work for N-pentenyl lactam. It was hoped that the resulting 
enamine 387 could then be reacted with an electrophile to furnish the substrate at the 3-position 
(Scheme 114).  N-Pentenyl lactam was subjected to the exact literature conditions, but by 1H NMR 
only starting material was observed. The reaction was repeated, but stirred with lithium 
triethylborohydride for longer, however still no reaction was observed. The literature conditions were 
then repeated, with the literature substrate N-benzyl lactam 388. This literature reaction was found 





Scheme 114. Literature procedure for the reduction/elimination of lactams 
A number of other reducing agents were trialled on the N-pentenyl substrate 382, including DIBAL, 
but for all conditions only starting material was observed.  
Table 15. Conditions for the reduction/elimination of 382 
 
Entry Conditions Solvent Temperature Yield of 381 (%) Observationsa 
1 
1. LiBHEt3 (1.05 equiv.) 
2. DMAP (0.02 equiv.), DIPEA 
(5.7 equiv.), TFAA (1.2 
equiv.) 
toluene -78 °C 0 SM 
2 LiBHEt3 (1.05 equiv.) toluene -78 °C 0 SM 
3 DIBAL-H DCM -78 °C 0 SM 
4 KO
tBu (0.05 equiv.), Si(EtO)3H 
(4 equiv.) 
THF 65 °C 0 SM 
aAs observed by TLC and 1H NMR analysis 
2.5.3 Substrate synthesis: Electrophilic attack on enamine 
As mentioned previously, if enamine 387 could be accessed reaction with an electrophile may 
introduce functionality at the 3-position of the ring (Scheme 115). An electrophile such as TFAA would 
install a trifluoroacetyl group at the 3-position. This could then be hydrolysed and then coupled with 
an amine to give the N-acyl sulfonamide. Alternatively, a reaction with tosyl isocyanate would directly 






Scheme 115. Installation of 3-substituent by electrophilic attack 
Imine 393a was synthesised by reaction of piperidine with NCS, followed by KOH, which gave a yield 
of 50%. This imine exists in an equilibrium with the trimer 393b. It was hoped that this imine could 
then be reacted with 5-bromo-1-pentene in the presence of base to install the tethered alkene and 
result in the desired enamine 387. Following workup only peaks from the tethered alkene were 
observed in the 1H NMR. This could be as a result of degradation of the generated enamine, so the 
reaction was repeated with tosyl isocyanate as an electrophile added in situ to see if any desired 
product could be generated. This was trialled with and without base. In the presence of base, a 
complex mixture was observed, with the major product being an undesired derivative of tosyl 
isocyanate, without base only tosyl proton peaks were observed. The reaction was trialled using MeI 
instead of 5-bromo-1-pentene, as it is a much stronger electrophile, to see if the reaction could work, 




Table 16. Alkylation conditions 
 
Entry Conditions Yield of 387 (%) Observationsa 










1. 5-Bromo-1-pentene, DMF 
2. TsNCO 
0 Just Ts peaks 
4 MeI, NEt3, DMF 0 No peaks in 1H NMR 
aAs observed by TLC and 1H NMR analysis 
An alternative route to enamine 387 was devised starting from pyridine. Pyridine was alkylated by 
refluxing with 5-bromo-1-pentene in MeCN, which gave pyridiunium salt 395 in a quantitative yield.  
Reduction with NaBH4 gave the 1,2,5,6-tetrahydropyridine 396 in a yield of 68%. A search of the 
literature found that stirring with tBuOK in DMSO should lead to isomerisation of the double bond to 
give the desired 1,4,5,6-tetrahydropyridine.176 396 was stirred at 90 °C with tBuOK  in DMSO. After two 
days analysis by TLC suggested most of the starting material had reacted so 1 equiv. of tosyl isocyanate 
was added. Following work up, a mass spec of the crude mixture was taken, but no mass peaks 
corresponding to the desired product were present.  
At this point, a route based on the electrophilic attack on a cyclic enamine was abandoned, as it 
appeared that the enamine was too unstable to be isolated and/or undergo subsequent reactions. 
 




2.5.4 Substrate synthesis: Construction of ring 
The final route towards the synthesis of substrate 361 attempted involved construction of the 6-
membered ring. This route had previously been undertaken by another member of the group but using 
a tethered diene instead of the tethered alkene, from which a 2% yield of the diene substrate was 
obtained over 6 steps.131 The synthesis of the alkene derivative began with the mesylation of 4-
penten-1-ol using standard the standard mesylation conditions, which gave mesylate 398 in an 
excellent yield of 96%. Mesylate 398 was reacted with trifluroacetamide under phase transfer 
conditions to give the secondary trifluoroacetamide 399, which was hydrolysed to give amine 400. 
The yield of this hydrolysis was lower than anticipated due to the low boiling point of the product. A 
Michael addition of amine 400 and methyl propiolate gave 402. Unfortunately, despite the reasonable 
yield of 65%, this reaction gave the undesired cis alkene as the major product (cis:trans 75:25). The 
synthetic aim was to then react 402 with acryloyl chloride to construct the ring, which would make 
the desired 1,4,5,6-tetrahydropyridine with an ester group in the 3-position. Under these conditions, 
by 1H NMR analysis, it appeared that some product had been formed. However due to the low yields 
this route was abandoned as the selectivity of the Michael addition meant that it would be challenging 
and/or wasteful to bring enough material through to make enough of the final substrate 404.  
 
Scheme 117. Synthesis of substrate 361 by construction of core 
2.6 Enamine-type test substrates 
2.6.1 Substrate Synthesis 
Due to the challenges associated with the synthesis of substrate 362 it was decided that attention 
should be turned to the synthesis of a test substrate in order to investigate whether or not the Pd(II)-
catalysed C–H activation of non-aromatic substrates would be feasible. It was envisaged that the 




were targeted as they still contain an N-tethered alkene, the carbon-carbon double bond and the N-
acyl mesylamide directing group. All that was needed was to establish the best substituent to have on 
the nitrogen. To obtain substrates in the form of 404, 404 could be accessed by the functional group 
interconversion of 405, which itself could be made by the alkylation of 406. 406 is the product of a 
Michael addition reaction between methyl propiolate and a primary amine. 
 
Scheme 118. Test substrate 404 and its retrosynthesis 
The first aim was to investigate the Michael addition reaction, as it had the potential to form both the 
cis and trans isomers and only the trans isomer was desired. A range of primary amines were screened 
in order to see which gave the best selectivity (Table 17). In general, a preference for the trans 
stereoisomer was observed with roughly a 70%:30% trans:cis ratio calculated for most amines. There 
was a slight trend, in that a higher percentage of trans was observed for amines with smaller alkyl 
groups. Methylamine and ethylamine could not be used as in their pure form due to their low boiling 
points, so they had to be used in solution or as the hydrochloride (Table 17, entries 1-3). For both the 
use of the hydrochloride resulted in an unclear 1H NMR spectrum. A solution of methylamine in EtOH 
gave a clean 1H NMR spectrum and gave the highest ratio of the desired trans product. As shown 
previously, 4-pent-1-amine gave the cis isomer as the major product. It is unclear why there is such a 
large shift in selectivity when switching from the butylamine to the pentenylamine. p-
Toluenesulfonamide, benzamide and acetamide were also trialled (Table 17, entries 8-10), but no 




Table 17. trans:cis ratios of Michael addition products 
 
Entry Amine Solvent Trans:Cis Observationsa 
1 MeNH2.HCl MeCN 77:23 Messy 
2 MeNH2 (33% in EtOH) THF 85:15 Clean 
3 EtNH2.HCl MeCN 70:30 Messy 
4 iPrNH2 DMSO 70:30 Clean 
5 BuNH2 THF 68:32 Clean 
6 BuNH2 DMSO 72:28 Clean 
7 4-Penten-1-amine THF 25:75 Clean 
8 p-Toluenesulfonamide DMSO NA No reaction 
9 Benzamide THF NA No reaction 
10 Acetamide THF NA No reaction 
aAs observed by TLC and 1H NMR analysis 
The next step was to alkylate the Michael addition product 406a. Using the standard alkylation 
conditions of NaH and 5-bromo-1-pentene in DMF a 91% yield of 405a was obtained. Interestingly 
only the desired trans stereoisomer was observed. This suggested that during the reaction the cis 
isomer isomerised to the desired trans isomer. 
 
Scheme 119. Synthesis of 405a 
From here it was thought that a functional group interconversion to transform the methyl ester to the 
acid and then to the mesylamide would complete the synthesis of 404a. However, as experienced 
before with the cyclic derivative (cf. Table 12, page 91), hydrolysis of the methyl ester proved 
challenging. As before a range of conditions were trialled. Under basic and acidic conditions no 
reaction occurred, and only clean starting material was recovered. Using Krapcho conditions a 




Table 18. Screen of conditions for the hydrolysis of 405a 
 
Entry Conditions Yield of 408a (%) Observationsa 
1 LiOH 0 Clean SM 
2 NaOH 0 Clean SM 
3 HCl 0 Clean SM 
4 LiCl 0 Messy 
aAs observed by TLC and 1H NMR analysis 
A substrate was then synthesised bearing a phenyl substituent on the nitrogen instead of the methyl 
group. A phenyl group is electron-withdrawing by induction, so should take some of the electron 
density away from the methyl ester, making it more susceptible to base-catalysed hydrolysis. It was 
therefore hoped that this change in electronics would allow the ester hydrolysis step to occur. The 
phenyl derivative 406b was again accessed from a Michael addition reaction. The resulting mixture of 
cis and trans isomers was subjected to the standard alkylation conditions, and pleasingly only the 
desired trans product was obtained, in a yield of 77%. 
 
Scheme 120. Synthesis of 405b 
As before, basic, acidic and Krapcho conditions were trialled for the hydrolysis of methyl ester 405b. 
Under Kraphco conditions a complex mixture was observed. Under basic and acidic conditions 405b 




Table 19. Screen of conditions for the hydrolysis of 405b 
 
Entry Conditions Yield of 408b (%) Observationsa 
1 NaOH 0 409 
2 HCl 0 409 
3 LiCl 0 Messy 
aAs observed by TLC and 1H NMR analysis 
To remove the need for the hydrolysis step, the Michael addition was attempted using propiolic acid 
(Scheme 121A). Unfortunately, only a complex 1H NMR spectrum was observed, containing no alkene 
peaks. The secondary amine 414 was synthesised by an amide coupling reaction between aniline and 
4-pentenoic acid, followed by reduction using LiAlH4 to give 415. This secondary amine was also 
subjected to the Michael addition reaction conditions with propiolic acid but still no product was 
obtained (Scheme 121B).  
 
Scheme 121. Attempted Michael addition reactions with propiolic acid 
Due to the lack of success in the synthesis of substrates bearing alkyl and aryl substituents on the 
nitrogen, a substrate with tosyl group on nitrogen was then targeted. As seen previously the Michael 
addition doesn’t work with p-toluenesulfonamide, so a secondary sulfonamide was synthesised as it 
should be more nucleophilic, making the Michael addition reaction more likely. To make the secondary 
sulfonamide, p-toluenesulfonamide was alkylated with 5-bromo-1-pentene using K2CO3 in MeCN. This 




solely the desired trans product 405c with a yield of 80%. 405c was then readily hydrolysed using 
NaOH and then converted to the desired N-acyl sulfonamide 404c by amide coupling.  
 
Scheme 122. Synthesis of and attempted cyclisation 404c 
2.6.2 Pd(II)-Catalysed cyclisation of test substrate 
The tosyl substrate 404c was subjected to standard Pd(II)-catalysed cyclisation conditions (Scheme 
122). The pivalic acid additive was omitted as it is known to not be vital for reaction to occur, so as to 
minimise the number of variables. No formation of the desired cyclisation product occurred, instead 
the hydrolysed derivative 416 was formed. It is thought that this occurred because the palladium 
catalyst can act as a Lewis acid to generate imine 419 which can then be hydrolysed by any trace 
amounts of water present in the reaction mixture.  
 
Scheme 123. Hydrolysis of 404c 
To avoid this hydrolysis, all traces of water needed to be eliminated from the reaction mixture. Several 
methods for drying the reaction mixture were investigated. 1 equiv. of the chemical drying agent Ac2O 
was added to the reaction mixture, prior to substrate addition, and the mixture stirred for 5 minutes. 
After 16 hours at 100 °C the 1H NMR of the crude material revealed that indeed the addition of Ac2O 
appeared to suppress the hydrolysis of the starting material. In the absence of Ac2O there was no 
starting material present at the end of the reaction, but with 1 equiv. of Ac2O there was some starting 
material left, along with some of the hydrolysed starting material and one other unknown derivative. 
The presence of these compounds could be monitored by looking at the aromatic region of the 1H 




to 3 equiv., only unreacted starting material was observed. Molecular sieves were also trialled, but 
they were not as effective as Ac2O. 
 
Figure 8. Comparison of aromatic region of 1H NMR for different drying agents. 
Having solved the hydrolysis problem, screening of reaction conditions was begun to see if any 
formation of the desired cyclisation product could be achieved. The first variable to be investigated 
was the source of palladium. A variety of palladium catalysts were screened, including more 
electrophilic sources of palladium such as Pd(TFA)2. Unfortunately, no formation of the desired 
cyclisation product was observed for any of the catalysts trialled. TLC and 1H NMR analysis of all 
reactions showed only unreacted starting material. Pd(OAc)2 was kept as the catalyst of choice 
because it resulted in the least amount of starting material degradation. 
Table 20. Palladium screen 
 
Entry Pd Catalyst Yield of 417 (%)a  Unreacted 404c (%)a 
1 Pd(OAc)2 0 58 
2 Pd(MeCN)2(OTs)2 0 50 
3 Pd(TFA)2 0 45 
4 PdCl2 0 32 
5 [Pd(allyl)Cl]2 0 50 
6 Pd(MeCN)2Cl2 0 46 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
Molecular 
sieves 
3 equiv. Ac2O 






An oxidant screen was then carried out to see if improving the catalytic turnover could result in the 
formation of product. When Cu(OAc)2 was swapped for AgOAc a higher amount of unreacted starting 
material remained, but there were unidentifiable impurities present. The common oxidant BQ was 
trialled, as was the bulky derivative 3,5-ditBu p-BQ but neither yielded any product. The stronger 
oxidant IBX was trialled to see if a Pd(II)/Pd(IV) pathway could be encouraged, but again no product 
was formed. 
Table 21. Oxidant screen 
 
Entry Oxidant Yield of 417 (%)a  Unreacted 404c (%)a Observationsa 
1 Cu(OAc)2 0 58 - 
2 AgOAc 0 82  Unidentified impurities 
3 p-BQ 0 -b - 
4 3,5-tBu p-BQ 0 74 Some loss of Ms 
5 IBX 0 60  Unidentified impurities 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard bInternal standard overlapped with 
BQ derivative so mass recovery could not be calculated by 1H NMR 
It is known that a change in solvent can drastically affect the outcome of a reaction. A number of 
solvents were screened, including the higher boiling point solvents DMF and DMSO so the reaction 
could be heated to a higher temperature (Table 22). Unfortunately, only starting material was 
observed for all solvents. It was expected that an increase in temperature would encourage either the 
product to form, the formation of another species, or increase the decomposition process by which 
the starting material was being lost. In fact, when the temperature was raised the amount of 




Table 22. Solvent and temperature screen 
 
Entry Solvent Temperature Yield of 418 (%)a Unreacted 404c (%)a 
1 DMF 100 °C 0 42 
2 DMSO 100 °C 0 72 
3 DMF 120 °C 0 65 
4 DMSO 120 °C 0 77 
5 THF 60 °C 0 56 
6 toluene 100 °C 0 41 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard 
2.6.3 Change of directing group 
For Pd(II)-catalysed indole and pyrrole cyclisation methodology N-acyl mesylamide was an effective 
directing group. Other directing groups were trialled for the enamine-type substrates to see if there 
was a more suitable directing group for these substrates. The directing groups must still have been 
secondary amides to have the N–H available for aza-Wacker reaction.  N-Alkoxy amide directing 
groups, such as N-methoxy amide, are known to be versatile directing groups.48 The N-methoxy amide 
was easily accessed from the acid 408c (Scheme 124). 408c was first reacted with oxalyl chloride to 
form the acid chloride, which was then reacted with methoxy amine hydrochloride to give 420 in a 
yield of 28%. Despite the poor yield enough material was generated to trial the cyclisation reaction. 
Unfortunately, under the standard cyclisation conditions no cyclised product 421 was formed. 
 
Scheme 124. Synthesis and attempted cyclisation of N-methoxy amide substrate 420 
There is also much literature precedent for the 8-aminoquinoline directing group.52 This could be a 
more effective directing group as the two nitrogen atoms allow it to act as a bidentate directing group 
thus binding and delivering the Pd(II) catalyst more efficiently. The 8-aminoqinoline group possesses 
a relatively acidic N–H bond, so deprotonation and coordination to Pd should have been able to occur. 




conditions (Scheme 125). This gave 423 in a yield of 38%. Under the standard cyclisation conditions, 
no product was observed.  
 
Scheme 125. Synthesis and cyclisation of 8-aminoquinoline substrate 422 
2.6.4 Change of N-substituent 
At this stage, no C–H activation of the enamine-type substrate had been achieved. The next step was 
to investigate a change in N-substituent as this would change the electronics of the substrate and was 
expected to make the C–H bond more reactive. 
One substrate that was easily synthesised was one with a triflyl group on the nitrogen. This was made 
in the same way as the tosyl substrate. Reaction of trifluoromethanesulfonamide with 5-bromo-1-
pentene gave the secondary sulfonamide 426. The yield obtained was lower than that of tosyl 
derivative 416 as a triflyl group is more electron-withdrawing, so the reaction was more susceptible 
to dialkylation. The subsequent Michael addition, ester hydrolysis and amide coupling reactions 
proceeded in moderate to excellent yields to give the triflyl-substituted substrate 404d. When 404d 
was subjected to standard cyclisation conditions the desired cyclisation product was not formed. This 
result was unsurprising as the electron-withdrawing nature of triflyl removes electron density from 
the C–H bond making it less likely to be activated by the electrophilic Pd(II) catalyst.   
 




A substrate with a N-substituent less electron withdrawing than tosyl and triflyl was desired. As 
described previously substrates with methyl and phenyl substituents were inaccessible. The synthesis 
of an acetyl or benzoyl derivative was targeted as, despite still being electron-withdrawing groups, 
they are less electron withdrawing than tosyl and triflyl. 
The Michael addition reaction of the primary amides acetamide and benzamide with methyl 
propiolate did not yield any product (Table 17, entries 9 and 10, page 103), due to the low 
nucleophilicity of these amides. A reaction was found in literature in which benzamide could be added 
to methyl propiolate using Pd catalysis. This reaction allowed 429 to be formed with a yield of 58%. 
However, instead of the desired trans product, only the cis isomer was formed. Previously it was found 
that upon alkylation the cis isomers isomerised to the desired trans-isomers, so it was hoped that 
following alkylation the desired trans product would be obtained. First the standard alkylation 
conditions of NaH and 5-bromo-1-pentene in DMF were trialled. The reaction was monitored by TLC, 
but no reaction was observed. After 1 week the reaction mixture was worked up and analysis by 1H 
NMR showed a complex mixture, with no appreciable amount of the desired product. Due to this lack 
of reactivity, the reaction was repeated but with the iodide instead of the bromide. Again, no reaction 
was observed by TLC and by 1H NMR of the crude material mainly unreacted starting material was 
present. In a distinct approach, Mitsunobu conditions were also trialled but once again a complex 
mixture was observed by 1H NMR, with the major component being unreacted starting material. 
 
Scheme 127. Attempted synthesis of 405e 
Attention was then turned back to the use of a Michael addition reaction. When making the tosyl 
derivative the Michael addition reaction did not work for the primary sulfonamide but did for the 
secondary sulfonamide. The secondary amide 431 was synthesised to see if this was also the case for 
acetamide and its derivatives. Amide 431 was obtained by the alkylation of acetamide with 5-bromo-
1-pentene using K2CO3 as a base which gave a yield of 34%. This low yield was due to the high 
proportion of the over alkylated by-product. The secondary amide 431 was stirred with methyl 




product was present, along with unreacted starting material and a large amount of by-product 432. A 
20% conversion to product with respect to unreacted starting material was calculated, but the desired 
product 405f accounted for only 7% of the total reaction mixture due to the presence of 61% by-
product 432, a dimer of methyl propiolate. To supress the formation of this by-product the reaction 
was repeated but with methyl propiolate added as a dilute solution in MeCN over a period of 30 
minutes in order to keep the concentration of methyl propiolate low to encourage it to react with the 
amide rather than itself. Indeed, this did slightly improve the outcome of the reaction, giving a 
conversion of 25%, with 405f accounting for 16% of the completed reaction mixture and 432 36%. 
Unfortunately, this conversion was still poor, and the dimer was inseparable by flash column 
chromatography. This meant that the material could not be taken forward for subsequent reactions. 
The reaction was also trialled using the stronger base NaH, but this resulted in a complex 1H NMR 
spectrum containing neither product nor by-product peaks. 
Table 23. Ratio of 405f, 431 and 432 
 
Entry Conditions 
% of reaction mixture by 1H NMR % Conversion to 
405f wrt 431 405f 431 432 





16 48 36 25 
 
It is thought that the formation of this dimer by-product is as a result of the secondary amide being 
able to act as a base as well as a nucleophile. The deprotonated amide is able to deprotonate methyl 
propiolate, enabling it to act as the Michael donor and attack another equivalent of methyl propiolate. 
The increased basicity of 431 compared to that of the tosyl derivative 417 may be due to the amide 






Scheme 128. Nucleophilic vs basic reactivity of 431 
2.6.5 The use of a shorter tether 
As discussed previously, it was hypothesised that the reason for the formation of undesired 417 when 
404c was subjected to the standard cyclisation conditions was due to Pd acting as a Lewis acid, and 
attacking β to the nitrogen (cf. Scheme 123, page 106). If the tether was one methylene unit shorter 
this may allow the alkene to coordinate to the Pd and then be inserted into the Pd–C bond to form a 
6-membered ring, which may result in a novel distinct Pd-catalysed methodology (Scheme 129).  
 
Scheme 129. Proposed cyclisation of 437 
The substrate with a shorter tether was synthesised in the same manner as tosyl substrate 404c: 
alkylation of tosyl sulfonamide with 4-bromo-1-butene and K2CO3, Michael addition to methyl 
propiolate in the presence of NMM, hydrolysis of the methyl ester and then amide coupling. All of 





Scheme 130. Synthesis of 437 
Substrate 437 was subjected to the standard cyclisation conditions. Unfortunately, no product 439 
was observed, with only unreacted starting material present in the 1H NMR of the crude material.  
2.7 Aniline-type substrates 
It is likely that the Pd(II)-catalysed C–H activation and cyclisation of the enamine-type substrates was 
unsuccessful due to their inability to undergo an SEAr C–H activation mechanism. The lack of 
aromaticity combined with the lack of electron density on the C–H bond meant that it would be 
difficult for the C–H to be activated by the electrophilic palladium catalyst. Because of this, aniline-
type substrates were then targeted. Anilines are aromatic and have a much greater electron density, 
so they are more likely to allow SEAr to occur. This was a move away from a system which would allow 
the synthesis of the matrine alkaloids, but it had the potential to still lead to an oxidative Heck/aza-
Wacker cascade sequence and would allow access to a new class of interesting novel polyheterocycles. 
It would also provide mechanistic information on the catalytic sequence. It was envisaged that such 
substrates could be easily synthesised from commercially available amino benzoate derivatives. 
 
Scheme 131. Retrosynthetic analysis of aniline-type substrates 443 
Once again, a substituent was needed on the nitrogen. Initially a substrate was synthesised with a 
tosyl substituent on the aniline nitrogen in order to more directly compare with the previous class of 
substrates. Methyl-3-aminobenzoate was reacted with TsCl in the presence of NMM to install the tosyl 
group, giving 447 in an excellent yield of 96%. The aniline nitrogen was then alkylated using 4-bromo-




membered rings in the cyclisation reaction. Hydrolysis of the methyl ester to uncover the acid was 
facile and proceeded in a near-quantitative yield. The acid 448a underwent an amide coupling reaction 
with methanesulfonamide to yield the desired substrate 443a. When subjected to the standard 
cyclisation conditions no formation of cyclised product 449 was observed, with only unreacted starting 
material recovered. For these substrates a drying agent was no longer needed because such substrates 
are much less likely to form a hydrolysable imine.  
 
Scheme 132. Synthesis and cyclisation of tosyl-substituted aniline substrate 443a 
An aniline substrate with a methyl substituent on nitrogen was then targeted. The removal of the 
electron-withdrawing tosyl group should increase electron density of the aromatic ring, increasing the 
likelihood of C–H activation by SEAr. The methyl group was necessary as a free N–H may interfere with 
the catalytic cycle, as it would have the possibility of coordinating to the Pd catalyst. Synthesis of an 
aniline substrate with a methyl group as the N-substituent was achieved in a similar manner to tosyl 
substrate 443a, but the alkylation step was carried out before methylation. The alkylation step was 
slow, with a yield of 445 of only 48% despite heating at reflux for 72 hours. Methylation using MeI and 
K2CO3 was also low yielding, but subsequent functional group interconversion resulted in enough of 
the desired substrate 443b to try the cyclisation reaction. Unfortunately, under the standard 





Scheme 133. Synthesis and cyclisation of methyl-substituted aniline substrate 443b 
The by-product of the alkylation of methyl-3-aminobenzoate was the dialkylated product 444c. This 
was also taken through to the mesylamide as it only involved two straightforward steps to get to the 
interesting substrate 443c. The use of this substrate is effectively doubling the concentration of alkene 
present, so if any C–H activation is occurring it would increase the changes of subsequent alkene 
coordination and migratory insertion. The presence of a second tethered alkene may also lead to the 
formation of more complex products. However, once again, no cyclised product was formed under 
the standard cyclisation conditions.  
 
Scheme 134. Synthesis and cyclisation of dialkylated aniline substrate 443c 
An aniline substrate with an acetyl substituent on the nitrogen was trialled. An acetyl substituent is 
less electron withdrawing than tosyl but more so than alkyl groups. As mentioned previously, the 
alkylation of methyl-3-amino benzoate gave only moderate yields even after heating at reflux for 72 
hours. Therefore, in an attempt to improve the yields of the synthesis, the acetylation step was carried 
out first. Acetylation was achieved using Ac2O, DIPEA and DMAP to give 452 in a yield of 59%. For the 




However, under these conditions no alkylation occurred at room temperature, and after heating to 
85 °C still only starting material was present. The bromide was converted to a tosyl group, as this 
would serve as a better leaving group, but still no reaction occurred. This could be because the 
substrate was not nucleophilic enough due to the electron withdrawing nature of both the acetyl and 
methyl benzoate groups. 
 
Scheme 135. Attempted acetylation and alkylation of 446 
It was therefore necessary to revert back to the alkylation of methyl-3-aminobenzoate followed by 
acetylation. This time acetylation was achieved using Et3N instead of DIPEA, giving 444d in a yield of 
84%. The synthesis was completed by hydrolysis of the methyl ester and amide coupling with 
methanesulfonamide. Substrate 443d was then subjected to the standard cyclisation conditions and 
1% yield of the cyclised product 453 was observed by 1H NMR. Despite this being a very poor yield, it 
served as a ‘proof of concept’ and demonstrated that C–H activation of these aniline-type substrates 
was possible. This supports the hypothesis that the C–H activation is occurring via an SEAr-type 
mechanism.  
 
Scheme 136. Synthesis and cyclisation of acetyl-substituted aniline substrate 443d 
Due to the success of the acetyl-substituted substrate, other substituents with similar pKa’s to acetyl 
were selected for investigation. Substrates with a urea and a carbamate substituent were trialled 
(Scheme 137). These were both synthesised in an analogous fashion to previous aniline-type 






Scheme 137. Synthesis and attempted cyclisation of urea- and carbamate-substituted aniline substrates 443e 
and 443f 
Another way of increasing the electron density of the aniline system was to introduce an electron 
donating substituent onto the aniline ring itself. A substrate with a methoxy group para- to the site of 
C–H activation was synthesised from commercially available 3-amino-5-methylbenzoic acid. First, the 
acid was protected by esterification using SOCl2 and MeOH which gave methyl ester 457 in a yield of 
87%. The aniline nitrogen of 457 was then alkylated using 4-bromo-1-butene, K2CO3 and TBAI in MeCN. 
As seen with previous alkylations of aniline substrates, this was a very slow reaction that required 
refluxing for 5 days and a yield of 458 of only 36% was obtained. The nitrogen was acetylated using 
Ac2O, DMAP and Et3N and then the methyl ester was converted to the mesylamide using the standard 
hydrolysis and amide coupling conditions, with all reactions proceeding in high yields to give the 
desired substrate 461. Under the standard cyclisation conditions the cyclisation product 462 was 
observed with a 1H NMR yield of 7%. Isolation of the cyclisation product by flash column 
chromatography gave an isolated yield of 5%. The fact that the addition of an electron-donating 
substituent resulted in an increase in yield further supports the theory that the C–H activation step is 
occurring by an SEAr-type mechanism and that a high electron density is needed for the reaction to 
occur. 
Unfortunately, full 13C NMR data could not be obtained for 462. This compound is very rich in 
quaternary carbons which have long T1-relaxation times. T1-relaxation is the rate of energy transfer 




relaxation times than other carbons because usually the main contribution to T1-relaxation comes 
from 1H-13C dipole interactions. Initial 13C NMR experiments were carried out with standard relaxation 
times, resulting in some missing peaks. When the NMR experiments were repeated with much longer 
relaxation times the compound appeared to have degraded significantly in the time since the previous 
NMR experiments. However, the NMR data obtained, along with mass spec and FTIR data, was enough 
to confidently confirm the structure of the cyclisation product 462.  
 
Scheme 138. Synthesis and cyclisation 4-methoxy substituted aniline substrate 461 
At this stage it was known that electronics were playing a significant role in whether or not C–H 
activation would occur. For this reason, a range of palladium sources were screened to see if a change 
in electrophilicity of the palladium would have an effect on the reaction outcome (Table 24). All 
catalysts trialled resulted in the formation of at least a trace amount of the cyclisation product, but 
none increased the 1H NMR yield by any significant amount. 
Table 24. Palladium screen 
 
Entry Catalyst Yield of 453 (%)a Unreacted 443d (%)a 
1 Pd(OAc)2 1 15 
2 Pd(TFA)2 <1 30 
3 PdCl2 <1 20 
4 Pd(MeCN)2Cl2 2 10 
5 Pd(MeCN)2(OTs)2 1 5 




An oxidant screen was then carried out to see if increasing catalytic turnover could increase the yield 
(Table 25). BQ was trialled as it is a common oxidant in oxidative Heck reactions, but no product 
formed and only 5% starting material remained (Table 25, entry 2). BQ was also trialled but as part of 
literature conditions using TsOH.H2O in THF (Table 25, entry 3). Again, this yielded no product, and 
under these conditions complete degradation of starting material was observed. Several other 
oxidants were screened, but still only trace amounts of the desired cyclisation product were formed. 
Table 25. Oxidant screen 
 
Entry Oxidant Yield of 453 (%)a Unreacted 443d (%)a 
1 Cu(OAc)2 1 15 
2 BQ 0 5 
3b BQ 0 0 
4 AgOAc <1 25 
5 oxone <1 10 
6 K2S2O8 1 30 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard b TsOH.H2O (2 equiv.) and THF 
instead of K2CO3 and dioxane 
It is known that a change in solvent can have a drastic effect on the outcome of the reaction, so a 
range of solvents were screened (Table 26). Unfortunately, for all solvents trialled, other than dioxane, 
no cyclisation product was observed. 
Table 26. Solvent screen 
 
Entry Solvent Yield of 453 (%)a Unreacted 443d (%)a 
1 Dioxane 1 15 
2 DMF 0 13 
3 DMSO 0 10 
4 Toluene 0 1 
5b THF 0 8 




When optimising the conditions for the indole cyclisation methodology it was found that the addition 
of an organic acid additive gave an increase in yield. The cyclisation of 443d was carried out with 30 
mol% PivOH as an additive to see this would result in any increase in yield. Sadly, still only a trace 
amount of product was observed in the 1H NMR of the crude material, along with 32% unreacted 
starting material. 
 
Scheme 139. Cyclisation of 443d with PivOH additive 
There are examples in literature of similar reactions being carried out under acidic conditions.117, 119 
The cyclisation reaction was carried out under acidic conditions rather than basic conditions, with 
K2CO3 replaced with AcOH. This resulted in a complex mixture as observed by TLC and 1H NMR analysis 
of the crude material, which appeared to include a trace amount of product. Purification of the crude 
mixture by flash column chromatography was attempted in order to elucidate the identity of the 
unknown by-products, however much coelution occurred so no by-products were isolated. 
 
Scheme 140. Cyclisation of 443d under acid conditions. 
One thing that could be noted from these optimisation experiments was the consistent poor mass 
recovery. For each reaction only up to 30% of the original mass could be accounted for, meaning the 
remaining 70% was being lost. This loss was likely due to degradation or polymerisation pathways. A 
series of control experiments were carried to determine what was causing this loss of material. The 
usual conditions were repeated but with 3 equiv. of Ac2O as a drying agent to see if elimination of all 
traces of water could improve the mass recovery. Indeed, the amount of unreacted starting material 
observed was increased to 75%, but under these conditions no product was formed. The reaction was 
then carried out in the absence of Pd(OAc)2 as this is the reagent most likely to be causing loss of mass 
by unfavourable Pd-catalysed pathways. The amount of unreacted starting material increased, but 




out in the absence of oxidant, with both a catalytic and stoichiometric amount of Pd(OAc)2. For both 
reactions a trace amount of product was observed but the mass recovery was poor. In the absence of 
base, a complex mixture was observed by 1H NMR, but with a high mass recovery. In the absence of 
both Pd(OAc)2 and Cu(OAc)2 100% starting material was recovered. 
Table 27. Control reactions for the cyclisation of 443d 
 
Entry Pd(OAc)2 Cu(OAc)2 K2CO3 Heating Yield of 453 (%)a Unreacted 443d (%)a 
1     Trace 15 
2b     0 75 
3     0 35 
4     0 45 
5     Trace 10 
6c     Trace 7 
7     Trace 
Complex mixture 
~90% Mass 
8     0 100 
9     0 100 
aAs determined by 1H NMR analysis with 1,4-dimethoxybenzene as an internal standard b Ac2O (3 equiv.) added. 
cStoichiometric Pd(OAc)2, run for only 30 minutes 
From these results it is still not clear what is the cause of the poor mass recovery. It is likely that it is 
not just one factor, but a combination. It was noticed previously that the isolated product appeared 
to be unstable, as when NMR experiments were repeated the sample appeared to have degraded. 
This may mean that the product is being formed during the reaction but then degrading before the 
end of the reaction. 
The C–H activation of 443d was then carried out with the addition of phenyl boronic acid. If any C–H 
activation was occurring, it was expected that the carbopalladated intermediate would be trapped 
out by the phenyl boronic acid and arylate the aniline. It was hoped that this would give information 
on which sites around the aniline ring were able to undergo C–H activation. If the yield of arylated 
product had been greater than 1% that would suggest that in the usual cyclisation reaction either C–
H activation was occurring, but migratory insertion of alkene was inefficient, or the reaction was 




arylation on the aniline ring occurred. Instead the phenyl ring was added to the terminal position of 
the alkene, and this product was obtained in a yield of 6%.   
 
Scheme 141. Addition of phenyl boronic acid 
2.8 Intramolecular C–H activation of acetanilides 
There is much literature precedent for the C–H activation of acetanilides and phenylureas.116 In these 
examples the amide/urea acts as the directing group to achieve ortho- C–H activation. This suggests 
for the C–H activation of substrates such as 443d, the N-acyl mesylamide directing group should not 
be necessary for the initial oxidative Heck reaction to occur as the amide should also be able to serve 
as a directing group. Removal of the N-acyl sulfonamide would also increase the electron density of 
the aromatic ring, favouring the electrophilic attack of palladium. All examples found in the literature 
of acetanilide and phenylurea directed C–H activation are intermolecular.116 It was thought that the 
presence of a tethered alkene on the nitrogen of the acetanilide, as seen in aniline substrates such as 
467, could mean that an intramolecular oxidative Heck reaction could be achieved.  
To synthesise the acetanilide with a tethered alkene literature conditions were found in which 
acetanilide could be alkylated using a tosylate.177 Tosylate 466 was synthesised from 3-buten-1-ol 
using tosyl chloride and DMAP. 466 was then reacted with acetanilide in the presence of NaOH, TBAHS 
and K2CO3 to give the desired substrate 467 in a yield of 76%. Acetanilide substrate 467 was subjected 
to the standard cyclisation conditions. No formation of the desired product occurred and 93% of 
unreacted starting material remained.  
 
Scheme 142. Synthesis and attempted cyclisation of 467 
To increase the electron density of the system and activate the C–H bond a substrate with a methoxy 




using Ac2O and pyridine in DCM to give 470 in an excellent yield of 93%. 470 was then alkylated using 
NaH and 4-bromo-1-butene in DMF. Substrate 471 was subjected to the standard cyclisation 
conditions but, as with substrate 467, no cyclisation occurred, and 90% unreacted starting material 
remained. 
 
Scheme 143. Synthesis and cyclisation of 471 
Given the complete lack of reactivity, it was not apparent whether it was the C–H activation step that 
was not occurring, or the incorporation of the alkene.  The cyclisation of 467 was repeated but with 
the addition of D2O. If the C–H activation step was occurring, deuterium incorporation ortho- to the 
directing group should occur, which would be observable by 1H NMR. In the 1H NMR spectrum of the 
crude material, following subjection to the cyclisation conditions, 100% of the starting material 
remained unreacted with no apparent deuterium incorporation. This implied that no C–H activation 
was occurring.  
 
Scheme 144. Deuterium incorporation experiment 
As it appeared that no C–H activation was occurring a change in conditions was investigated. An 
example was found in the literature that used a Pd(OAc)2 catalyst, K2S2O8 as the oxidant and a mixture 
of TFA and DCM as the solvent to couple methyl acrylate to the ortho-position of acetanilide (Scheme 
145A).118 The paper also included an example in which the reaction was directed by a tertiary amide 
(Scheme 145B), albeit in a much lower yield and with increased heating, which suggested that C–H 
activation of the alkene-tethered acetanilide substrate may be feasible using these conditions. When 
467 was subjected to these literature conditions no cyclisation occurred (Scheme 145C). Another 
factor was the reactivity of the alkene: the majority of literature reactions use activated alkenes such 
as acrylates. The reaction was repeated but with the addition of 4 equiv. of ethyl acrylate, to give the 






Scheme 145. Literature conditions for the C–H activation of acetanilides  
Another search of the literature found an example of the oxidative coupling of acetanilide with butyl 
acrylate using a Pd(OAc)2 catalyst, BQ as the oxidant and TsOH.H2O as an additive in AcOH (Scheme 
146A).117 Interestingly, this study reported that methylation of the amide directing group completely 
shut down the reaction (Scheme 146B). 
 
Scheme 146. Literature conditions for the C–H activation of acetanilides 
This example of the necessity of the N–H bond, along with the fact that the majority of other examples 
in the literature are with secondary amides instead of tertiary amides may shed light onto why the 
reactions of alkene tethered amides were not working. It may be that the N–H is necessary to allow 





Scheme 147. Possible palladacycles 
Substrates containing an N–H bond within the directing group were therefore targeted. The urea 
substrate 484 was synthesised. First alkylation of aniline using K2CO3 in DMF gave 483 in a yield of 
57%. This was followed by reaction with t-butyl isocyanate which gave the urea substrate 484 in a 
yield of 84%. Substrate 484 was subjected to standard cyclisation conditions, but no cyclisation 
occurred. 
 
Scheme 148. Synthesis and attempted cyclisation of urea substrate 484 
Another substrate targeted was 486. This substrate is an acetamide with the free N–H with the alkene 
tethered to the phenyl ring rather than the acetanilide nitrogen. It was thought that this substrate 
could be easily accessed in one step by the coupling of the acetamide moiety with the tethered alkene 
moiety.   
 
Scheme 149. Retrosynthetic analysis of 486 
A wide range of transition metal-catalysed cross coupling conditions were employed in an attempt to 
obtain substrate 486 (Table 28.). Negishi coupling conditions were found for a very similar reaction in 
which 3-bromo acetanilide is coupled to an alkyl bromide.178 These conditions were trialled (Table 28, 
entry 1) but by 1H NMR analysis of the crude material mainly starting material remained with only a 
trace amount of the desired product. Upon flash column chromatography no product was isolated. 
The lack of reactivity of this reaction may have been caused by difficulties in activating the zinc. An 
alternative approach was to use a Kumada coupling reaction (Table 28, entries 2-6). A variety of 
conditions were trialled, utilising a number of different transition metal catalysts including Nickel, Iron 




3-Bromo aniline was also used as a substrate in case the lack of reactivity was being caused by the 
presence of the amide (Table 28,entry 6), but still no product was observed. A number of Suzuki 
reactions were also trialled (Table 28, entries 7-9) with the chloro- and iodoacetanilides trialled in 
addition to the bromoacetanilide, but once again no reaction occurred. Finally, a Heck reaction was 
attempted between 3-bromo acetanilide and 1,4-pentadiene (Table 28, entry 10) but once again no 
product was observed. 
Table 28. Conditions for the coupling of 487 and 366 
 
Entry Conditions Yield of 486 (%)  Observationsa 
1 Ni(COD)2, bipy, Zn, NaI, 
pyridine, DMPU, 60 °C 
0% SM 
2 Mg, NiCl2(dppp), THF 0% SM 
3 Mg, FeCl3, TMEDA, THF, 0 °C 0% SM 
4 Mg, CoCl3, TMEDA, THF, 0 °C 0% SM 
5 Mg, Li2CuCl4, THF, reflux 0% SM 
6b Mg, NiCl2(dppp), THF 0% SM 
7c Pd(PPh3)4, K2CO3, THF 0% SM 
8c,d Pd(PPh3)4, K2CO3, THF 0% SM 
9c,e Pd(PPh3)4, K2CO3, THF 0% SM 
8f PdCl2(PPh3)2, NEt3, DMF, 90 °C 0% SM 
aAs observed by TLC and 1H NMR analysis bBromo-aniline instead of acetamide c4-Pentenyl boronic acid instead used of 





3. Conclusions and Future Work 
In conclusion, a novel Pd(II)-catalysed C–H activation/aza-Wacker cascade sequence has been 
optimised for indoles bearing an N-tethered alkene and an N-acyl mesylamide directing group. This 
allows for the generation of complex polycyclic heterocycles. 
Following an investigation into directing groups, a DoE, and a screen of MPAA ligands and acid 
additives the following optimised conditions were established: 10 mol% Pd(OAc)2, 3 equiv. Cu(OAc)2, 
2 equiv. K2CO3, 30 mol% PivOH, dioxane (0.1 M), 100 °C. 
 
Scheme 150. Optimised reaction conditions for the oxidative Heck/aza-Wacker cyclisation of 201 
The scope of this cyclisation reaction was investigated. The reaction was shown to be tolerant to 
substituents on the tether and on the terminal position of the alkene, but with the methyl-substituted 
substrate 220a resulting in the surprising formation of the seven-membered derivative 231. The 
tolerance to substituents on the indole ring was also explored. A variety of substituents were chosen 
at different positions around the indole ring, including ether, nitrile and halide groups. The majority 
of these substrates underwent the cyclisation reaction in good yields, with the reaction showing a 
slight preference for electron-donating substituents in the C5 position.   The scope of the reaction was 
then expanded by switching the indole core for a pyrrole core. Six examples were synthesised with 
substituents at both the 4- and 5-positions. The cyclisation of these pyrrole substrates proceeded in 
moderate yields, but less than those seen for indoles. Further optimisation studies were undertaken 
but no improvement in the yields was seen.  
 
Scheme 151. Scope of the oxidative Heck/aza-Wacker cyclisation 
An area of further exploration could involve substrates bearing a phenyl ring at the terminal position 




an excellent yield of 75%. Incorporation of electron-withdrawing and -donating groups onto the 
phenyl ring would be interesting as this would greatly change the electronics of the alkene. Any trends 
observed may give more information on the reaction mechanism. The products generated from these 
substrates also contain a chiral centre. The addition of chiral ligands may result in enantioselectivity. 
It is known that MPAA’s can be used as additives in the cyclisation reaction, so may represent an 
excellent source of chirality.  
 
A number of experiments have been carried out to gain evidence to support the proposed mechanism. 
When the cyclisation reaction was carried out using only one equiv. of the Cu(OAc)2 oxidant the yield 
was poor. The need more than 1 equiv. of Cu(OAc)2 supported a dual catalytic cycle. Cyclisation using 
the N-methylated mesylamide substrate 334 yielded only unreacted starting material, suggesting that 
the first step in the mechanism is pre-coordination of the Pd(II) centre to the N-atom, which is likely 
facilitated by K2CO3. Synthesis and cyclisation of the putative N-tosylamide intermediate 188 strongly 
suggested its involvement in the catalytic cycle. The mechanism was subsequently revised to reflect 
these observations. In order to confirm the reaction mechanism, kinetic studies must be carried out, 
as the determination of a KIE would provide further evidence for the mechanism in operation. 
The use of the cyclisation reaction as the key step in the total synthesis of the Matrine alkaloids was 
then targeted. For this to be realised the development of a scalable and straightforward synthesis 
towards substrates in the form of 361, containing a tetrahydropyridine core, was necessary. 
Unfortunately, despite a diverse range of routes trialled the synthesis of 361 was unsuccessful. 
 
Scheme 152. Matrine synthesis via a Pd(II)-catalysed cascade reaction 
In order to test the C–H activation chemistry of non-aromatic substrates, the acyclic substrate 404c 
was synthesised as a test substrate due to its similar electronic properties to 361. Unfortunately, 




postulated that the lack of reactivity of these enamine-type substrates was due to the lack of electron 
density and the absence of aromaticity, prohibiting C – H activation via an SEAr-type mechanism.  
 
Scheme 153. Attempted oxidative Heck/aza-Wacker cyclisation of enamine-type substrates 
It was proposed that an aniline-type substrates 443 would be more likely to undergo C – H activation 
via an SEAr-type mechanism. Indeed, under the standard cyclisation conditions, the acetyl substituted 
aniline substrate 443d gave a 1% yield of the desired cyclisation product 453. This served as a proof 
of concept. When the electron density of the system was increased by the addition of a methoxy group 
the yield increased, further supporting a SEAr-type mechanism.  
 
Scheme 154. Oxidative Heck/aza-Wacker cyclisation reaction of aniline-type substrates 
A comprehensive screen for the cyclisation of aniline-type substrates was carried out, but to date no 
improvement on the initial yields has been achieved. Despite this, the optimisation of this 
methodology remains a key area of interest as it represents a route to a novel class of complex N-
containing polyheterocycles, which are likely to possess biological activity.  
A brief investigation into the intramolecular C–H activation and cyclisation of acetanilide and its 
derivatives has also been undertaken, but to date no success has been achieved in this area. 
 
Scheme 155. Attempted intramolecular C–H activation and cyclisation of acetanilide 
It was hypothesised that substrates with a free N–H in the directing group may be more effective, so 




targeted. Initial attempts to synthesise 486 using transition metal catalysed cross-coupling reactions 
were unsuccessful. Another potential route is proposed below. If 486 could be accessed it would allow 
the investigation of it’s potential as a substrate for C–H activation.  
 
Scheme 156. Potential route towards 492 
An alternative method of achieving substrates with a free amide N–H would be to incorporate the 
amide into the tether (Scheme 157). 
 







4.1 General information 
All reactions were performed in flame-dried glassware under N2 using anhydrous solvents unless 
otherwise stated. Anhydrous THF, DCM, Et2O and MeCN were dried using an Anhydrous Engineering 
Grubbs-type system (alumina columns). Other solvents (e.g. dioxane, DMF) were purchased in 
suresealTM containers and transferred to a Straus flask prior to use. Chemicals were purchased from 
Acros Organics, Alfa Aesar, Fisher Scientific, Fluorochem, Sigma-Aldrich or TCI and were used without 
further purification. Flash column chromatography was performed using silica gel (Merck Kieselgel 60 
F254 230-400 mesh (40-63 μm)). The crude material was applied to the column as a solution, or by 
pre-adsorption onto silica where necessary. Aluminium-backed silica plates (0.2 mm, 60 F254) were 
used for TLC analysis, and visualisation was achieved either by UV fluorescence or KMnO4 solution and 
heat. 
Melting points were obtained using Stuart Scientific SMP10 melting point apparatus and are 
uncorrected.  
NMR spectra were recorded at 25 °C. Samples were prepared in Norell 502-7 standard series 
borosilicate tubes. NMR spectra were recorded using Jeol ECZ 400, Varian 400-MR and Bruker 400 
spectrometers at 400 MHz (1H) and 101 MHz (13C). Selected NMR spectra were measured using a 
Bruker Advance III HD 500 Cryo instrument at 500 MHz (1H) and 126 MHz (13C). Chemical shifts are 
quoted in parts per million and are referenced to residual solvent peaks in the deuterated solvents 
(CDCl3: 7.260 (1H) 77.160 (13C), DMSO-d6: 2.500 (1H), 39.520 (13C), acetone-d6: 2.050 (1H), 29.840 (13C)). 
Coupling constants (J) are given in Hz and are rounded to the nearest 0.5 Hz. Multiplicities are 
indicated as s (singlet), d (doublet), t (triplet), q (quartet), qn (quintet), m (multiplet), br. (broad) and 
app. (apparent). Assignments were made with the assistance of gCOSY, gc2HSQC, gc2HMBC, and 
gc2H2BC. 
Mass spectra were recorded by the University of Bristol Mass Spectrometry Service on a VG Analytical 
Autospec (ESI) spectrometer.  






4.2 Ligand synthesis 
(Ethoxycarbonyl)glycine181 
 
To a cooled solution of NaOH (22.0 mmol, 0.88 g) in water (20 mL) was added glycine methyl ester 
hydrochloride (8.0 mmol, 1.00 g). The solution was stirred until homogenous. A solution of ethyl 
chloroformate (10.5 mmol, 1.00 mL) in dioxane (10 mL) was added dropwise and the reaction mixture 
was stirred at room temperature for 16 hours. The solution was acidified with 3 M HCl and extracted 
with Et2O (3 × 30 mL). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude product was dissolved in MeOH (26 mL) and THF (14 mL). Aqueous NaOH (2 
M, 20.0 mmol, 10.0 mL) was added, and the resulting solution was stirred at room temperature for 1 
hour. On completion, the volatiles were removed, and the remaining mixture was acidified with 3 M 
HCl. This was extracted with Et2O (3 × 30 mL), and the combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to afford the crude product. This was recrystallised from 
Et2O to give the title compound (222 mg, 19% over two steps) as a colourless solid. 
M.p. 74-75 °C (Et2O); 1H NMR (400 MHz, D2O): δ 4.12 (q, J = 7.5 Hz, 2H, OCH2CH3), 3.91 (s, 2H, NCH2), 
1.23 (t, J = 7.0 Hz, 3H, OCH2CH3); 13C NMR (101 MHz, D2O): δ 174.2 (CO), 158.9 (CO), 62.1 (NCH2), 42.0 
(OCH2CH3), 13.7 (OCH2CH3); HRMS (ESI+): Calculated for C5H9NO4 [M+Na]+: 170.0424, found 170.0431; 
IR νmax (neat)/cm-1: 3314 (NH), 3072 (br. OH), 2987 (CH), 1686 (C=O). 
((Benzyloxy)carbonyl)glycine182 
 
To a cooled solution of NaOH (22.0 mmol, 0.88 g) in water (20 mL) was added glycine methyl ester 
hydrochloride (8.0 mmol, 1.00 g). The solution was stirred until homogenous. A solution of benzyl 
chloroformate (10.5 mmol, 1.50 mL) in dioxane (10 mL) was added dropwise and the reaction mixture 
was stirred at room temperature for 16 hours. On completion, the solution was acidified with 3 M HCl, 
extracted with Et2O (3 × 30 mL), and the combined organic layers were washed with brine, dried over 
MgSO4 and concentrated. The crude product was dissolved in MeOH (26 mL) and THF (14 mL). 
Aqueous NaOH (2 M, 20.0 mmol, 10.0 mL) was then added, and the resulting solution was stirred at 
room temperature for 1 hour. The volatiles were removed, and the remaining mixture was acidified 




with brine, dried over MgSO4 and concentrated to afford the crude product. This was recrystallised 
from MeCN to give the title compound (1.53 g, 91% over two steps) as a colourless solid. 
M.p. 121-122 °C (MeCN, lit. = 116-118 °C183); 1H NMR (400 MHz, CDCl3): δ 7.40-7.29 (m, 5H, ArH), 5.26 
(s, 1H, NH), 5.15 (s, 2H, CH2), 4.04 (d, J = 5.5 Hz, 2H, NCH2); IR νmax (neat)/cm-1: 3328 (NH), 2972 (br. 
OH), 2573 (CH), 1726 (C=O), 1679 (C=O). Data are consistent with literature precedent.182 
Pivaloylglycine 
 
To a mixture of glycine methyl ester (8.0 mmol, 1.00 g) and triethylamine (9.6 mmol, 1.30 mL) in DCM 
(10 mL) was added pivaloyl chloride (9.6 mmol, 1.20 mL) dropwise at 0 °C. The reaction mixture was 
allowed to cool to room temperature and was stirred for 16 hours. Water (10 mL) was added, the 
organic layer separated, and the aqueous layer was washed with DCM (3 × 30 mL). The organic layers 
were combined, washed with brine, dried over MgSO4 and concentrated. The resulting product was 
then dissolved in MeOH (26 mL) and THF (14 mL), and aqueous NaOH (2 M, 20.0 mmol, 10.0 mL) was 
added. The mixture was stirred at room temperature for 1 hour. The volatiles were then removed, 
and the remaining mixture acidified with 3 M HCl. This was extracted with Et2O (3 × 30 mL), and the 
organic layers were combined, washed with brine, dried over MgSO4 and concentrated to afford the 
title compound (163 mg, 12%) as an off-white solid.  
M.p. 140-142 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 3.85 (s, 2H, NCH2), 1.19 (s, 9H, 3 × CH3); 13C 
NMR (101 MHz, CDCl3): δ 181.9 (CO), 173.2 (CO), 42.0 (NCH2), 39.6 (Cq), 27.2 (3 × CH3); HRMS (ESI+): 
Calculated for C7H13NO3 [M+H]+: 160.0968, found 160.0967; IR νmax (neat)/cm-1: 3405 (NH), 2965 (br. 
OH), 1742 (C=O), 1610 (C=O). 
Acetylglycine184 
 
To a solution of glycine (8.0 mmol, 601 mg) in MeOH (20 mL) was added acetic anhydride (21.6 mmol, 
2.04 mL). The resulting mixture was stirred at reflux for 16 hours. On completion, the volatiles were 
removed to give the crude product. This was recrystallised from MeOH to afford acetylglycine (913 




M.p. 203-205 °C (MeOH, lit. = 208 °C184); 1H NMR (400 MHz, MeOD): δ 3.88 (s, 2H, NCH2), 1.98 (s, 3H, 




To a solution of NaOH (5.9 mmol, 236 mg) in water (3 mL) was added β-alanine (5.6 mmol, 500 mg), 
tBuOH (3 mL) and di-tert-butyl dicarbonate (5.9 mmol, 1.29 g), and the mixture was stirred for 16 hours 
at room temperature. On completion, the reaction mixture was diluted with water (20 mL) and 
washed with EtOAc (30 mL). The aqueous layer was acidified to pH 2 with acetic acid and extracted 
with EtOAc (3 × 30 mL). The combined organic layers were dried over MgSO4 and concentrated. The 
crude product was recrystallised from EtOAc/Hex to give the title compound (94 mg, 8%) as a 
colourless solid. 
M.p. 79-81 °C (EtOAc/Hex, lit. = 73-75 °C186); 1H NMR (400 MHz, CDCl3): δ 6.24 (br. s, 1H, OH), 5.07 
(br. s, 1H, NH), 3.48-3.27 (m, 2H, NCH2), 2.64-2.44 (m, 2H, CH2), 1.44 (s, 9H, 3 × CH3); IR νmax (neat)/cm-
1: 3440 (NH), 2967 (br. OH), 2911 (CH), 1701 (C=O). Data are consistent with literature precedent.185 
Formylglycine187 
 
Formic acid (600 mmol, 23.0 mL) and acetic anhydride (80.0 mmol, 7.60 mL) were stirred at 45 °C for 
1 hour. This was followed by the addition of glycine (8.0 mmol, 601 mg). The reaction mixture was 
stirred at room temperature for 72 hours. The volatiles were removed, and the resulting mixture was 
azeotroped with 70% Toluene/EtOH. The crude product was recrystallised from MeOH to yield 
formylglycine (765 mg, 93%) as a white solid. 
M.p. 148-152 °C (MeOH); 1H NMR (400 MHz, CDCl3): δ 8.17 (s, 1H, CHO), 4.06 (s, 2H, NCH2); IR νmax 







To a solution of glycine (8.0 mmol, 600 mg) in MeOH (20 mL) was added trimethylamine (8.0 mmol, 
1.12 mL). After stirring for 5 minutes, ethyl trifluoroacetate (10.0 mmol, 1.19 mL) was added dropwise. 
The reaction mixture was stirred at room temperature for 24 hours. On completion the volatiles were 
removed, and the crude residue dissolved in water. This was extracted with 1:2 MeOH:CHCl3 (×3) and 
the combined organic extracts were washed with brine, dried over MgSO4 and concentrated to afford 
the title compound (1.18 g, 86%) as a white solid. 
M.p. 110-115 °C (CHCl3, lit = 117-118 °C188); 1H NMR (400 MHz, CDCl3): δ 3.83 (s, 2H, NCH2); IR νmax 
(neat)/cm-1: 3314 (br. NH), 3104-2948 (CH), 2576 (br. OH), 1698 (C=O). Data are consistent with 
literature precedent.188 
4.3 Substrate synthesis 
4.3.1 General alkylation procedure 
Synthesised using a modified literature procedure.189  
Indole substrate (1 equiv.) was added portionwise to a suspension of NaH (1.2 equiv. as a 60% 
dispersion in mineral oil) in DMF (0.5 M) at 0 °C. This was stirred at room temperature for 30-60 
minutes, until a clear solution formed. The reaction mixture was re-cooled to 0 °C, and a bromide or 
mesylate substrate (1 equiv.) was added dropwise. The mixture was then stirred at room temperature 
until complete consumption of the indole starting material was observed by TLC. On completion, the 
reaction mixture was quenched with water and extracted with EtOAc (×3). The combined organic 
extracts were washed with water (×3) and brine, dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography. 
4.3.2 General hydrolysis procedure 
The alkylated indole substrate (1 equiv.) was dissolved in a mixture of aqueous NaOH (10 equiv. of a 
2 M solution), THF (0.3 M), and MeOH (0.3 M), and heated at reflux until complete consumption of 
the indole starting material was observed by TLC. The reaction mixture was then cooled to room 
temperature and the volatile solvents removed. The mixture was diluted with water and washed with 
Et2O. The aqueous layer was acidified with 3 M HCl to give a white suspension. This suspension was 
extracted with Et2O (×3) and the organic layers were combined, washed with brine, dried over MgSO4 




4.3.3 General amide coupling procedure 
To a solution of the hydrolysed indole substrate (1 equiv.) in MeCN (0.1 M) was added CDI (2.2 equiv.) 
and DMAP (10 mol%). The resulting mixture was stirred at 50 °C until complete consumption of the 
indole starting material was observed by TLC. The reaction mixture was then allowed to cool to room 
temperature and methanesulfonamide (2.5 equiv.) and DBU (2.5 equiv.) were added. The reaction 
mixture was then stirred at 50 °C for 16 hours. On completion, acetic acid (5 mL) was added. The 
mixture was concentrated, redissolved in EtOAc and washed with water (×3). The combined organic 
layers were washed with brine, dried over MgSO4 and concentrated. The crude material was purified 
by recrystallisation from MeCN.  
4.3.4 General mesylation procedure 
To a solution of alcohol substrate (1 equiv.) and triethylamine (2 equiv.) in DCM (0.3 M) was added 
methanesulfonyl chloride (1.5 equiv.) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 5 
minutes before being allowed to warm to room temperature, at which it was stirred for a further 2 
hours. Water was added, and the phases separated. The aqueous layer was then extracted with DCM 
(×2). The combined organic layers were washed with brine, dried over MgSO4 and concentrated. The 
crude material was purified by flash column chromatography. 
4.3.5 General carboxylation procedure 
Synthesised using a modified literature procedure.146 
To a solution of indole substrate (1 equiv.) in DCM at 0 °C was added TFAA (1.5 equiv.) dropwise. The 
reaction mixture was stirred at room temperature for 1 hour, and the volatiles were then removed. 
The crude residue was dissolved in MeOH (1 M) and aqueous KOH (5 equiv. of a 5 M solution) was 
added. The reaction mixture was stirred at 80 °C for 16 hours and was then allowed to cool to room 
temperature. The mixture was acidified to pH 1 with 3 M HCl, then extracted with EtOAc (×3). The 
combined organic phases were washed with brine, dried over MgSO4 and concentrated. The crude 
material was purified by recrystallization from MeCN.  






p-Toluenesulfonamide (4.5 mmol, 770 mg) was added dropwise to a stirred solution of EDC.HCl (4.5 
mmol, 862 mg), DMAP (6.9 mmol, 843 mg) and 1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 
mmol, 688 mg) in DCM (12 mL). The resulting mixture was stirred at room temperature for 18 hours. 
On completion, the reaction mixture was washed with 1 M HCl, water (×2) and brine, dried over MgSO4 
and concentrated to give the title compound (631 mg, 55%) as a white solid (analytically pure), which 
was used without further purification. 
M.p. 157-160 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.86 (s, 1H, NH), 8.40 (s, 1H, ArH), 7.99-
7.95 (m, 1H, ArH), 7.92-7.87 (m, 2H, ArH), 7.57 (d, J = 8.0 Hz, 1H, ArH), 7.45-7.39 (m, 2H, ArH), 7.23 
(ddd, J = 8.0, 7.0, 1.5 Hz, 1H, ArH), 7.16 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H, ArH), 5.84 (ddt, J = 17.0, 10.5, 7.0 
Hz, 1H, CH=CH2), 5.09-4.97 (m, 2H, CH=CH2), 4.22 (t, J = 7.0 Hz, 2H, NCH2), 2.38 (s, 3H, CH3), 2.03 (q, J 
= 7.0 Hz, 2H, CH2), 1.88 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 161.6 (CO), 143.7 
(Cq), 137.5 (Cq), 137.4 (CH=CH2), 136.2 (Cq), 134.4 (CH), 129.4 (CH), 127.6 (CH), 126.6 (Cq), 122.8 (CH), 
121.8 (CH), 120.9 (CH), 115.5 (CH=CH2), 110.8 (CH), 106.7 (Cq), 45.6 (NCH2), 30.2 (CH2), 28.4 (CH2), 21.1 
(CH3); HRMS (ESI+): Calculated for C21H22N2O3S [M+H]+: 383.1424, found 383.1430; IR νmax (neat)/cm-
1: 3200-2928 (CH), 1643 (C=O). 
9-Methylene-N-tosyl-6,7,8,9-tetrahydro[1,2-a]indole-10-carboxamide 188 
 
9-Methylene-6,7,8,9-tetrahydropyrido[1,2-a]indole (1 mmol, 183 mg) was dissolved in toluene (2.5 
mL). Tosyl isocyanate (1 mmol, 197 mg) was added dropwise and the reaction mixture was stirred at 
room temperature for 18 hours. On completion the mixture was filtered, and the filtrate concentrated. 
The crude residue was purified by recrystallisation from MeCN to yield the title compound (54 mg, 
14%) as an off-white solid. 
M.p. 175-177 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.48 (s, 1H, ArH), 8.05 (m, 2H, ArH), 8.01 (d, J = 
7.5 Hz, 1H, ArH), 7.35 (d, J = 8.0 Hz, 2H, ArH), 7.25-7.20 (m, 2H, ArH), 5.77 ( s, 1H, C=CHH), 5.54 (s, 1H, 
C=CHH), 4.14 (t, J = 6.5 Hz, 2H, NCH2), 2.66 (t, J = 6.5 Hz, 2H, CH2), 2.44 (s, 3H, ArCH3), 2.22 (qn, J = 6.5 
Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.1 (CO), 144.8 (Cq), 139.1 (Cq), 136.4 (Cq), 135.8 (Cq), 
135.7 (Cq), 129.6 (CH), 128.6 (CH), 127.2 (Cq), 123.7 (CH), 122.8 (CH), 121.0 (CH), 119.6 (C=CH2), 109.6 
(CH), 104.6 (Cq), 42.7 (NCH2), 31.5 (CH2), 23.9 (CH2), 21.8 (CH3); HRMS (ESI+): Calculated for 




Methyl 1-(pent-4-en-1-yl)-1H-indole-3-carboxylate 195 
 
Methyl indole-3-carboxylate (17.0 mmol, 3.00 g) was subjected to the general alkylation conditions 
described above with 5-bromo-1-pentene. The crude material was purified by flash column 
chromatography (10% EtOAc/petrol) to afford the title compound (3.50 g, 85%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.24-8.14 (m, 1H, ArH), 7.85 (s, 1H, ArH), 7.42-7.36 (m, 1H, ArH), 7.34-
7.27 (m, 2H, ArH), 5.82 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.08 (m, 1H, CH=CHH), 5.07-5.05 
(m, 1H, CH=CHH), 4.18 (t, J = 7.0 Hz, 2H, NCH2), 3.94 (s, 3H, OCH3), 2.14-2.07 (m, 2H, CH2), 2.05-1.96 
(m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 136.9 (CH=CH2), 136.6 (Cq), 134.3 (CH), 126.9 
(Cq), 122.8 (CH), 121.9 (CH), 121.9 (CH), 116.2 (CH=CH2), 110.1 (CH), 107.1 (Cq), 51.1 (CH3), 46.3 (NCH2), 
30.8 (CH2), 28.9 (CH2); HRMS (ESI+): Calculated for C15H17NO2 [M+H]+: 244.1332, found 244.1332; IR 
νmax (neat)/cm-1: 2946 (CH), 1694 (C=O). 
1-(Pent-4-en-1-yl)-1H-indole-3-carboxylic acid 196 
 
Methyl 1-(pent-4-en-1-yl)-1H-indole-3-carboxylate (14.0 mmol, 3.50 g) was subjected to the general 
hydrolysis conditions described above, to give the title compound (2.98 g, 92%) as an off-white solid 
(analytically pure), which was used without further purification. 
M.p. 123-125 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.32-8.25 (m, 1H, ArH), 7.94 (s, 1H, ArH), 7.43-
7.36 (m, 1H, ArH), 7.36-7.29 (m, 2H, ArH), 5.81 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.08 (m, 
1H, CH=CHH), 5.08-5.06 (m, 1H, CH=CHH), 4.17 (t, J = 7.0 Hz, 2H, NCH2), 2.17-2.08 (m, 2H, CH2), 2.05-
1.96 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 171.7 (CO), 136.9 (Cq), 136.8 (CH=CH2), 135.7 (CH), 
127.1 (Cq), 123.0 (CH), 122.8 (CH), 122.1 (CH), 116.3 (CH=CH2), 110.2 (CH), 106.5 (Cq), 46.4 (NCH2), 
30.7 (CH2), 28.8 (CH2); HRMS (ESI+): Calculated for C14H15NO2 [M+Na]+: 252.0995, found 252.0998; IR 






Indole (5.0 mmol, 585 mg) was subjected to the general alkylation conditions described above with 5-
bromo-1-pentene. The crude material was purified by flash column chromatography (1% 
EtOAc/petrol) to afford the title compound (879 g, 95%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.66-7.61 (m, 1H, ArH), 7.38-7.30 (m, 1H, ArH), 7.21 (ddd, J = 8.0, 7.0, 1.0 
Hz, 1H, ArH), 7.14-7.07 (m, 2H, ArH), 6.50 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.82 (ddt, J = 17.0, 10.0, 7.0 Hz, 
1H, CH=CH2), 5.10-5.01 (m, 2H, CH=CH2), 4.14 (t, J = 7.0 Hz, 2H, NCH2), 2.13-2.05 (m, 2H, CH2), 2.01-




Benzoyl isocyante (2.4 mmol, 0.33 mL) was added dropwise to a solution of 1-(Pent-4-en-yl)-1H-indole 
(2.0 mmol, 474 mg) in toluene (5 mL). The reaction mixture was heated to 50 °C and stirred for 16 
hours. The reaction mixture was diluted with EtOAc and washed with water (×3). The combined 
organic layers were washed with brine, dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography (30% EtOAc/petrol) followed by recrystallisation from MeCN 
to afford the title compound (53 mg, 8%) as a white solid. 
M.p. 162-163 °C (MeCN); 1H NMR (500 MHz, CDCl3): δ 8.74 (br. s, 1H, NH), 8.21-8.14 (m, 1H, ArH), 
8.03 (s, 1H, ArH), 7.93-7.87 (m, 2H, ArH), 7.63-7.57 (m, 1H, ArH), 7.55-7.47 (m, 2H, ArH), 7.44-7.40 (m, 
1H, ArH), 7.36-7.29 (m, 2H, ArH), 5.80 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.02 (m, 2H, 
CH=CH2), 4.20 (t, J = 7.0 Hz, 2H, NCH2), 2.12 (q, J = 7.0 Hz, 2H, CH2), 2.01 (qn, J = 7.0 Hz, 2H, CH2); 13C 
NMR (126 MHz, CDCl3): δ 166.8 (CO), 163.0 (CO), 136.8 (Cq), 136.7 (CH), 134.8 (CH), 134.2 (Cq), 132.8 
(CH), 128.9 (CH), 128.0 (CH), 126.9 (Cq), 123.4 (CH), 122.7 (CH), 121.5 (CH), 116.4 (CH=CH2), 110.5 (CH), 
109.4 (Cq), 46.6 (NCH2), 30.8 (CH2), 28.9 (CH2); HRMS (ESI+): Calculated for C21H20N2O2 [M+H]+: 







1-(Pent-4-en-1-yl)-1H-indole-3-carboxylic acid (2.0 mmol, 459 mg) was subjected to the general amide 
coupling conditions described above. The crude material was purified by recrystallisation from MeCN 
to give the title compound (443 mg, 72%) as an off-white solid. 
M.p. 216-217 °C (MeCN); 1H NMR (500 MHz, CDCl3): δ 8.33 (br. s, 1H, NH), 8.19-8.10 (m, 1H, ArH), 
7.78 (s, 1H, ArH), 7.45-7.39 (m, 1H, ArH), 7.37-7.30 (m, 2H, ArH), 5.86-5.72 (m, 1H, CH=CH2), 5.12-5.02 
(m, 2H, CH=CH2), 4.19 (t, J = 7.0 Hz, 2H, NCH2), 3.48 (s, 3H, SO2CH3), 2.10 (q, J = 7.0 Hz, 2H, CH2), 2.00 
(qn, J = 7.0 Hz, 2H, CH2); 13C NMR (126 MHz, CDCl3): δ 162.7 (CO), 137.5 (CH=CH2), 136.3 (Cq), 134.5 
(CH), 126.7 (Cq), 122.8 (CH), 121.9 (CH), 121.0 (CH), 115.6 (CH=CH2), 110.9 (CH), 106.8 (Cq), 45.6 
(NCH2), 41.9 (SO2CH3), 30.2 (CH2), 28.4 (CH2); HRMS (ESI+): Calculated for C15H18N2O3S [M+Na]+: 
329.0930, found 329.0926; IR νmax (neat)/cm-1: 3218 (NH), 2951 (CH), 1647 (C=O). 
5-((tert-Butyldimethylsilyl)oxy)pentan-2-one191 209 
 
γ-Butyrolactone (15.0 mmol, 1.20 mL) was dissolved in Et2O (30 mL) and the solution was cooled to -
78 °C. Methyllithium (15.9 mmol, 9.90 mL, 1.6 M solution in Et2O) was added dropwise over 10 
minutes, and the reaction mixture was then stirred at -78 °C for 1 hour. This was quenched with 
saturated aqueous NH4Cl and allowed to warm to room temperature. Brine was added and extracted 
with Et2O (3 × 50 mL) and EtOAc (50 mL). The combined organic layers were dried over MgSO4 and 
concentrated. The crude product was used without further purification. 
The crude alcohol was then dissolved in DMF (30 mL). Imidazole (18.0 mmol, 1.23 g) was added, and 
the solution was cooled to 0 °C. TBSCl (16.5 mmol, 2.49 g) was added and the reaction mixture was 
left to warm to room temperature and was stirred for 16 hours. On completion, water (50 mL) was 
added and the reaction mixture was extracted with Et2O (3 × 50 mL). The combined organic layers 
were then washed with water (50 mL) and brine, dried over MgSO4 and concentrated. The crude 
product was purified by flash column chromatography (3% EtOAc/petrol) to yield the title compound 
(1.40 g, 43% over two steps) as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ 3.61 (t, J = 6.0 Hz, 2H, OCH2), 2.51 (t, J = 7.0 Hz, 2H, COCH2), 2.15 (s, 3H, 
CH3), 1.84-1.72 (m, 2H, CH2), 0.88 (s, 9H, 3 × CH3), 0.04 (s, 6H, 2 × CH3); IR νmax (neat)/cm-1: 2954-2857 






NaHMDS (20.0 mmol, 10.0 mL, 2 M solution in THF) was added dropwise to a suspension of 
methyltriphenylphosphonium iodide (20.0 mmol, 8.09 g) in THF (50 mL) at -78 °C. The solution was 
allowed to warm to room temperature and was stirred for 1 hour before being re-cooled to -78 °C. 5-
((tert-Butyldimethylsilyl)oxy)pentan-2-one (10.0 mmol, 2.15 g) in THF (15 mL) was added, and the 
reaction mixture was allowed to warm to room temperature and was then stirred for 16 hours. On 
completion, the reaction mixture was quenched with a saturated aqueous solution of NH4Cl (30 mL) 
and extracted with EtOAc (3 × 45 mL). The combined organic phases were washed with water (50 mL) 
and brine, dried over MgSO4 and concentrated. The crude material was purified by flash column 
chromatography (2% EtOAc/petrol) to yield the title compound (1.77 g, 83%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 4.72-4.66 (m, 2H, C=CH2), 3.61 (t, J = 6.5 Hz, 2H, OCH2), 2.05 (t, J = 8.0 Hz, 
2H, CH2), 1.73 (s, 3H, CH3), 1.70-1.61 (m, 2H, CH2), 0.90 (s, 9H, 3 × CH3), 0.05 (s, 6H, 2 × CH3); IR νmax 




To a stirred solution of tert-butyldimethyl((4-methylpent-4-en-1-yl)oxy)silane (6.5 mmol, 1.39 g) in 
THF (8 mL) was added TBAF (13.0 mmol, 13.0 mL, 1M in THF) dropwise at 0 °C. The reaction mixture 
was left to warm to room temperature and was then stirred for 90 minutes. On completion, water (20 
mL) was added and the mixture was extracted with Et2O (3 × 45 mL). The combined organic layers 
were then washed with brine, dried over MgSO4 and concentrated. The crude material was purified 
by flash column chromatography (20% Et2O/petrol) to yield the title compound (500 mg, 76%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ 4.74-4.70 (m, 2H, C=CH2), 3.66 (t, J = 6.5 Hz, 2H, OCH2), 2.10 (t, J = 7.5 Hz, 
2H, CH2), 1.76-1.68 (m, 5H, CH2 + CH3); IR νmax (neat)/cm-1: 3317 (br. OH), 3075 (CH), 2933 (CH), 1650 
(C=C). Data are consistent with literature precedent.193 
4-Methylpent-4-en-1-yl methanesulfonate194 212 
 
4-Methylpent-4-en-1-ol (4.3 mmol, 435 mg) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (10% 




1H NMR (400 MHz, CDCl3): δ 4.78-4.75 (m, 1H, C=CHH), 4.73-4.69 (m, 1H, C=CHH), 4.22 (t, J = 6.5 Hz, 
2H, OCH2), 3.00 (s, 3H, SO2CH3), 2.13 (t, J = 7.5 Hz, 2H, CH2), 1.94-1.85 (m, 2H, CH2), 1.73 (s, 3H, CH3); 
IR νmax (neat)/cm-1: 3076 (CH), 2970-2941 (CH), 1650 (C=C). Data are consistent with literature 
precedent.194 
Methyl 1-(4-methylpent-4-en-1-yl)-1H-indole-3-carboxylate 213 
 
Methyl indole-3-carboxylate (7.5 mmol, 1.31 g) was subjected to the general alkylation conditions 
described above with 4-methylpent-4-en-1-yl methanesulfonate. The crude material was purified by 
flash column chromatography (8% EtOAc/petrol) to afford the title compound (1.68 g, 87%) as a yellow 
oil. 
1H NMR (400 MHz, CDCl3): δ 8.16-8.11 (m, 1H, ArH), 7.76 (s, 1H, ArH), 7.33-7.27 (m, 1H, ArH), 7.25-
7.19 (m, 2H, ArH), 4.76-4.72 (m, 1H, C=CHH), 4.68-4.63 (m, 1H, C=CHH), 4.11-4.04 (m, 2H, NCH2), 3.86 
(s, 3H, OCH3), 2.03-1.90 (m, 4H, 2 × CH2), 1.66 (s, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 165.9 (CO), 
144.2 (Cq), 136.9 (Cq), 134.7 (CH), 127.1 (Cq), 123.1 (CH), 122.2 (CH), 122.2 (CH), 111.5 (C=CH2), 110.4 
(CH), 107.4 (Cq), 51.4 (OCH3), 46.8 (NCH2), 35.0 (CH2), 27.9 (CH2), 22.8 (CH3); HRMS (ESI+): Calculated 
for C16H19NO2 [M+H]+: 258.1489, found 258.1494; IR νmax (neat)/cm-1: 3072 (CH), 2944 (CH), 1697 
(C=O).  
1-(Methylpent-4-en-1-yl)-1H-indole-3-carboxylic acid 214 
 
Methyl 1-(4-methylpent-4-en-1-yl)-1H-indole-3-carboxylate (6.5 mmol, 1.68 g) was subjected to the 
general hydrolysis conditions described above, to give the title compound (1.41 g, 89%) as an off-white 
solid (analytically pure), which was used without further purification. 
M.p. 111-113 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.29-8.23 (m, 1H, ArH), 7.94 (s, 1H, ArH), 7.42-
7.37 (m, 1H, ArH), 7.35-7.29 (m, 2H, ArH), 4.84-4.79 (m, 1H, C=CHH), 4.76-4.69 (m, 1H, C=CHH), 4.23-
4.11 (m, 2H, NCH2), 2.10-2.03 (m, 4H, 2 × CH2), 1.73 (s, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 170.6 




110.2 (CH), 106.5 (Cq), 46.6 (NCH2), 34.7 (CH2), 27.2 (CH2), 22.5 (CH3); HRMS (ESI+): Calculated for 




1-(Methylpent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 730 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (649 mg, 68%) as a white solid.  
M.p. 146-147 °C (MeCN) 1H NMR (400 MHz, acetone-d6): δ 8.29 (s, 1H, ArH), 8.27-8.22 (m, 1H, ArH), 
7.59-7.50 (m, 1H, ArH), 7.32-7.22 (m, 2H, ArH), 4.78-4.63 (m, 2H, C=CH2), 4.30 (t, J = 6.5 Hz, 2H, NCH2), 
3.38 (s, 3H, SO2CH3), 2.08-2.06 (m, 4H, 2 × CH2), 1.70 (s, 3H, CH3); 13C NMR (101 MHz, acetone-d6): δ 
163.4 (CO), 145.4 (Cq), 137.8 (Cq), 134.3 (CH), 128.2 (Cq), 123.9 (CH), 122.8 (CH), 122.4 (CH), 111.4 
(CH), 111.1 (C=CH2), 108.5 (Cq), 47.1 (NCH2), 42.2 (SO2CH3), 35.3 (CH2), 28.5 (CH2), 22.5 (CH3); HRMS 
(ESI+): Calculated for C16H20N2O3S [M+H]+: 321.1267, found 321.1265; IR νmax (neat)/cm-1: 3226 (NH), 
3118 (CH), 2952 (CH), 1645 (C=O), 1322 (S=O). 
1-(Hex-4-en-1-yl)-N-(methylsulfonyl)-1H-indole-3-carboxamide 220a 
 
1-(Hex-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 730 mg) was subjected to the general amide 
coupling conditions described above. The crude material was purified by recrystallisation from MeCN 
to give the title compound (694 mg, 72%, mixture of stereoisomers, cis:trans 16:14) as a white solid.  
M.p. 176-178 °C (MeCN) 1H NMR (400 MHz, DMSO-d6): δ 11.52 (s, 1H, NH), 8.42 (d, J = 4.0 Hz, 1H, 
ArH), 8.16-8.11 (m, 1H, ArH), 7.62-7.55 (m, 1H, ArH), 7.31-7.19 (m, 2H, ArH), 5.52-5.34 (m, 2H, CH=CH), 
4.27-4.17 (m, 2H, NCH2), 3.38 (s, 3H, SO2CH3), 2.06-1.92 (m, 2H, CH2), 1.91-1.80 (m, 2H, CH2), 1.62-1.59 
(m, 1.4H, trans CH3), 1.54-1.47 (m, 1.6H, cis CH3); 13C NMR (101 MHz, DMSO-d6): δ 162.7 (CO), 136.4 
(Cq), 134.5 (CH), 129.9 (CH=CH, trans), 129.0 (CH=CH, cis), 126.7 (Cq), 125.4 (CH=CH, trans), 124.7 
(CH=CH, cis), 122.8 (CH), 121.9 (CH), 121.0 (CH), 110.9 (CH), 106.8 (Cq), 45.7 (NCH2), 41.8 (SO2CH3), 








1-(5-Phenylpent-4-en-1-yl)-1H-indole-3-carboxylic acid (2.5 mmol, 763 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (548 mg, 57%) as a white solid.  
M.p. 146-148 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.06 (br. s, 1H, NH), 8.37 (s, 1H, ArH), 
8.27 (ddd, J = 7.5, 1.5, 1.0 Hz, 1H, ArH), 7.60 (dt, J = 8.5, 1.0 Hz, 1H, ArH), 7.42-7.12 (m, 7H, ArH), 6.47-
6.39 (m, 1H, CH=CHPh), 6.30 (dt, J = 16.0, 7.0 Hz, 1H, CH=CHPh), 4.39 (t, J = 7.0 Hz, 2H, NCH2), 3.39 (s, 
3H, SO2CH3), 2.34-2.24 (m, 2H, CH2), 2.12 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 
163.3 (CO), 138.5 (Cq), 137.7 (Cq), 134.3 (CH), 131.7 (CH=CH), 129.9 (CH=CH), 129.3 (CH), 128.2 (Cq), 
127.8 (CH), 126.8 (CH), 123.9 (CH), 122.8 (CH), 122.4 (CH), 111.4 (CH), 108.5 (Cq), 47.0 (CH2), 42.3 
(SO2CH3), 30.7 (CH2), 30.2 (CH2); HRMS (ESI+): Calculated for C21H22N2O3S [M+Na]+: 405.1243, found 
405.1249; IR νmax (neat)/cm-1: 3655 (NH), 2987 (CH), 2901 (CH), 1649 (C=O), 1399 (S=O), 1142 (S=O). 
Butyl (E)-6-(3-((methylsulfonyl)carbamoyl)-1H-indole-1-yl)hex-2-enoate 220c 
 
To a solution of N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (1.3 mmol, 400 mg) 
in DCM (50 mL) was added butyl acrylate (3.9 mmol, 0.56 mL). Grubbs catalyst 2nd generation was 
added (0.013 mmol, 11 mg), and the solution stirred at reflux for 2 hours. The reaction mixture was 
then concentrated directly onto silica and purified by flash column chromatography (60% 
EtOAc/petrol) to afford the title compound (273 mg, 52%) as an off-white solid. 
M.p. 140-144 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.18-8.99 (m, 1H, NH), 8.27-8.17 (m, 1H, ArH), 
7.92 (s, 1H, ArH), 7.42-7.28 (m, 3H, ArH), 6.86 (dt, J = 15.5, 6.5 Hz, 1H, CH=CH), 5.81 (d, J = 15.5 Hz, 1H, 
CH=CH), 4.18 (t, J = 6.5 Hz, 2H, NCH2), 4.12 (t, J = 6.5 Hz, 2H, OCH2), 3.50 (s, 3H, SO2CH3), 2.27-2.15 (m, 
2H, CH2), 2.12-1.99 (m, 2H, CH2), 1.62 (qn, J = 7.0 Hz, 2H, CH2), 1.38 (h, J = 7.0 Hz, 2H, CH2), 0.93 (t, J = 




(CH), 127.0 (Cq), 123.7 (CH), 122.8 (CH), 122.6 (CH=CH), 121.8 (CH), 110.2 (CH), 107.6 (Cq), 64.4 (OCH2), 
46.4 (NCH2), 42.3 (SO2CH3), 30.7 (CH2), 29.2 (CH2), 28.0 (CH2), 19.2 (CH2), 13.8 (CH3); HRMS (ESI+): 
Calculated for C20H26N2O5S [M+H]+: 407.1635, found 407.1630; IR νmax (neat)/cm-1: 3230 (NH), 2965 
(CH), 1716 (C=O), 1650 (C=O). 
Hex-4-en-1-yl methanesulfonate195 221a 
 
Hex-4-en-1-ol (6.9 mmol, 689 mg) was subjected to the general mesylation conditions described 
above. The crude material was purified by flash column chromatography (10% EtOAc/petrol) to yield 
the title compound (1.03 g, 80%, mixture of stereoisomers, cis:trans 11:9) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.58-5.43 (m, 1H, CH=CH), 5.42-5.29 (m, 1H, CH=CH), 4.21 (t, J = 6.5Hz, 
2H, OCH2), 2.99 (s, 1.65H, SO2CH3), 2.99 (s, 1.35H, SO2CH3), 2.22-2.14 (m, 1.10H, cis CH2), 2.14-2.06 (m, 
0.90H, trans CH2), 1.80 (dt, J = 7.5, 6.5 Hz, 2H, CH2), 1.65 (d, J = 6.0 Hz, 1.35H, trans CH3), 1.61 (d, J = 
7.0 Hz, 1.65H, cis CH3) ; IR νmax (neat)/cm-1: 2941 (CH), 1351 (S=O). Data are consistent with literature 
precedent.195 
5-Phenylpent-4-en-1-yl methanesulfonate196 221b 
 
5-Phenylpent-4-en-1-ol (6.9 mmol, 1.11 g) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (20% 
EtOAc/petrol) to yield the title compound (1.38 g, 83%, mixture of stereoisomers) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.41-7.15 (m, 5H, ArH), 6.44 (d, J = 16.0 Hz, 1H, CH=CH), 6.17 (dt, J = 16.0, 
7.0 Hz, 1H, CH=CH), 4.28 (t, J = 6.5 Hz, 2H, OCH2), 3.00 (s, 3H, SO2CH3), 2.41-2.27 (m, 2H, CH2), 1.99-
1.87 (m, 2H, CH2); IR νmax (neat)/cm-1: 3024 (CH), 2939 (CH), 1350 (S=O). Data are consistent with 
literature precedent.196  
Hex-4-en-1-ol197 222a 
 
To a stirred solution of tert-butyl(hex-4-en-1-yloxy)dimethylsilane (9.8 mmol, 2.10 g) in THF (12 mL) 
was added TBAF (19.6 mmol, 19.6 mL, 1M in THF) dropwise at 0 °C. The reaction mixture was left to 
warm to room temperature and was then stirred for 60 minutes. On completion, water (20 mL) was 
added and the mixture was extracted with Et2O (3 × 45 mL). The combined organic layers were then 




column chromatography (15% Et2O/petrol) to yield the title compound (730 mg, 74%, mixture of 
stereoisomers) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.53-5.35 (m, 2H, CH=CH), 3.64 (td, J = 6.5, 4.0 Hz, 2H, OCH2), 2.17-2.02 
(m, 2H, CH2), 1.69-1.52 (m, 5H, CH2 + CH3); IR νmax (neat)/cm-1: 2987 (CH), 2901 (CH). Data are 
consistent with literature precedent.197 
5-Phenylpent-4-en-1-ol150 222b 
 
To a suspension of LiAlH4 (17.5 mmol, 7.29 mL, 2.4 M solution in THF) in THF (10 mL) at 0 °C was added 
5-phenylpent-4-yn-1-ol (5.0 mmol, 801 mg) dropwise. The reaction mixture was stirred at 0 °C for 20 
minutes before slowly being heated to reflux and stirred for 18 hours. On completion, the mixture was 
cooled to 0 °C and quenched by the slow addition of water (1.00 mL), NaOH (2M, 1.00 mL), and water 
(2.00 mL) while stirring vigorously. The mixture was extracted with EtOAc (3 × 30 mL), and the 
combined organic layers were washed with water and brine, dried over MgSO4 and concentrated. The 
crude material was purified by flash column chromatography (30% EtOAc/petrol) to yield the title 
compound (698 mg, 83%, mixture of stereoisomers) as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ 7.38-7.16 (m, 5H, ArH), 6.42 (d, J = 15.5 Hz, 1H, CH=CH), 6.23 (dt, J = 15.5, 
7.0 Hz, 1H, CH=CH), 3.71 (t, J = 7.0 Hz, 2H, OCH2), 2.31 (q, J = 7.0 Hz, 2H, CH2), 1.76 (qn, J = 7.0 Hz, 2H, 
CH2); IR νmax (neat)/cm-1: 3327 (OH), 2951 (CH). Data are consistent with literature precedent.150, 196 
tert-Butyl(hex-4-en-1-yloxy)dimethylsilane198 223a 
 
Ethyl triphenylphosphonium bromide (2.2 mmol, 0.82 g) was dissolved in THF (5 mL) and cooled to -
78 °C. n-Butyllithium (2.2 mmol, 0.88 mL, 2.5 M solution in hexane) was added dropwise, and the 
mixture was left to stir at -78 °C for 2 hours. The mixture was then left to warm to room temperature 
for 20 minutes, before being re-cooled to -78 °C. 4-((tert-Butyldimethylsilyl)oxy)butanal (2.0 mmol, 
0.41 g) in THF (2.5 mL) was added dropwise. The reaction mixture was allowed to warm to room 
temperature and was stirred for 16 hours. On completion, the THF was removed in vacuo and 
saturated aqueous NH4Cl (20 mL) was added to the crude residue. This was extracted with EtOAc (3 × 
30 mL) and the organic layers were combined, washed with brine, dried over MgSO4 and concentrated. 
The crude material was purified by flash column chromatography (2% EtOAc/petrol) to yield the title 




1H NMR (400 MHz, CDCl3): δ 5.50-5.33 (m, 2H, CH=CH), 3.64-3.55 (m, 2H, OCH2), 2.14-1.97 (m, 2H, 
CH2), 1.66-1.52 (m, 5H, CH2 + CH3), 0.90 (s, 9H, 3 × CH3), 0.05 (s, 6H, 2 × CH3); IR νmax (neat)/cm-1: 2954-
2857 (CH), 1253 (SiC), 1098 (SiO). Data are consistent with literature precedent.198 
4-((tert-Butyldimethylsilyl)oxy)butanal199 224 
 
A suspension of NaHCO3 (18.9 mmol, 1.59 g) in DMSO (15 mL) was heated to 110 °C. tert-Butyl(4-
iodobutoxy)dimethylsilane (3.2 mmol, 1.00 g) was added, and the reaction mixture was stirred at 110 
°C for 20 minutes. The mixture was then rapidly cooled to room temperature and poured into water 
(30 mL). The mixture was extracted with Et2O (3 × 40 mL) and EtOAc (40 mL) and the combined organic 
layers were washed with water and brine, dried over MgSO4 and concentrated. The crude material 
was purified by flash column chromatography (2% EtOAc/petrol) to yield the title compound (341 mg, 
53%) as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ 9.79 (t, J = 2.0 Hz, 1H, CHO), 3.65 (t, J = 6.0 Hz, 2H, OCH2), 2.50 (td, J = 
7.0, 2.0 Hz, 2H, CH2), 1.90-1.81 (m, 2H, CH2), 0.88 (s, 9H, 3 × CH3), 0.04 (s, 6H, 2 × CH3); IR νmax 




THF (145 mmol, 8 mL), TBS (40.0 mmol, 6.00 g), and NaI (80.0 mmol, 12.0 g) were dissolved in MeCN 
(80 mL). The resulting mixture was stirred at 55 °C for 20 hours. On completion, the reaction mixture 
was cooled to room temperature and the solvent was removed. The crude material was then diluted 
with water (50 mL) and extracted with 90% pentane/Et2O (3 × 50 mL). The organic extracts were 
combined, washed with saturated NaHCO3, 1M NaSO3, and with brine, dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (2% EtOAc/ petrol) to 
yield the title compound (9.73 g, 77%) as a pale-orange oil.  
1H NMR (400 MHz, CDCl3): δ 3.63 (t, J = 6.0 Hz, 2H, OCH2), 3.22 (t, J = 7.0 Hz, 2H, ICH2), 1.97-1.84 (m, 
2H, CH2), 1.66-1.57 (m, 2H, CH2), 0.89 (s, 9H, 3 × CH3), 0.05 (s, 6H, 2 × CH3); IR νmax (neat)/cm-1: 2953-




Methyl 1-(hex-4-en-1-yl)-1H-indole-3-carboxylate 228 
 
Methyl indole-3-carboxylate (5.7 mmol, 999 mg) was subjected to the general alkylation conditions 
described above with hex-4-en-1-yl methanesulfonate. The crude material was purified by flash 
column chromatography (4% EtOAc/petrol) to afford the title compound (1.14 g, 77%, mixture of 
stereoisomers, cis:trans 17:13) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 8.24-8.12 (m, 1H, ArH), 7.81 (s, 1H, ArH), 7.41-7.33 (m, 1H, ArH), 7.31-
7.22 (m, 2H, ArH), 5.61-5.32 (m, 2H, CH=CH), 4.20-4.08 (m, 2H, NCH2), 3.91 (s, 3H, OCH3), 2.14-1.87 
(m, 4H, 2 × CH2), 1.69-1.63 (m, 1.3H, trans CH3), 1.61-1.53 (m, 1.7H, cis CH3); 13C NMR (101 MHz, CDCl3): 
δ 165.7 (CO), 136.6 (Cq), 134.4 (CH), 129.4 (CH=CH, trans), 128.6 (CH=CH, cis), 126.9 (Cq), 126.8 
(CH=CH, trans), 125.9 (CH=CH, cis), 122.8 (CH), 121.9 (CH), 121.9 (CH), 110.1 (CH), 107.0 (Cq), 51.1 
(CH3), 46.4 (CH2), 29.7 (CH2), 23.9 (CH2), 18.1 (CH3, trans), 13.0 (CH3, cis); HRMS (ESI+): Calculated for 
C16H19NO2 [M+H]+: 258.1489, found 258.1487; IR νmax (neat)/cm-1: 2971 (CH), 2901 (CH), 1700 (C=O). 
1-(Hex-4-en-1-yl)-1H-indole-3-carboxylic acid 229 
 
Methyl 1-(hex-4-en-1-yl)-1H-indole-3-carboxylate (4.4 mmol, 1.07 g) was subjected to the general 
hydrolysis conditions described above, to give the title compound (990 mg, 93%, mixture of 
stereoisomers, cis:trans 17:13) as an off-white solid (analytically pure), which was used without 
further purification. 
M.p. 102-104 °C (MeCN) 1H NMR (400 MHz, CDCl3): δ 8.28-8.21 (m, 1H, ArH), 7.92 (s, 1H, ArH), 7.42-
7.35 (m, 1H, ArH), 7.34-7.29 (m, 1H, ArH), 5.61-5.34 (m, 2H, CH=CH), 4.21-4.13 (m, 2H, NCH2), 2.15-
1.91 (m, 4H, 2 × CH2), 1.67 (d, J = 5.5 Hz, 1.3H, trans CH3), 1.58 (d, J = 7.0 Hz, 1.7H, cis CH3); 13C NMR 
(101 MHz, CDCl3): δ 170.6 (CO), 136.8 (Cq), 135.7 (CH), 129.3 (CH=CH, trans), 128.5 (CH=CH, cis), 127.2 
(Cq), 126.0 (CH=CH, trans), 123.0 (CH=CH, cis), 122.3 (CH), 122.1 (CH), 110.2 (CH), 106.4 (Cq), 46.5 
(CH2), 29.5 (CH2), 23.9 (CH2), 18.1 (CH3, trans), 13.1 (CH3, cis); HRMS (ESI+): Calculated for C15H17NO2 







To a solution of iodobenzene (16.0 mmol, 1.78 mL), 4-pentyn-1-ol (8.0 mmol, 0.74 mL) and 
triethylamine (160 mmol, 22.3 mL) in THF (3 mL) was added Pd(PPh3)4 (1 mol%, 92.4 mg) and CuI (2 
mol%, 30.5 mg). The reaction mixture was stirred at room temperature for 20 hours. The reaction 
mixture was filtered, and the filtrate concentrated. The crude residue was purified by flash column 
chromatography (20% EtOAC/Petrol) to yield the title compound (1.19 g, 93%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.40-7.35 (m, 2H, ArH), 7.29-7.23 (m, 3H, ArH), 3.81 (t, J = 6.5 Hz, 2H, 
OCH2), 2.53 (t, J = 6.5 Hz, 2H, CH2), 1.85 (qn, J = 6.5 Hz, 2H, CH2); IR νmax (neat)/cm-1: 3327 (br. OH), 
2950 (CH). Data are consistent with literature precedent.150 
Methyl 1-(5-phenylpent-4-en-1-yl)-1H-indole-3-carboxylate 244 
 
Methyl indole-3-carboxylate (5.0 mmol, 876 mg) was subjected to the general alkylation conditions 
described above with 5-phenylpent-4-en-1-yl methanesulfonate. The crude material was purified by 
flash column chromatography (5% EtOAc/petrol) to afford the title compound (1.55 g, 97%, mixture 
of stereoisomers trans:cis 15:1) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.24-8.15 (m, 1H, ArH), 7.85 (s, 1H, ArH), 7.43-7.16 (m, 8H, ArH), 6.50 (d, 
J = 11.5 Hz, 0.06H, cis CH=CH), 6.40 (d, J = 16.0 Hz, 0.94H, trans CH=CH), 6.16 (dt, J = 16.0, 7.0 Hz, 
0.94H, trans CH=CH), 5.63 (dt, J = 11.5, 7.5 Hz, 0.06H, cis CH=CH), 4.41-4.35 (m, 0.12H, cis NCH2), 4.21 
(t, J = 7.0 Hz, trans 1.88H, NCH2), 3.92 (s, 2.82H, trans OCH3), 3.90 (s, 0.18H, cis OCH3), 2.29-2.20 (m, 
2H, CH2), 2.12-2.03 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 137.4 (Cq), 136.6 (Cq), 134.4 
(CH), 131.6 (CH=CH), 128.7 (CH), 128.5 (CH=CH), 127.4 (CH), 126.9 (Cq), 126.1 (CH), 122.8 (CH), 122.0 
(CH), 121.0 (CH), 110.1 (CH), 107.2 (Cq), 51.1 (CH3), 46.3 (CH2), 30.1 (CH2), 29.4 (CH2); HRMS (ESI+): 
Calculated for C21H21NO2 [M+Na]+: 342.1465, found 342.1470; IR νmax (neat)/cm-1: 3055 (CH), 2945 
(CH), 1697 (C=O). 





Methyl 1-(5-phenylpent-4-en-1-yl)-1H-indole-3-carboxylate (4.5 mmol, 1.44 g) was subjected to the 
general hydrolysis conditions described above, to give the title compound (899 mg, 65%, mixture of 
stereoisomers trans:cis 15:1) as an off-white solid (analytically pure), which was used without further 
purification. 
M.p. 157-159 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.23-8.16 (m, 1H, ArH), 7.89 (s, 1H, ArH), 7.35-
7.13 (m, 8H, ArH), 6.45 (d, J = 11.5 Hz, 0.06H, cis CH=CH), 6.35 (d, J = 15.5 Hz, 0.94H, trans CH=CH), 
6.10 (dt, J = 15.5, 7.0 Hz, 0.94H, trans CH=CH), 5.57 (dt, J = 11.5, 7.0 Hz, 0.06 H, cis CH=CH), 4.33 (t, J = 
7.0 Hz, 0.12H, cis NCH2), 4.16 (t, J = 7.0 Hz, 1.88H, trans NCH2), 2.20 (m, 2H, CH2), 2.03 (m, 2H, CH2); 
13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 137.3 (Cq), 136.8 (Cq), 135.6 (CH), 131.7 (CH=CH), 128.7 (CH), 
128.5 (CH=CH), 127.4 (CH), 127.2 (Cq), 126.2 (CH), 123.0 (CH), 122.3 (CH), 122.2 (CH), 110.2 (CH), 106.6 
(Cq), 46.5 (CH2), 30.1 (CH2), 29.4 (CH2); HRMS (ESI+): Calculated for C20H19NO2 [M+Na]+: 328.1308, 
found 328.1305; IR νmax (neat)/cm-1: 3675 (OH), 2988 (CH), 1655 (C=O). 
Pent-4-yn-1-yl methanesulfonate201 249 
 
4-Pentyn-1-ol (10.0 mmol, 0.93 mL) was subjected to the general mesylation conditions described 
above. The crude material was purified by flash column chromatography (40% Et2O/ petrol) to yield 
4-pentyn-1-yl methanesulfonate (694 mg, 40%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 4.35 (t, J = 6.0 Hz, 2H, OCH2), 3.02 (s, 3H, SO2CH3), 2.36 (td, J = 7.0, 3.0 
Hz, 2H, CH2C≡CH), 2.01 (t, J = 3.0 Hz, 1H, C≡CH), 1.99-1.92 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 
82.8 (C≡CH), 69.9 (C≡CH), 68.4 (OCH2), 37.4 (CH3), 27.9 (CH2), 14.8 (CH2); HRMS (ESI+): Calculated for 
C6H10O3S [M+Na]+: 185.0243, found 185.0250; IR νmax (neat)/cm-1: 3286 (CH), 2940 (CH). 
Methyl 1-(pent-4-yn-yl)-1H-indole-3-carboxylate 250 
 
Methyl indole-3-carboxylate (7.4 mmol, 1.30 g) was subjected to the general alkylation conditions 
described above with 4-pentyn-1-yl methanesulfonate. The crude material was purified by flash 
column chromatography (10% EtOAc/ petrol) to yield the title compound (1.67 g, 93%) as a colourless 
oil. 
1H NMR (400 MHz, CDCl3): δ 8.21-8.15 (m, 1H, ArH), 7.86 (s, 1H, ArH), 7.44-7.37 (m, 1H, ArH), 7.32-




2.03 (m, 3H, CH2 + C≡CH); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 136.6 (Cq), 134.5 (CH), 126.9 (Cq), 
122.9 (CH), 122.1 (CH), 122.0 (CH), 110.0 (CH), 107.3 (Cq), 82.5 (C≡CH), 70.3 (C≡CH), 51.1 (OCH3), 45.4 
(NCH2), 28.4 (CH2), 15.8 (CH2); HRMS (ESI+): Calculated for C15H15NO2 [M+H]+: 242.1176, found 
242.1181; IR νmax (neat)/cm-1: 3273 (CH), 3121 (CH), 2947 (CH), 2114 (C≡C), 1684 (C=O). 
1-(Pent-4-yn-1-yl)-1H-indole-3-carboxylic acid 251 
 
Methyl 1-(pent-4-yn-yl)-1H-indole-3-carboxylate (6.6 mmol, 1.60 g) was subjected to the general 
hydrolysis conditions described above. The crude material was recrystallised from MeCN to give the 
title compound (1.20 g, 80%) as an off-white solid. 
M.p. 136-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.31-8.21 (m, 1H, ArH), 7.97 (s, 1H, ArH), 7.46-
7.41 (m, 1H, ArH), 7.34-7.29 (m, 2H, ArH), 4.36 (t, J = 6.5 Hz, 2H, NCH2), 2.22 (td, J = 6.5, 2.5 Hz, 2H, 
CH2C≡CH), 2.14-2.06 (m, 3H, CH2 + C≡CH); 13C NMR (101 MHz, CDCl3): δ 170.4 (CO), 136.7 (Cq), 135.8 
(CH), 127.2 (Cq), 123.1 (CH), 122.4 (CH), 122.2 (CH), 110.2 (CH), 106.7 (Cq), 82.5 (C≡CH), 70.4 (C≡CH), 
45.5 (NCH2), 28.4 (CH2), 15.9 (CH2); HRMS (ESI-): Calculated for C14H13NO2 [M-H]-: 226.0874, found 
226.0870; IR νmax (neat)/cm-1: 3299 (CH), 2953 (CH), 2571 (br. OH), 2118 (C≡C), 1659 (C=O). 
N-(Methylsulfonyl)-1-(pent-4-yn-1-yl)-1H-indole-3-carboxamide 252 
 
1-(Pent-4-yn-1-yl)-1H-indole-3-carboxylic acid (4.4 mmol, 1.00 g) was subjected to the general amide 
coupling conditions described above. The crude material was purified by recrystallisation from MeCN 
to give the title compound (860 mg, 64%) as a white solid.  
M.p. 191-194 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.12 (br. s, 1H, NH), 8.32 (s, 1H, ArH), 
8.29-8.23 (m, 1H, ArH), 7.64-7.52 (m, 1H, ArH), 7.29 (dddd, J = 19.5, 8.0, 7.0, 1.0 Hz, 2H, ArH), 4.42 (t, 
J = 7.0 Hz, 2H, NCH2), 3.40 (s, 3H, SO2CH3), 2.49 (t, J = 2.5 Hz, 1H, C≡CH), 2.24 (td, J = 6.5, 2.5 Hz, 2H, 
CH2C≡CH), 2.15-2.07 (m, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 163.4 (CO), 137.7 (Cq), 134.3 
(CH), 128.2 (Cq), 124.0 (CH), 122.9 (CH), 122.5 (CH), 111.4 (CH), 108.7 (Cq), 83.6 (C≡CH), 71.2 (C≡CH), 








Ethyl 2-methylpent-4-enoate (10.0 mmol, 1.63 mL) in Et2O (25 mL) was added slowly to a solution of 
LiAlH4 (10.0 mmol, 4.20 mL, 2.4 M solution in THF) in Et2O (25 mL) at 0 °C. The reaction mixture was 
stirred for 30 minutes, before being quenched by the slow addition of water (0.50 mL), NaOH (2 M, 
0.50 mL) and water (1.00 mL) while stirring vigorously. The mixture was left to warm to room 
temperature and was stirred for a further 90 minutes. The reaction mixture was then filtered through 
Celite® and concentrated to yield the title compound (1.06 g, quantitative) as a colourless oil, without 
the need for further purification. 
1H NMR (400 MHz, CDCl3): δ 5.81 (ddt, J = 17.5, 10.0, 7.0 Hz, 1H, CH=CH2), 5.09-4.98 (m, 2H, CH=CH2), 
3.56-3.41 (m, 2H, OCH2), 2.22-2.13 (m, 1H, CHH), 2.00-1.89 (m, 1H, CHH), 1.80-1.66 (m, 1H, CH), 0.95-
0.89 (d, J = 6.5 Hz, 3H, CH3); IR νmax (neat)/cm-1: 3324 (br. OH), 3077 (CH), 2958 (CH), 2911 (CH). Data 
are consistent with literature precedent.202 
2-Methylpent-4-en-1-yl methanesulfonate 255 
 
2-Methylpent-4-en-1-ol (10.0 mmol, 1.00 g) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (8% EtOAc/petrol) 
to yield the title compound (1.63 g, 91%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.75 (dddd, J = 16.5, 12.5, 8.0, 6.0 Hz, 1H, CH=CH2), 5.11-5.03 (m, 2H, 
CH=CH2), 4.14-3.98 (m, 2H, OCH2), 3.00 (s, 3H, SO2CH3), 2.23-2.14 (m, 1H, CHH), 2.06-1.93 (m, 2H, CHH 
+ CH), 1.00 (d, J = 6.5 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 135.4 (CH=CH2), 117.4 (CH=CH2), 74.0 
(OCH2), 37.3 (SO2CH3), 37.2 (CH2), 32.9 (CH), 16.3 (CH3); HRMS (ESI+): Calculated for C7H14O3S [M+Na]+: 
201.0556, found 201.0560; IR νmax (neat)/cm-1: 3078 (CH), 2972 (CH), 2901 (CH), 1350 (S=O). 





Methyl indole-3-carboxylate (8.4 mmol, 1.47 g) was subjected to the general alkylation conditions 
described above with 2-methylpent-4-en-1-yl methanesulfonate. The crude material was purified by 
flash column chromatography (5% EtOAc/petrol) to afford the title compound (982 mg, 45%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ 8.25-8.08 (m, 1H, ArH), 7.79 (s, 1H, ArH), 7.39-7.31 (m, 1H, ArH), 7.29-
7.24 (m, 2H, ArH), 5.78 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.04 (m, 2H, CH=CH2), 4.11 (dd, 
J = 14.0, 6.0 Hz, 1H, NCHH), 3.91 (s, 3H, OCH3), 3.86 (dd, J = 14.0, 8.0 Hz, 1H, NCHH), 2.23-2.06 (m, 2H, 
CHH + CH), 2.04-1.94 (m, 1H, CHH), 0.90 (d, J = 6.5 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 165.7 
(CO), 136.9 (Cq), 135.6 (CH=CH2), 134.9 (CH), 126.8 (Cq), 122.8 (CH), 121.9 (CH), 121.9 (CH), 117.5 
(CH=CH2), 110.3 (CH), 107.0 (Cq), 52.9 (NCH2), 51.1 (OCH3), 38.9 (CH2), 33.9 (CH), 17.7 (CH3); HRMS 
(ESI+): Calculated for C16H19NO2 [M+H]+: 258.1489, found 258.1494; IR νmax (neat)/cm-1: 3067 (CH), 
2949 (CH), 1698 (C=O). 
1-(2-Methylpent-4-en-1-yl)-1H-indole-carboxylic acid 257 
 
Methyl 1-(2-methylpent-4-en-1-yl)-1H-indole-3-carboxylate (3.5 mmol, 901 mg) was subjected to the 
general hydrolysis conditions described above, to give title compound (733 mg, 81%) as an off-white 
solid (analytically pure), which was used without further purification. 
M.p. 110-113 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.30-8.18 (m, 1H, ArH), 7.91 (s, 1H, ArH), 7.39-
7.35 (m, 1H, ArH), 7.33-7.28 (m, 2H, ArH), 5.80 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.17-4.99 (m, 
2H, CH=CH2), 4.15 (dd, J = 14.0, 6.0 Hz, 1H, NCHH), 3.90 (dd, J = 14.0, 8.0 Hz, 1H, NCHH), 2.28-2.09 (m, 
2H, CHH + CH), 2.07-1.98 (m, 1H, CHH), 0.93 (d, J = 6.5 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 170.7 
(CO), 137.1 (Cq), 136.2 (CH), 135.5 (CH=CH2), 127.1 (Cq), 123.0 (CH), 122.3 (CH), 122.1 (CH), 117.6 
(CH=CH2), 110.4 (CH), 106.5 (Cq), 53.0 (NCH2), 38.9 (CH2), 33.8 (CH), 17.8 (CH3); HRMS (ESI+): Calculated 







1-(2-Methylpent-4-en-1-yl)-1H-indole-carboxylic acid (2.5 mmol, 608 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (436 g, 54%) as a white solid.  
M.p. 129-130 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.11 (br. s, 1H, NH), 8.31 (s, 1H, ArH), 
8.28-8.24 (m, 1H, ArH), 7.67-7.50 (m, 1H, ArH), 7.36-7.17 (m, 2H, ArH), 5.84 (ddt, J = 17.0, 10.0, 7.5 Hz, 
1H, CH=CH2), 5.11-4.97 (m, 2H, CH=CH2), 4.25 (dd, J = 14.0, 6.0 Hz, 1H, NCHH), 4.08 (dd, J = 14.0, 8.0 
Hz, 1H, NCHH), 3.40 (s, 3H, SO2CH3), 2.29-2.11 (m, 2H, CHH + CH), 2.03-1.94 (m, 1H, CHH), 0.90 (d, J = 
6.5 Hz, 3H, CH3); 13C NMR (101 MHz, acetone-d6): δ 163.3 (CO), 138.0 (Cq), 137.0 (CH=CH2), 134.7 (CH), 
128.1 (Cq), 123.9 (CH), 122.8 (CH), 122.4 (CH), 117.2 (CH=CH2), 111.6 (CH), 108.4 (Cq), 53.2 (NCH2), 
42.3 (SO2CH3), 39.3 (CH2), 34.6 (CH), 17.5 (CH3); HRMS (ESI+): Calculated for C16H20N2O3S [M+Na]+: 
343.1087, found 343.1080; IR νmax (neat)/cm-1: 3225 (NH), 3116 (CH), 2976 (CH), 2927 (CH), 1646 
(C=O), 1321 (S=O). 
3-Methylpent-4-en-1-ol203 260 
 
3-Methylpent-4-enoic acid (8.8 mmol, 1.00 g) in Et2O (25 mL) was added slowly to a solution of LiAlH4 
(8.8 mmol, 3.67 mL, 2.4M solution in THF) in Et2O (25 mL) at 0 °C. The reaction mixture was stirred for 
30 minutes, before being quenched by the slow addition of water (0.50 mL), NaOH (2 M, 0.50 mL) and 
water (1.00 mL) while stirring vigorously. The mixture was allowed to warm to room temperature and 
was stirred for a further 90 minutes. The mixture was filtered through Celite®, and concentrated to 
yield the title compound (692 mg, 79%) as a colourless oil, without the need for further purification. 
1H NMR (400 MHz, CDCl3): δ 5.72 (ddd, J = 17.0, 10.0, 8.0 Hz, 1H, CH=CH2), 5.07-4.89 (m, 2H, CH=CH2), 
3.67 (t, J = 6.5 Hz, 2H, OCH2), 2.31 (app. dt, 1H, CH), 1.63-1.54 (m, 2H, CH2), 1.30 (br. s, 1H, OH), 1.03 





3-Methylpent-4-en-1-yl methanesulfonate 262 
 
3-Methylpent-4-en-1-ol (6.5 mmol, 650 mg) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (20% 
EtOAc/petrol) to yield the title compound (1.07 g, 92%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.65 (ddd, J = 17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 5.12-4.86 (m, 2H, CH=CH2), 
4.30-4.14 (m, 2H, OCH2), 2.99 (s, 3H, SO2CH3), 2.33 (qn, J = 7.5 Hz, 1H, CH), 1.84-1.65 (m, 2H, CH2), 1.05 
(d, J = 7.0 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 142.7 (CH=CH2), 114.4 (CH=CH2), 68.5 (OCH2), 
37.4 (SO2CH3), 35.5 (CH2), 34.5 (CH), 20.4 (CH3); HRMS (ESI+): Calculated for C7H14O3S [M+H]+: 
201.0556, found 201.0563; IR νmax (neat)/cm-1: 3078 (CH), 2968 (CH), 1351 (S=O).  
Methyl 1-(3-methylpent-4-en-1-yl)-1H-indole-3-carboxylate 263 
 
Methyl indole-3-carboxylate (5.5 mmol, 963 mg) was subjected to the general alkylation conditions 
described above with 3-Methylpent-4-en-1-yl methanesulfonate. The crude material was purified by 
flash column chromatography (10% EtOAc/petrol) to afford the title compound (1.31 g, 92%) as a 
yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.21-8.14 (m, 1H, ArH), 7.82 (s, 1H, ArH), 7.39-7.33 (m, 1H, ArH), 7.32-
7.25 (m, 2H, ArH), 5.78-5.64 (m, 1H, CH=CH2), 5.11-5.07 (m, 1H, CH=CHH), 5.07-5.03 (m, 1H, CH=CHH), 
4.22-4.05 (m, 2H, NCH2), 3.91 (s, 3H, OCH3), 2.17 (qn, J = 7.0 Hz, 1H, CH), 1.98-1.75 (m, 2H, CH2), 1.05 
(d, J = 7.0 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 142.9 (CH=CH2), 136.5 (Cq), 134.3 
(CH), 126.9 (Cq), 122.8 (CH), 121.9 (CH), 121.9 (CH), 114.7 (CH=CH2), 110.1 (CH), 107.1 (Cq), 51.1 
(OCH3), 45.1 (NCH2), 36.4 (CH2), 35.7 (CH), 20.7 (CH3); HRMS (ESI+): Calculated for C16H19NO2 [M+H]+: 
258.1489, found 258.1498; IR νmax (neat)/cm-1: 2950 (CH), 2952 (CH), 1698 (C=O). 





Methyl 1-(3-methylpent-4-en-1-yl)-1H-indole-3-carboxylate (5.0 mmol, 1.30 g) was subjected to the 
general hydrolysis conditions described above, to give the title compound (1.02 g, 84%) as an off-white 
solid (analytically pure), which was used without further purification. 
M.p. 102-104 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.28 (m, 1H, ArH), 7.93 (s, 1H, ArH), 7.41-7.35 
(m, 1H, ArH), 7.34-7.28 (m, 2H, ArH), 5.72 (ddd, J = 17.5, 10.0, 8.0 Hz, 1H, CH=CH2), 5.12-5.08 (m, 1H, 
CH=CHH), 5.08-5.05 (m, 1H, CH=CHH), 4.27-4.06 (m, 2H, NCH2), 2.19 (qn, J = 7.0 Hz, 1H, CH), 2.01-1.77 
(m, 2H, CH2), 1.07 (d, J = 7.0 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 142.7 (CH=CH2), 
136.6 (Cq), 135.4 (CH), 127.0 (Cq), 122.8 (CH), 122.1 (CH), 121.9 (CH), 114.7 (CH=CH2), 110.1 (CH), 
106.3 (Cq), 45.1 (NCH2), 36.2 (CH), 35.6 (CH2), 20.6 (CH3); HRMS (ESI+): Calculated for C15H17NO2 
[M+Na]+: 266.1151, found 266.1153; IR νmax (neat)/cm-1: 3675 (OH), 2971 (CH), 2901 (CH), 1654 (C=O). 
1-(3-Methylpent-4-en-yl)-N-indole-3-carboxamide 265 
 
1-(3-Methylpent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 730 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (607 mg, 63%) as a white solid.  
M.p. 148-149 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.50 (s, 1H, NH), 8.43 (s, 1H, ArH), 8.14 
(dt, J = 7.5, 1,0 Hz, 1H, ArH), 7.57 (dt, J = 8.5, 1.0 Hz, 1H, ArH), 7.30-7.19 (m, 2H, ArH), 5.79 (ddd, J = 
17.5, 10.5, 7.5 Hz, 1H, CH=CH2), 5.08-4.98 (m, 2H, CH=CH2), 4.21 (dd, J = 8.0, 6.5 Hz, 2H, NCH2), 3.38 
(s, 3H, SO2CH3), 2.15 (qn, J = 7.0 Hz, 1H, CH), 1.82 (q, J = 7.0 Hz, 2H, CH2), 1.03 (d, J = 6.5 Hz, 3H, CH3); 
13C NMR (101 MHz, DSMO-d6): δ 162.6 (CO), 143.2 (CH=CH2), 136.2 (Cq), 134.3 (CH), 126.7 (Cq), 122.8 
(CH), 121.8 (CH), 121.0 (CH), 113.9 (CH=CH2), 110.8 (CH), 106.8 (Cq), 44.3 (NCH2), 41.8 (SO2CH3), 35.6 
(CH2), 34.5 (CH), 19.8 (CH3); HRMS (ESI+): Calculated for C16H20N2O3S [M+Na]+: 343.1087, found 
343.1090; IR νmax (neat)/cm-1: 3680 (NH), 2969 (CH), 1637 (C=O), 1317 (S=O). 
3,3-Dimethylpent-4-en-1-ol204 268 
 
3,3-Dimethylpent-4-enoic acid (10.0 mmol, 1.58 mL) in Et2O (25 mL) was added slowly to a solution of 
LiAlH4 (10.0 mmol, 4.20 mL, 2.4 M solution in THF) in Et2O (25 mL) at 0 °C. The reaction mixture was 
stirred for 30 minutes before being quenched by the slow addition of water (0.50 mL), NaOH (2 M, 




temperature and was stirred for a further 90 minutes. The reaction mixture was then filtered through 
Celite®, and the solvent was removed. The crude residue was purified by flash column 
chromatography (15% Et2O/petrol) to yield the title compound (957 mg, 84%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.85 (ddt, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.00-4.88 (m, 2H, CH=CH2), 3.65 
(t, J = 7.0 Hz, 2H, OCH2), 1.67-1.57 (m, 2H, CH2), 1.03 (s, 6H, C(CH3)2); IR νmax (neat)/cm-1: 2964 (CH). 
Data are consistent with literature precedent.204 
3,3-Dimethylpent-4-en-1-yl methanesulfonate205 269 
 
3,3-Dimethylpent-4-en-1-ol (8.2 mmol, 950 mg) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (8% EtOAc/petrol) 
to yield the title compound (1.51 g, 96%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.76 (dd, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.04-4.92 (m, 2H, CH=CH2), 4.20 
(t, J = 7.5 Hz, OCH2), 2.98 (s, 3H, SO2CH3), 1.79 (t, J = 7.5 Hz, 2H, CH2), 1.06 (s, 6H, C(CH3)2); IR νmax 
(neat)/cm-1: 2965 (CH), 1352 (S=O). Data are consistent with literature precedent.205 
Methyl 1-(3,3-dimethylpent-4-en-1-yl)-1H-indole-3-carboxylate 270 
 
Methyl indole-3-carboxylate (7.8 mmol, 1.37 g) was subjected to the general alkylation conditions 
described above with 3,3-dimethylpent-4-en-1-yl methanesulfonate. The crude material was purified 
by flash column chromatography (4% EtOAc/petrol) to afford the title compound (1.24 g, 58%) as a 
white solid. 
M.p. 93-96 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.19-8.14 (m, 1H, ArH), 7.81 (s, 1H, ArH), 7.35-
7.23 (m, 3H, ArH), 5.85 (dd, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.13-5.01 (m, 2H, CH=CH2), 4.11-4.03 (m, 
2H, NCH2), 3.91 (s, 3H, OCH3), 1.88-1.82 (m, 2H, CH2), 1.12 (s, 6H, C(CH3)2); 13C NMR (101 MHz, CDCl3): 
δ 165.5 (CO), 146.6 (CH=CH2), 136.5 (Cq), 134.2 (CH), 126.9 (CH), 122.8 (CH), 121.9 (CH), 112.3 
(CH=CH2), 110.0 (CH), 107.1 (Cq), 51.1 (OCH3), 43.6 (NCH2), 42.3 (CH2), 36.1 (C(CH3)2), 26.9 (C(CH3)2); 
HRMS (ESI+): Calculated for C17H21NO2 [M+H]+: 272.1645, found 272.1647; IR νmax (neat)/cm-1: 3107 




1-(3,3-Dimethylpent-4-en-1-yl)-1H-indole-3-carboxylic acid 271 
 
Methyl 1-(3,3-dimethylpent-4-en-1-yl)-1H-indole-3-carboxylate (4.5 mmol, 1.22 g) was subjected to 
the general hydrolysis conditions described above, to give the title compound (954 mg, 82%) as an off-
white solid (analytically pure), which was used without further purification. 
M.p. 154-156 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.27-8.20 (m, 1H, ArH), 7.92 (s, 1H, ArH), 7.41-
7.28 (m, 3H, ArH), 5.86 (dd, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.20-5.01 (m, 2H, CH=CH2), 4.16-4.04 (m, 
2H, NCH2), 1.96-1.80 (m, 2H, CH2), 1.13 (s, 6H, C(CH3)2); 13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 146.5 
(CH=CH2), 136.7 (Cq), 135.5 (CH), 127.2 (Cq), 122.9 (CH), 122.3 (CH), 122.1 (CH), 112.4 (CH), 110.1 
(CH=CH2), 106.5 (Cq), 43.8 (NCH2), 42.2 (CH2), 36.2 (C(CH3)2), 26.9 (C(CH3)2); HRMS (ESI+): Calculated 




1-(3,3-Dimethylpent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 772 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (646 mg, 64%) as a white solid.  
M.p. 152-154 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.89 (br. s, 1H, NH), 8.24-8.13 (m, 1H, ArH), 
7.89 (s, 1H, ArH), 7.36-7.26 (m, 3H, ArH), 5.83 (dd, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.14-4.98 (m, 2H, 
CH=CH2), 4.12-3.99 (m, 2H, NCH2), 3.49 (s, 3H, SO2CH3), 1.89-1.82 (m, 2H, CH2), 1.11 (s, 6H, C(CH3)2); 
13C NMR (101 MHz, CDCl3): δ 162.0 (CO), 146.3 (CH=CH2), 136.6 (Cq), 132.7 (CH), 126.5 (Cq), 123.4 
(CH), 122.6 (CH), 121.4 (CH), 112.3 (CH=CH2), 110.2 (CH), 107.4 (Cq), 43.7 (NCH2), 42.3 (SO2CH3), 41.9 
(CH2), 36.0 (Cq), 26.7 (C(CH3)2); HRMS (ESI+): Calculated for C17H22N2O3S [M+Na]+: 357.1243, found 
357.1249; IR νmax (neat)/cm-1: 3154 (NH), 2962 (CH), 1640 (C=O), 1327 (S=O). 





Ethylene glycol vinyl ether (20.0 mmol, 1.79 mL) was subjected to the general mesylation conditions 
described above. The crude material was purified by flash column chromatography (40% EtOAc/ 
petrol) to yield the title compound (2.22 g, 67%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 6.46 (dd, J = 14.5, 7.0 Hz, 1H, CH=CH2), 4.47-4.42 (m, 2H, OCH2), 4.22 (dd, 
J = 14.5, 2.5 Hz, 1H, CH=CHH), 4.09 (dd, J = 7.0, 2.5 Hz, 1H, CH=CHH), 3.98-3.93 (m, 2H, OCH2), 3.05 (s, 
3H, SO2CH3); 13C NMR (101 MHz, CDCl3): δ 151.1 (CH=CH2), 87.9 (CH=CH2), 68.0 (OCH2), 65.7 (OCH2), 
37.8 (CH3); HRMS (ESI+): Calculated for C5H10O4S [M+Na]+: 189.0192, found 189.0196.  
Methyl 1-(2-(vinyloxy)ethyl)-1H-indole-3-carboxylate 276 
 
Methyl indole-3-carboxylate (18.0 mmol, 3.15 g) was subjected to the general alkylation conditions 
described above with 2-(vinyloxy)ethyl methanesulfonate. The crude material was purified by flash 
column chromatography (10% EtOAc/ petrol) to yield the title compound (2.99 g, 68%) as a white 
solid. 
M.p. 66-68 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.22-8.16 (m, 1H, ArH), 7.88 (s, 1H, ArH), 7.41-
7.36 (m, 1H, ArH), 7.34-7.25 (m, 2H, ArH), 6.41 (dd, J = 14.5, 7.0 Hz, 1H, CH=CH2), 4.43 (t, J = 5.5 Hz, 
2H, NCH2), 4.16 (dd, J = 14.5, 2.5 Hz, 1H, CH=CHH), 4.04-3.99 (m, 3H, OCH2 + CH=CHH), 3.91 (s, 3H, 
OCH3); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 151.1 (CH=CH2), 136.6 (Cq), 135.0 (CH), 126.8 (Cq), 
123.0 (CH), 122.0 (CH), 109.8 (CH), 107.7 (CH), 87.6 (CH=CH2), 66.0 (OCH2), 51.2 (OCH3), 46.1 (NCH2); 
HRMS (ESI+): Calculated for C14H15NO3 [M+H]+: 246.1125, found 246.1128; IR νmax (neat)/cm-1: 2949 
(CH), 1688 (C=O). 
1-(2-(Vinyloxy)ethyl)-1H-indole-3-carboxylic acid 277 
 
Methyl 1-(2-(vinyloxy)ethyl)-1H-indole-3-carboxylate (10.2 mmol, 2.50 g) was subjected to the general 
hydrolysis conditions described above. The crude material was recrystallised from MeCN to yield the 
title compound (1.38 g, 59%) as a white solid. 
M.p. 140-141 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.28-8.22 (m, 1H, ArH), 7.99 (s, 1H, ArH), 7.45-




5.5 Hz, 2H, NCH2), 4.17 (dd, J = 14.5, 2.5 Hz, 1H, CH=CHH), 4.07-4.02 (m, 3H, OCH2 + CH=CHH); 13C NMR 
(101 MHz, CDCl3): δ 170.5 (CO), 151.1 (CH), 136.8 (Cq), 136.3 (CH), 127.1 (Cq), 123.1 (CH), 122.4 (CH), 
122.2 (CH), 109.9 (CH), 107.1 (Cq), 87.6 (CH=CH2), 65.9 (OCH2), 46.2 (NCH2); HRMS (ESI-): Calculated 
for C13H13NO3 [M-H]-: 230.0823, found 230.0817; IR νmax (neat)/cm-1: 2923 (CH), 1661 (C=O). 
N-(Methylsulfonyl)-1-(2-vinyloxy)ethyl)-1H-indole-3-carboxamide 278 
 
1-(2-(Vinyloxy)ethyl)-1H-indole-3-carboxylic acid (4.3 mmol, 1.00 g) was subjected to the general 
amide coupling conditions described above. The crude material was purified by recrystallisation from 
MeCN to give the title compound (1.01 g, 77%) as a white solid.  
M.p. 183-185 °C (MeCN); 1H NMR (400 MHz, MeCN-d3): δ 9.22 (br. s, 1H, NH), 8.20-8.11 (m, 1H, ArH), 
8.01 (s, 1H, ArH), 7.61-7.50 (m, 1H, ArH), 7.39-7.23 (m, 2H, ArH), 6.41 (dd, J = 14.5, 7.0 Hz, 1H, CH=CH2), 
4.47 (t, J = 5.0 Hz, 2H, NCH2), 4.21 (dd, J = 14.5, 2.0 Hz, 1H, CH=CHH), 4.06 (t, J = 5.0 Hz, 2H, OCH2), 4.00 
(dd, J = 7.0 Hz, 2.0 Hz, 1H, CH=CHH), 3.34 (s, 3H, SO2CH3); 13C NMR (101 MHz, MeCN-d3): δ 163.5 (CO), 
152.2 (CH=CH2), 137.8 (Cq), 135.1 (CH), 127.8 (Cq), 124.2 (CH), 123.2 (CH), 122.2 (CH), 111.7 (CH), 
108.5 (Cq), 88.0 (CH=CH2), 67.4 (OCH2), 47.0 (NCH2), 42.4 (SO2CH3); HRMS (ESI+): Calculated for 
C14H16N2O4S [M+H]+: 331.0723, found 331.0707; IR νmax (neat)/cm-1: 3168 (NH), 3110 (CH), 2932 (CH). 
Methyl 1-(hex-5-en-1-yl)-1H-indole-3-carboxylate 280a 
 
Methyl indole-3-carboxylate (10.0 mmol, 1.75 g) was subjected to the general alkylation conditions 
described above with 6-bromohex-1-ene. The crude material was purified by flash column 
chromatography (10% EtOAc/petrol) to afford the title compound (2.26 g, 84%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.22-8.15 (m, 1H, ArH), 7.81 (s, 1H, ArH), 7.39-7.32 (m, 1H, ArH), 7.31-
7.22 (m, 2H, ArH), 5.74 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.04-4.90 (m, 2H, CH=CH2), 4.13 (t, J = 
7.0 Hz, 2H, NCH2), 3.91 (s, 3H, OCH3), 2.08 (q, J = 7.0 Hz, 2H, CH2), 1.87 (qn, J = 7.0 Hz, 2H, CH2), 1.42 
(qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 138.0 (CH=CH2), 136.6 (Cq), 134.3 




(OCH3), 47.0 (NCH2), 33.3 (CH2), 29.3 (CH2), 26.2 (CH2); HRMS (ESI+): Calculated for C16H19NO2 [M+H]+: 
258.1489, found 258.1498; IR νmax (neat)/cm-1: 3116 (CH), 2939 (CH), 1699 (C=O). 
Methyl 1-(but-3-en-1-yl)-1H-indole-3-carboxylate 280b 
 
Methyl indole-3-carboxylate (10.0 mmol, 1.75 g) was subjected to the general alkylation conditions 
described above with 4-bromo-1-butene. The crude material was purified by flash column 
chromatography (8% EtOAc/petrol) to afford the title compound (1.25 g, 54%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.21-8.15 (m, 1H, ArH), 7.81 (s, 1H, ArH), 7,39-7.35 (m, 1H, ArH), 7.32-
7.23 (m, 2H, ArH), 5.76 (ddt, J = 17.5, 11.0, 7.0 Hz, 1H, CH=CH2), 5.11-5.00 (m, 2H, CH=CH2), 4.20 (t, J = 
7.0 Hz, 2H, NCH2), 3.91 (s, 3H, OCH3), 2.61 (app. qt, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 
136.5 (Cq), 134.3 (CH), 133.9 (CH=CH2), 126.9 (Cq), 122.8 (CH), 122.0 (CH), 121.9 (CH), 118.3 (CH=CH2), 
110.0 (CH), 107.1 (Cq), 51.1 (OCH3), 46.7 (NCH2), 34.2 (CH2); HRMS (ESI+): Calculated for C14H15NO2 
[M+Na]+: 252.0995, found 252.0992; IR νmax (neat)/cm-1: 3109 (CH), 3053 (CH), 2952 (CH), 1684 (C=O). 
1-(Hex-5-en-1-yl)-1H-indole-3-carboxylic acid 281a 
 
Methyl 1-(hex-5-en-1-yl)-1H-indole-3-carboxylate (8.4 mmol, 2.16 g) was subjected to the general 
hydrolysis conditions described above, to give the title compound (1.59 g, 78%) as an off-white solid 
(analytically pure), which was used without further purification. 
M.p. 119-120 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.29-8.22 (m, 1H, ArH), 7.93 (s, 1H, ArH), 7.42-
7.36 (m, 1H, ArH), 7.34-7.28 (m, 2H, ArH), 5.76 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.05-4.94 (m, 
2H, CH=CH2), 4.18 (t, J = 7.0 Hz, 2H, NCH2), 2.10 (q, J = 7.0 Hz, 2H, CH2), 1.91 (qn, J = 7.0 Hz, 2H, CH2), 
1.46 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 138.0 (CH=CH2), 136.8 (Cq), 
135.6 (CH), 127.1 (Cq), 123.0 (CH), 122.3 (CH), 122.1 (CH), 115.4 (CH=CH2), 110.2 (CH), 106.5 (Cq), 47.1 
(NCH2), 33.3 (CH2), 29.3 (CH2), 26.2 (CH2); HRMS (ESI+): Calculated for C15H17NO2 [M+Na]+: 266.1151, 




1-(But-3-en-1-yl)-1H-indole-3-carboxylic acid 281b 
 
Methyl 1-(but-3-en-1-yl)-1H-indole-3-carboxylate (5.4 mmol, 1.24 g) was subjected to the general 
hydrolysis conditions described above, to give the title compound (1.07 g, 92%) as an off-white solid 
(analytically pure), which was used without further purification. 
M.p. 124-126 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.45-8.14 (m, 1H, ArH), 7.93 (s, 1H, ArH), 7.43-
7.37 (m, 1H, ArH), 7.35-7.29 (m, 2H, ArH), 5.79 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.04 (m, 
2H, CH=CH2), 4.24 (t, J = 7.0 Hz, 2H, NCH2), 2.64 (q, J =  7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 
170.4 (CO), 136.5 (Cq), 135.5 (CH), 133.6 (CH=CH2), 127.0 (Cq), 122.9 (CH), 122.2 (CH), 121.9 (CH), 
118.3 (CH=CH2), 110.0 (CH), 106.3 (Cq), 46.6 (NCH2), 34.0 (CH2); HRMS (ESI+): Calculated for C13H13NO2 




1-(Hex-5-en-1-yl)-1H-indole-3-carboxylic acid (5.8 mmol, 1.41 g) was subjected to the general amide 
coupling conditions described above. The crude material was purified by recrystallisation from MeCN 
to give the title compound (1.52 g, 81%) as a white solid.  
M.p. 181-182 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.06 (br. s, 1H, NH), 8.33 (s, 1H, ArH), 
8.30-8.21 (m, 1H, ArH), 7.60-7.50 (m, 1H, ArH), 7.37-7.15 (m, 2H, ArH), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 
1H, CH=CH2), 5.02-4.95 (m, 1H, CH=CHH), 4.94-4.89 (m, 1H, CH=CHH), 4.31 (t, J = 7.0 Hz, 2H, NCH2), 
3.39 (s, 3H, SO2CH3), 2.09 (q, J = 7.0 Hz, 2H, CH2), 1.91 (qn, J = 7.0 Hz, 2H, CH2), 1.48-1.40 (m, 2H, CH2); 
13C NMR (101 MHz, acetone-d6): δ 163.3 (CO), 139.1 (CH=CH2), 137.7 (Cq), 134.2 (CH), 128.2 (Cq), 
123.9 (CH), 122.8 (CH), 122.4 (CH), 115.3 (CH=CH2), 111.4 (CH), 108.4 (Cq), 47.4 (NCH2), 42.3 (SO2CH3), 
33.9 (CH2), 30.0 (CH2), 26.7 (CH2); HRMS (ESI+): Calculated for C16H20N2O3S [M+Na]+: 343.1087, found 






1-(But-3-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 645 mg) was subjected to the general amide 
coupling conditions described above. The crude material was purified by recrystallisation from MeCN 
to give the title compound (490 mg, 56%) as a white solid.  
M.p. 186-188 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.06 (br. s, 1H, NH), 8.32 (s, 1H, ArH), 
8.29-8.24 (m, 1H, ArH), 7.62-7.56 (m, 1H, ArH), 7.34-7.21 (m, 2H, ArH), 5.84 (ddt, J = 17.5, 9.5, 7.0 Hz, 
1H, CH=CH2), 5.09-4.97 (m, 2H, CH=CH2), 4.37 (t, J = 7.0 Hz, 2H, NCH2), 3.39 (s, 3H, SO2CH3), 2.66 (app. 
qd, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 163.3 (CO), 137.7 (Cq), 135.4 (CH=CH2), 134.3 (CH), 
128.2 (Cq), 123.9 (CH), 122.8 (CH), 122.4 (CH), 118.0 (CH=CH2), 111.4 (CH), 108.4 (Cq), 47.0 (NCH2), 
42.3 (SO2CH3), 38.4 (CH2); HRMS (ESI+): Calculated for C14H16N2O3S [M+Na]+: 315.0774, found 
315.0770; IR νmax (neat)/cm-1: 3214 (NH), 3119 (CH), 2931 (CH), 1646 (C=O), 1321 (S=O). 
1-(2-(Cyclopent-2-en-1-yl)ethyl)-N-(methylsulfonyl)-1H-indole-3-carboxamide 285a 
 
1-(2-(Cyclopent-2-en-1-yl)ethyl)-1H-indole-3-carboxylic acid (3.0 mmol, 766 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (743 mg, 75%) as a white solid. 
M.p. 164-165 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.07 (br. s, 1H, NH), 8.36 (s, 1H, ArH), 
8.27 (ddd, J = 7.5, 1.5, 1.0 Hz, 1H, ArH), 7.62-7.56 (m, 1H, ArH), 7.35-7.22 (m, 2H, ArH), 5.77-5.73 (m, 
1H, CH=CH), 5.71-5.67 (m, 1H, CH=CH), 4.35 (t, J = 7.5 Hz, 2H, NCH2), 3.40 (s, 3H, SO2CH3), 2.72-2.62 
(m, 1H, CH), 2.41-2.19 (m, 2H, CH2), 2.13-1.97 (m, 2H, CH2), 1.92-1.82 (m, 1H, CHH), 1.54-1.43 (m, 1H, 
CHH); 13C NMR (101 MHz, acetone-d6): δ 163.4 (CO), 137.8 (Cq), 134.8 (CH=CH), 134.3 (CH), 131.8 
(CH=CH), 128.3 (Cq), 124.0 (CH), 122.9 (CH), 122.5 (CH), 111.5 (CH), 108.6 (Cq), 46.4 (NCH2), 43.8 (CH), 
42.4 (CH3), 36.8 (CH2), 32.6 (CH2), 30.3 (CH2); HRMS (ESI+): Calculated for C17H20N2O3S [M+H]+: 
333.1267, found 333.1253; IR νmax (neat)/cm-1: 3223 (br. NH), 3115 (CH), 2930 (CH), 1647 (C=O), 1321 






1-(2-(Cyclohex-2-en-1-yl)ethyl)-1H-indole-3-carboxylic acid (3.0 mmol, 808 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (727 mg, 70%) as a white solid. 
M.p. 135-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.31 (br. s, 1H, NH), 8.31-8.25 (m, 1H, ArH), 
8.02 (s, 1H, ArH), 7.46-7.29 (m, 3H, ArH), 5.84-5.74 (m, 1H, CH=CH), 5.67-5.63 (m, 1H, CH=CH), 4.23 (t, 
J = 7.5 Hz, 2H, NCH2), 3.54 (s, 3H, SO2CH3), 2.18-2.09 (m, 1H, CH), 2.04-1.99 (m, 2H, CH2), 1.98-1.82 (m, 
3H, 3 × CHH), 1.81-1.71 (m, 1H, CHH), 1.62-1.50 (m, 1H, CHH), 1.40-1.28 (m, 1H, CHH); 13C NMR (101 
MHz, CDCl3): δ 162.4 (CO), 136.7 (Cq), 133.1 (CH), 130.0 (CH=CH), 128.6 (CH=CH), 126.9 (Cq), 123.5 
(CH), 122.7 (CH), 121.7 (CH), 110.3 (CH), 107.4 (Cq), 45.0 (NCH2), 42.3 (SO2CH3), 36.0 (CH2), 32.6 (CH), 
28.8 (CH2), 25.2 (CH2), 21.2 (CH2); HRMS (ESI+): Calculated for C18H22N2O3S [M+H]+: 347.1424, found 




1-(3-Cyclohex-1-en-1-yl)propyl)-1H-indole-3-carboxylic acid (3.0 mmol, 850 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (968 mg, 90%) as a white solid. 
M.p. 149-150 °C (MeCN); 1H NMR (400 MHz, acetone-d3): δ 10.06 (br. s, 1H, NH), 8.33 (s, 1H, ArH), 
8.29-8.23 (m, 1H, ArH), 7.59-7.52 (m, 1H, ArH), 7.35-7.21 (m, 2H, ArH), 5.43-5.37 (m, 1H, CH=C), 4.28 
(t, J = 6.5 Hz, 2H, NCH2), 3.40 (s, 3H, SO2CH3), 2.05-1.85 (m, 8H, 4 × CH2), 1.63-1.47 (m, 4H, 2 × CH2); 13C 
NMR (101 MHz, acetone-d3): δ 163.3 (CO), 137.7 (Cq), 137.0 (Cq), 134.2 (CH), 128.2 (Cq), 123.8 (CH), 
122.7 (CH), 122.5 (d, CH=C), 122.4 (CH), 111.4 (CH), 108.4 (Cq), 47.1 (NCH2), 42.2 (SO2CH3), 35.6 (CH2), 
28.7 (CH2), 28.4 (CH2), 25.8 (CH2), 23.6 (CH2), 23.1 (CH2); HRMS (ESI+): Calculated for C19H24N2O3S 
[M+H]+: 361.1580, found 361.1581; IR νmax (neat)/cm-1: 3304 (NH), 3126 (CH), 2923 (CH), 1668 (C=O), 






Synthesised using a modified literature procedure.206 
To a solution of 2-cyclopentene-1-acetic acid (8.0 mmol, 0.96 mL) in Et2O (40 mL) at 0 °C was added 
LiAlH4 (16.0 mmol, 6.67 mL, 2.4 M solution in THF) dropwise. The reaction mixture was then allowed 
to warm to room temperature and was stirred for 3 hours. On completion, the mixture was re-cooled 
to 0 °C and quenched by the addition of water (0.42 mL), NaOH (2 M, 0.42 mL), and water (1.26 mL). 
The mixture was filtered through Celite®, washed with DCM, dried over MgSO4 and concentrated to 
yield the title compound (846 mg, 94%) as a colourless oil (analytically pure), which was used without 
further purification. 
1H NMR (400 MHz, CDCl3): δ 5.77-5.72 (m, 1H, CH=CH), 5.71-5.66 (m, 1H, CH=CH), 3.76-3.64 (m, 2H, 
OCH2), 2.83-2.72 (m, 1H, CH), 2.41-2.23 (m, 2H, CH2), 2.13-2.01 (m, 1H, CHH), 1.75-1.65 (m, 1H, CHH), 
1.63-1.53 (m, 1H, CHH), 1.50-1.38 (m, 1H, CHH); IR νmax (neat)/cm-1: 3312 (br. OH), 3050 (CH), 2927 
(CH), 2850 (CH). Data are consistent with literature precedent.206 
2-(Cyclohex-2-en-1-yl)ethan-1-ol206 291b 
 
To a suspension of NaH (24.0 mmol, 960 mg, 60% dispersion in mineral oil) in THF (30 mL) was added 
diethyl malonate (24.0 mmol, 3.66 mL) dropwise at 0 °C. The mixture was stirred at 0 °C for 1 hour 
before the dropwise addition of 3-bromocyclohexene (12.0 mmol, 1.38 mL). The reaction mixture was 
allowed to warm to room temperature and was stirred for 1 hour. On completion the mixture was 
poured into a solution of KOH (12 equiv.) in water/MeOH (1:1 v:v 30 mL), and stirred for a further 30 
minutes. This was acidified with HCl (20 equiv.) and extracted with EtOAc (×3). The combined organic 
extracts were washed with brine, dried over MgSO4 and concentrated. The crude residue was then 
refluxed in DMF for 3 hours. EtOAc was added, and the solution was washed with water (×3), washed 
with brine (×3), dried over MgSO4 and concentrated. The crude product was used in the next step 
without further purification. 
To a solution of crude 2-(cyclohex-2-en-1-yl)acetic acid (12.0 mmol) in Et2O (55 mL) was added LiAlH4 
(20.0 mmol, 8.30 mL, 2.4 M solution in THF) dropwise at 0 °C. The reaction mixture was allowed to 
warm to room temperature and was stirred for 1 hour. On completion, the mixture was re-cooled to 
0 °C and quenched by the addition of water (1.06 mL), NaOH (2 M, 1.06 mL), and water (3.18 mL). The 




crude residue was purified by flash column chromatography to yield the title compound (1.32 g, 87% 
over two steps) as a colourless oil. 
1H NMR (400 MHz, acetone-d6): δ 5.73-5.65 (m, 1H, CH=CH), 5.62-5.55 (m, 1H, CH=CH), 3.79-3.69 (m, 
2H, CH2OH), 2.29-2.19 (m, 1H, CH), 2.02-1.94 (m, 2H, CH2), 1.85-1.75 (m, 1H, CHH), 1.76-1.68 (m, 1H, 
CHH), 1.66-1.47 (m, 3H, 3 × CHH), 1.32-1.16 (m, 1H, CHH); IR νmax (neat)/cm-1: 3314 (br. OH), 3015 
(CH), 2923 (CH). Data are consistent with literature precedent.206 
2-(Cyclopent-2-en-1-yl)ethyl methanesulfonate 292a 
 
2-(Cyclopent-2-en-1-yl)ethan-1-ol (7.0 mmol, 785 mg) was subjected to the general mesylation 
conditions described above. The crude material was purified by flash column chromatography (20% 
EtOAc/petrol) to yield the title compound (1.17 g, 88%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.80-5.76 (m, 1H, CH=CH), 5.68-5.63 (m, 1H, CH=CH), 4.32-4.22 (m, 2H, 
OCH2), 3.01 (s, 3H, SO2CH3), 2.84-2.75 (m, 1H, CH), 2.43-2.24 (m, 2H, CH2), 2.15-2.06 (m, 1H, CHH), 
1.93-1.83 (m, 1H, CHH), 1.79-1.68 (m, 1H, CHH), 1.49-1.38 (m, 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 
133.5 (CH=CH), 131.7 (CH=CH), 69.1 (OCH2), 42.0 (SO2CH3), 37.6 (CH), 35.2 (CH2), 32.0 (CH2), 29.7 (CH2); 
HRMS (ESI+): Calculated for C8H14O3S [M+Na]+: 213.0556, found 213.0552; IR νmax (neat)/cm-1: 3048 
(CH), 2938 (CH), 1345 (S=O), 1171 (S=O). 
2-(Cyclohex-2-en-1-yl)ethyl methanesulfonate 292b 
 
2-(Cyclohex-2-en-1-yl)ethan-1-ol (10.0 mmol, 1.26 g) was subjected to the general mesylation 
conditions described above. The crude material was purified by flash column chromatography (5% 
EtOAc/petrol) to yield the title compound (1.94 g, 95%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.76-5.69 (m, 1H, CH=CH), 5.57-5.50 (m, 1H, CH=CH), 4.30 (t, J = 6.5 Hz, 
2H, OCH2), 3.00 (s, 3H, SO2CH3), 2.31-2.21 (m, 1H, CH), 2.02-1.94 (m, 2H, CH2), 1.86-1.77 (m, 2H, CH2), 
1.77-1.65 (m, 2H, CH2), 1.59-1.48 (m, 1H, CHH), 1.30-1.20 (m, 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 
130.1 (CH=CH), 128.4 (CH=CH), 68.3 (OCH2), 37.5 (SO2CH3), 35.4 (CH2), 31.6 (CH), 28.7 (CH2), 25.2 (CH2), 
21.2 (CH2); HRMS (ESI+): Calculated for C9H16O3S [M+Na]+: 227.0712, found 227.0714; IR νmax 




Methyl 1-(2-(cyclopent-2-en-1-yl)ethyl)-1H-indole-3-carboxylate 293a 
 
Methyl indole-3-carboxylate (6.0 mmol, 1.05 g) was subjected to the general alkylation conditions 
described above with 2-(cyclopent-2-en-1-yl)ethyl methanesulfonate. The crude material was purified 
by flash column chromatography (5% EtOAc/petrol) to afford the title compound (1.35 g, 84%) as a 
white paste. 
1H NMR (400 MHz, CDCl3): δ 8.23-8.14 (m, 1H, ArH), 7.83 (s, 1H, ArH), 7.39-7.35 (m, 1H, ArH), 7.32-
7.24 (m, 2H, ArH), 5.81-5.75 (m, 1H, CH=CH), 5.65-5.61 (m, 1H, CH=CH), 4.20-4.14 (m, 2H, NCH2), 3.91 
(s, 3H, OCH3), 2.72-2.61 (m, 1H, CH), 2.44-2.24 (m, 2H, CH2), 2.16-2.06 (m, 1H, CHH), 2.06-1.95 (m, 1H, 
CHH), 1.89-1.78 (m, 1H, CHH), 1.50-1.40 (m, 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 165.7 (CO), 136.6 
(Cq), 134.3 (CH), 133.5 (CH=CH), 131.8 (CH=CH), 126.9 (Cq), 122.8 (CH), 121.9 (CH), 121.9 (CH), 110.1 
(CH), 107.1 (Cq), 51.1 (CH3), 45.7 (NCH2), 43.0 (CH), 36.0 (CH2), 32.1 (CH2), 29.7 (CH2); HRMS (ESI+): 
Calculated for C17H19NO2 [M+H]+: 270.1489, found 270.1491; IR νmax (neat)/cm-1: 3109 (CH), 2945 (CH), 
2854 (CH), 1686 (C=O).  
Methyl 1-2-(cyclohex-2-en-1-yl)ethyl)-1H-indole-3-carboxylate 293b 
 
Methyl indole-3-carboxylate (9.0 mmol, 1.58 g) was subjected to the general alkylation conditions 
described above with 2-(cyclohex-2-en-1-yl)ethyl methanesulfonate. The crude material was purified 
by flash column chromatography (5% EtOAc/petrol) to afford the title compound (2.04 g, 80%) as a 
white solid. 
M.p. 72-73 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.22-8.16 (m, 1H, ArH), 7.84 (s, 1H, ArH), 7.41-
7.34 (m, 1H, ArH), 7.31-7.24 (m, 2H, ArH), 5.79-5.71 (m, 1H, CH=CH), 5.60-5.53 (m, 1H, CH=CH), 4.20 
(t, J = 7.5 Hz, 2H, NCH2), 3.91 (s, 3H, OCH3), 2.18-2.08 (m, 1H, CH), 2.04-1.96 (m, 2H, CH2), 1.96-1.80 
(m, 3H, 3 × CHH), 1.78-1.69 (m, 1H, CHH), 1.60-1.48 (m, 1H, CHH), 1.36-1.26 (m, 1H, CHH); 13C NMR 
(101 MHz, CDCl3): δ 165.6 (CO), 136.6 (Cq), 134.2 (CH), 130.1 (CH=CH), 128.5 (CH=CH), 126.8 (Cq), 
122.8 (CH), 121.9 (CH), 121.9 (CH), 110.1 (CH), 107.1 (Cq), 51.1 (OCH3), 44.8 (NCH2), 36.3 (CH2), 32.7 
(CH), 28.9 (CH2), 25.3 (CH2), 21.3 (CH2); HRMS (ESI+): Calculated for C18H21NO2 [M+H]+: 284.1645, found 




1-(2-(Cyclopent-2-en-1-yl)ethyl)-1H-indole-3-carboxylic acid 294a 
 
Methyl 1-(2-(cyclopent-2-en-1-yl)ethyl)-1H-indole-3-carboxylate (5.0 mmol, 1.35 g) was subjected to 
the general hydrolysis conditions described above to give the title compound (1.02 g, 80%) as a white 
solid (analytically pure), which was used without further purification. 
M.p. 152-153 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.30-8.23 (m, 1H, ArH), 7.95 (s, 1H, ArH), 7.44-
7.37 (m, 1H, ArH), 7.35-7.28 (m, 2H, ArH), 5.84-5.77 (m, 1H, CH=CH), 5.68-5.62 (m, 1H, CH=CH), 4.24-
4.17 (m, 2H, NCH2), 2.74-2.64 (m, 1H, CH), 2.46-2.26 (m, 2H, CH2), 2.17-1.98 (m, 2H, CH2), 1.94-1.80 
(m, 1H, CHH), 1.57-1.38 (m 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 170.9 (CO), 136.8 (Cq), 135.6 (CH), 
133.5 (CH=CH), 131.8 (CH=CH), 127.1 (Cq), 123.0 (CH), 122.3 (CH), 122.1 (CH), 110.2 (CH), 106.5 (Cq), 
45.9 (NCH2), 43.0 (CH), 36.0 (CH2), 32.1 (CH2), 29.7 (CH2); HRMS (ESI-): Calculated for C16H17NO2 [M-H]-
: 254.1187, found 254.1182; IR νmax (neat)/cm-1: 2988-2901 (CH), 2551 (br. OH), 1650 (C=O). 
1-(2-(Cyclohex-2-en-1-yl)ethyl)-1H-indole-3-carboxylic acid 294b 
 
Methyl 1-2-(cyclohex-2-en-1-yl)ethyl)-1H-indole-3-carboxylate (7.0 mmol, 1.98 g) was subjected to 
the general hydrolysis conditions described above to give the title compound (1.76 g, 93%) as an off-
white solid (analytically pure), which was used without further purification. 
M.p. 144-145 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.28-8.22 (m, 1H, ArH), 7.94 (s, 1H, ArH), 7.44-
7.37 (m, 1H, ArH), 7.34-7.27 (m, 2H, ArH), 5.80-5.71 (m, 1H, CH=CH), 5.62-5.53 (m, 1H, CH=CH), 4.22 
(t, J = 7.5 Hz, 2H, NCH2), 2.21-2.09 (m, 1H, CH), 2.05-1.81 (m, 5H, 5 × CHH), 1.79-1.70 (m, 1H, CHH), 
1.61-1.49 (m, 1H, CHH), 1.39-1.27 (m, 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 136.8 (Cq), 
135.5 (CH), 130.1 (CH=CH), 128.6 (CH=CH), 127.2 (Cq), 123.0 (CH), 122.3 (CH), 122.1 (CH), 110.2 (CH), 
106.6 (Cq), 45.0 (NCH2), 36.2 (CH2), 32.8 (CH), 28.9 (CH2), 25.3 (CH2), 21.3 (CH2); HRMS (ESI-): Calculated 







Synthesised using a modified literature procedure.206  
To a solution of methyl 1-cyclohexene-1-carboxylate (20.0 mmol, 2.80 g) in DCM (40 mL) was added 
DIBAL-H (44 mmol, 44 mL, 1 M solution in hexane) dropwise at -78 °C. The reaction mixture was stirred 
at -78 °C for 3 hours before the addition of MeOH (40 mL) and saturated aqueous Rochelle’s salt (40 
mL). The mixture was allowed to warm to room temperature and then was stirred for 18 hours. The 
resulting phases were separated, and the aqueous phase extracted with EtOAc (×3). The combined 
organic extracts were dried over MgSO4 and concentrated to yield the title compound (2.00 g, 89%) 
as a colourless oil (analytically pure), which was used without further purification. 
1H NMR (400 MHz, CDCl3): δ 5.71-5.66 (m, 1H, CH=C), 3.98 (s, 2H, CH2OH), 2.06-1.98 (m, 4H, 2 × CH2), 
1.69-1.54 (m, 4H, 2 × CH2); IR νmax (neat)/cm-1: 3305 (br. OH), 2922 (CH), 2856 (CH). Data are consistent 
with literature precedent.207 
1-(Bromomethyl)cyclohex-1-ene208 300 
 
Synthesised using a modified literature procedure.206 
To a solution of cyclohex-1-en-1-ylmethanol (17.0 mmol, 1.90 g) in Et2O (80 mL) at 0 °C was added 
PBr3. The reaction mixture was allowed to warm to room temperature and was stirred for 5 hours. On 
completion, the reaction mixture was poured into aqueous K2CO3 (17.0 mmol, 2.35 g). The resulting 
phases were separated, and the aqueous phase extracted with Et2O (×2). The combined organic 
phases were dried over MgSO4 and concentrated to yield the title compound (2.02 g, 68%) as a 
colourless oil (analytically pure), which was used without further purification. 
1H NMR (400 MHz, CDCl3): δ 5.90-5.85 (m, 1H, CH=C), 3.94 (s, 2H, CH2Br), 2.16-2.09 (m, 2H, CH2), 2.07-
2.00 (m, 2H, CH2), 1.72-1.63 (m, 2H, CH2), 1.61-1.53 (m, 2H, CH2); IR νmax (neat)/cm-1: 2927 (CH). Data 
are consistent with literature precedent.208 
3-(Cyclohex-1-en-1-yl)propanoic acid209 301 
 
Synthesised using a modified literature procedure.206 
To a suspension of NaH (22.0 mmol, 880 mg, 60% dispersion in mineral oil) in THF (30 mL) was added 
diethyl malonate (22.0 mmol, 3.34 mL) dropwise at 0 °C. The mixture was stirred at 0 °C for 1 hour 
before the dropwise addition of 1-(bromomethyl)cyclohex-1-ene (11.0 mmol, 1.93 g). The reaction 




mixture was poured into a solution of KOH (12 equiv.) in water/MeOH (1:1 v:v 30 mL), and stirred for 
a further 30 minutes. The mixture was then acidified with HCl (20 equiv.) and extracted with EtOAc 
(×3). The combined organic extracts were washed with brine, dried over MgSO4 and concentrated. 
The crude residue was then refluxed in DMF (30 mL) for 3 hours. EtOAc was added, and the solution 
was washed with water (×3), washed with brine (×3), dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography (15% EtOAc/petrol) to yield the title compound 
(891 mg, 66%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.46-5.41 (m, 1H, CH=C), 2.46 (dd, J = 9.0, 6.5 Hz, 2H, CH2), 2.26 (t, J = 8.0 
Hz, 2H, CH2), 2.01-1.89 (m, 4H, 2 × CH2), 1.66-1.50 (m, 4H, 2 × CH2); IR νmax (neat)/cm-1: 2926 (CH), 
1709 (C=O). Data are consistent with literature precedent.209 
3-(Cyclohex-1-en-1-yl)propan-1-ol206 302 
 
Synthesised using a modified literature procedure.206 
To a solution of 3-(cyclohex-1-en-1-yl)propanoic acid (7.0 mmol, 1.08 g) in Et2O (40 mL) was added 
LiAlH4 (14.0 mmol, 5.80 mL, 2.4 M solution in THF) dropwise at 0 °C. The reaction mixture was allowed 
to warm to room temperature and was stirred for 1 hour. On completion, the mixture was re-cooled 
to 0 °C and quenched by the addition of water (0.63 mL), NaOH (2 M, 0.63 mL), and water (1.89 mL). 
The mixture was filtered through Celite®, washed with DCM, dried over MgSO4 and concentrated. The 
crude residue was purified by flash column chromatography to yield the title compound (938 mg, 96%) 
as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.49-5.39 (m, 1H, CH=C), 3.72-3.53 (m, 2H, CH2), 2.08-1.84 (m, 6H, 3 × 
CH2), 1.75-1.45 (m, 6H, 3 × CH2); IR νmax (neat)/cm-1: 3316 (br. OH), 2923 (CH). Data are consistent with 
literature precedent.206 
3-(Cyclohex-1-en-1-yl)propyl methanesulfonate210 303 
 
3-(Cyclohex-1-en-1-yl)propan-1-ol (6.4 mmol, 897 mg) was subjected to the general mesylation 
conditions described above. The crude material was purified by flash column chromatography (12% 
EtOAc/petrol) to yield the title compound (1.22 g, 86%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.47-5.38 (m, 1H, CH=C), 4.20 (t, J = 6.5 Hz, 2H, OCH2), 2.99 (s, 3H, SO2CH3), 
2.04 (t, J = 7.5 Hz, 2H, CH2), 2.01-1.95 (m, 2H, CH2), 1.93-1.79 (m, 4H, 2 × CH2), 1.66-1.58 (m, 2H, CH2), 




Methyl 1-(3-cyclohex-1-en-1-yl)propyl)-1H-indole-3-carboxylate 304 
 
Methyl indole-3-carboxylate (5.5 mmol, 963 mg) was subjected to the general alkylation conditions 
described above with 3-(cyclohex-1-en-1-yl)propyl methanesulfonate. The crude material was purified 
by flash column chromatography (4% EtOAc/petrol) to afford the title compound (1.50 g, 91%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ 8.20-8.15 (m, 1H, ArH), 7.82 (s, 1H, ArH), 7.38-7.32 (m, 1H, ArH), 7.31-
7.23 (m, 2H, ArH), 5.44-5.38 (m, 1H, CH=C), 4.16-4.08 (m, 2H, NCH2), 2.03-1.94 (m, 6H, 3 × CH2), 1.93-
1.83 (m, 2H, CH2), 1.68-1.50 (m, 4H, 2 × CH2); 13C NMR (101 MHz, CDCl3): δ 165.7 (CO), 136.6 (Cq), 
136.0 (Cq), 134.5 (CH), 126.8 (Cq), 122.7 (CH), 122.4 (CH=C), 121.9 (CH), 121.9 (CH), 110.1 (CH), 107.0 
(Cq), 51.1 (OCH3), 46.6 (NCH2), 35.1 (CH2), 28.4 (CH2), 27.6 (CH2), 25.3 (CH2), 23.0 (CH2), 22.6 (CH2); 
HRMS (ESI+): Calculated for C19H23NO2 [M+H]+: 298.1802, found 298.1809; IR νmax (neat)/cm-1: 2925 
(CH), 1699 (C=O). 
1-(3-Cyclohex-1-en-1-yl)propyl)-1H-indole-3-carboxylic acid 305 
 
Methyl 1-(3-cyclohex-1-en-1-yl)propyl)-1H-indole-3-carboxylate (5.0 mmol, 1.49 g) was subjected to 
the general hydrolysis conditions described above to give the title compound (1.22 g, 86%) as an off-
white solid (analytically pure), which was used without further purification. 
M.p. 136-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.29-8.22 (m, 1H, ArH), 7.93 (s, 1H, ArH), 7.41-
7.34 (m, 1H, ArH), 7.34-7.27 (m, 2H, ArH), 5.47-5.41 (m, 1H, CH=C), 4.22-4.06 (m, 2H, NCH2), 2.07-1.97 
(m, 6H, 3 × CH2), 1.94-1.86 (m, 2H, CH2), 1.68-1.51 (m, 2H, 2 × CH2); 13C NMR (101 MHz, CDCl3): δ 170.8 
(CO), 136.8 (Cq), 135.9 (Cq), 135.7 (CH), 127.1 (Cq), 122.9 (CH), 122.5 (CH=C), 122.2 (CH), 122.1 (CH), 
110.2 (CH), 106.4 (Cq), 46.7 (NCH2), 35.1 (CH2), 28.3 (CH2), 27.5 (CH2), 25.4 (CH2), 23.0 (CH2), 22.6 (CH2); 
HRMS (ESI-): Calculated for C18H21NO2 [M-H]-: 282.1500, found 282.1495; IR νmax (neat)/cm-1: 2925-






5-Fluoroindole (10.0 mmol, 1.35 g) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (2% 
EtOAc/petrol) to afford the title compound (2.08g, 103%) as a brown oil. 
1H NMR (400 MHz, CDCl3): δ 7.30-7.22 (m, 2H, ArH), 7.13 (d, J = 3.0 Hz, 1H, ArH), 6.96 (td, J = 9.0, 2.5 
Hz, 1H, ArH), 6.45 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.10-5.00 
(m, 2H, CH=CH2), 4.12 (t, J = 7.0 Hz, 2H, NCH2), 2.12-2.04 (m, 2H, CH2), 2.00-1.89 (m, 2H, CH2); 13C NMR 
(101 MHz, CDCl3): δ 157.9 (d, J = 234.0 Hz, CF), 137.3 (CH=CH2), 132.7 (Cq), 129.5 (CH), 128.9 (d, J = 
10.0 Hz, Cq), 115.9 (CH=CH2), 110.0 (d, J = 10.0 Hz, CH), 109.9 (d, J = 26.5 Hz, CH), 105.7 (d, J = 23.5 Hz, 
CH), 101.1 (d, J = 4.5 Hz, CH), 46.0 (NCH2), 30.9 (CH2), 29.3 (CH2); 19F NMR (377 MHz, CDCl3): δ -125.67 
(td, J = 10.0, 4.5 Hz, ArF); HRMS (ESI+): Calculated for C13H14FN [M+H]+: 204.1183, found 204.1182; IR 
νmax (neat)/cm-1: 3077 (CH), 2925 (CH), 1486 (CF). 
1-(Pent-4-en-1-yl)-1H-indole-5-carbonitrile 307b 
 
5-Cyanoindole (10.0 mmol, 1.42 g) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (4% 
EtOAc/petrol) to give the title compound (1.57 g, 75%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.97 (s, 1H, ArH), 7.47-7.32 (m, 2H, ArH), 7.21 (d, J = 3.0 Hz, 1H, ArH), 
6.57 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.86-5.71 (m, 1H, CH=CH2), 5.08-5.05 (m, 1H, CH=CHH), 5.05-5.02 
(m, 1H, CH=CHH), 4.16 (t, J = 7.0 Hz, 2H, NCH2), 2.12-2.01 (m, 2H, CH2), 1.95 (qn, J = 7.0 Hz, 2H, CH2); 
13C NMR (101 MHz, CDCl3): δ 137.6 (Cq), 137.0 (CH=CH2), 130.2 (CH), 128.4 (Cq), 126.7 (CH), 124.5 
(CH), 121.0 (Cq), 116.2 (CH=CH2), 110.3 (CH), 102.5 (Cq), 102.4 (CH), 45.9 (NCH2), 30.8 (CH2), 29.3 (CH2); 
HRMS (ESI+): Calculated for C14H14N2 [M+H]+: 211.1230, found 211.1234; IR νmax (neat)/cm-1: 3071 






5-Methylindole (17 mmol, 2.23 g) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (5% 
DCM/petrol) to give the title compound (3.47 g, quantitative) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.44 (dt, J = 1.5, 1.0 Hz, 1H, ArH), 7.26 (d, J = 8.5 Hz, 1H, ArH), 7.09-7.03 
(m, 2H, ArH), 6.43 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.83 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.13-5.00 
(m, 2H, CH=CH2), 4.12 (t, J = 7.0 Hz, 2H, NCH2), 2.48 (s, 3H, CH3), 2.13-2.02 (m, 2H, CH2), 2.00-1.91 (m, 
2H, CH2); 13C NMR (101 MHz, CDCl3): δ 137.5 (CH), 134.5 (Cq), 129.0 (Cq), 128.5 (Cq), 128.0 (CH=CH2), 
123.0 (CH), 120.7 (CH), 115.6 (CH=CH2), 109.2 (CH), 100.5 (CH), 45.8 (NCH2), 21.5 (CH3), 30.1 (CH2), 29.4 
(CH2); HRMS (ESI+): Calculated for C14H17N [M+H]+: 200.1434, found 200.1443; IR νmax (neat)/cm-1: 
2922 (CH), 1640 (C=C). 
5-Methoxy-1-(pent-4-en-1-yl)-1H-indole 307d 
 
5-Methoxyindole (10.0 mmol, 1.47 g) was subjected to the general alkylation conditions described 
above with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (2% 
EtOAc/petrol) to give the title compound (1.93 g, 90%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.24 (dt, J = 9.0, 0.5 Hz, 1H, ArH), 7.10 (d, J = 2.5 Hz, 1H, ArH), 7.07 (d, J = 
3.0 Hz, 1H, ArH), 6.88 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 6.41 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.81 (ddt, J = 
17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.10-4.97 (m, 2H, CH=CH2), 4.10 (t, J = 7.0 Hz, 2H, NCH2), 3.86 (s, 3H, 
OCH3), 2.11-2.03 (m, 2H, CH2), 1.99-1.89 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 154.0 (Cq), 137.5 
(CH=CH2), 131.4 (Cq), 129.0 (Cq), 128.4 (CH), 115.8 (CH=CH2), 111.9 (CH), 110.2 (CH), 102.7 (CH), 100.6 
(CH), 56.0 (OCH3), 45.9 (NCH2), 31.0 (CH2), 29.4 (CH2); HRMS (ESI+): Calculated for C14H17NO [M+H]+: 
216.1383, found 216.1390; IR νmax (neat)/cm-1: 2931 (CH). 
5-Nitro-1-(pent-4-en-1-yl)-1H-indole 307e 
 
5-Nitroindole (10.0 mmol, 1.62 g) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (10% 
EtOAc/petrol) to give the title compound (2.30 g, quantitative) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.59 (d, J = 2.0 Hz, 1H, ArH), 8.11 (dd, J = 9.0, 2.0, 1H, ArH), 7.34 (dt, J = 




CH=CH2), 5.11-4.95 (m, 2H, CH=CH2), 4.18 (t, J = 7.0 Hz, 2H, NCH2), 2.12-2.03 (m, 2H, CH2), 1.97 (qn, J 
= 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 141.6 (Cq), 138.9 (Cq), 136.9 (CH=CH2), 131.1 (CH), 
127.8 (Cq), 118.4 (CH), 117.3 (CH), 116.2 (CH=CH2), 109.3 (CH), 104.1 (CH), 46.1 (NCH2), 30.8 (CH2), 
29.3 (CH2); HRMS (ESI+): Calculated for C13H14N2O2 [M+Na]+: 253.0975 found 253.0955; IR νmax 
(neat)/cm-1: 3076 (CH), 2922-2852 (CH), 1512 (NO2), 1330 (NO2). 
4-Methyl-1-(pent-4-en-1-yl)-1H-indole 307f 
 
5-Methylindole (4.3 mmol, 0.48 mL) was subjected to the general alkylation conditions described 
above with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (4% 
DCM/petrol) to give the title compound (634 g, 73%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.23-7.08 (m, 3H, ArH), 6.92 (dt, J = 7.0, 1.0 Hz, 1H, ArH), 6.52 (dd, J = 3.0, 
1.0 Hz, 1H, ArH), 5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.11-5.02 (m, 2H, CH=CH2), 4.14 (t, J = 
7.0 Hz, 1H, NCH2), 2.58 (s, 3H, CH3), 2.15-2.05 (m, 2H, CH2), 1.97 (dt, J = 8.0, 7.0 Hz, 2H, CH2); 13C NMR 
(101 MHz, CDCl3): δ 137.5 (CH=CH2), 135.8 (Cq), 130.6 (Cq), 128.6 (Cq), 127.3 (CH), 121.7 (CH), 119.6 
(CH), 115.7 (CH=CH2), 107.2 (CH), 99.6 (CH), 45.9 (NCH2), 31.0 (CH2), 29.4 (CH2), 18.9 (CH3); HRMS 
(ESI+): Calculated for C14H17N [M+H]+: 200.1434, found 200.1439; IR νmax (neat)/cm-1: 2926 (CH).  
4-Methoxy-1-(pent-4-en-1-yl)-1H-indole 307g 
 
4-Methoxyindole (10.0 mmol, 1.47 g) was subjected to the general alkylation conditions described 
above with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (2% 
EtOAc/petrol) to give the title compound (2.15 g, quantitative) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.14 (t, J = 8.0 Hz, 1H, ArH), 7.04-6.94 (m, 2H, ArH), 6.60 (dd, J = 3.0, 1.0, 
1H, ArH), 6.53 (d, J = 7.5 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.11-5.00 (m, 2H, 
CH=CH2), 4.11 (t, J = 7.0 Hz, 2H, NCH2), 3.97 (s, 3H, OCH3), 2.13-2.04 (m, 2H, CH2), 1.99-1.88 (m, 2H, 
CH2); 13C NMR (101 MHz, CDCl3): δ 153.6 (Cq), 137.6 (CH=CH2), 137.5 (CH), 126.5 (CH), 122.3 (CH), 
119.2 (Cq), 115.7 (CH=CH2), 103.1 (CH), 99.2 (CH), 98.4 (CH), 55.4 (OCH3), 46.0 (NCH2), 31.0 (CH2), 29.4 







6-Chloroindole (3.6 mmol, 547 mg) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (5% 
EtOAc/petrol) to give the title compound (768 mg, 97%) as an orange oil. 
1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 8.5 Hz, 1H, ArH), 7.35-7.32 (m, 1H, ArH), 7.11-7.05 (m, 2H, 
ArH), 6.47 (dd, J = 3.0, 1.0 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.05 (m, 1H, 
CH=CHH), 5.05-5.02 (m, H, CH=CHH), 4.08 (t, J = 7.0 Hz, 2H, NCH2), 2.07 (q, J = 7.0 Hz, 2H, CH2), 1.98-
1.89 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 137.3 (CH=CH2), 136.5 (Cq), 128.6 (CH), 127.6 (Cq), 
127.2 (Cq), 121.9 (CH), 120.1 (CH), 116.0 (CH=CH2), 109.5 (CH), 101.4 (CH), 45.8 (NCH2), 30.9 (CH2), 
29.2 (CH2); HRMS (ESI+): Calculated for C13H1435ClN [M+H]+: 220.0888, found 220.0892; IR νmax 
(neat)/cm-1: 3076 (CH), 2930 (CH). 
7-Nitro-1-(pent-4-en-1-yl)-1H-indole 307i 
 
7-Nitroindole (5.0 mmol, 811 mg) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (4% 
EtOAc/petrol) to give the title compound (846 mg, 75%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.87 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.82 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.18 
(d, J = 3.0 Hz, 1H, ArH), 7.14 (t, J = 8.0 Hz, 1H, ArH), 6.64 (d, J = 3.5 Hz, 1H, ArH), 5.73 (ddt, J = 16.0, 
11.0, 6.5 Hz, 1H, CH=CH2), 5.04-4.99 (m, 1H, CH=CHH), 4.99-4.94 (m, 1H, CH=CHH), 4.27 (t, J = 7.0 Hz, 
2H, NCH2), 1.98-1.88 (m, 2H, CH2), 1.77-1.68 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 137.2 
(CH2=CH2), 137.2 (Cq), 134.0 (Cq), 133.0 (CH), 127.3 (CH), 126.3 (Cq), 120.1 (CH), 118.6 (CH), 115.9 
(CH=CH2), 102.9 (CH), 49.6 (NCH2), 30.7 (CH2), 29.8 (CH2); HRMS (ESI+): Calculated for C13H14N2O2 







7-Azaindole (10.0 mmol, 1.18 g) was subjected to the general alkylation conditions described above 
with 5-bromo-1-pentene. The crude material was purified by flash column chromatography (4% 
EtOAc/petrol) to give the title compound (1.84 g, 99%) as a pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.32 (dd, J = 5.0, 1.5 Hz, 1H, ArH), 7.90 (dd, J = 8.0, 1.5 Hz, 1H, ArH), 7.21 
(d, J = 3.5 Hz, 1H, ArH), 7.05 (dd, J = 8.0, 4.5, Hz, 1H, ArH), 6.45 (d, J = 3.5, 1H, ArH), 5.82 (ddt, J = 17.0, 
10.0, 6.5 Hz, 1H, CH=CH2), 5.10-4.94 (m, 2H, CH=CH2), 4.32 (t, J = 7.0 Hz, 2H, NCH2), 2.10 (q, J = 7.0 Hz, 
2H, CH2), 2.04-1.92 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 147.6 (Cq), 142.8 (CH), 137.7 
(CH=CH2), 128.8 (CH), 128.1 (CH), 120.7 (Cq), 115.7 (CH), 115.5 (CH=CH2), 99.4 (CH), 44.1 (NCH2), 31.1 
(CH2), 29.6 (CH2); HRMS (ESI+): Calculated for C12H14N2 [M+H]+: 187.1230, found 187.1234; IR νmax 
(neat)/cm-1: 3056 (CH), 2925 (CH). 
3-Bromo-5-fluoro-1-(pent-4-en-1-yl)-1H-indole 308a 
 
To a solution of 5-fluoro-1-(pent-4-en-1-yl)-1H-indole (10.0 mmol, 2.03 g) in DMF (60 mL) was added 
NBS (10.0 mmol, 1.78 g) at 0 °C. The reaction mixture was shielded from light and stirred at 0 °C for 2 
hours. The completed reaction mixture was quenched with saturated aqueous NaHCO3, diluted with 
water and extracted with Et2O (×3). The combined organic layers were washed with water (×3), 
washed with brine, dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography (100% petrol) to give the title compound (2.02 g, 72%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.26-7.19 (m, 2H, ArH), 7.15 (s, 1H, ArH), 6.99 (td, J = 9.0, 2.5 Hz, 1H, ArH), 
5.85-5.73 (m, 1H, CH=CH2), 5.09-5.505 (m, 1H CH=CHH), 5.06-5.00 (m, 1H, CH=CHH), 4.09 (t, J = 7.0 Hz, 
2H, NCH2), 2.10-2.03 (m, 2H, CH2), 1.97-1.88 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 158.2 (d, J = 
236.0 Hz, CF), 136.9 (CH=CH2), 132.2 (Cq), 128.2 (CH), 127.7 (d, J = 10.5 Hz, Cq), 116.0 (CH=CH2), 111.2 
(d, J = 26.5 Hz, CH), 110.5 (d, J = 9.5 Hz, CH), 104.3 (d, J = 24.5 Hz, CH), 89.1 (d, J = 5.0 Hz, Cq), 46.1 
(NCH2), 30.7 (CH2), 29.1 (CH2); HRMS (ESI+): Calculated for C13H1379BrFN [M+H]+: 282.0288, found 
282.0290; IR νmax (neat)/cm-1: 3077 (CH), 2974 (CH), 1486 (CF). 
3-Bromo-1-(pent-4-en-1-yl)-1H-indole-5-carbonitrile 308b 
 
To a solution of 1-(pent-4-en-1-yl)-1H-indole-5-carbonitrile (7.5 mmol, 1.58 g) in DMF (45 mL) was 




for 2 hours. The completed reaction mixture was quenched with saturated aqueous NaHCO3, diluted 
with water and extracted with Et2O (×3). The combined organic layers were washed with water (×3), 
washed with brine, dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography (15% Et2O/petrol), to give the title compound as a colourless solid (1.83 g, 
85%). 
M.p. 64-66 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.93-7.90 (m, 1H, ArH), 7.47 (dd, J = 8.5, 1.5 Hz, 
1H, ArH), 7.37 (d, J = 8.5 Hz, 1H, ArH), 7.27-7.23 (m, 1H, ArH), 5.78 (ddt, J = 17.0, 11.0, 7.0 Hz, 1H, 
CH=CH2), 5.10-5.01 (m, 2H, CH=CH2), 4.14 (t, J = 7.0 Hz, 2H, NCH2), 2.11-2.04 (m, 2H, CH2), 1.94 (qn, J 
= 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 137.3 (Cq), 136.7 (CH=CH2), 129.1 (CH), 127.4 (Cq), 
125.5 (CH), 125.4 (CH), 120.3 (Cq), 116.4 (CH=CH2), 110.8 (CH), 103.6 (Cq), 90.9 (Cq), 46.2 (NCH2), 30.7 
(CH2), 29.2 (CH2); HRMS (ESI+): Calculated for C14H1379BrN2 [M+H]+: 289.0335, found 289.0337; IR νmax 
(neat)/cm-1: 3106 (CH), 2929 (CH), 2220 (CN). 
5-Fluoro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309a 
 
A solution of 3-bromo-5-fluoro-1-(pent-4-en-1-yl)-1H-indole (2.0 mmol, 564 mg) in THF (10 mL) was 
cooled to -78 °C. n-Butyllithium (2.2 mmol, 0.88 mL, 2.5 M solution in hexane) was added dropwise 
over 10 minutes. The reaction mixture was stirred at -78 °C for 30 minutes. CO2 was bubbled through 
the mixture until complete consumption of indole starting material was observed by TLC. The 
completed reaction was allowed to warm to room temperature and was quenched with water (10 
mL). The mixture was acidified to pH 1 with 3 M HCl and extracted with EtOAc (×3). The combined 
organic phases were washed with brine, dried over MgSO4 and concentrated. The crude material was 
purified by flash column chromatography (30% EtOAc/petrol) to give the title compound (359 mg, 
73%) as an off-white solid. 
M.p. 167-168 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 8.08 (s, 1H, ArH), 7.79 (dd, J = 10.0, 2.5 
Hz, 1H, ArH), 7.58 (dd, J = 9.0, 4.5 Hz, 1H, ArH), 7.06 (td, J = 9.0, 2.5 Hz, 1H, ArH), 5.86 (ddt, J = 17.0, 
10.0, 6.5 Hz, 1H, CH=CH2), 5.04 (app. dq, 1H, CH=CHH), 5.00-4.93 (m, 1H, CH=CHH), 4.34 (t, J = 7.0 Hz, 
2H, NCH2), 2.15-2.07 (m, 2H, CH2), 2.04-1.96 (m, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 164.9 
(CO), 159.0 (d, J = 235.0 Hz, CF), 137.4 (CH=CH2), 136.3 (CH), 133.4 (Cq), 127.8 (d, J = 11.0 Hz, Cq), 114.9 
(CH=CH2), 111.7 (d, J = 10.0 Hz, CH), 110.5 (d, J = 26.5 Hz, CH), 106.5 (d, J = 4.5 Hz, Cq), 106.0 (d, J = 
25.0 Hz, CH), 46.2 (NCH2), 30.5 (CH2), 29.0 (CH2); HRMS (ESI+): Calculated for C14H14FNO2 [M+H]+: 




5-Cyano-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309b 
 
A solution of 3-bromo-1-(pent-4-en-1-yl)-1H-indole-5-carbonitrile (5.8 mmol, 1.66 g) in THF (25 mL) 
was cooled to -78 °C. n-Butyllithium (6.6 mmol, 2.64 mL, 2.5 M solution in hexane) was added 
dropwise over 10 minutes. The reaction mixture was stirred at -78 °C for 30 minutes. CO2 was bubbled 
through the mixture until complete consumption of indole starting material was observed by TLC. The 
completed reaction was allowed to warm to room temperature and was quenched with water (10 
mL). The mixture was acidified to pH 1 with 3 M HCl and extracted with EtOAc (×3). The combined 
organic phases were washed with brine, dried over MgSO4 and concentrated. The crude material was 
purified by flash column chromatography (40% EtOAc/petrol) to give the title compound (632 mg, 
73%) as an orange solid. 
M.p. 169-169 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.61-8.54 (m, 1H, ArH), 8.03 (s, 1H, ArH), 7.53 
(dd, J = 8.5, 1.5 Hz, 1H, ArH), 7.45 (d, J = 8.5 Hz, 1H, ArH), 5.79 (ddt, J = 16.0, 11.5, 7.0 Hz, 1H, CH=CH2), 
5.13-5.02 (m, 2H, CH=CH2), 4.22 (t, J = 7.0 Hz, 2H, NCH2), 2.12 (q, J = 7.0 Hz, 2H, CH2), 2.06-1.97 (m, 2H, 
CH2); 13C NMR (101 MHz, CDCl3): δ 169.6 (CO), 138.3 (Cq), 137.4 (CH), 136.4 (CH=CH2), 127.6 (CH), 
126.8 (Cq), 126.1 (CH), 120.1 (Cq), 116.8 (CH=CH2), 111.2 (CH), 107.4 (Cq), 105.8 (Cq), 46.7 (NCH2), 30.6 
(CH2), 28.9 (CH2); HRMS (ESI-): Calculated for [M-H]-: 253.0983, found 253.0978; IR νmax (neat)/cm-1: 
3109 (CH), 2945 (br. OH), 2225 (CN), 1656 (C=O). 
5-Methyl-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309c 
 
5-Methyl-1-(pent-4-en-1-yl)-1H-indole (5.0 mmol, 997 mg) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (891 mg, 73%) as an off-white solid.  
M.p. 135-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.06 (dt, J = 2.0, 1.0 Hz, 1H, ArH), 7.88 (s, 1H, 
ArH), 7.27 (d, J = 8.5 Hz, 1H, ArH), 7.13 (dd, J = 8.5, 1.5 Hz, 1H, ArH), 5.80 (ddt, J = 17.0, 10.5, 6.5 Hz, 
1H, CH=CH2), 5.12-5.03 (m, 2H, CH=CH2), 4.16 (t, J = 7.0 Hz, 2H, NCH2), 2.51 (s, 3H, CH3), 2.14-2.06 (m, 
2H, CH2), 2.04-1.94 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 136.9 (CH=CH2), 135.6 (CH), 




(NCH2), 30.8 (CH2), 28.9 (CH2), 21.7 (CH3); HRMS (ESI-): Calculated for C15H17NO2 [M-H]-: 242.1187, 
found 242.1188; IR νmax (neat)/cm-1: 2918 (CH), 2852 (CH), 2546 (br. OH), 1614 (C=O). 
5-Methoxy-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309d 
 
5-Methoxy-1-(pent-4-en-1-yl)-1H-indole (5.0 mmol, 1.08 g) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (843 mg, 65%) as an off-white solid.  
M.p. 129-130 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.88 (s, 1H, ArH), 7.72 (d, J = 2.5 Hz, 1H, ArH), 
7.26 (dd, J = 9.0, 0.5 Hz, 1H, ArH), 6.94 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 5.80 (ddt, J = 17.0, 10.5, 6.5 Hz, 
1H, CH=CH2), 5.12-5.03 (m, 2H, CH=CH2), 4.14 (t, J = 7.0 Hz, 2H, NCH2), 3.93 (s, 3H, OCH3), 2.14-2.06 
(m, 2H, CH2), 2.03-1.94 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 170.0 (CO), 156.2 (Cq), 136.9 
(CH=CH2), 135.6 (CH), 131.8 (Cq), 128.0 (Cq), 116.3 (CH=CH2), 113.6 (CH), 111.1 (CH), 106.0 (Cq), 103.3 
(CH), 56.0 (OCH3), 46.6 (NCH2), 30.7 (CH2), 28.9 (CH2); HRMS (ESI-): Calculated for C15H17NO3 [M-H]-: 
258.1136, found 258.1135; IR νmax (neat)/cm-1: 2971 (CH), 2551 (br. OH), 1651 (C=O). 
5-Nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309e 
 
5-Nitro-1-(pent-4-en-1-yl)-1H-indole (5.0 mmol, 1.15 g) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (1.21 g, 88%) as a yellow solid.  
M.p. 198-199 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 12.54 (s, 1H, OH), 8.89 (d, J = 2.5 Hz, 1H, 
ArH), 8.36 (s, 1H, ArH), 8.12 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.84 (d, J = 9.0 Hz, 1H, ArH), 5.81 (ddt, J = 
17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.06-4.88 (m, 2H, CH=CH2), 4.34 (t, J = 7.0 Hz, 2H, NCH2), 2.06-1.97 (m, 
2H, CH2), 1.90 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 164.8 (CO), 142.3 (Cq), 139.3 
(Cq), 138.6 (CH), 137.4 (CH=CH2), 125.7 (Cq), 117.5 (CH), 117.2 (CH), 115.4 (CH=CH2), 111.7 (CH), 108.7 
(Cq), 46.0 (NCH2), 30.1 (CH2), 28.6 (CH2); HRMS (ESI-): Calculated for C14H14N2O4 [M-H]-: 273.0881, 




4-Methyl-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309f 
 
4-Methyl-1-(pent-4-en-1-yl)-1H-indole (3.0 mmol, 598 mg) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (309 mg, 42%) as an off-white solid. 
M.p. 96-100 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.01 (s, 1H, ArH), 7.25-7.18 (m, 2H, ArH), 7.11-
7.04 (m, 1H, ArH), 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.13-5.05 (m, 2H, CH=CH2), 4.15 (t, J = 
7.0 Hz, 2H, NCH2), 2.93 (s, 3H, CH3), 2.16-2.08 (m, 2H, CH2), 2.04-1.94 (m, 2H, CH2); 13C NMR (101 MHz, 
CDCl3): δ 170.3 (CO), 137.6 (Cq), 137.2 (CH), 136.9 (CH=CH2), 133.1 (Cq), 125.6 (Cq), 124.3 (CH), 123.2 
(CH), 116.3 (CH=CH2), 107.8 (CH), 107.3 (Cq), 46.4 (NCH2), 30.8 (CH2), 28.7 (CH2), 22.8 (CH3); HRMS 
(ESI+): Calculated for C15H17NO2 [M+Na]+: 266.1151, found 266.1165; IR νmax (neat)/cm-1: 2935 (CH), 
2675 (br. OH), 1662 (C=O). 
4-Methoxy-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309g 
 
4-Methoxy-1-(pent-4-en-1-yl)-1H-indole (5.0 mmol, 1.08 g) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (482 mg, 37%) as an off-white solid. 
M.p. 91-93 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 11.40 (s, 1H, COOH), 8.04 (s, 1H, ArH), 7.31-7.22 
(m, 2H, ArH), 6.89 (dd, J = 6.0, 2.5 Hz, 1H, ArH), 5.85 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.08-5.00 
(m, 1H, CH=CHH), 5.00-4.95 (m, 1H, CH=CHH), 4.31 (t, J = 7.0 Hz, 2H, NCH2), 4.15 (s, 3H, OCH3), 2.15-
2.04 (m, 2H, CH2), 2.02-1.91 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 163.5 (CO), 152.0 (Cq), 139.4 
(Cq), 138.3 (CH=CH2), 137.4 (CH), 124.5 (CH), 115.8 (CH=CH2), 115.2 (Cq), 108.0 (Cq), 106.3 (CH), 103.4 
(CH), 57.0 (OCH3), 47.0 (NCH2), 31.4 (CH2), 29.7 (CH2); HRMS (ESI+): Calculated for C15H17NO3 [M+H]+: 




6-Chloro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309h 
 
6-Chloro-1-(pent-4-en-1-yl)-1H-indole (3.0 mmol, 659 mg) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (599 mg, 75%) as an off-white solid. 
M.p. 130-133 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 8.11 (d, J = 8.5 Hz, 1H, ArH), 8.07 (s, 1H, 
ArH), 7.64 (d, J = 2.0 Hz, 1H, ArH), 7.22 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 5.87 (ddt, J = 17.0, 10.0, 6.5 Hz, 
1H, CH=CH2), 5.09-5.01 (m, 1H, CH=CHH), 5.01-4.95 (m, 1H, CH=CHH), 4.34 (t, J = 7.0 Hz, 2H, NCH2), 
2.17-2.08 (m, 2H, CH2), 2.07-1.96 (m, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 165.8 (CO), 138.3 
(Cq), 138.1 (CH=CH2), 136.7 (CH), 128.9 (Cq), 126.6 (Cq), 123.4 (CH), 122.7 (CH), 115.8 (CH=CH2), 111.4 
(CH), 107.7 (Cq), 46.9 (NCH2), 31.4 (CH2), 29.8 (CH2); HRMS (ESI+): Calculated for C14H1435ClNO2 
[M+Na]+: 286.0605, found 286.0612; IR νmax (neat)/cm-1: 3124 (CH), 2921 (CH), 2555 (br. OH), 1642 
(C=O). 
7-Nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid 309i 
 
7-Nitro-1-(pent-4-en-1-yl)-1H-indole (3.1 mmol, 723 mg) was subjected to the general carboxylation 
conditions described above. The crude material was purified by recrystallization from MeCN to give 
the title compound (735 mg, 86%) as a yellow solid.  
M.p. 127-128 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.59 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 8.01 (s, 1H, 
ArH), 7.87 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.36 (t, J = 8.0 Hz, 1H, ArH), 5.73 (ddt, J = 17.5, 10.0, 7.0 Hz, 
1H, CH=CH2), 5.07-5.03 (m, 1H, CH=CHH), 5.03-4.99 (m, 1H, CH=CHH), 4.32 (t, J = 7.0 Hz, 2H, NCH2), 
1.99 (q, J = 7.0 Hz, 2H, CH2), 1.80 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 169.7 (CO), 
140.0 (CH), 137.7 (Cq), 136.6 (CH=CH2), 131.4 (Cq), 127.9 (CH), 126.9 (Cq), 121.6 (CH), 121.0 (CH), 116.5 
(CH=CH2), 107.4 (Cq), 50.6 (NCH2), 30.5 (CH2), 29.4 (CH2); HRMS (ESI-): Calculated for C14H14N2O4 [M-
H]-: 273.0881, found 273.0882; IR νmax (neat)/cm-1: 2961 (CH), 2613 (br. OH), 1677 (C=O), 1523 (NO2), 




1-(Pent-4-en-1-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid 309j 
 
1-(Pent-4-en-1-yl)-1H-pyrrolo[2,3-b]pyridine (4.9 mmol, 911 mg) was subjected to the general 
carboxylation conditions described above. The crude material was purified by recrystallization from 
MeCN to give the title compound (1.03 mg, 91%) as a yellow solid.  
M.p. 119-120 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.48 (dd, J = 8.0, 1.5 Hz, 1H, ArH), 8.42 (dd, J = 
5.0, 1.5 Hz, 1H, ArH), 8.05 (s, 1H, ArH), 7.29-7.24 (m, 1H, ArH), 5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, 
CH=CH2), 5.11-5.00 (m, 2H, CH=CH2), 4.37 (t, J = 7.0 Hz, 2H, NCH2), 2.17-2.09 (m, 2H, CH2), 2.09-2.02 
(m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 169.8 (CO), 148.0 (Cq), 144.2 (CH), 137.1 (CH=CH2), 135.5 
(CH), 130.3 (CH), 119.6 (Cq), 118.4 (CH), 116.0 (CH=CH2), 105.0 (Cq), 45.0 (CH2), 30.9 (CH2), 29.2 (CH2); 
HRMS (ESI+): Calculated for C13H14N2O2 [M+H]+: 231.1128, found 231.1130; IR νmax (neat)/cm-1: 2923 
(CH), 2583 (br. OH), 1655 (C=O). 
5-Fluoro-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 310a 
 
5-Fluoro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 741 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (719 mg, 74%) as an off-white solid.  
M.p. 197-198 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.13 (br. s, 1H, NH), 8.38 (s, 1H, ArH), 
7.92 (dd, J = 10.0, 2.5 Hz, 1H, ArH), 7.59 (dd, J = 9.0, 4.5 Hz, 1H, ArH), 7.10 (td, J = 9.0, 2.5 Hz, 1H, ArH), 
5.83 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.09-4.93 (m, 2H, CH=CH2), 4.31 (t, J = 7.0 Hz, 2H, NCH2), 
3.40 (s, 3H, SO2CH3), 2.15-1.95 (m, 4H, 2 × CH2); 13C NMR (101 MHz, acetone-d6): δ 163.1 (CO), 160.1 
(d, J = 236.0 Hz, CF), 138.2 (CH=CH2), 135.5 (CH), 134.3 (Cq), 128.8 (d, J = 11.0 Hz, Cq), 115.9 (CH=CH2), 
112.8 (d, J = 10.0 Hz, CH), 112.1 (d, J = 26.5 Hz, CH), 108.4 (d, J = 4.5 Hz, Cq), 107.2 (d, J = 25.0 Hz, CH), 
47.2 (NCH2), 42.2 (d, J = 2.5 Hz, SO2CH3), 31.3 (CH2), 29.8 (CH2); HRMS (ESI+): Calculated for 
C15H17FN2O3S [M+H]+: 325.1017, found 325.1026; IR νmax (neat)/cm-1: 3225 (NH), 2931 (CH), 1643 






5-Cyano-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (2.3 mmol, 587 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (427 mg, 56%) as a pink solid. 
M.p. 199 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.29 (br. s, 1H, NH), 8.59 (dd, J = 1.5, 0.5 Hz, 
1H, ArH), 8.51 (s, 1H, ArH), 7.80 (dd, J = 8.5, 0.5 Hz, 1H, ArH), 7.61 (dd, J = 8.5, 1.5 Hz, 1H, ArH), 5.84 
(ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-4.94 (m, 2H, CH=CH2), 4.40 (t, J = 7.0, 2H, NCH2), 3.42 (s, 
3H, SO2CH3), 2.16-2.08 (m, 2H, CH2), 2.07-1.99 (m, 2H, CH2); 13C NMR (101 MHz, acetone-d6): δ 162.9 
(CO), 139.3 (Cq), 138.1 (CH=CH2), 136. (CH), 127.8 (Cq), 127.4 (CH), 126.7 (CH), 120.4 (Cq), 116.0 
(CH=CH2), 113.0 (CH), 109.2 (Cq), 106.1 (Cq), 47.2 (NCH2), 42.2 (SO2CH3), 31.3 (CH2), 29.7 (CH2); HRMS 
(ESI+): Calculated for C16H17N3O3S [M+Na]+: 354.0883, found 354.0881; IR νmax (neat)/cm-1: 3242 (CH), 
3130 (CH), 2990 (CH), 2224 (CN), 1655 (C=O). 
5-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 310c 
 
5-Methyl-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 730 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (601 mg, 63%) as an off-white solid. 
M.p. 160-161 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.02 (br. s, 1H, NH), 8.27 (s, 1H, ArH), 
8.07 (dt, J = 1.5, 1.0 Hz, 1H, ArH), 7.44 (d, J = 8.5 Hz, 1H, ArH), 7.13 (dd, J = 8.5, 1.5 Hz, 1H, ArH), 5.84 
(ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.08-4.95 (m, 2H, CH=CH2), 4.27 (t, J = 7.0 Hz, 2H, NCH2), 3.39 
(s, 3H, SO2CH3), 2.45 (s, 3H, CH3), 2.13-2.02 (m, 2H, CH2), 2.02-1.94 (m, 2H, CH2); 13C NMR (101 MHz, 
acetone-d6): δ 163.3 (CO), 138.3 (CH=CH2), 136.1 (Cq), 134.2 (CH), 132.1 (Cq), 128.4 (Cq), 125.4 (CH), 
122.1 (CH), 115.8 (CH=CH2), 111.1 (CH), 108.0 (Cq), 46.9 (NCH2), 42.2 (SO2CH3), 31.4 (CH2), 29.7 (CH2), 
21.6 (CH3); HRMS (ESI+): Calculated for C16H20N2O3S [M+H]+: 321.1267, found 321.1255; IR νmax 






5-Methoxy-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 778 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (812 mg, 80%) as an off-white solid.  
M.p. 131-132 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.04 (br. s, 1H, NH), 8.27 (s, 1H, ArH), 
7.78 (d, J = 2.5 Hz, 1H, ArH), 7.51-7.43 (m, 1H, ArH), 6.92 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 5.83 (ddt, J = 
17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.10-5.00 (m, 1H, CH=CHH), 5.00-4.95 (m, 1H, CH=CHH), 4.26 (t, J = 
7.0 Hz, 2H, NCH2), 3.85 (s, 3H, OCH3), 3.40 (s, 3H, SO2CH3), 2.13-2.03 (m, 2H, CH2), 2.02-1.93 (m, 2H, 
CH2); 13C NMR (101 MHz, acetone-d6): δ 163.4 (CO), 157.0 (Cq), 138.3 (CH=CH2), 134.2 (CH), 132.6 (Cq), 
129.1 (Cq), 115.9 (CH=CH2), 114.1 (CH), 112.2 (CH), 107.9 (Cq), 103.8 (CH), 55.9 (OCH3), 47.1 (NCH2), 
42.3 (SO2CH3), 31.4 (CH2), 29.8 (CH2); HRMS (ESI+): Calculated for C16H20N2O4S [M+H]+: 337.1217, found 
337.1192; IR νmax (neat)/cm-1: 3307 (NH), 3116 (CH), 2932 (CH), 1667 (C=O), 1131 (S=O). 
N-(Methylsulfonyl)-5-nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 310e 
 
5-Nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 823 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (800 mg, 76%) as a yellow solid. 
M.p. 190-192 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.85 (s, 1H, NH), 9.00 (d, J = 2.5 Hz, 1H, 
ArH), 8.63 (s, 1H, ArH), 8.16 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.78 (d, J = 9.0 Hz, 1H, ArH), 5.83 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.10-4.96 (m, 2H, CH=CH2), 4.34 (t, J = 7.0 Hz, 2H, NCH2), 3.41 (s, 3H, 
SO2CH3), 2.04 (q, J = 7.0 Hz, 2H, CH2), 1.91 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 
162.7 (CO), 143.2 (Cq), 139.8 (Cq), 138.1 (CH), 137.8 (CH=CH2), 126.4 (Cq), 118.5 (CH), 117.8 (CH), 116.1 
(CH=CH2), 112.3 (CH), 109.3 (Cq), 46.6 (NCH2), 42.3 (SO2CH3), 30.5 (CH2), 28.9 (CH2); HRMS (ESI+): 
Calculated for C15H17N3O5S [M+H]+: 352.0962, found 352.0984; IR νmax (neat)/cm-1: 3274 (NH), 3123 






4-Methyl-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (1.0 mmol, 243 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (140 mg, 64%) as a white solid. 
M.p. 149 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 10.23 (br. s, 1H, NH), 8.14 (s, 1H, ArH), 7.37 
(d, J = 8.5 Hz, 1H, ArH), 7.18 (dd, J = 8.5, 7.0 Hz, 1H, ArH), 6.99 (dt, J = 7.0, 1.0 Hz, 1H, ArH), 5.85 (ddt, 
17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-5.00 (m, 1H, CH=CHH), 5.00-4.95 (m, 1H, CH=CHH), 4.28 (t, J = 
7.0 Hz, 2H, NCH2), 3.39 (s, 3H, SO2CH3), 2.72 (s, 3H, CH3), 2.14-2.07 (m, 2H, CH2), 2.02-1.93 (m, 2H, 
CH2); 13C NMR (101 MHz, acetone-d6): δ 163.8 (CO), 138.4 (CH=CH2), 138.2 (Cq), 135.2 (CH), 132.8 (Cq), 
126.2 (Cq), 124.4 (CH), 124.0 (CH), 115.8 (CH=CH2), 110.4 (Cq), 109.0 (CH), 46.8 (NCH2), 41.9 (CH3), 31.4 
(CH2), 29.7 (CH2), 22.2 (CH3); HRMS (ESI+): Calculated for C16H20N2O3S [M+H]+: 321.1267, found 
321.1278 ; IR νmax (neat)/cm-1: 3069-2919 (CH), 1633 (C=O), 1336 (S=O), 1155 (S=O). 
4-Methoxy-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 310g 
 
4-Methoxy-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (1.5 mmol, 389 g) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (307 mg, 61%) as a white solid. 
M.p. 138 °C (MeCN); 1H NMR (400 MHz, acetone-d6): δ 11.65 (br. s, 1H, NH), 8.15 (s, 1H, ArH), 7.31-
7.25 (m, 2H, ArH), 6.90 (dd, J = 5.5, 3.0 Hz, 1H, ArH), 5.85 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.08-
5.01 (m, 1H, CH=CHH), 5.00-4.95 (m, 1H, CH=CHH), 4.33 (t, J = 7.0 Hz, 2H, NCH2), 4.11 (s, 3H, OCH3), 
3.39 (s, 3H, SO2CH3), 2.14-2.07 (m, 2H, CH2), 1.99 (dt, J = 9.0, 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, 
acetone-d6): δ 162.2 (CO), 152.3 (Cq), 139.8 (Cq), 138.3 (CH=CH2), 137.5 (CH), 124.7 (CH), 115.8 
(CH=CH2), 114.4 (Cq), 109.7 (Cq), 106.3 (CH), 104.1 (CH), 56.6 (OCH3), 47.2 (NCH2), 41.7 (SO2CH3), 31.4 
(CH2), 29.7 (CH2); HRMS (ESI+): Calculated for C10H13NO2 [M+Na]+: 180.1019, found 180.1020; IR νmax 






6-Chloro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (2.0 mmol, 527 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (507 mg, 74%) as an off-white solid. 
M.p. 232-234 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.60 (s, 1H, NH), 8.44 (s, 1H, ArH), 8.11 (d, 
J = 8.5 Hz, 1H, ArH), 7.79 (d, J = 2.0 Hz, 1H, ArH), 7.25 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 5.84 (ddt, J = 17.0, 
10.0, 6.5 Hz, 1H, CH=CH2), 5.10-4.94 (m, 2H, CH=CH2), 4.24 (t, J = 7.0 Hz, 2H, NCH2), 3.37 (s, 3H, SO2CH3), 
2.09-1.98 (m, 2H, CH2), 1.92-1.83 (m, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 162.4 (CO), 137.4 
(CH=CH2), 136.9 (Cq), 135.2 (CH), 127.7 (Cq), 125.4 (Cq), 122.2 (CH), 122.2 (CH), 115.5 (CH=CH2), 110.9 
(CH), 107.0 (Cq), 45.7 (NCH2), 41.8 (SO2CH3), 30.1 (CH2), 28.4 (CH2); HRMS (ESI+): Calculated for 
C15H1735ClN2O3S [M+Na]+: 363.0541, found 363.0541; IR νmax (neat)/cm-1: 3231 (NH), 3119 (CH), 2951 
(CH), 1646 (C=O), 1321 (S=O), 1149 (S=O).  
N-(Methylsulfonyl)-7-nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 310i 
 
7-Nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (2.0 mmol, 549 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from MeCN to give the title compound (592 mg, 84%) as a brown solid. 
M.p. 173-175 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.83 (br. s, 1H, NH), 8.58 (s, 1H, ArH), 8.56 
(dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.93 (dd, J = 8.0, 1.0 Hz, 1H ArH), 7.42 (t, J = 8.0 Hz, 1H, ArH), 5.76 (ddt, J 
= 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.04-4.90 (m, 2H, CH=CH2), 4.21 (t, J = 7.0 Hz, 2H, NCH2), 3.40 (s, 3H, 
SO2CH3), 2.01-1.90 (m, 2H, CH2), 1.81-1.65 (m, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 162.7 (CO), 
139.2 (CH), 137.6 (CH=CH2), 137.5 (Cq), 131.4 (Cq), 127.5 (CH), 126.4 (Cq), 122.1 (CH), 121.0 (CH), 116.1 
(CH=CH2), 108.4 (Cq), 49.9 (NCH2), 42.2 (SO2CH3), 30.4 (CH2), 29.2 (CH2); HRMS (ESI+): Calculated for 
C15H17N3O5S [M+H]+: 352.0962, found 352.0957; IR νmax (neat)/cm-1: 3231 (NH), 3131 (CH), 2969 (CH), 






1-(Pent-4-en-1-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid (3.0 mmol, 691 mg) was subjected to 
the general amide coupling conditions described above. The crude material was purified by 
recrystallization from MeCN to give the title compound (461 mg, 50%) as a white solid. 
M.p. 223-225 °C (MeCN); 1H NMR (500 MHz, acetone-d6): δ 10.34 (br. s, 1H, NH), 8.52 (dd, J = 8.0, 1.5 
Hz, 1H, ArH), 8.49 (s, 1H, ArH), 8.40 (dd, J = 4.5, 1.5 Hz, 1H, ArH), 7.30 (dd, J = 8.0, 4.5 Hz, 1H, ArH), 
5.84 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-5.01 (m, 1H, CH=CHH), 4.98-4.93 (m, 1H, CH=CHH), 
4.41 (t, J = 7.0 Hz, 2H, NCH2), 3.39 (s, 3H, SO2CH3), 2.13-2.07 (m, 2H, CH2), 2.04-1.98 (m, 2H, CH2); 13C 
NMR (126 MHz, acetone-d6): δ 163.0 (CO), 148.9 (Cq), 145.2 (CH), 138.3 (CH=CH2), 134.3 (CH), 130.6 
(CH), 120.3 (Cq), 119.0 (CH), 115.7 (CH=CH2), 107.2 (Cq), 45.2 (NCH2), 42.2 (SO2CH3), 31.4 (CH2), 29.9 
(CH2); HRMS (ESI+): Calculated for C14H17N3O3S [M+H]+: 308.1063, found 308.1073; IR νmax (neat)/cm-
1: 3230 (NH), 3107 (CH), 2927 (CH), 1651 (C=O), 1326 (S=O), 1156 (S=O).  
Ethyl 1H-pyrrole-3-carboxylate128 314a 
 
Synthesised using a modified literature procedure.128 
A solution of TosMIC (11.0 mmol, 2.15 g) and ethyl acrylate (10.0 mmol, 1.09 mL) in Et2O/DMSO (1:1 
v:v 50 ml) was added dropwise to a suspension of NaH (11.0 mmol, 440 mg, 60% suspension in mineral 
oil) in Et2O (20 mL) at 0 °C, over 30 minutes. The reaction mixture was stirred for a further 3 hours, 
before being quenched with water (50 mL). The layers were separated, and the aqueous layer was 
extracted with EtOAc (×3). The combined organic layers were washed with water (×3) and brine, dried 
over MgSO4 and concentrated. The crude material was purified by flash column chromatography (25% 
EtOAc/petrol) to yield the title compound (280 mg, 20%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 8.62 (br. s, 1H, NH), 7.45-7.41 (m, 1H, ArH), 6.75 (dt, J = 3.0, 2.0 Hz, 1H, 
ArH), 6.66 (td, J = 3.0, 1.5 Hz, 1H, ArH), 4.29 (q, J = 7.0 Hz, 2H, OCH2CH3), 1.34 (t, J = 7.0 Hz, 3H, 





Ethyl 4-phenyl-1H-pyrrole-3-carboxylate128 314c 
 
Synthesised using a modified literature procedure.128 
A solution of TosMIC (8.0 mmol, 1.56 g) and ethyl cinnamate (8.0 mmol, 1.34 mL) in Et2O/DMSO (1:2 
v:v 30 ml) was added dropwise to a suspension of NaH (10.4 mmol, 416 mg, 60% suspension in mineral 
oil) in Et2O (15 mL) at 0 °C over 30 minutes. The reaction mixture was stirred for a further 3 hours, 
before being quenched with water (30 mL). The layers were separated, and the aqueous layer was 
extracted with EtOAc (×3). The combined organic layers were then washed with water (×3) and brine, 
dried over MgSO4 and concentrated. The crude material was purified by flash column chromatography 
(20% EtOAc/petrol) to give the title compound (1.32 g, 76%) as a yellow solid. 
M.p. 122-124 °C (EtOAc, lit. = 121-124 °C); 1H NMR (400 MHz, CDCl3): δ 8.58 (br. s, 1H, NH), 7.53-7.45 
(m, 3H, ArH), 7.35 (tq, J = 8.0, 1.5, 1,0 Hz, 2H, ArH), 7.30-7.24 (m, 1H, ArH), 6.76 (t, J = 2.5 Hz, 1H, ArH), 
4.22 (q, J = 7.0 Hz, 2H, OCH2CH3), 1.24 (t, J = 7.0 Hz, 3H, OCH2CH3); IR νmax (neat)/cm-1: 3318 (NH), 2980 
(CH), 1683 (C=O). Data are consistent with literature precedent.128 
Ethyl 1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylate 315a 
 
Ethyl 1H-pyrrole-3-carboxylate (3.5 mmol, 487 mg) was subjected to the general alkylation conditions 
described above with 5-bromo-1-pentene. The crude material was purified by flash column 
chromatography (20% EtOAc/petrol) to give the title compound (602 mg, 83%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.27 (t, J = 2.0 Hz, 1H, ArH), 6.59-6.6.56 (m, 2H, ArH), 5.77 (ddt, J = 17.0, 
10.5, 6.5 Hz, 1H, CH=CH2), 5.08-5.03 (m, 1H, CH=CHH), 5.03-5.01 (m, 1H, CH=CHH), 4.26 (q, J = 7.0 Hz, 
2H, OCH2CH3), 3.88 (t, J = 6.5 Hz, 2H, NCH2), 2.04 (td, J = 7.5, 6.5 Hz, 2H, CH2), 1.87 (qn, J = 7.5 Hz, 2H, 
CH2), 1.33 (t, J = 7.0 Hz, 3H, OCH2CH3); 13C NMR (101 MHz, CDCl3): δ 165.0 (CO), 137.0 (CH=CH2), 125.9 
(CH), 121.6 (CH), 116.2 (CH=CH2), 116.0 (Cq), 110.2 (CH), 59.7 (OCH2CH3), 49.3 (NCH2), 30.5 (CH2), 30.3 
(CH2), 14.6 (OCH2CH3); HRMS (ESI+): Calculated for C12H17NO2 [M+H]+: 208.1332, found 208.1336; IR 




Methyl 4-methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylate 315b 
 
A solution of TosMIC (13.2 mmol, 2.58 g) and methyl crotonate (12.0 mmol, 1.28 mL) in Et2O/DMSO 
(1:1 v:v 30 ml) was added dropwise to a suspension of NaH (26.4 mmol, 1.06 g, 60% suspension in 
mineral oil) in Et2O (15 mL) at 0 °C over 30 minutes. The reaction mixture was stirred for a further 3 
hours, before being quenched with water (50 mL). The layers were separated, and the aqueous layer 
extracted with EtOAc (×3). The combined organic layers were then washed with water (×3) and brine, 
dried over MgSO4 and concentrated. The crude material was purified by flash column chromatography 
(0.5-2% DCM/petrol), but complete purification could not be achieved due to the presence of 
inseparable impurities. The material was therefore taken straight through to the next step.  
The crude pyrrole was subjected to the general alkylation conditions described above with 5-bromo-
1-pentene. The crude material was purified by flash column chromatography (4% EtOAc/petrol) to 
give the title compound (1.49 g, 60% over two steps) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.20 (d, J = 2.5 Hz, 1H, ArH), 6.37 (dd, J = 2.5, 1.0 Hz, 1H, ArH), 5.76 (ddt, 
J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.08-4.99 (m, 2H, CH=CH2), 3.83-3.87 (m, 5H, NCH2 + OCH3), 2.25 
(s, 3H, CH3), 2.08-1.99 (m, 2H, CH2), 1.89-1.78 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.9 (CO), 
137.1 (CH=CH2), 126.7 (CH), 121.7 (Cq), 120.4 (CH), 116.0 (CH=CH2), 113.9 (Cq), 50.7 (OCH3), 49.2 
(NCH2), 30.6 (CH2), 30.2 (CH2), 11.8 (CH3); HRMS (ESI+): Calculated for C12H17NO2 [M+H]+: 208.1332, 
found 208.1337; IR νmax (neat)/cm-1: 2972-2901 (CH), 1702 (C=O). 
Ethyl 1-(pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxylate 315c 
 
Ethyl 4-phenyl-1H-pyrrole-3-carboxylate (5.5 mmol, 1.18 g) was subjected to the general alkylation 
conditions described above with 5-bromo-1-pentene. The crude material was purified by flash column 
chromatography (2-20% EtOAc/petrol) to give the title compound (1.34 g, 86%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.52-7.46 (m, 2H, ArH), 7.37-7.30 (m, 3H, ArH), 7.29-7.22 (m, 1H, ArH), 
6.64 (t, J = 2.5 Hz, 1H, ArH), 5.79 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.12-5.00 (m, 2H, CH=CH2), 
4.20 (q, J = 7.0 Hz, 2H, CH2CH3), 3.90 (t, J = 7.0 Hz, 2H, NCH2), 2.13-2.05 (m, 2H, CH2), 1.96-1.88 (m, 2H, 




129.4 (CH), 127.8 (CH), 127.7 (Cq), 127.1 (Cq), 126.5 (CH), 121.2 (CH), 116.1 (CH=CH2), 113.3 (Cq), 59.6 
(OCH2), 49.4 (NCH2), 30.6 (CH2), 30.2 (CH2), 14.4 (CH3); HRMS (ESI+): Calculated for C18H21NO2 [M+Na]+: 
306.1464, found 306.1463; IR νmax (neat)/cm-1: 2976 (CH), 1709 (C=O). 
1-(Pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid 316a 
 
Ethyl 1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylate (2.5 mmol, 518 mg) was subjected to the general 
hydrolysis conditions described above, to give the title compound (508 mg, quantitative) as a pink 
solid (analytically pure), which was used without further purification. 
M.p. 76-78 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.36 (t, J = 2.0 Hz, 1H, ArH), 6.66-6.58 (m, 2H, 
ArH), 5.77 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.09-4.99 (m, 2H, CH=CH2), 3.90 (t, J = 7.0 Hz, 2H, 
NCH2), 2.05 (q, J = 7.0 Hz, 2H, CH2), 2.05 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 170.0 
(CO), 136.9 (CH=CH2), 127.2 (CH), 122.0 (CH), 116.2 (CH=CH2), 115.1 (Cq), 100.8 (CH), 49.5 (NCH2), 30.5 
(CH2), 30.2 (CH2); HRMS (ESI+): Calculated for C10H13NO2 [M+H]+: 180.1019, found 180.1020; IR νmax 
(neat)/cm-1: 2977-2914 (CH), 2560 (br. OH), 1665 (C=O). 
4-Methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid 316b 
 
Methyl 4-methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylate (3.0 mmol, 622 mg) was dissolved in 
MeOH (20 mL) and water (10 mL) and treated with aqueous NaOH (2 M, 30 mmol, 15 mL). The 
resulting solution was heated to reflux and stirred for 16 hours. On completion, the reaction mixture 
was cooled to room temperature and the volatiles were removed. The remaining solution was 
acidified to pH 1 with 3 M HCl and extracted with EtOAc (×3). The combined organic extracts were 
washed with brine, dried over MgSO4 and concentrated to give the title compound (503 mg, 87%) as 
a brown solid (analytically pure), which was used without further purification. 
M.p. 64-66 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.30 (d, J = 2.5 Hz, 1H, ArH), 6.39 (dd, J = 2.5, 1.0 
Hz, 1H, ArH), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.08-5.00 (m, 2H, CH=CH2), 3.81 (t, J = 7.0 
Hz, 2H, NCH2), 2.26 (app. d, 3H, CH3), 2.09-2.00 (m, 2H, CH2), 1.90-1.80 (m, 2H, CH2); 13C NMR (101 




(Cq), 49.2 (NCH2), 30.6 (CH2), 30.1 (CH2), 11.9 (CH3); HRMS (ESI+): Calculated for C11H15NO2 [M+H]+: 
194.1176, found 194.1177; IR νmax (neat)/cm-1: 2951 (CH), 2602 (br. OH), 1659 (C=O). 
1-(Pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxylic acid 316c 
 
Ethyl 1-(pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxylate (4.5 mmol, 1.28 g) was dissolved in EtOH 
(20 mL) and treated with aqueous NaOH (2 M, 45 mmol, 22.5 mL). The reaction mixture was heated 
to reflux and stirred for 18 hours. On completion, the reaction mixture was allowed to cool to room 
temperature and the volatiles were removed. The remaining aqueous solution was acidified to pH 1 
with 3 M HCl and then extracted with EtOAc (×3). The combined organic extracts were washed with 
brine, dried over MgSO4 and concentrated to give the title compound (1.10 g, 95%) as a pale-yellow 
solid (analytically pure), which was used without further purification. 
M.p. 101-104 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.52-7.47 (m, 2H, ArH), 7.43 (d, J = 2.5 Hz, 1H, 
ArH), 7.34 (J = 7.5 Hz, 2H, ArH), 7.29-7.25 (m, 1H, ArH), 6.65 (d, J = 2.5 Hz, ArH), 5.78 (ddt, J = 17.0, 
10.0, 7.0 Hz, 1H, CH=CH2), 5.10-5.03 (m, 2H, CH=CH2), 3.90 (t, J = 7.0 Hz, 2H, NCH2), 2.10 (q, J = 7.0 Hz, 
2H, CH2), 1.92 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 169.7 (CO), 136.9 (CH=CH2), 134.6 
(Cq), 129.3 (CH), 129.3 (CH), 127.9 (CH), 127.5 (Cq), 126.7 (CH), 121.6 (CH), 116.2 (CH=CH2), 112.0 (Cq), 
49.5 (NCH2), 30.6 (CH2), 30.1 (CH2); HRMS (ESI+): Calculated for C16H17NO2 [M+H]+: 256.1332, found 
256.1328; IR νmax (neat)/cm-1: 2934 (CH), 2552 (br. OH), 1660 (C=O). 
N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide 317a 
 
1-(Pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid (2.3 mmol, 407 mg) was subjected to the general 
amide coupling conditions described above. The crude material was purified by recrystallisation from 
EtOAc to give the title compound (276 mg, 47%) as a white solid. 
M.p. 98-101 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 8.62 (br. s, 1H, NH), 7.38 (t, J = 2.0 Hz, 1H, ArH), 
6.62 (t, J = 2.5 Hz, 1H, ArH), 6.52 (dd, J = 3.0, 1.5 Hz, 1H, ArH), 5.76 (ddt, J = 17.5, 9.5, 7.0 Hz, 1H, 
CH=CH2), 5.07-5.04 (m, 1H, CH=CHH), 5.03-5.01 (m, 1H, CH=CHH), 3.90 (t, J = 7.0 Hz, 2H, NCH2), 3.40 




δ 162.2 (CO), 136.8 (CH=CH2), 126.0 (CH), 122.7 (CH), 116.6 (Cq), 116.3 (CH=CH2), 108.7 (CH), 49.6 
(NCH2), 42.1 (SO2CH3), 30.5 (CH2), 30.1 (CH2); HRMS (ESI+): Calculated for C11H16N2O3s [M+H]+: 
257.0954, found 257.0952; IR νmax (neat)/cm-1: 3162-2901 (CH), 1644 (C=O), 1323 (S=O), 1154 (S=O). 
4-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide 317b 
 
4-Methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid (2.0 mmol, 386 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from EtOAc to give the title compound (94 mg, 17%) as a brown solid. 
M.p. 105-106 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.23 (d, J = 2.5 Hz, 1H, ArH), 6.42 (dq, J = 2.0, 
1.0 Hz, 1H, ArH), 5.76 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.08-4.99 (m, 2H, CH=CH2), 3.82 (t, J = 
7.0 Hz, 2H, NCH2), 3.40 (s, 3H, SO2CH3), 2.27 (app. d, 3H, CH3), 2.07-1.99 (m, 2H, CH2), 1.89-1.80 (m, 
2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.6 (CO), 136.9 (CH=CH2), 125.4 (CH), 121.8 (CH), 121.6 (Cq), 
116.2 (CH=CH2), 114.6 (Cq), 49.4 (NCH2), 42.3 (SO2CH3), 30.5 (CH2), 30.0 (CH2), 11.8 (CH3); HRMS (ESI+): 
Calculated for C12H18N2O3S [M+H]+: 271.1111, found 271.1116; IR νmax (neat)/cm-1: 3165 (NH), 2938 
(CH), 1646 (C=O), 1325 (S=O), 1151 (S=O). 
N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxamide 317c 
 
1-(Pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxylic acid (3.0 mmol, 766 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from EtOAc to give the title compound (592 mg, 60%) as a white solid. 
M.p. 106-107 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.80 (br. s, 1H, NH), 7.51-7.33 (m, 6H, ArH), 
6.62 (d, J = 2.5 Hz, 1H, ArH), 5.78 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.05 (m, 1H, CH=CHH), 
5.05-5.03 (m, 1H, CH=CHH), 3.91 (t, J = 7.0, 2H, NCH2), 3.28 (s, 3H, SO2CH3), 2.09 (q, J = 7.0 Hz, 2H, CH2), 
1.92 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.3 (CO), 136.7 (CH=CH2), 133.4 (Cq), 
129.6 (CH), 129.2 (CH), 128.3 (CH), 128.1 (CH), 124.9 (Cq), 121.6 (CH), 116.3 (CH=CH2), 114.6 (Cq), 49.6 
(NCH2), 42.0 (SO2CH3), 30.5 (CH2), 30.0 (CH2); HRMS (ESI+): Calculated for C17H20N2O3S [M+H]+: 







5-Methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid (2.0 mmol, 387 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from EtOAc to give the title compound (160 mg, 30%) as a pale-yellow solid. 
M.p. 90-92°C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 8.57 (br. s, 1H, NH), 7.31 (d, J = 2.0 Hz, 1H, ArH), 
6.23 (dq, J = 2.0, 1.0 Hz, 1H, ArH), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.10-4.96 (m, 2H, 
CH=CH2), 3.80 (t, J = 7.5 Hz, 2H, NCH2), 3.39 (s, 3H, SO2CH3), 2.19 (app. d, 3H, CH3), 2.10-2.00 (m, 2H, 
CH2), 1.81 (qn, J = 7.5 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.3 (CO), 136.9 (CH=CH2), 130.8 
(Cq), 125.7 (CH), 116.1 (CH=CH2), 115.1 (Cq), 106.8 (CH), 46.7 (NCH2), 42.1 (SO2CH3), 30.5 (CH2), 29.8 
(CH2), 12.0 (CH3); HRMS (ESI+): Calculated for C12H18N2O3 [M+H]+: 271.1111, found 271.1108; IR νmax 
(neat)/cm-1: 3153 (CH), 2987 (CH), 1644 (C=O), 1325 (S=O), 1147 (S=O). 
5-Acetyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide 317e 
 
5-Acetyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid (1.8 mmol, 387 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from EtOAc to give the title compound (359 mg, 69%) as a white solid. 
M.p. 126-128 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 9.19 (br. s, 1H, NH), 7.54 (d, J = 2.0 Hz, 1H, ArH), 
7.42 (d, J = 2.0 Hz, 1H, ArH), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-4.97 (m, 2H, CH=CH2), 
4.33 (t, J = 7.0 Hz, 2H, NCH2), 3.43 (s, 3H, SO2CH3), 2.46 (s, 3H, COCH3), 2.10-1.99 (m, 2H, CH2), 1.88-
1.77 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 188.9 (CO), 161.5 (CO), 137.1 (CH=CH2), 132.9 (CH), 
131.4 (Cq), 119.4 (CH), 115.8 (CH=CH2), 115.6 (Cq), 50.2 (NCH2), 42.2 (SO2CH3), 30.5 (CH2), 30.1 (CH2), 
27.5 (COCH3); HRMS (ESI+): Calculated for C13H18N2O4S [M+H]+: 299.1060, found 299.1064; IR νmax 






5-Benzoyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid (2.0 mmol, 567 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recrystallisation from EtOAc to give the title compound (533 mg, 74%) as a white solid. 
M.p. 147-147 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 9.25 (s, 1H, NH), 7.80-7.74 (m, 2H, ArH), 7.66 
(d, J = 2.0 Hz, 1H, ArH), 7.61-7.51 (m, 1H, ArH), 7.50-7.45 (m, 2H, ArH), 7.17 (d, J = 2.0 Hz, 1H, ArH), 
5.78 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.08-4.97 (m, 2H, CH=CH2), 4.41 (t, J = 7.0 Hz, 2H, NCH2), 
3.25 (s, 3H, SO2CH3), 2.09 (q, J = 7.0 Hz, 2H, CH2), 1.91 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, 
CDCl3): δ 186.4 (CO), 161. (CO), 138.8 (Cq), 137.0 (CH=CH2), 133.6 (CH), 132.3 (CH), 131.0 (Cq), 129.4 
(CH), 128.6 (CH), 121.6 (CH), 115.9 (CH=CH2), 115.8 (Cq), 49.9 (NCH2), 42.0 (SO2 CH3), 30.6 (CH2), 30.3 
(CH2); HRMS (ESI+): Calculated for C18H20N2O4S [M+H]+: 361.1217, found 361.1218; IR νmax (neat)/cm-
1: 3266 (NH), 2987-2901 (CH), 1682 (C=O), 1631 (C=O), 1147 (S=O).  
1-((1-Isocyanoethyl)sulfonyl)-4-methylbenzene128 319 
 
Synthesised using a modified literature procedure.128 
To a solution of TosMIC (10.0 mmol, 1.95 g) and benzyl triethyl ammonium chloride (2.0 mmol, 456 
mg) in DCM was added aqueous NaOH (6 M, 160 mmol, 26 mL). The resulting mixture was cooled to 
0 °C and methyl iodide (12.0 mmol, 1.70 g) was added. The reaction mixture was stirred at room 
temperature for 2.5 hours and then diluted with water. The layers were separated, and the aqueous 
layer was extracted with EtOAc (×2). The organic layers were then combined, dried over MgSO4 and 
concentrated. The crude residue was purified by flash column chromatography (10% EtOAc/petrol) to 
give the title compound (1.08 g, 52%) as a brown oil. 
1H NMR (400 MHz, CDCl3): δ 7.92-7.84 (m, 2H, ArH), 7.46-7.39 (m, 2H, ArH), 4.59 (q, J = 7.0 Hz, 1H, 
CH), 2.50 (s, 3H, ArCH3), 1.75 (d, J = 7.0 Hz, 3H, CH3); IR νmax (neat)/cm-1: 2989 (CH), 2133 (C≡N), 1330 




Ethyl 5-methyl-1H-pyrrole-3-carboxylate128 320 
 
Synthesised using a modified literature procedure.128 
A solution of 1-((1-isocyanoethyl)sulfonyl)-4-methylbenzene (7.7 mmol, 1.61 g) and ethyl acrylate (7.0 
mmol, 0.76 mL) in Et2O/DMSO (2:1 v:v 30 ml) was added dropwise to a suspension of NaH (14.0 mmol, 
560 mg, 60% suspension in mineral oil) in Et2O (15 mL) at 0 °C over 20 minutes. The reaction mixture 
was then stirred for a further 2 hours, before being quenched with water (30 mL). The layers were 
separated, and the aqueous layer extracted with EtOAc (×3). The combined organic layers were then 
washed with water (×3) and brine, dried over MgSO4 and concentrated. The crude material was 
purified by flash column chromatography (25% EtOAc/petrol) to give the title compound (588 mg, 
50%) as a yellow solid. 
M.p. 69-70 °C (EtOAc, Lit. = 68-72 °C); 1H NMR (400 MHz, CDCl3): δ 8.50 (br. s, 1H, NH), 7.30-7.24 (m, 
1H, ArH), 6.29 (ddt, J = 2.5, 2.0, 1.0 Hz, 1H, ArH), 4.26 (q, J = 7.0 Hz, 2H, OCH2CH3), 2.24 (app. d, 3H, 
ArCH3), 1.32 (t, J = 7.0 Hz, 3H, OCH2CH3); IR νmax (neat)/cm-1: 3268 (NH), 2980-2870 (CH), 1672 (C=O). 
Data are consistent with literature precedent.128 
Ethyl 5-methyl-1-pentyl-1H-pyrrole-3-carboxamide 321 
 
Ethyl 5-methyl-1H-pyrrole-3-carboxylate (3.5 mmol, 536 mg) was subjected to the general alkylation 
conditions described above with 5-bromo-1-pentene. The crude material was purified by flash column 
chromatography (8% EtOAc/petrol) to give the title compound (612 mg, 78%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.21 (d, J = 2.0 Hz, 1H, ArH), 6.29 (dt, J = 2.0, 1.0 Hz, 1H, ArH), 5.78 (ddt, 
J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.09-5.00 (m, 2H, CH=CH2), 4.24 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.81-
3.74 (m, 2H, NCH2), 2.19 (app. d, 3H, CH3), 2.12-2.04 (m, 2H, CH2), 1.87-1.76 (m, 2H, CH2), 1.32 (t, J = 
7.0 Hz, 3H, OCH2CH3); 13C NMR (101 MHz, CDCl3): δ 165.2 (CO), 137.1 (CH=CH2), 129.6 (Cq), 125.6 (CH), 
116.0 (CH=CH2), 114.7 (Cq), 108.2 (CH), 59.6 (OCH2CH3), 46.5 (NCH2), 30.7 (CH2), 30.0 (CH2), 14.7 
(OCH2CH3), 12.0 (CH3); HRMS (ESI+): Calculated for C13H19NO2 [M+H]+: 222.1489, found 222.1492; IR 




5-Methyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid 322 
 
Ethyl 5-methyl-1-pentyl-1H-pyrrole-3-carboxamide (2.5 mmol, 558 mg) was dissolved in THF (20 mL) 
and treated with aqueous NaOH (2 M, 25 mmol, 12.5 mL). The reaction mixture was then heated at 
reflux for 72 hours. On completion, the reaction mixture was allowed to cool to room temperature 
and the volatiles were removed. The remaining aqueous solution was acidified to pH 1 with 3 M HCl 
and then extracted with EtOAc (×3). The combined organic extracts were then washed with brine, 
dried over MgSO4 and concentrated to give the title compound (465 mg, 96%) as a pale-orange solid 
(analytically pure), which was used without further purification. 
M.p. 99-100 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.29 (d, J = 2.0 Hz, 1H, ArH), 6.33 (s, 1H, ArH), 
5.78 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.10-5.01 (m, 2H, CH=CH2), 3.81 (t, J = 7.0 Hz, 2H, NCH2), 
2.21 (s, 3H, CH3), 2.09 (q, J = 7.0 Hz, 2H, CH2), 1.83 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): 
δ 170.5 (CO), 137.0 (CH=CH2), 130.0 (Cq), 127.0 (CH), 116.0 (CH=CH2), 113.7 (Cq), 108.7 (CH), 46.6 
(NCH2), 30.6 (CH2), 30.0 (CH2), 12.0 (CH2); HRMS (ESI+): Calculated for C11H15NO2 [M+H]+: 194.1176, 
found 194.1173; IR νmax (neat)/cm-1: 2988-2901 (CH), 2565 (br. OH), 1645 (C=O). 
1-(5-Benzoyl-1H-pyrrol-3-yl)-2,2,2-trichloroetan-1-one128 323b 
 
Synthesised using a modified literature procedure.128 
To a suspension of aluminiumtrichloride (10.0 mmol, 1.33 g) in DCM (16 mL) was added trichloroacetyl 
chloride (6.0 mmol, 0.66 mL). The resulting solution was cooled to 0 °C and phenyl(1H-pyrrol-2-
yl)methanone (4.0 mmol, 684 mg) was added. The reaction mixture was stirred at 0 °C for 10 minutes 
before being allowed to warm to room temperature and heated to reflux, at which it was stirred for 
20 hours. On completion, the mixture was quenched by the addition of saturated aqueous NaHCO3 
(30 mL). The volatiles were removed, and the resulting aqueous solution extracted with Et2O (×3). The 
combined organic layers were washed with brine, dried over MgSO4 and concentrated to yield the 
title compound (1.06 g, 84%) as a pale-pink solid.  
M.p. 148-150 °C (EtOAc, lit = 150-151 °C128); 1H NMR (400 MHz, CDCl3): δ 10.51 (br. s, 1H, NH), 8.06 








To a solution of triphenylphosphine (3.3 mmol, 865 mg) in THF (12 mL) at -78 °C was added DIAD (3.2 
mmol, 0.62 mL). The resulting mixture was stirred for 1 hour. 4-Penten-1-ol (3.8 mmol, 0.39 mL) was 
added and the reaction mixture was stirred for a further hour. 1-(5-Acetyl-1H-pyrrol-3-yl)-2,2,2-
trichloroethan-1-one (2.8 mmol, 720 mg) was added and the reaction mixture was stirred at -78 °C for 
a further 15 minutes, and then room temperature for 16 hours. The volatiles were removed, and the 
residue was triturated with cold Et2O and petrol. The crude material was purified by flash column 
chromatography (2-5% EtOAc/petrol) to yield the title compound (689 mg, 73%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.73 (d, J = 2.0 Hz, 1H, ArH), 7.59 (d, J = 2.0 Hz, 1H, ArH), 5.79 (ddt, J = 
17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 5.09-5.01 (m, 2H, CH=CH2), 4.39-4.33 (m, 2H, NCH2), 2.51-2.47 (m, 3H, 
COCH3), 2.09 (q, J = 7.5 Hz, 2H, CH2), 1.88 (qn, J = 7.5 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 188.9 
(CO), 176.5 (CO), 137.1 (CH=CH2), 136.2 (CH), 131.1 (Cq), 122.8 (CH), 116.0 (CH=CH2), 113.8 (Cq), 50.3 
(NCH2), 30.5 (CH2), 30.1 (CH2), 27.6 (COCH3); HRMS (ESI+): Calculated for C13H14Cl3NO2 [M+H]+: 
322.0163, found 322.0176; IR νmax (neat)/cm-1: 2987-2901 (CH), 1692 (C=O), 1665 (C=O).  
1-(5-Benzoyl-1-(pent-4-en-1-yl)-1H-pyrrol-3-yl)-2,2,2-trichloroethan-1-one 324b 
 
To a solution of triphenylphosphine (3.3 mmol, 866 mg) in THF (12 mL) at -78 °C was added DIAD (3.2 
mmol, 0.62 mL). The resulting mixture was stirred for 1 hour. 4-Penten-1-ol (3.8 mmol, 0.39 mL) was 
added and the reaction mixture was stirred for a further hour. 1-(5-Benzoyl-1H-pyrrol-3-yl)-2,2,2-
trichloroetan-1-one (3.0 mmol, 950 mg) was added and the reaction mixture was stirred at -78 °C for 
a further 15 minutes, and then room temperature for 16 hours. The volatiles were removed, and the 
residue was triturated with cold Et2O and petrol. The crude material was purified by flash column 




1H NMR (400 MHz, CDCl3): δ 7.87-7.79 (m, 3H, ArH), 7.61 (t, J = 7.5 Hz, 1H, ArH), 7.50 (t, J = 7.5 Hz, 1H, 
ArH), 7.37 (d, J = 2.0 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.12-5.01 (m, 2H, 
CH=CH2), 4.45 (t, J = 7.0 Hz, 2H, NCH2), 2.14 (q, J = 7.0 Hz, 2H, CH2), 1.97 (qn, J = 7.0 Hz, 2H, CH2); 13C 
NMR (101 MHz, CDCl3): δ 186.3 (CO), 176.4 (CO), 138.6 (Cq), 136.9 (CH=CH2), 136.2 (CH), 132.5 (CH), 
130.6 (Cq), 129.3 (CH), 128.4 (CH), 124.9 (CH), 116.0 (CH=CH2), 113.8 (Cq), 95.9 (Cq), 49.8 (NCH2), 30.5 
(CH2), 30.2 (CH2); HRMS (ESI+): Calculated for C18H16Cl3NO2 [M+H]+: 384.0319, found 384.0348; IR νmax 
(neat)/cm-1: 2973 (CH), 1692 (C=O), 1639 (C=O). 
5-Acetyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid 325a 
 
1-(5-Acetyl-1-(pent-4-en-1-yl)-1H-pyrrol-3-yl)-2,2,2-trichloroethan-1-one (2.0 mmol, 665 mg) was 
dissolved in THF (10 mL) and treated with aqueous NaOH (1 M, 5 mmol, 5.00 mL). The resulting mixture 
was stirred at room temperature for 30 minutes. The volatiles were removed, and the aqueous 
solution was washed with Et2O. The aqueous layer was acidified to pH 1 with 3 M HCl and extracted 
with EtOAc (×3). The organic layers were combined, washed with brine, dried over MgSO4 and 
concentrated. This gave the title compound (435 mg, 98%) as an off-white solid (analytically pure), 
which was used without further purification. 
M.p. 83-84 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.50 (d, J = 1.5 Hz, 1H, ArH), 7.43 (d, J = 1.5 Hz, 1H, 
ArH), 5.79 (ddt, J = 17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 5.09-4.99 (m, 2H, CH=CH2), 4.34 (t, J = 7.5 Hz, 2H, 
NCH2), 2.47 (s, 3H, COCH3), 2.07 (q, J = 7.5 Hz, 2H, CH2), 1.86 (qn, J = 7.5 Hz, 2H, CH2); 13C NMR (101 
MHz, CDCl3): δ 189.3 (CO), 169.5 (CO), 137.6 (CH=CH2), 134.7 (CH), 131.5 (Cq), 121.8 (CH), 116.1 
(CH=CH2), 114.5 (Cq), 50.4 (NCH2), 30.9 (CH2), 30.5 (CH2), 27.9 (COCH3); HRMS (ESI+): Calculated for 
C12H15NO3 [M+H]+: 222.1125, found 222.1130; IR νmax (neat)/cm-1: 2971 (CH), 1697 (C=O), 1625 (C=O). 
5-Benzoyl-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxylic acid 325b 
 
1-(5-Benzoyl-1-(pent-4-en-1-yl)-1H-pyrrol-3-yl)-2,2,2-trichloroethan-1-one (2.4 mmol, 923 mg) was 
dissolved in THF (12 mL) and treated with aqueous NaOH (1 M, 6 mmol, 6.00 mL). The resulting mixture 




solution washed with Et2O. The aqueous layer was acidified to pH 1 with 3 M HCl and extracted with 
EtOAc (×3). The organic layers were combined, washed with brine, dried over MgSO4 and 
concentrated. This gave the title compound (634 mg, 93%) as an off-white solid (analytically pure), 
which was used without further purification. 
M.p. 117-119 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.85-7.77 (m, 2H, ArH), 7.62 (d, J = 1.5 Hz, 1H, 
ArH), 7.61-7.54 (m, 1H, ArH), 7.48 (t, J = 7.5 Hz, 2H, ArH), 7.19 (d, J = 1.5 Hz, 1H, ArH), 5.81 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.11-4.99 (m, 2H, CH=CH2), 4.43 (t, J = 7.0 Hz, 2H, NCH2), 2.12 (q, J = 
7.0 Hz, 2H, CH2), 1.95 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 186.6 (CO), 169.1 (CO), 
139.1 (Cq), 137.2 (CH=CH2), 134.7 (CH), 132.2 (CH), 130.9 (Cq), 129.4 (CH), 128.5 (CH), 124.0 (CH), 
115.9 (CH=CH2), 114.4 (Cq), 49.8 (NCH2), 30.7 (CH2), 30.5 (CH2); HRMS (ESI+): Calculated for C17H17NO3 
[M+H]+: 284.1281, found 284.1270; IR νmax (neat)/cm-1: 2987 (CH), 1681 (C=O), 1634 (C=O). 
2,2,2-Trichloro-1-(1-(pent-4-en-yl)-1H-pyrrol-2-yl)ethan-1-one 327 
 
To a solution of triphenylphosphine (6.6 mmol, 1.73 g) in THF (24 mL) at -78 °C was added DIAD (6.3 
mmol, 1.24 mL). The resulting mixture was stirred for 1 hour. 4-Penten-1-ol (7.5 mmol, 0.78 mL) was 
added and the reaction mixture was stirred for a further hour. 2,2,2-Trichloro-1-(1H-pyrrol-2-yl)ethan-
1-one (6.0 mmol, 1.28 g) was added and the reaction mixture was stirred at -78 °C for a further 15 
minutes, and then room temperature for 16 hours. The volatiles were removed, and the residue was 
triturated with cold Et2O and petrol. The crude material was purified by flash column chromatography 
(2% EtOAc/petrol) to yield the title compound (1.42 g, 84%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 4.5, 1.5 Hz, 1H, ArH), 7.01 (t, J = 2.0 Hz, 1H, ArH), 6.23 (dd, J 
= 4.5, 2.5 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.10-4.99 (m, 2H, CH=CH2), 4.36-
4.29 (m, 2H, NCH2), 2.10 (q, J = 7.0 Hz, 2H, CH2), 1.87 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, 
CDCl3): δ 172.6 (CO), 137.5 (CH=CH2), 133.2 (CH), 124.7 (CH), 121.2 (Cq), 115.7 (CH=CH2), 109.1 (CH), 
96.6 (Cq), 50.2 (NCH2), 30.7 (CH2), 30.3 (CH2); HRMS (ESI+): Calculated for C11H12Cl3NO [M+H]+: 
280.0057, found 280.0058; IR νmax (neat)/cm-1: 2928 (CH), 1665 (C=O). 
tert-Butyl 1-(pent-4-en-1-yl)-1H-pyrrole-2-carboxylate 328 
 
A solution of 2,2,2-trichloro-1-(1-(pent-4-en-yl)-1H-pyrrol-2-yl)ethan-1-one (8.0 mmol, 2.24 g) in THF 




volatiles were then removed, and the remaining aqueous solution was acidified to pH 1 with 3 M HCl. 
This was extracted with Et2O (×3), and the organic layers were combined, washed with brine, dried 
over MgSO4 and concentrated. The crude product was used without further purification. 
 To a solution of the crude acid in DCM (11 mL) at 0 °C was added oxalyl chloride (9.6 mmol, 0.81 mL) 
over 5 minutes. The reaction mixture was stirred at room temperature for 1 hour, before being re-
cooled to 0 °C. tBuOK (24.0 mmol, 2.69 g) was added portionwise over 5 minutes, and the reaction 
mixture was stirred at room temperature for 18 hours. Water (20 mL) was added and the phases were 
separated. The aqueous layer was extracted with DCM (×3), and the combined organic layers were 
washed with brine, dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography (1% EtOAc/petrol) to give the title compound (1.41 g, 75% over two steps) 
as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 6.88 (dd, J = 4.0, 2.0 Hz, 1H, ArH), 6.79-6.76 (m, 1H, ArH), 6.08 (dd, J = 
4.0, 2.5 Hz, 1H, ArH), 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-4.97 (m, 2H, CH=CH2), 4.28 (t, 
J = 7.0 Hz, 2H, NCH2), 2.09-2.01 (m, 2H, CH2), 1.91-1.82 (m, 2H, CH2), 1.55 (s, 9H, C(CH3)3); 13C NMR 
(101 MHz, CDCl3): δ 160.7 (CO), 137.8 (CH=CH2), 128.3 (CH), 123.4 (Cq), 118.0 (CH), 115.4 (CH=CH2), 
107.6 (CH), 80.3 (C(CH3)3), 48.6 (NCH2), 30.8 (CH2), 30.8 (CH2), 28.6 (C(CH3)3); HRMS (ESI+): Calculated 
for C14H21NO2 [M+Na]+: 258.1465, found 258.1467; IR νmax (neat)/cm-1: 2977 (CH), 1697 (C=O). 
N-Methoxy-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 332 
 
To a solution of 1-(pent-4-en-1-yl)-1H-indole-3-carboxylic acid (3.0 mmol, 688 mg) in DCM (10 mL) at 
0 °C was added oxalyl chloride (3.6 mmol, 0.31 mL) dropwise, followed by DMF (2 drops). The reaction 
mixture was allowed to warm to room temperature and was stirred for 20 hours. On completion, the 
volatiles were removed to yield the crude acid chloride. Methoxyamine hydrochloride (3.6 mmol, 301 
mg) was added to a biphasic mixture of K2CO3 (6.0 mmol, 829 mg) in EtOAc/water (2:1 v:v 36 mL). The 
solution was cooled to 0 °C and the crude acid chloride dissolved in a minimum amount of EtOAc was 
added dropwise. The reaction mixture was allowed to warm to room temperature and was stirred for 
4 hours. The phases were separated, and the aqueous phase extracted with EtOAc. The combined 
organic layers were dried over MgSO4 and concentrated. The crude residue was purified by flash 





M.p. 100-103 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.34 (s, 1H, NH), 8.04-7.97 (m, 1H, ArH), 7.79 
(s, 1H, ArH), 7.41-7.36 (m, 1H, ArH), 7.32-7.42 (m, 2H, ArH), 5.79 (ddt, J = 16.0, 11.0, 7.0 Hz, 1H, 
CH=CH2), 5.09-5.05 (m, 1.5 Hz, 1H, CH=CHH), 5.05-5.02 (m, 1H, CH=CHH), 4.16 (t, J = 7.0 Hz, 2H, NCH2), 
3.91 (s, 3H, OCH3), 2.09 (q, J = 7.0 Hz, 2H, CH2), 1.97 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, 
CDCl3): δ 165.9 (CO), 136.9 (CH=CH2), 136.5 (Cq), 132.2 (CH), 125.8 (Cq), 122.9 (CH), 121.9 (CH), 121.0 
(Cq), 116.2 (CH=CH2), 110.4 (CH), 107.5 (Cq), 64.9 (OCH3), 46.3 (NCH2), 30.8 (CH2), 29.0 (CH2); HRMS 
(ESI+): Calculated for C15H18N2O2 [M+H]+: 259.1441, found 259.1452; IR νmax (neat)/cm-1: 3237 (NH), 
3087 (CH), 2932 (CH), 1632 (C=O).  
N-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide 334 
 
To a suspension of N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.7 mmol, 200 
mg) and K2CO3 (9.8 mmol, 1.34 g) in acetone (10 mL) was added iodomethane (9.8 mmol, 0.61 mL). 
The reaction mixture was stirred at room temperature for 96 hours, and then passed through a short 
silica pad eluted with DCM. The solution was then concentrated to yield the title compound (188 mg, 
91%) as an off-white solid (analytically pure), which was used without further purification. 
M.p. 48-50 °C (MeCN); 1H NMR (500 MHz, CDCl3): δ 8.09-8.04 (m, 1H, ArH), 7.75 (s, 1H, ArH), 7.43-
7.36 (m, 1H, ArH), 7.35-7.28 (m, 2H, ArH), 5.79 (ddt, J = 16.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.12-5.07 (m, 
1H, CH=CHH), 5.06-5.03 (m, 1H, CH=CHH), 4.18 (t, J = 7.0 Hz, 2H, NCH2), 3.42 (s, 3H, SO2CH3), 3.30 (s, 
3H, NCH3), 2.11 (q, J = 7.0 Hz, 2H, CH2), 2.05-1.93 (m, 2H, CH2); 13C NMR (126 MHz, CDCl3): δ 167.8 
(CO), 136.7 (CH=CH2), 136.5 (Cq), 135.5 (CH), 127.0 (Cq), 123.6 (CH), 122.7 (CH), 121.8 (CH), 116.5 
(CH=CH2), 110.4 (CH), 109.1 (Cq), 46.5 (NCH2), 39.9 (NCH3), 36.1 (SO2CH3) 30.7 (CH2), 28.8 (CH2); HRMS 
(ESI+): Calculated for C16H20N2O3S [M+H]+: 321.1267, found 321.1279; IR νmax (neat)/cm-1: 2928 (CH), 
1639 (C=O), 1333 (S=O), 1157 (S=O).  
Ethyl 1-(4-ethoxy-4-oxobutyl)-1H-indole-2-carboxylate211 337 
 
Ethyl indole-2-carboxylate (26.0 mmol, 5.00 g) was subjected to the general alkylation conditions 
described above with ethyl 4-bromobutyrate. The crude material was purified by flash column 





1H NMR (400 MHz, CDCl3): δ 7.67 (dt, J = 8.0, 1.0 Hz, 1H, ArH), 7.45 (dd, J = 8.5, 1.0 Hz, 1H, ArH), 7.38-
7.31 (m, 2H, ArH), 7.14 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H, ArH), 4.64 (t, J = 7.0 Hz, 2H, NCH2), 4.37 (q, J = 7.0 
Hz, 2H, OCH2CH3), 4.12 (q, J = 7.0 Hz, 2H, OCH2CH3), 2.34 (t, J = 7.0 Hz, 2H, CH2), 2.15 (qn, J = 7.0 Hz, 
2H, CH2), 1.41 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.24 (t, J = 7.0 Hz, 3H, OCH2CH3); IR νmax (neat)/cm-1: 2987 
(CH), 1732 (C=O), 1708 (C=O). Data are consistent with literature precedent.211  
Ethyl 9-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-8-carboxylate and ethyl 6,7-dihydro-9-
hydroxypyrido[1,2-a]indole-8-carboxylate211 338 
A A’ 
Synthesised using a modified literature procedure.211 
A solution of ethyl 1-(4-ethoxy-4-oxobutyl)-1H-indole-2-carboxylate (26.0 mmol, 7.89 g) in THF (50 
mL) was added to a stirred suspension of tBuOK (31.2, 3.50 g) in THF (40 mL) at room temperature. 
The resulting mixture was stirred for 16 hours before being quenched with water (50 mL). The volatiles 
were removed, and the remaining aqueous solution was extreacted with DCM (×3). The combined 
organic layers were washed with brine, dried over MgSO4 and concentrated. The crude material was 
purified by flash column chromatography (4% EtOAc/petrol) to give the title compounds (5.43 g, 
81%(A:A’ 1:4)) as a yellow solid. 
M.p. 69-74 °C, (EtOAc, lit = 100-102 °C211); 1H NMR (400 MHz, CDCl3): δ 12.17 (s, 0.8H, OH of A’), 7.74 
(dt, J = 8.0, 1.0 Hz, 0.2H, ArH of A), 7.67 (dd, J = 8.0, 1.0 Hz, 0.8 Hz, ArH of A’), 7.44-7.27 (m, 2.2H, 3 × 
ArH of A and 2 × ArH of A’), 7.19 (ddd, J = 8.0, 6.5, 1.5 Hz, 0.2H, ArH of A), 7.13 (ddd, J = 8.0, 6.5, 1.0 
Hz, 0.8H, ArH of A’), 7.04 (s, 0.8H, ArH of A’), 4.47-4.18 (m, 2.4H, NCH2 of A, OCH2CH3 of A and A’), 4.12 
(t, J = 7.0 Hz, 1.6H, NCH2 of A’), 3.73 (dd, J = 8.5, 4.5 Hz, 0.2H, CH of A), 2.89 (t, J = 7.0 Hz, 1.6H, CH2 of 
A’), 2.84-2.73 (m, 0.2H, CHH of A), 2.65-2.54 (m, 0.2H, CHH of A), 1.37 (t, J = 7.0 Hz, 0.6H, OCH2CH3 of 
A’), 1.30 (t, J = 7.0 Hz, 2.4H, CH2CH3 of A); IR νmax (neat)/cm-1: 2973 (CH), 1734 (C=O), 1674 (C=O), 1623 
(C=O). 1H NMR and IR data are consistent with literature precedent.211 
7,8-Dihydropyrido[1,2-a]indol-9(6H)-one211  339 
 
Synthesised using a modified literature procedure.211 
To a solution of ethyl 9-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-8-carboxylate and ethyl 6,7-
dihydro-9-hydroxypyrido[1,2-a]indole-8-carboxylate (21.1 mmol, 5.40 g) in EtOH (100 mL) was added 




removed, and the remaining aqueous solution was extracted with DCM (×3). The combined organic 
layers were washed with saturated aqueous NaHCO3, dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography (25-50% EtOAc/petrol) to yield the title 
compound (2.99 g, 77%) as an off-white solid.  
M.p. 139-140 °C (MeCN, lit. = 140-142 °C211); 1H NMR (400 MHz, CDCl3): δ 7.74 (d, J = 8.0 Hz, 1H, ArH), 
7.42-7.35 (m, 2H, ArH), 7.32 (s, 1H, ArH), 7.17 (ddd, J = 8.0, 5.5, 2,0 Hz, 1H, ArH), 4.30-4.23 (m, 2H, 
NCH2), 2.76 (dd, J = 7.0, 6.0 Hz, 2H, CH2), 2.45-2.38 (m, 2H, CH2); IR νmax (neat)/cm-1: 2969 (CH), 11669 
(C=O). Data are consistent with literature precedent.211 
9-Methylene-6,7,8,9-tetrahydropyrido[1,2-a]indole211 340 
 
Synthesised using a modified literature procedure.211 
To a solution of methyl triphenylphosphonium bromide (11.0 mmol, 3.93 g) in THF (35 mL) at 0 °C was 
added n-Butyllithium (11.0 mmol, 4.4 mL, 2.5 M solution in THF) dropwise. After stirring for 30 minutes 
a solution of 7,8-dihydropyrido[1,2-a]indol-9(6H)-one (10.0 mmol, 1.85 g) in THF (35 mL) was added 
dropwise. The reaction mixture was stirred at 0 °C for 4 hours before being quenched with water (25 
mL). The volatiles were removed, and the remaining aqueous solution extracted with DCM (×3). The 
combined organic layers were washed with brine, dried over MgSO4 and concentrated. The crude 
residue was purified by flash column chromatography (5% EtOAc/petrol) to give the title compound 
(1.34 g, 73%) as a white solid.  
M.p. 135-137 °C, (EtOAc, lit = 82-84 °C211); 1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 8.0 Hz, 1H, ArH), 
7.30-7.25 (m, 1H, ArH), 7.21-7.14 (m, 1H, ArH), 7.10 (t, J = 7.5 Hz, 1H, ArH), 6.75 (s, 1H, ArH), 5.66-5.59 
(m, 1H, C=CHH), 5.05-4.97 (m, 1H, C=CHH), 4.12 (t, J = 6.5 Hz, 2H, NCH2), 2.66-2.58 (m, 2H, CH2), 2.14 
(qn, J = 6.5 Hz, 2H, CH2); IR νmax (neat)/cm-1: 2954 (CH). 1H NMR and IR data are consistent with 
literature precedent.211 
 9-Methylene-6,7,8,9-tetrahydropyrido[1,2-a]indole-10-carboxaldehyde212 344 
 
Synthesised using a modified literature procedure.212 
To a portion of DMF (1 mL) at 0 °C was added POCl3 (2.2 mmol, 0.20 mL) dropwise. A solution of 9-




dropwise over a period of 5 minutes. The reaction mixture was stirred at 0 °C for 1 hour. The 
completed reaction mixture was poured onto ice and neutralised with saturated aqueous NaHCO3. 
The mixture was extracted with EtOAc (×3), dried over MgSO4 and concentrated. The crude material 
was purified by flash column chromatography (10% EtOAc/petrol) to give the title compound (91 mg, 
22%) as an orange solid. 
M.p. 79-81 °C, (MeCN, lit = 84-86 °C212); 1H NMR (400 MHz, CDCl3): δ 10.30 (s, 1H, CHO), 8.43-8.37 (m, 
1H, ArH), 7.35-7.29 (m, 3H, ArH), 5.80 (s, 1H, C=CHH), 5.51 (s, 1H, C=CHH), 4.18 (t, J = 7.0 Hz, 2H, NCH2), 
2.72-2.66 (m, 2H, CH2), 2.28 (qn, J = 7.0 Hz, 2H, CH2); IR νmax (neat)/cm-1: 2957 (CH), 1632 (C=O). Data 
are consistent with literature precedent.212 
1-Methylene-2,3,4a-tetrahydro-1H-fluorene-9-carboxaldehyde oxime212 345 
 
To a solution of 9-methylene-6,7,8,9-tetrahydropyrido[1,2-a]indole-10-carboxaldehyde (0.8 mmol, 
173 mg) in MeOH (3 mL) was added hydroxylamine hydrochloride (1.6 mmol, 114 mg) and KOAc (1.6 
mmol, 161 mg). The reaction mixture was heated at reflux for 4 hours. On completion, the volatiles 
were removed, and the crude residue was purified by flash column chromatography (15% 
EtOAc/petrol) to yield the title compound (113 mg, 61%) as a yellow solid. 
M.p. 167-168 °C, (MeCN, lit = 88-90 °C212); 1H NMR (400 MHz, CDCl3): δ 8.62 (s, 1H, CH=N), 8.18 (d, J 
= 8.0 Hz, 1H, ArH), 7.30-7.27 (m, 2H, ArH), 7.25-7.20 (m, 1H, ArH), 5.45 (s, 1H, C=CHH), 5.33 (s, 1H, 
C=CHH), 4.13 (t, J = 6.5 Hz, 2H, NCH2), 2.67-2.54 (m, 2H, CH2), 2.26-2.19 (m, 2H, CH2); 13C NMR (101 
MHz, CDCl3): δ 146.9 (CH), 138.0 (Cq), 136.4 (Cq), 136.1 (Cq), 125.6 (Cq), 123.3 (CH), 122.4 (CH), 121.7 
(CH), 115.8 (C=CH2), 109.2 (CH), 105.0 (Cq), 42.5 (NCH2), 31.8 (CH2), 23.9 (CH2); IR νmax (neat)/cm-1: 
3262 (br. OH), 2956 (CH). NMR and IR data are consistent with literature precedent.212 
4.3.7 Natural product synthesis substrate data 
Methyl 1-(pent-4-en-1-yl)-1,4,5,6-tetrahydropyridine-3-carboxylate 359 
 
To a solution of methyl nicotinate (30.0 mmol, 4.12 g) in degassed EtOH (20 mL) was added 5% Pd/C 
(6 wt%, 248 mg). A magnetic stir bar was added, and the resulting suspension was sealed in an 




72 hours, before being filtered and concentrated. The product was inseparable from the remaining 
starting material so was used in the next step without further purification. 
The crude material was subjected to the general alkylation conditions described above with 5-bromo-
1-pentene. The crude product was purified by flash column chromatography (20% EtOAc/petrol) to 
afford the title compound (50% over two steps) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.37-7.31 (m, 1H, C=CH), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 
5.07-4.96 (m, 2H, CH=CH2), 3.66 (s, 3H, OCH3), 3.20-3.02 (m, 4H, 2 × NCH2), 2.27 (tt, J = 5.5, 1.0 Hz, 2H, 
CH2), 2.08-1.99 (m, 2H, CH2), 1.85-1.77 (m, 2H, CH2), 1.68-1.58 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): 
δ 169.2 (CO), 146.3 (C=CH), 137.5 (CH=CH2), 115.6 (CH=CH2), 93.5 (C=CH), 55.3 (NCH2), 50.6 (OCH3), 
45.8 (NCH2), 30.7 (CH2), 27.6 (CH2), 21.5 (CH2), 20.2 (CH2); HRMS (ESI+): Calculated for C12H19NO2 
[M+H]+: 210.1485, found 210.1488; IR νmax (neat)/cm-1: 2942 (CH), 1676 (C=O). 
3-(Methoxycarbonyl)-1-(pent-4-en-1-yl)pyridine-1-ium bromide 362 
 
To a solution of methyl nicotinate (10.0 mmol, 1.37 g) in MeCN (10 mL) was added 5-bromo-1-pentene 
(10.0 mmol, 1.20 mL). The resulting solution was stirred at reflux for 18 hours, after which a second 
portion of 5-bromo-1-pentene (10.0 mmol, 1.20 mL) was added. The reaction mixture was stirred for 
a further 30 hours at reflux and then cooled to toom temperature. The mixture was filtered, washed 
with Et2O and dried in vacuo to give the title compound (2.86 g, quantitative) as a viscous orange oil, 
without need for further purification.  
1H NMR (400 MHz, acetone-d6): δ 10.12 (dt, J = 6.0, 1.5 Hz, 1H, ArH), 10.00-9.90 (m, 1H, ArH), 9.13 (dt, 
J = 8.0, 1.5 Hz, 1H, ArH), 8.47 (dd, J = 8.0, 6.0 Hz, 1H, ArH), 5.94-5.83 (m, 1H, CH=CH2), 5.26-5.18 (m, 
2H, C=CH2), 5.15-5.05 (m, 2H, NCH2), 5.03-4.93 (m, 2H, CH2), 4.02 (s, 3H, CH3), 2.00-1.87 (m, 2H, CH2); 
13C NMR (101 MHz, acetone-d6): δ 162.8 (CO), 149.9 (CH), 147.2 (CH), 146.3 (CH), 138.8 (CH=CH2), 
138.1 (Cq), 129.8 (CH), 116.3 (CH=CH2), 115.8 (NCH2), 62.3 (OCH3); 54.1 (NCH2), 31.7 (CH2), 28.5 (CH2) 
HRMS (ESI+): Calculated for C12H16BrNO2 [M-Br]+: 206.1176, found 206.1172. 
5-Iodopent-1-ene213 367 
 
5-Bromo-1-pentene (20.0 mmol, 2.37 mL) was added to a solution of NaI (40.0 mmol, 6.00 g) in 
acetone (60 mL). The reaction mixture was heated at reflux for 3 hours. On completion, the mixture 




with pentane (×3), and the combined organic layers were washed with brine, dried over MgSO4 and 
concentrated to give the title compound (3.10 g, 80%) as a colourless oil (analytically pure) which was 
used without further purification. 
1H NMR (400 MHz, CDCl3): δ 5.75 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.18-5.04 (m, 1H, CH=CHH), 
5.04-4.99 (m, 1H, CH=CHH), 3.19 (t, J = 7.0 Hz, 2H, ICH2), 2.21-2.12 (m, 2H, CH2), 1.92 (qn, J = 7.0 Hz, 
2H, CH2); IR νmax (neat)/cm-1: 2975 (CH). Data are consistent with literature precedent.213 
3-Carbamoyl-1-(pent-4-en-1-yl)pyridine-1-ium bromide 370 
 
To a solution of nicotinamide (10.0 mmol, 1.22 g) in MeCN (20 mL) was added 5-bromo-1-pentene 
(12.0 mmol, 1.42 mL). The reaction mixture was stirred at reflux for 72 hours. On completion the 
mixture was concentrated to give the title compound (2.75 g, quantitative) as a yellow solid, without 
need for further purification. 
1H NMR (400 MHz, DMSO-d6): δ 9.49 (s, 1H, ArH), 9.21 (d, J = 6.0 Hz, 1H, ArH), 8.93 (d, J = 8.0 Hz, 1H, 
ArH), 8.55 (br. s, 1H, NHH), 8.27 (t, J = 7.0 Hz, 1H, ArH), 8.16 (br. s, 1H, NHH), 5.81 (ddt, J = 16.5, 11.0, 
6.0 Hz, 1H, CH=CH2), 5.10-4.97 (m, 2H, CH=CH2), 4.65 (t, J = 7.0 Hz, 2H, NCH2), 2.14-2.01 (m, 4H, 2 × 
CH2); 13C NMR (101 MHz, DMSO-d6): δ 162.8 (CO), 146.5 (CH), 144.8 (CH), 143.5 (CH), 136.9 (CH=CH2), 
133.7 (Cq), 127.9 (CH), 115.8 (CH=CH2), 60.7 (NCH2), 29.6 (CH2), 29.5 (CH2); HRMS (ESI+): Calculated for 




To a solution of 3-carbamoyl-1-(pent-4-en-1-yl)pyridine-1-ium bromide (10.0 mmol, 2.71 g) and 
NaHCO3 (40.0 mmol, 3.36 g) in EtOAc/water (1:1 v:v 100 mL) was added Na2S2O4 (30.0 mmol, 5.22 g) 
slowly. The resulting mixture was stirred at room temperature for 6 hours. The layers were separated, 
and the aqueous layer was further extracted with EtOAc (×2). The combined organic layers were 
washed with brine, dried over MgSO4 and concentrated to give the title compound (1.72 g, 90%) as an 




1H NMR (400 MHz, CDCl3): δ 7.02 (d, J = 1.5 Hz, 1H, CH=CCONH2), 5.81-5.68 (m, 2H, CH=CH2 + NCH=CH), 
5.23 (br. s, 2H, NH2), 5.06-4.97 (m, 2H, CH=CH2), 4.71 (dt, J = 8.0, 3.5 Hz, 1H, NCH=CH), 3.15 (dd, J = 
3.5, 1.5 Hz, 2H, CH2), 3.09 (t, J = 7.0 Hz, 2H, NCH2), 2.11-2.02 (m, 2H, CH2), 1.63 (qn, J = 7.0 Hz, 2H, CH2); 
13C NMR (101 MHz, CDCl3): δ 170.6 (CO), 139.8 (CH=CCONH2), 137.3 (CH=CH2), 129.1 (NCH=CH), 115.7 
(CH=CH2), 102.8 (NCH=CH), 98.0 (Cq).53.3 (NCH2), 30.4 (CH2), 29.1 (CH2), 22.9 (CH2); HRMS (ESI+): 
Calculated for C11H16N2O [M+H]+: 193.1335, found 193.1330; IR νmax (neat)/cm-1: 3333 (br. NH), 3202 
(br. NH), 2928 (CH), 1680 (C=O), 1637 (C=C). 
Methyl 6-hydroxynicotinate214 376 
 
Synthesised using a modified literature procedure. 
A mixture of 6-hydroxynicotinic acid (20.0 mmol, 2.78 g) and concentrated H2SO4 (2.0 mmol, 0.1 mL) 
in MeOH (25 mL) was heated at reflux for 24 hours. The reaction mixture was then allowed to cool to 
room temperature and NaHCO3 (25 mL) was added dropwise until pH 11-12. The mixture was 
extracted with EtOAc (×3) and the combined organic layers were dried over MgSO4 and concentrated. 
This gave the title compound (1.59 g, 54%) as an off-white solid (analytically pure), which was used 
without further purification. 
M.p. 166-167 °C, (EtOAc, lit = 164-165 °C214); 1H NMR (400 MHz, CDCl3): δ 12.02 (br. s, 1H, OH), 8.17 
(d, J = 2.5 Hz, 1H, ArH), 7.99 (dd, J = 9.5, 2.5 Hz, 1H, ArH), 6.57 (d, J = 9.5 Hz, 1H, ArH), 3.87 (s, 3H, 
OCH3); IR νmax (neat)/cm-1: 2912 (CH), 1724 (C=O), 1706 (C=O), 1688 (C=O), 1642 (C=O), 1610 (C=O). 
Data are consistent with literature precedent.214 
Methyl 6-oxo-1-(pent-4-en-1-yl)-1,6-dihydropyridine-3-carboxylate215 377 
 
Synthesised using a modified literature procedure.215 
To a solution of methyl 6-hydroxynicotinate (2.0 mmol, 306 mg) and 5-bromo-1-pentene (3.0 mmol, 
0.34 mL) in toluene (16 mL) and water (0.5 mL) was added K2CO3 (4.0 mmol, 553 mg) and TBAB (0.2 
mmol, 56 mg) and this was refluxed for 1 hour. The reaction mixture was then filtered, concentrated 
and purified by flash column chromatography (50% EtOAc/petrol) to give the title compound (524 mg, 




1H NMR (400 MHz, CDCl3): δ 8.14 (dd, J = 2.5, 0.5 Hz, 1H, CH), 7.82 (dd, J = 9.5, 2.5 Hz, 1H, CH), 6.52 
(dd, J = 9.5, 0.5 Hz, 1H, CH), 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.12-4.98 (m, 2H, CH=CH2), 
4.00-3.94 (m, 2H, NCH2), 3.86 (s, 3H, OCH3), 2.18-2.09 (m, 2H, CH2), 1.92-1.83 (m, 2H, CH2); 13C NMR 
(101 MHz, CDCl3): δ 164.9 (CO), 162.5 (CO), 143.1 (CH), 138.5 (CH), 137.0 (CH=CH2), 120.0 (CH), 116.1 
(CH=CH2), 109.7 (Cq), 52.2 (OCH3), 50.2 (NCH2), 30.7 (CH2), 28.2 (CH2); HRMS (ESI+): Calculated for 
C12H15NO3 [M+H]+: 222.1125, found 222.1128; IR νmax (neat)/cm-1: 2988 (CH), 1718 (C=O), 1667 (C=O).  
6-Oxo-1-(pent-4-en-yl)-1,6-dihydropyridine-3-carboxylic acid 378 
 
Methyl 6-oxo-1-(pent-4-en-1-yl)-1,6-dihydropyridine-3-carboxylate (2.4 mmol, 524 mg) was subjected 
to the general hydrolysis conditions described above, to give the title compound (430 mg, 87%) as an 
off-white solid (analytically pure), which was used without further purification. 
M.p. 166-167 °C, (EtOAc); 1H NMR (400 MHz, DMSO-d6): 12.80 (br. s, 1H, OH), 8.46-8.39 (m, 1H, CH), 
7.77 (dd, J = 9.5, 2.5 Hz, 1H, CH), 6.40 (d, J = 9.5 Hz, 1H, CH), 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, 
CH=CH2), 5.06-5.01 (m, CH=CHH), 5.00-4.94 (m, 1H, CH=CHH), 3.99-3.92 (m, 2H, NCH2), 2.07-1.99 (m, 
2H, CH2), 1.73 (tt, J = 8.5, 6.5 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d3): δ 165.3 (CO), 161.5 (CO), 
144.1 (CH), 138.7 (CH), 137.6 (CH=CH2), 118.6 (CH), 115.3 (CH=CH2), 109.2 (Cq), 48.8 (NCH2), 30.1 (CH2), 
27.6 (CH2); HRMS (ESI+): Calculated for C11H13NO3 [M+Na]+: 230.0788, found 230.0790; IR νmax 
(neat)/cm-1: 2996 (CH), 2488 (br. OH), 1701 (C=O), 1636 (C=O). 
N-(Methylsulfonyl)-6-oxo-1-(pent-4-en-yl)-1,6-dihydropyridine-3-carboxamide 379 
 
6-Oxo-1-(pent-4-en-yl)-1,6-dihydropyridine-3-carboxylic acid (2.0 mmol, 414 mg) was subjected to the 
general amide coupling conditions described above. The crude material was purified by 
recreystalisation from EtOAc to give the title compound (134 mg, 24%) as an off-white solid. 
M.p. 118-119 °C, (EtOAc); 1H NMR (400 MHz, CDCl3): δ 9.64 (br. s, 1H, NH), 8.25 (d, J = 2.5 Hz, 1H, CH), 
7.81 (dd, J = 9.5, 2.5 Hz, 1H, ArH), 6.58 (d, J = 9.5 Hz, 1H, ArH), 5.78 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, 
CH=CH2), 5.12-4.99 (m, 2H, CH=CH2), 4.03-3.96 (m, 2H, NCH2), 3.41 (s, 3H, SO2CH3), 2.17-2.09 (m, 2H, 
CH2), 1.93-1.81 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.9 (CO), 162.4 (CO), 143.1 (CH), 136.9 




28.3 (CH2); HRMS (ESI+): Calculated for C12H16N2O4S [M+H]+:285.0904, found 285.0900; IR νmax 
(neat)/cm-1: 3075 (br. NH), 2932 (CH), 1655 (C=O), 1646 (C=O). 
1-(Pent-4-en-1-yl)piperidin-2-one216 382 
 
To a suspension of powdered KOH (40 mmol, 4.48 g) in DMSO (20 mL) was added δ-valerolactam (20.0 
mmol, 2.00 g). The resulting mixture was cooled to 0 °C and 5-bromo-1-pentene (30.0 mmol, 3.55 mL) 
was added dropwise. The reaction mixture was stirred at room temperature for 2 hours. Water was 
added and the mixture was extracted with EtOAc (×3) and the combined organic layers were washed 
with water (×2) and brine, dried over MgSO4 and concentrated. The crude material was purified by 
flash column chromatography (0.5-2% MeOH/DCM) to yield the title compound (2.41 g, 72%) as a 
pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.05-5.01 (m, 1H, CH=CHH), 
4.99-4.93 (m, 1H, CH=CHH), 3.38-3.33 (m, 2H, NCH2), 3.28-3.24 (m, 2H, NCH2), 2.38-2.34 (m, 2H, CH2), 
2.09-2.02 (m, 2H, CH2), 1.82-1.73 (m, 4H, 2 × CH2), 1.68-1.59 (m, 2H, CH2); IR νmax (neat)/cm-1: 2933 
(CH), 1630 (C=O). Data are consistent with literature precedent.216 
Ethyl 2-oxo-1-(pent-4-en-1-yl)piperidine-3-carboxylate 383 
 
To a solution of 1-(pent-4-en-1-yl)piperidin-2-one (5.0 mmol, 835 mg) in THF (15 mL) at -78 °C was 
added LiHMDS (10.0 mmol, 10 mL, 1 M solution in hexane) dropwise. The mixture was stirred for 1 
hour, and ethyl chloroformate (5.0 mmol, 0.48 mL) was added. The reaction mixture was stirred at 
room temperature for a further 18 hours, before being poured onto ice. This was extracted with EtOAc 
(×3) and the combined organic layers were then washed with brine, dried over MgSO4 and 
concentrated. The crude material was purified by flash column chromatography (1% MeOH/DCM) to 
give the title compound (919 mg, 77%) as a pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.04-5.00 (m, 1H, CH=CHH), 
4.98-4.93 (m, 1H, CH=CHH), 4.27-4.12 (m, 2H, OCH2CH3), 3.45-3.22 (m, 5H, 2 × NCH2 + CH), 2.15-1.90 
(m, 5H, 2 × CH2 + CHH), 1.82-1.71 (m, 1H, CHH), 1.65 (qn, J = 7.0 Hz, 2H, CH2), 1.27 (t, J = 7.0 Hz, 3H, 
OCH2CH3); 13C NMR (101 MHz, CDCl3): δ 171.4 (CO), 165.7 (CO), 138.0 (CH=CH2), 155.1 (CH=CH2), 61.4 




(OCH2CH3); HRMS (ESI+): Calculated for C13H21NO3 [M+Na]+: 262.1414, found 262.1413; IR νmax 
(neat)/cm-1: 2935 (CH), 1732 (C=O), 1641 (C=O). 
2-Oxo-1-(pent-4-en-1-yl)piperidine-3-carboxylic acid 384 
 
To a stirring solution of ethyl 2-oxo-1-(pent-4-en-1-yl)piperidine-3-carboxylate (5.5 mmol, 1.32 g) in 
MeOH (10 mL) was added aqueous NaOH (2 M, 5.5 mmol, 2.70 mL) and water (8 mL). The reaction 
mixture was stirred at room temperature for 18 hours. On completion, the mixture was quenched 
with aqueous HCl (2 M) and extracted with DCM (×3). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to give the title compound (935 mg, 80%) as an off-white 
solid (analytically pure), which was used without further purification. 
1H NMR (400 MHz, DMSO-d6): δ 12.54 (br. s, 1H, COOH), 5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 
5.07-4.93 (m, 2H, CH=CH2), 3.31-3.19 (m, 5H, 2 × NCH2 + CH), 2.03-1.95 (m, 3H, CH2 + CHH), 1.93-1.77 
(m, 2H, CHH + CHH), 1.71 (dddd, J = 12.5, 9.5, 7.0, 4.0 Hz, 1H, CHH), 1.55 (qn, J = 7.5 Hz, 2H, CH2); 13C 
NMR (101 MHz, DMSO-d3): δ 172.3 (CO), 165.5 (CO), 138.2 (CH=CH2), 115.0 (CH=CH2), 48.6 (CH), 47.1 
(NCH2), 46.0 (NCH2), 30.5 (CH2), 25.7 (CH2), 24.7 (CH2), 20.6 (CH2); HRMS (ESI+): Calculated for 
C11H17NO3 [M+H]+: 212.1281, found 212.1271; IR νmax (neat)/cm-1: 2973-2871 (CH), 2543 (br. OH), 
1707 (C=O), 1593 (C=O). 
N-(Methylsulfonyl)-2-oxo-1-(pent-4-en-1-yl)piperidine-3-carboxamide 385 
 
2-Oxo-1-(pent-4-en-1-yl)piperidine-3-carboxylic acid (4.0 mmol, 845 mg), EDC.HCl (6.0 mmol, 1.15 g) 
and DMAP (9.2 mmol, 1.12 g) were dissolved in DCM (15 mL). Methanesulfonamide (6.0 mmol, 571 
mg) was added and the reaction mixture was stirred at room temperature for 18 hours. The mixture 
was washed with aqueous HCl (1 M), water (×2) and brine. The organic layer was dried over MgSO4 
and concentrated to give the title compound (775 mg, 60%) as an off-white solid. 
M.p. 100-102 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 11.12 (br. s, 1H, NH), 5.80 (ddt, J = 17.0, 10.0, 
6.5 Hz, 1H, CH=CH2), 5.13-4.89 (m, 2H, CH=CH2), 3.48-3.40 (m, 1H, CHCON), 3.39-3.27 (m, 4H, 2 × 
NCH2), 3.26 (s, 3H, SO2CH3), 2.29-2.18 (m, 1H, CHH), 2.13-2.03 (m, 3H, CHH + CH2), 1.96-1.76 (m, 2H, 




(CH=CH2), 48.4 (NCH2), 48.0 (NCH2), 47.4 (CH), 41.5 (SO2CH3), 31.1 (CH2), 26.0 (CH2), 22.4 (CH2), 21.4 
(CH2); HRMS (ESI+): Calculated for C12H20N2O4S [M+H]+: 289.1217, found 289.1225; IR νmax (neat)/cm-
1: 3185 (br. NH), 2922 (CH), 1686 (C=O), 1624 (C=O). 
1-Benzylpiperidin-2-one217 388 
 
To a solution of NaH (22.0 mmol, 880 mg, 60% dispersion in mineral oil) in THF (10 mL) at 0 °C was 
added a solition of δ-valerolactam (20.0 mmol, 2.00 g) in THF (30 mL) dropwise. The mixture was 
allowed to warm to room temperature and was stirred for two hours. Benzyl bromide (22.0 mmol, 
2.60 mL) was added dropwise and the reaction mixture was stirred for a further 20 hours. Upon 
completion the mixture was diluted with water and extracted with EtOAc (×3). The combined organic 
layers were washed with brine, dried over MgSO4 and concentrated. The crude material was purified 
by flash column chromatography (50-80% EtOAc/petrol) to give the title compound (3.78 g, 
quantitative) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.35-7.29 (m, 2H, ArH), 7.28-7.23 (m, 3H, ArH), 4.60 (s, 2H, NCH2Ar), 3.22-
3.17 (m, 2H, CH2), 2.47 (t, J = 6.5 Hz, 2H, CH2), 1.84-1.72 (m, 2H, CH2); IR νmax (neat)/cm-1: 2946 (CH), 
1630 (C=O). Data are consistent with literature precedent.217 
2,3,4,5-Tetrahydropyridine218 393 
 
To a stirring solution of N-chlorosuccinimide (5.05 mmol, 674 mg) in Et2O (5 mL) at 0 °C was added 
piperidine (5.0 mmol, 0.50 mL) dropwise. The resulting solution was stirred at room temperature for 
2 hours. The reaction mixture was filterered and the filtrate was washed with water, dried and reduced 
to approximately 1/3 volume (without heating – potentially hazardous/explosive). EtOH (3 mL) and 
KOH (10.0 mmol, 560 mg) were added, and the mixture was heated at 60 °C for two hours. On 
completion the reaction mixture was diluted with water and the layers separated. The aqueous layer 
was further extracted with Et2O (×2) and the combined organic layers dried over MgSO4 and 
concentrated. This gave the title compound (233 mg, 56% as the trimer) as a colourless solid. 
M.p. 82-84 °C (MeCN, lit = 59-61.5 °C); 1H NMR (400 MHz, CDCl3): δ 3.11 (dt, J = 10.5, 5.0 Hz, 3H, 3 × 




1.59-1.51 (m, 6H, 3 × CH2), 1.31-1.19 (m, 3H, 3 × CHH); IR νmax (neat)/cm-1: 2945 (CH). 1H NMR and IR 
data are consistent with literature precedent.218 
1-(Pent-4-en-1-yl)pyridin-1-ium bromide 395 
 
To a solution of pyridine (10.0 mmol, 0.81 mL) in MeCN (20 mL) was added 5-bromo-1-pentene (20.0 
mmol, 2.37 mL). The reaction mixture was stirred at 70 °C for 24 hours. On completion, the mixture 
was concentrated to give the title compound (2.51 g, quantitative) as an off-white solid (analytically 
pure), which was used without furher purification. 
1H NMR (400 MHz, CDCl3): δ 9.55 (d, J = 6.0 Hz, 2H, ArH), 8.52 (t, J = 8.0 Hz, 1H, ArH), 8.14 (t, J = 7.0 
Hz, 2H, ArH), 5.76 (ddt, J = 19.5, 12.5, 4.5 Hz, 1H, CH=CH2), 5.10-4.95 (m, 4H, CH=CH2 + NCH2), 2.25-
2.12 (m, 4H, 2 × CH2); 13C NMR (101 MHz, CDCl3): δ 145.4 (CH), 145.4 (CH), 135.9 (CH=CH2), 128.6 (CH), 
116.8 (CH=CH2), 61.4 (NCH2), 30.9 (CH2), 30.0 (CH2); HRMS (ESI+): Calculated for C10H14BrN [M-Br]+: 
148.1121, found 148.1127; IR νmax (neat)/cm-1: 3050-2973 (CH). 
1-(Pent-4-en-1-yl)-1,2,3,6-tetrahydropyridine 396 
 
To a solution of 1-(pent-4-en-1-yl)pyridin-1-ium bromide (20.0 mmol, 4.56 g) in EtOH (50 mL) at 0 °C 
was added NaBH4 (30 mmol, 1.13 g) portionwise over 30 minutes. The mixture was allowed to warm 
to room temperature and was stirred for a further 18 hours. The reaction mixture was diluted with 
water and extracted with DCM (×3). The combined organic layers were washed with water, dried over 
MgSO4 and concentrated. The crude material was purified by flash column chromatography (2.5 % 
MeOH/DCM) to give the title compound (2.19 g, 73%) as a pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 5.81 (ddt, J = 17.0 Hz, 10.0 Hz, 6.5 Hz, 1H, CH=CH2), 5.76-5.62 (m, 2H, 
CH=CH), 5.03-4.99 (m, 1H, CH=CHH), 4.94 (ddt, J = 10.0, 2.5, 1.5 Hz, 1H, CH=CHH), 2.94 (dt, J = 5.0, 2.5 
Hz, 2H, NCH2), 2.53 (t, J = 5.5 Hz, 2H, NCH2), 2.43-2.36 (m, 2H, NCH2), 2.21-2.13 (m, 2H, CH2), 2.12-2.03 
(m, 2H, CH2), 1.67-1.57 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 138.7 (CH=CH2), 125.5 (CH=CH), 
125.2 (CH=CH), 114.7 (CH=CH2), 58.4 (NCH2), 53.0 (NCH2), 50.3 (NCH2), 31.9 (CH2), 26.4 (CH2), 26.4 
(CH2); HRMS (ESI+): Calculated for C10H17N [M+H]+: 152.1434, found 152.1430; IR νmax (neat)/cm-1: 




Pent-4-en-1-yl methanesulfonate219 398 
 
4-Penten-1-ol (20.0 mmol, 2.06 mL) was subjected to the general mesylation conditions described 
above. The crude material was purified by flash column chromatography (15% EtOAc/petrol) to yield 
the title compound (3.15 g, 96%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.78 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.11-5.01 (m, 2H, CH=CH2), 
4.24 (t, J = 6.5 Hz, 2H, OCH2), 3.00 (s, 3H, SO2CH3), 2.24-2.13 (m, 2H, CH2), 1.92-1.79 (m, 2H, CH2); IR 
νmax (neat)/cm-1: 2942 (CH), 1349 (S=O), 1171 (S=O). Data are consistent with literature precedent.219 
2,2,2-Trifluoro-N-(pent-4-en-1-yl)acetamide220 399 
 
To a solution of trifluoroacetamide (25.0 mmol, 2.83 g), K2CO3 (25.0 mmol, 3.46 g) and TBAB (1.0 
mmol, 322 mg) in DMF (35 mL) was added a solution of pent-4-en-1-yl methanesulfonate (10.0 mmol, 
1.64 g) in DMF (15 mL). The resulting mixture was stirred vigorously at 45 °C for 48 hours. On 
completion the mixture was diluted with water and extracted with Et2O (×3). The combined organic 
layers were washed with water (×2) and brine, dried over MgSO4 and concentrated. The crude material 
was purified by flash column chromatography (5% EtOAc/petrol) to give the title compound (1.29 g, 
71%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 6.40 (br. s, 1H, NH), 5.79 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.11-
4.99 (m, 2H, CH=CH2), 3.38 (q, J = 7.0 Hz, 2H, NCH2), 2.13 (q, J = 7.0 Hz, 2H, CH2), 1.70 (qn, J = 7.0 Hz, 




2,2,2-Trifluoro-N-(pent-4-en-1-yl)acetamide (7.0 mmol, 1.27 g) was dissolved in THF (25 mL) and 
treated with aqueous NaOH (2M, 35 mmol, 17.5 mL). The reaction mixture was stirred at room 
temperature for 18 hours, before being diluted with Et2O and washed with saturated aqueous 
NaHCO3. The aqueous layer was extracted with Et2O (×2), and the combined organic extracts were 
washed with brine, dried over MgSO4 and concentrated (without heating). The crude product (400 




1H NMR (400 MHz, CDCl3): δ 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-4.83 (m, 2H, CH=CH2), 
2.75-2.67 (m, 2H, NCH2), 2.17-2.03 (m, 2H, CH2), 1.60-1.49 (m, 2H, CH2); νmax (neat)/cm-1: 3277 (NH2), 
2928 (CH). Data are consistent with literature precedent.221 
Methyl-3-(pent-4-en-1-ylamino)acrylate 402 
 
A solution of methyl propiolate (5.0 mmol, 0.44 mL) and pent-4-en-1-amine (5.0 mmol, 426 mg) in THF 
(20 mL) was stirred at room temperature for 20 hours. The reaction mixture was concentrated to give 
the title compound (547 mg, 65%, mixture of stereoisomers cis:trans 3:1) as a colourless oil, without 
need for further purification. 
1H NMR (400 MHz, CDCl3): δ 7.49 (dd, J = 13.5, 8.5 Hz, 0.25H, trans CH=CH), 6.61 (dd, J = 13.5, 8.0 Hz, 
0.75H, cis CH=CH), 5.84-5.70 (m, 1H, CH=CH2), 5.09-4.96 (m, 2H, CH=CH2), 4.73 (d, J = 13.5 Hz, 0.25H, 
trans CH=CH), 4.46 (d, J = 8.0 Hz, 0.75H, cis CH=CH), 3.66 (s, 0.75H, trans CH3), 3.64 (s, 2.25H, cis CH3), 
3.17 (q, J = 7.5 Hz, 1.5H, cis NCH2), 3.06 (q, J = 7.5 Hz, 0.5H, trans NCH2), 2.15-2.05 (m, 2H, CH2), 1.71-
1.55 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 171.3 (cis CO), 170.1 (trans CO), 157.5 (trans CH=CH), 
152.5 (cis CH=CH), 137.5 (CH=CH2), 115.6 (CH=CH2), 85.3 (trans CH=CH), 81.3 (cis CH=CH), 50.2 (OCH3), 
48.0 (NCH2), 30.6 (CH2), 30.3 (CH2); HRMS (ESI+): Calculated for C9H15NO2 [M+Na]+: 192.0995, found 
192.0993; IR νmax (neat)/cm-1: 3331 (NH), 2944 (CH), 1665 (C=O), 1610 (C=C). 
4.3.8 Enamine-type substrate data 
(E)-3-((-4-Methyl-N-(pent-4-en-1-yl)phenyl)sulfonamido)-N-(methylsulfonyl)acrylamide 404c 
 
(E)-3-((4-Methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylic acid (6.0 mmol, 1.86 g) was dissolved in 
DCM (40 mL) and cooled to 0 °C. EDC.HCl (9.0 mmol, 1.73 g), methanesulfonamide (6.6 mmol, 628 mg) 
and DMAP (9.0 mmol, 1.09 g) were added and the mixture was stirred at 0 °C for 15 minutes then at 
room temperature for 18 hours. On completion the reaction was quenched with 1 M HCl, and the 
volatiles were removed. The remaining aqueous mixture was extracted with DCM (×3), and the 
combined organic layers were washed with water (×2) and brine, dried over MgSO4 and concentrated. 
The crude material was purified by flash column chromatography (0-1% MeOH/DCM) to give the title 




M.p. 136-140 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 11.52 (br.s, 1H, NH), 7.88 (d, J = 14.0 Hz, 
1H, NCH=CH), 7.77 (d, J = 8.0 Hz, 2H, ArH), 7.48 (d, J = 8.0 Hz, 2H, ArH), 5.79 (ddt, J = 17.0, 10.0, 7.5 Hz, 
1H, CH=CH2), 5.40 (d, J = 14.0 Hz, NCH=CH), 5.09-4.92 (m, 2H, CH=CH2), 3.40 (t, J = 7.5 Hz, 2H, NCH2), 
3.27 (s, 3H, SO2CH3), 2.41 (s, 3H, ArCH3), 2.02 (q, J = 7.5 Hz, 2H, CH2), 1.55 (qn, J = 7.5 Hz, 2H, CH2); 13C 
NMR (101 MHz, DMSO-d6): δ 164.5 (CO), 145.1 (Cq), 140.5 (NCH=CH), 137.2 (CH=CH2), 134.5 (Cq), 
130.5 (CH), 127.0 (CH), 115.7 (CH=CH2), 99.0 (NCH=CH), 45.6 (NCH2), 41.3 (SO2CH3), 30.1 (CH2), 25.2 
(CH2), 21.0 (CH3); HRMS (ESI+): Calculated for C16H22N2O5S2 [M+H]+: 387.1043, found 387.1046; IR νmax 
(neat)/cm-1: 2952 (CH), 1704 (C=O), 1622 (C=C).  
(E)-N-(Methylsulfonyl)-3-((1,1,1-trifluoro-N-(pent-4-en-1-yl)methyl)sulfonamido)acrylamide 404d 
 
(E)-3-((1,1,1-Trifluoro-N-(pent-4-en-1-yl)sulfonamide)acrylic acid (1.0 mmol, 287 mg) was dissolved in 
DCM (10 mL) and the solution was cooled to 0 °C. EDC.HCl (1.5 mmol, 287 mg) was added, followed 
by methanesulfonamide (1.1 mmol, 105 mg) and DMAP (1.5 mmol, 183 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 20 hours. The mixture was quenched by 
the addition of 1M HCl (1.5 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude material was purified by flash column chromatography (1% MeOH/DCM) to 
give the title compound (149 mg, 41%) as a pale-pink solid.  
M.p. 101-108 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.66 (br. s, 1H, NH), 7.84 (d, J = 14.0 Hz, 1H, 
NCH=CH), 5.79 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.64 (d, J = 14.0 Hz, 1H, NCH=CH), 5.14-5.06 
(m, 2H, CH=CH2), 3.69 (t, J = 7.0 Hz, 2H, NCH2), 3.36 (s, 3H, SO2CH3), 2.14 (q, J = 7.0 Hz, 2H, CH2), 1.82 
(qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 163.3 (CO), 141.6 (NCH=CH), 136.2 (CH=CH2), 
116.8 (CH=CH2), 102.4 (NCH=CH), 48.2 (NCH2), 42.1 (SO2CH3), 30.5 (CH2), 26.2 (CH2); HRMS (ESI+): 
Calculated for C10H15F3N2O5S2 [M+H]+: 365.0447, found 365.0459; IR νmax (neat)/cm-1: 3224 (br. NH), 
2930 (CH), 1694 (C=O), 1622 (C=C). 







Methyl 3-(methylamino)acrylate (8.0 mmol, 921 mg) was subjected to the general alkylation 
conditions described above with 5-bromo-1-pentene. The crude material was purified by flash column 
chromatography (10% EtOAc/petrol) to afford the title compound (1.33 g, 96%) as a yellow oil. 
Method B 
A solution of 5-bromo-1-pentene (10.0 mmol, 1.18 mL) and methylamine (40.0 mmol, 4.80 mL, 33% 
in EtOH) in THF (15 mL) was stirred at room temperature for 18 hours. Methyl propiolate (20.0 mmol, 
1.80 mL) was added and the mixture was stirred for a further 24 hours. The mixture was filtered, 
concentrated and the crude material purified by flash column chromatography (4-10% EtOAc/petrol) 
to afford the title compound (1.14 g, 62%) as a yellow oil.  
1H NMR (400 MHz, CDCl3): δ 7.45 (d, J = 13.0 Hz, 1H, NCH=CH), 5.76 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, 
NCH=CH2), 5.08-4.98 (m, 2H, NCH=CH2), 4.51 (d, J = 13.0 Hz, 1H, NCH=CH), 3.65 (s, 3H, OCH3), 3.16 (t, 
J = 7.5 Hz, 2H, NCH2), 2.79 (s, 3H, NCH3), 2.03 (q, J = 7.0 Hz, 2H, CH2), 1.72-1.54 (m, 2H, CH2); 13C NMR 
(101 MHz, CDCl3): δ 168.6 (CO), 152.6 (NCH=CH), 137.8 (CH=CH2), 115.3 (CH=CH2), 82.4 (NCH=CH), 
55.8 (NCH2), 49.7 (OCH3), 34.7 (NCH3), 30.0 (CH2), 27.3 (CH2); HRMS (ESI+): Calculated for C10H17NO2 
[M+H]+: 184.1332, found 184.1338; IR νmax (neat)/cm-1: 2976-2869 (CH), 1686 (C=O), 1608 (C=C). 
Methyl (E)-3-(pent-4-en-1-yl(phenyl)amino)acrylate 405b 
 
To a suspension of NaH (10.8 mmol, 432 mg, 60% dispersion in mineral oil) in DMF (27 mL) at 0 °C was 
added methyl 3-(phenylamino)acrylate (8.0 mmol, 1.41 g) dropwise. The resulting mixture was stirred 
at room temperature for 30 minutes. 5-Bromo-1-pentene (9.0 mmol, 1.07 mL) was added at 0 °C and 
the reaction mixture was stirred at room temperature for 21 hours. The mixture was quenched with 
water and extracted with EtOAc (×3). The combined organic layers were washed with water (×2) and 
brine, dried over MgSO4 and concentrated. The crude material was purified by flash column 
chromatography (4% EtOAc/petrol) to yield the title compound (1.51 g, 77%) as a yellow solid. 
1H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 13.5 Hz, 1H, NCHCH), 7.36-7.28 (m, 2H, ArH), 7.15-7.07 (m, 
3H, ArH), 5.75 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.05-4.92 (m, 2H, CH=CH2), 4.89 (d, J = 13.5 Hz, 
1H, NCH=CH), 3.68 (s, 3H, OCH3), 3.64-3.56 (m, 2H, NCH2), 2.12-1.99 (m, 2H, CH2), 1.80-1.68 (m, 2H, 
CH2); 13C NMR (101 MHz, CDCl3): δ 169.9 (CO), 148.6 (NCH=CH), 145.5 (Cq), 137.2 (CH=CH2), 129.6 




(CH2); HRMS (ESI+): Calculated for C15H19NO2 [M+H]+: 246.1494, found 246.1494; IR νmax (neat)/cm-1: 
2945 (CH), 1695 (C=O), 1615 (C=C). 
Methyl (E)-3-((4-methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylate 405c 
 
To a solution of 4-methyl-N-(pent-4-en-yl)benzenesulfonamide (17.0 mmol, 4.07 g) and methyl 
propiolate (22.1 mmol, 1.97 mL) in MeCN (70 mL) was added N-methylmorpholine (22.1 mmol, 2.43 
mL) dropwise at 0 °C. The mixture was allowed to warm to room temperature and was stirred for 2 
hours. On completion the volatiles were removed, and the residue was diluted with EtOAc, washed 
with 1M HCl, washed with brine, dried over MgSO4 and concentrated. The crude material was purified 
by flash column chromatography (3-15% EtOAc/petrol) to give the title compound (4.40 g, 80%) as a 
colourless oil.  
1H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 14.0 Hz, 1H, NCH=CH), 7.71-7.66 (m, 2H, ArH), 7.35-7.30 (m, 
2H, ArH), 5.74 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.08-4.96 (m, 3H, CH=CH2 + NCH=CH), 3.73 (s, 
3H, OCH3), 3.38-3.31 (m, 2H, NCH2), 2.43 (s, 3H, ArCH3), 2.09-2.01 (m, 2H, CH2), 1.67 (qn, J = 7.0 Hz, 
2H, CH2); 13C NMR (101 MHz, CDCl3): δ 167.7 (CO), 144.9 (Cq), 142.0 (NCH=CH), 136.8 (CH=CH2), 135.5 
(Cq), 130.3 (CH), 127.3 (CH), 116.1 (CH=CH2), 97.6 (NCH=CH), 51.6 (OCH3), 45.7 (NCH2), 30.8 (CH2), 25.7 
(CH2), 21.7 (CH3); HRMS (ESI+): Calculated for C16H21NO4S [M+H]+: 324.1264, found 324.1257; IR νmax 
(neat)/cm-1: 2977-2901 (CH), 1712 (C=O), 1621 (C=C). 
Methyl (E)-3-((1,1-trifluoro-N-(pent-4-en-1-yl)methyl)sulfonamido)acrylate 405d 
 
To a solution of 1,1,1-trifluoro-N-(pent-4-en-1-yl)methanesulfonamide (2.5 mmol, 543 mg) in MeCN 
(10 mL) was added N-methylmorpholine (3.3 mmol, 0.36 mL) dropwise, followed by a solution of 
methyl propiolate (2.5 mmol, 0.22 mL) in MeCN (2 mL) over 30 minutes. The reaction mixture was 
stirred at room temperature for 3 hours. The volatiles were removed, and the remaining residue was 
redissolved in EtOAc, washed with 1 M HCl, washed with brine, dried over MgSO4 and concentrated. 
The crude product was purified by flash column chromatography (2% EtOAc/petrol) to yield the title 




1H NMR (400 MHz, CDCl3): δ 7.73 (d, J = 14.0 Hz, 1H, NCH=CH), 5.78 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, 
CH=CH2), 5.39 (d, J = 14.0 Hz, 1H, NCH=CH), 5.12-5.02 (m, 2H, CH=CH2), 3.76 (s, 3H, OCH3), 3.66 (t, J = 
7.0 Hz, 2H, NCH2), 2.13 (q, J = 7.0 Hz, 2H, CH2), 1.81 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): 
δ 166.2 (CO), 139.7 (NCH=CH), 136.2 (CH=CH2), 116.7 (CH=CH2), 103.2 (NCH=CH). 52.0 (OCH3), 47.6 
(NCH2), 30.5 (CH2), 26.2 (CH2); HRMS (ESI+): Calculated for C10H14F3NO4S [M+H]+: 302.0668, found 
302.0671; IR νmax (neat)/cm-1: 2955 (CH), 1723 (C=O), 1638 (C=C). 
Methyl 3-(methylamino)acrylate 406a 
 
A solution of methyl propiolate (10.0 mmol, 0.88 mL) and methylamine (10.0 mmol, 1.20 mL, 33% in 
EtOH) in DMSO (40 mL) was stirred at room temperature for 18 hours. The mixture was diluted with 
water and extracted with EtOAc (×3). The combined organic extracts were washed with water (×2) 
and brine, dried over MgSO4 and concentrated. This gave the title compound (870 mg, 76%, mixture 
of stereoisomers, trans:cis 17:3) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 13.0 Hz, 7.5 Hz, 0.85H, trans NCH=CH), 6.58 (dd, J = 13.0, 8.0 
Hz, 0.15H, cis NCH=CH), 4.70 (d, J = 13.0 Hz, 0.85H, trans NCH=CH), 4.46 (d, J = 8.0 Hz, 0.15H, cis 
NCH=CH), 3.66 (s, 2.55H, trans OCH3), 3.63 (s, 0.45H, cis OCH3), 2.95 (d, J = 5.0 Hz, 0.45H, cis NCH3), 
2.76 (d, J = 5.0 Hz, 2.55H, trans NCH3); 13C NMR (101 MHz, CDCl3): δ 171.3 (cis CO), 170.2 (trans CO), 
153.6 (cis NCH=CH), 150.2 (trans NCH=CH), 85.2 (trans NCH=CH), 81.4 (cis NCH=CH), 50.6 (OCH3), 41.0 
(cis (NCH3), 35.0 (trans NCH3); HRMS (ESI+): Calculated for C5H9NO2 [M+Na]+: 138.0525, found 
138.0530; IR νmax (neat)/cm-1: 3342 (br. NH), 2950 (CH), 1664 (C=O), 1610 (C=C). 
Methyl 3-(phenylamino)acrylate222-223 406b 
 
A solution of aniline (10.0 mmol, 0.90 mL) and methyl propiolate (10.0 mmol, 0.88 mL) in EtOH (40 
mL) was stirred at 50 °C for 72 hours. On completion, water was added, and the mixture was extracted 
with EtOAc (×3). The combined organic extracts were washed with brine, dried over MgSO4 and 
concentrated to give the title zcompound (1.64 g, 93%, mixture of stereoisomers, trans:cis 6:4) as a 
yellow solid (analytically pure), which was used without further purification. 
M.p. 113-114 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.84 (br. d, J = 12.5 Hz, 0.4H, cis NH), 7.98-7.85 




J = 13.0 Hz, 0.4H, cis NCH=CH), 5.19 (d, J = 13.0 Hz, 0.6H, trans NCH=CH), 4.82 (d, J = 8.5 Hz, 0.4H, cis 
NCH=CH), 3.69 (s, 3H, OCH3); HRMS (ESI+): Calculated for C10H11NO2 [M+H]+: 178.0863, found 
178.0864; IR νmax (neat)/cm-1: 3274 (br. NH), 2953 (CH), 1694 (C=O), 1614 (C=C). Data are consistent 
with literature precedent.222-223 
(E)-3-((4-Methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylic acid 408c 
 
A solution of methyl (E)-3-((4-methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylate (5.0 mmol, 1.62 g) 
in THF (15 mL) and MeOH (15 mL) was treated with aqueous NaOH (4 M, 50.0 mmol, 12.5 mL). The 
mixture was stirred at reflux for 2 hours and then allowed to cool to room temperature. The volatiles 
were removed, and the aqueous solution was acidified with 3 M HCl, extracted with Et2O (×3), washed 
with brine, dried over MgSO4 and concentrated. This gave the title compound (1.29 g, 83%) as a white 
solid (analytically pure), which was used without further purification. 
M.p. 117-118 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.20 (d, J = 14.0 Hz,1H,  NCH=CH), 7.75-7.64 (m, 
2H, ArH), 7.34 (J = 8.0 Hz, 2H, ArH), 5.75 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.10-4.97 (m, 3H, 
CH=CH2 + NCH=CH), 3.43 (m, 2H, NCH2), 2.44 (s, 3H, ArCH3), 2.06 (q, J = 7.0 Hz, 2H, CH2), 1.68 (qn, J = 
7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 173.1 (CO), 145.1 (Cq), 144.0 (NCH=CH), 136.8 (CH=CH2), 
135.3 (Cq), 130.3 (CH), 127.3 (CH), 116.1 (CH=CH2), 96.7 (NCH=CH), 45.8 (NCH2), 30.8 (CH2), 25.8 (CH2), 
21.8 (CH3); HRMS (ESI+): Calculated for C15H19NO4S [M+H]+: 310.1108, found 310.1096; IR νmax 
(neat)/cm-1: 2946 (CH), 2640 (br. OH), 1668 (C=O), 1590 (C=C). 
(E)-3-((1,1,1-Trifluoro-N-(pent-4-en-1-yl)sulfonamide)acrylic acid 408d 
 
A solution of methyl (E)-3-((1,1-trifluoro-N-(pent-4-en-1-yl)methyl)sulfonamido)acrylate (1.6 mmol, 
482 mg) in THF (10 mL) and MeOH (10 mL) was treated with aqueous NaOH (2 M, 16.0 mmol, 8 mL). 
The mixture was stirred at reflux for 3 hours and then allowed to cool to room temperature. The 
volatiles were removed, and the aqueous solution was acidified with 3 M HCl, extracted with EtOAc 
(×3), washed with brine, dried over MgSO4 and concentrated. This gave the title compound (428 mg, 





M.p. 66-69 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.46 (d, J = 14.0 Hz, 1H, NCH=CH), 5.88-5.78 
(m, 1H, CH=CH2), 5.76 (d, J = 14.0 Hz, 1H, NCH=CH), 5.10-4.96 (m, 2H, CH=CH2), 3.80 (t, J = 7.5 Hz, 2H, 
NCH2), 2.09 (q, J = 7.5 Hz, 2H, CH2), 1.71 (qn, J = 7.5 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 
166.5 (CO), 137.8 (NCH=CH), 137.1 (CH=CH2), 115.7 (CH=CH2), 105.7 (NCH=CH), 47.3 (NCH2), 29.6 
(CH2), 25.8 (CH2); HRMS (ESI+): Calculated for C9H12F3NO4S [M+H]+: 288.0512, found 288.0498; IR νmax 
(neat)/cm-1: 2958 (CH), 2565 (br. OH), 1682 (C=O), 1616 (C=C). 
N-Phenylpent-4-enamide224 414 
 
EDC.HCl (13.0 mmol, 2.49 g) and DMAP (14.0 mmol, 1.71 g) were dissolved in DCM (25 mL). The 
solution was cooled to 0 °C and 4-pentenoic acid (10.0 mmol, 1.02 mL) was added. The mixture was 
stirred for 5 minutes at 0 °C and then aniline (12.0 mmol, 1.09 mL) was added. The reaction mixture 
was allowed to warm to room temperature and was stirred for 18 hours. On completion, the reaction 
mixture was quenched with 1M HCl (25 mL). The layers were separated, and the aqueous layer was 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude material was recrystallised from hexane/EtOAc to give the title compound 
(1.37 g, 78%) as a pale-orange solid. 
M.p. 82-85 °C (MeCN);  1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 8.0 Hz, 2H, ArH), 7.31 (t, J = 8.0 Hz, 
2H, ArH), 7.10 (t, J = 7.5 Hz, 1H, ArH), 5.89 (ddt, J = 16.5, 10.5, 6.0 Hz, 1H, CH=CH), 5.18-5.10 (m, 1H, 
CH=CHH), 5.08-5.04 (m, 1H, CH=CHH), 2.48 (m, 4H, 2 × CH2); IR νmax (neat)/cm-1: 3317 (NH), 2978 (CH), 
1645 (C=O). Data are consistent with literature precedent.224 
N-(Pent-4-en-1-yl)aniline225 415 
 
N-Phenylpent-4-enamide (7.5 mmol, 1.31 g) was dissolved in Et2O (25 mL). The solution was cooled to 
0 °C and LiAlH4 (18.8 mmol, 7.80 mL, 2.4 M solution in THF) was added dropwise. The reaction mixture 
was allowed to warm to room temperature and was stirred for 18 hours. The reaction mixture was 
quenched at 0 °C by the sequential addition of water (0.71 mL), 2M NaOH (0.71 mL), water (2.13 mL) 
and MgSO4. After stirring vigorously for 1 hour the mixture was filtered and washed with EtOAc. The 
filtrate was washed with a saturated aqueous solution of NaHCO3. The aqueous later was further 
extracted with EtOAc (×2), washed with brine, dried over MgSO4 and concentrated. This gave the title 





1H NMR (400 MHz, CDCl3): δ 7.22-7.14 (m, 2H, ArH), 6.69 (tt, J = 7.5, 1.0 Hz, 1H, ArH), 6.64-6.60 (m, 
2H, ArH), 5.85 (ddt, J = 17.0, 10.1, 6.5 Hz, 1H, CH=CH2), 5.10-5.03 (m, 1H, CH=CHH), 5.03-4.98 (m, 1H, 
CH=CHH), 3.14 (t, J = 7.0 Hz, 2H, NCH2), 2.23-2.13 (m, 2H, CH2), 1.73 (qn, J = 7.0 Hz, 2H, CH2); IR νmax 
(neat)/cm-1: 2924 (CH). Data are consistent with literature precedent.225 
4-Methyl-N-(pent-4-en-yl)benzenesulfonamide226 417 
 
To a solution of toluenesulfonamide (10.0 mmol, 1.71 g) in MeCN (30 mL) was added K2CO3 (10.0 
mmol, 1.38 g) and 5-bromo-1-pentene (11.0 mmol, 1.30 mL). The resulting mixture was heated at 
reflux for 24 hours. On completion the mixture was filtered over Celite® and concentrated. The crude 
material was purified by flash column chromatography (5-20% EtOAc/petrol) to give the title 
compound (2.00 g, 83%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.74 (d, J = 8.0 Hz, 2H, ArH), 7.31 (d, J = 8.0 Hz, 2H, ArH), 5.70 (ddt, J = 
17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.02-4.88 (m, 2H, CH=CH2), 4.51 (br. t, J = 6.5 Hz, 1H, NH), 2.95 (q, J = 
7.0 Hz, 2H, NCH2), 2.43 (s, 3H, ArCH3), 2.04 (q, J = 7.0 Hz, 2H, CH2), 1.56 (qn, J = 7.0 Hz, 2H, CH2); 13C 
NMR (101 MHz, CDCl3): δ 143.5 (Cq), 137.3 (CH=CH2), 137.1 (Cq), 129.8 (CH), 127.2 (CH), 115.7 
(CH=CH2), 42.8 (NCH2), 30.8 (CH2), 28.8 (CH2), 21.7 (CH3); HRMS (ESI+): Calculated for C12H17NO2S 
[M+H]+: 240.1053, found 240.1050; IR νmax (neat)/cm-1: 3277 (br. NH), 2975-2870 (CH), 1322 (S=O), 
1157 (S=O). 
  
 (E)-N-Methoxy-3-((4-methyl-N-(pent-4-en-1-yl)phenyl)sulfonamido)acrylamide 420 
 
To a solution of (E)-3-((4-methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylic acid (3.0 mmol, 928 mg) 
in DCM (10 mL) at 0 °C was added oxalyl chloride (3.6 mmol, 0.31 mL) dropwise, followed by a catalytic 
amount of DMF. The reaction mixture was allowed to warm to room temperature and stirred for 27 
hours. The solvent was removed to give the crude acid chloride. Methoxyamine hydrochloride (3.6 
mmol, 301 mg) was added to a biphasic mixture of K2CO3 (6.0 mmol, 829 mg) in EtOAc/water (2:1 v:v 
36 mL). The mixture was cooled to 0 °C and the crude acid chloride dissolved in a minimum amount 
of EtOAc was added dropwise. The reaction mixture was stirred at room temperature for 24 hours. 
On completion the phases were separated, and the aqueous layer was extracted with EtOAc (×2). The 




material was purified by flash column chromatography (40% EtOAc/petrol) to yield the title compound 
(289 mg, 28%) as a white solid. 
M.p. 113-114 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.34 (br. s, 1H, NH), 8.12 (d, J = 14.0 Hz, 1H, 
NCH=CH), 7.70 (d, J = 8.0 Hz, 2H, ArH), 7.31 (d, J = 8.0 Hz, 2H, ArH), 5.76 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, 
CH=CH2), 5.37-5.18 (br. m, 1H, NCH=CH), 5.08-4.95 (m, 2H, CH=CH2), 3.74 (s, 3H, OCH3), 3.43-3.34 (m, 
2H, NCH2), 2.42 (s, 3H, ArCH3), 2.07 (q, J = 7.0 Hz, 2H, CH2), 1.69 (qn, J = 7.0 Hz, 2H, CH2); 13C NMR (101 
MHz, CDCl3): δ 144.8 (Cq), 141.1 (NCH=CH), 137.0 (CH=CH2), 135.6 (Cq), 130.2 (CH), 127.3 (CH), 116.1 
(CH=CH2), 95.6 (NCH=CH), 65.1 (OCH3), 45.9 (NCH2), 30.8 (CH2), 25.9 (CH2), 21.7 (CH3); HRMS (ESI+): 
Calculated for C16H22N2O4S [M+H]+: 339.1373, found 339.1388; IR νmax (neat)/cm-1: 3137 (br. NH), 2938 
(CH), 1659 (C=O), 1610 (C=C), 1357 (S=O), 1163 (S=O). 
(E)-3-((4-Methyl-N-(pent-4-en-1-yl)phenyl)sulfonamido)-N-(quinoline-8-yl)acrylamide 423 
 
To a solution of (E)-3-((4-methyl-N-(pent-4-en-yl)phenyl)sulfonamido)acrylic acid (2.0 mmol, 619 mg) 
in DCM (20 mL) at 0 °C was added EDC.HCl (3.0 mmol, 574 mg), 8-aminoquinoline (2.2 mmol, 317 mg) 
and DMAP (3.0 mmol, 367 mg). The reaction mixture was stirred at 0 °C for 15 minutes and then room 
temperature for 18 hours. The mixture was quenched with 1M HCl (3 mL) and the layers were 
separated. The aqueous layer was extracted with DCM (×2) and the combined organic layers were 
washed with brine, dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography (10-20% EtOAc/petrol) to give the title compound (332 mg, 38%) as a yellow 
solid. 
M.p. 158-160 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.66 (br. s, 1H, NH), 8.84 (dd, J = 7.5, 1.5 Hz, 1H, 
ArH), 8.80 (dd, J = 4.5 Hz, 1H, ArH), 8.20 (d, J = 13.5 Hz, 1H, NCH=CH), 8.19-8.15 (m, 1H, ArH), 7.74 (d, 
J = 8.3 Hz, 2H, ArH), 7.59-7.48 (m, 2H, ArH), 7.46 (dd, J = 8.5, 4.0 Hz, 1H, ArH), 7.32 (d, J = 8.0 Hz, 2H, 
ArH), 5.84 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.45 (d, J = 13.5 Hz, 1H, NCH=CH), 5.17-5.00 (m, 
2H, CH=CH2), 3.52-3.39 (m, 2H, NCH2), 2.42 (s, 3H, ArCH3), 1.79 (q, J = 7.0 Hz, 2H, CH2), 1.79 (qn, J = 7.0 
Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 164.5 (CO), 148.1 (CH), 144.7 (Cq), 140.3 (NCH=CH), 138.5 
(Cq), 137.2 (CH=CH2), 136.6 (CH), 135.8 (Cq), 135.0 (Cq), 130.2 (CH), 128.1 (Cq), 127.7 (CH), 127.3 (CH), 
121.7 (CH), 121.4 (CH), 116.8 (CH), 116.0 (CH=CH2), 101.6 (NCH=CH), 46.2 (NCH2), 30.9 (CH2), 26.2 
(CH2), 21.7 (CH3); HRMS (ESI+): Calculated for C24H25N3O3S [M+H]+: 436.1689, found 436.1678; IR νmax 






To a solution of trifluoromethanesulfonamide (10.0 mmol, 1.49 g) in MeCN (30 mL) was added K2CO3 
(10.0 mmol, 1.38 g) and 5-bromo-1-pentene (11.0 mmol, 1.30 mL). The resulting mixture was heated 
at reflux for 24 hours. On completion the mixture was filtered over Celite® and concentrated. The 
crude material was purified by flash column chromatography (3-20% EtOAc/petrol) to give the title 
compound (561 mg, 26%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.78 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.12-5.01 (m, 2H, CH=CH2), 
4.84 (br. s, 1H, NH)), 3.33 (q, J = 7.0 Hz, 2H, NCH2), 2.21-2.09 (m, 2H, CH2), 1.73 (qn, J = 7.0 Hz, 2H, CH2); 
IR νmax (neat)/cm-1: 3317 (br. NH), 2949 (CH), 1368 (S=O), 1188 (S=O). Data are consistent with 
literature precedent.227 
Methyl (Z)-3-benzamidoacrylate228 429 
 
Benzamide (5.0 mmol, 606 mg), Pd(OAc)2 (0.05 mmol, 11.2 mg), NaOAc (10.0 mmol, 820 mg), TFA (5.0 
mmol, 1.90 mL) and toluene (20 mL) were stirred together for 5 minutes at room temperature. Methyl 
propiolate (7.5 mmol, 630 mg) was added and the reaction mixture was stirred at 70 °C for 18 hours. 
The mixture was diluted with ethyl acetate and washed with water. The aqueous layer was extracted 
with ethyl acetate (×2) and the combined organic layers were washed with brine, dried over MgSO4 
and concentrated. The crude material was purified by flash column chromatography (5% 
EtOAc/petrol) to give the title compound (598 mg, 58%) as an off-white solid.  
M.p. 65-67 °C (MeCN, lit = 70 °C228); 1H NMR (400 MHz, CDCl3): δ 7.98-7.94 (m, 2H, ArH + NCH=CH), 
7.75 (dd, J = 11.0, 9.0 Hz, 1H, ArH), 7.60 (ddt, J = 8.5, 1.5 Hz, 1H, ArH), 7.53-7.48 (m, 2H, ArH), 5.28 (d, 
J = 9.0 Hz, 1H, NCH=CH), 3.78 (s, 3H, OCH3); HRMS (ESI+): Calculated for C11H11NO3 [M+H]+: 206.0812, 
found 206.0802; IR νmax (neat)/cm-1: 3326 (NH), 2961 (CH), 1694 (C=O), 1683 (C=O), 1623 (C=C). Data 
are consistent with literature precedent.228 
N-(Pent-4-en-1-yl)acetamide229 431 
 
To a suspension of NaH (11.0 mmol, 440 mg, 60% dispersion in mineral oil) in DMF (30 mL) at 0 °C was 




minutes. 5-Bromo-1-pentene (11.0 mmol, 1.30 mL) was added dropwise and the reaction mixture was 
allowed to warm to room temperature and was stirred for 40 hours. On completion, the reaction was 
quenched with water and extracted with EtOAc (×3). The combined organic layers were washed with 
water (×2) and brine, dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography (30-80% EtOAc/petrol) to give the title compound (438 mg, 34%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ 5.79 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.06-5.00 (m, 1H, CH=CHH), 
4.99-4.95 (m, 1H, CH=CHH), 3.25 (td, J = 7.5, 6.0 Hz, 2H, NCH2), 2.12-2.05 (m, 2H, CH2), 1.96 (s, 3H, 
COCH3), 1.65-1.55 (m, 2H, CH2); IR νmax (neat)/cm-1: 3288 (NH), 2962 (CH), 1633 (C=O). Data are 
consistent with literature precedent.229 
(E)-3-((N-(But-3-en-1-yl)-4-methylphenyl)sulfonamido)-N-(methylsulfonyl)acrylamide 437 
 
(E)-3-((N-(But-3-en-1-yl)-4-methylphenyl)sulfonamido)acrylic acid (5.0 mmol, 1.48 g) was dissolved in 
DCM (50 mL) and the solution was cooled to 0 °C. EDC.HCl (7.5 mmol, 1.44 g) was added, followed by 
methanesulfonamide (5.5 mmol, 523 mg) and DMAP (7.5 mmol, 916 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 20 hours. The mixture was quenched by 
the addition of 1M HCl (7.5 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude material was purified by flash column chromatography (20-60% 
EtOAc/petrol) to give the title compound (963 mg, 52%) as a pale-yellow solid. 
M.p. 137-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.66 (br.s, 1H, NH), 8.18 (d, J = 13.5 Hz, 1H, 
NCH=CH), 7.71 (d, J = 8.0 Hz, 2H, ArH), 7.35 (d, J = 8.0 Hz, 2H, ArH), 5.76-5.62 (m, 1H, CH=CH2), 5.14 (d, 
J = 13.5 Hz, 1H, NCH=CH), 5.10-5.03 (m, 2H, CH=CH2), 3.51-3.39 (m, 2H, NCH2), 3.34 (s, 3H, SO2CH3), 
2.44 (s, 3H, ArCH3), 2.30 (q, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 164.7 (CO), 145.4 (Cq), 
143.5 (NCH=CH), 135.0 (Cq), 133.4 (CH=CH2), 130.5 (CH), 127.4 (CH), 118.2 (CH=CH2), 97.0 (NCH=CH), 
46.0 (NCH2), 42.1 (SO2CH3), 31.2 (CH2), 21.8 (CH3); HRMS (ESI+): Calculated for C15H20N2O5S2 [M+H]+: 






To a solution of toluenesulfonamide (10.0 mmol, 1.71 g) in MeCN (30 mL) was added K2CO3 (10.0 
mmol, 1.38 g) and 4-bromo-1-butene (11.0 mmol, 1.12 mL). The resulting mixture was heated at reflux 
for 18 hours. On completion the mixture was filtered over Celite® and concentrated. The crude 
material was purified by flash column chromatography (3-20% EtOAc/petrol) to give the title 
compound (1.56 g, 68%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.77-7.71 (m, 2H, ArH), 7.33-7.28 (m, 2H, ArH), 5.62 (ddt, J = 17.0, 10.5, 
7.0 Hz, 1H, CH=CH2), 5.08-4.99 (m, 2H, CH=CH2), 4.57 (br. t, J = 6.5 Hz, NH), 3.01 (q, J = 6.5 Hz, 2H, 
NCH2), 2.42 (s, 3H, ArCH3), 2.23-2.15 (m, 1H, CH2); 13C NMR (101 MHz, CDCl3): δ 143.6 (Cq), 137.0 (Cq), 
134.3 (CH=CH2), 129.8 (CH), 127.2 (CH), 118.3 (CH=CH2), 42.2 (NCH2), 33.7 (CH2), 21.7 (CH3); IR νmax 
(neat)/cm-1: 3273 (br. NH), 2929 (CH), 1322 (S=O), 1157 (S=O). Data are consistent with literature 
precedent.230 
Methyl (E)-3-((N-(but-3-en-1-yl)-4-methylphenyl)sulfonamido)acrylate 441 
 
To a solution of N-(but-3-en-1-yl)-4-methylbenzenesulfonamide (6.0 mmol, 1.35 g) and methyl 
propiolate (7.8 mmol, 0.69 mL) in MeCN (25 mL) was added N-methylmorpholine (7.8 mmol, 0.86 mL) 
dropwise at 0 °C. The mixture was allowed to warm to room temperature and was stirred for two 
hours. On completion the volatiles were removed, and the residue was diluted with EtOAc, washed 
with 1M HCl, washed with brine, dried over MgSO4 and concentrated. The crude material was purified 
by flash column chromatography (3-15% EtOAc/petrol) to give the title compound (1.41g, 76%) as a 
colourless oil.  
1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 14.0 Hz, 1H, NCH=CH), 7.73-7.65 (m, 2H, ArH), 7.36-7.30 (m, 
2H, ArH), 5.74-5.63 (m, 1H, CH=CH2), 5.11-5.02 (m, 3H, CH=CH2 + NCH=CH), 3.73 (s, 3H, OCH3), 3.44-
3.37 (m, 2H, NCH2), 2.43 (s, 3H, ArCH3), 2.35-2.27 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 167.6 
(CO), 145.0 (Cq), 141.9 (NCH=CH), 135.5 (Cq), 133.6 (CH=CH2), 130.3 (CH), 127.3 (CH), 118.0 (CH=CH2), 
97.8 (NCH=CH), 51.6 (OCH3), 45.6 (NCH2), 31.1 (CH2), 21.8 (CH3); HRMS (ESI+): Calculated for 
C15H19NO4S [M+Na]+: 332.0927, found 332.0941; IR νmax (neat)/cm-1: 2949 (CH), 1708 (C=O), 1621 




(E)-3-((N-(But-3-en-1-yl)-4-methylphenyl)sulfonamido)acrylic acid 442 
 
A solution of methyl (E)-3-((N-(but-3-en-1-yl)-4-methylphenyl)sulfonamido)acrylate (4.5 mmol, 1.39 
g) in THF (10 mL) and MeOH (10 mL) was treated with aqueous NaOH (6 M, 45.0 mmol, 7.5 mL). The 
mixture was stirred at reflux for 2 hours and then allowed to cool to room temperature. The volatiles 
were removed, and the aqueous solution was acidified with 3 M HCl, extracted with EtOAc (×3), 
washed with brine, dried over MgSO4 and concentrated. This gave the title compound (1.00 g, 75%) 
as a pale-yellow solid (analytically pure), which was used without further purification. 
M.p. 118-119 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.20 (d, J = 14.0 Hz, 1H, NCH=CH), 7.77-7.63 (m, 
2H, ArH), 7.39-7.31 (m, 2H, ArH), 5.70 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.15-5.01 (m, 3H, 
CH=CH2 + NCH=CH), 3.49-3.40 (m, 2H, NCH2), 2.45 (s, 3H, ArCH3), 2.38-2.27 (m, 2H, CH2); 13C NMR (101 
MHz, CDCl3): δ 172.7 (CO), 145.2 (q), 143.9 (NCH=CH), 135.3 (Cq), 133.4 (CH=CH2), 130.4 (CH), 127.4 
(CH), 118.1 (CH=CH2), 96.7 (NCH=CH), 45.7 (NCH2), 31.1 (CH2), 21.8 (CH3); HRMS (ESI+): Calculated for 
C14H17NO4S [M+H]+: 296.0951, found 296.0959; IR νmax (neat)/cm-1: 2899 (CH), 2601 (br. OH), 1667 
(C=O), 1161 (S=O). 
4.3.9   Aniline-type substrate data 
3-((N-(But-3-en-en-1-yl)-4-methylphenyl)sulfonamido)-N-(methysulfonyl)benzamide 443a 
 
3-((N-(But-3-en-1-yl)-4-methylphenyl)sulfonamido)benzoic acid (3.0 mmol, 1.04 g) was dissolved in 
DCM (30 mL) and the solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed 
by methanesulfonamide (3.3 mmol, 314 mg) and DMAP (4.5 mmol, 550 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 20 hours. The mixture was quenched by 
the addition of 1M HCl (4.5 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude material was purified by flash column chromatography (2% MeOH/DCM) to 




M.p. 95-100 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.82 (d, J = 8.0 Hz, 1H, ArH), 7.56-7.54 (m, 1H, 
ArH), 7.49-7.43 (m, 3H, ArH), 7.31-7.26 (m, 3H, ArH), 5.70 (ddt, J = 17.0, 10.5, 7.5 Hz, CH=CH2), 5.09-
4.94 (m, 2H, CH=CH2), 3.61 (t, J = 7.5 Hz, 2H, NCH2), 3.43 (s, 3H, SO2CH3), 2.44 (ArCH3), 2.16 (q, J = 7.5 
Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 164.8 (CO), 144.2 (Cq), 140.1 (Cq), 134.8 (Cq), 134.1 
(CH=CH2), 133.8 (CH), 132.4 (Cq), 129.9 (CH), 129.8 (CH), 128.7 (CH), 127.8 (CH), 127.7 (CH), 117.6 
(CH=CH2), 49.9 (NCH2), 41.9 (SO2CH3), 32.8 (CH2), 21.7 (CH3); HRMS (ESI+): Calculated for C19H22N2O5S2 
[M+H]+: 423.1043, found 423.1045; IR νmax (neat)/cm-1: 3125 (br. NH), 2984 (CH), 1681 (C=O), 1335 
(S=O), 1157 (S=O). 
3-(But-3-en-1-yl(methyl)amino)-N-(methylsulfonyl)benzamide 443b 
 
3-(But-3-en-1-yl(methyl)amino)benzoic acid (1.5 mmol, 308 mg) was dissolved in DCM (15 mL) and 
the solution was cooled to 0 °C. EDC.HCl (2.3 mmol, 421 mg) was added, followed by 
methanesulfonamide (1.7 mmol, 157 mg) and DMAP (2.3 mmol, 275 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 16 hours. The mixture was quenched by 
the addition of 1M HCl (2.25 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated. The crude material was purified by flash column chromatography (0.5% MeOH/DCM) 
to give the title compound (198 mg, 47%) as a pale-yellow solid. 
M.p. 124-126 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.60 (br.s, 1H, NH), 7.33-7.27 (m, 1H, ArH), 7.15 
(dd, J = 3.0, 1.5 Hz, 1H, ArH), 7.00 (dd, J = 7.5, 1.5 Hz, 1H, ArH), 6.91 (dd, J = 8.5 Hz, 2.5 Hz, 1H, ArH), 
5.88-5.75 (m, 1H, CH=CH2), 5.15-5.03 (m, 2H, CH=CH2), 3.49-3.40 (m, 5H, SO2CH3 + NCH2), 2.99 (s, 3H, 
NCH3), 2.37-2.30 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 166.3 (CO), 149.6 (Cq), 135.5 (CH=CH2), 
132.0  (Cq), 129.9 (CH), 117.1 (CH), 117.1 (CH=CH2), 114.4 (CH), 111.2 (CH), 52.3 (NCH2), 41.9 (SO2CH3), 
38.6 (NCH3), 31.2 (CH2);  HRMS (ESI+): Calculated for C13H18N2O3S [M+H]+: 283.1111, found 283.1114; 






3-(Di(but-3-en-1-yl)amino)benzoic acid (3.0 mmol, 736 mg) was dissolved in DCM (30 mL) and the 
solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed by methanesulfonamide 
(3.3 mmol, 314 mg) and DMAP (4.5 mmol, 550 mg). The reaction mixture was stirred at 0 °C for 15 
minutes and then room temperature for 16 hours. The mixture was quenched by the addition of 1M 
HCl (4.5 mL). The phases were separated, and the aqueous layer was further extracted with DCM (×2). 
The combined organic layers were washed with brine, dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography (1% MeOH/DCM) to give the title compound 
(522 mg, 54%) as a pale-pink solid. 
M.p. 89-91 °C (MeCN);  1H NMR (400 MHz, CDCl3): δ 8.62 (br. s, 1H, NH), 7.29 (t, J = 8.5 Hz, 1H, ArH), 
7.19-7.16 (m, 1H, ArH), 6.96 (d, J = 8.0 Hz, 1H, ArH), 6.87 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 5.88-5.76 (m, 
2H, 2 × CH=CH2), 5.15-5.05 (m, 4H, 2 × CH=CH2), 3.44-3.38 (m, 7H, SO2CH3 + 2 × NCH2), 2.34 (q, J = 7.0 
Hz, 4H, 2 × CH2); 13C NMR (101 MHz, CDCl3): δ 166.3 (CO), 148.3 (Cq), 135.4 (CH=CH2), 132.1 (Cq), 129.9 
(CH), 117.1 (CH=CH2), 117.0 (CH), 113.9 (CH), 111.2 (CH), 50.7 (SO2CH3), 41.9 (NCH2), 31.6 (CH2); HRMS 
(ESI+): Calculated for C16H22N2O3S [M+H]+: 323.1424, found 323.1424; IR νmax (neat)/cm-1: 3195 (br. 
NH), 2953 (CH), 1652 (C=O), 1339 (S=O), 1154 (S=O).  
3-(N-(But-3-en-1-yl)acetamido)-N-(methylsulfonyl)benzamide 443d 
 
3-(N-But-3-en-1-yl)acetamido)benzoic acid (3.0 mmol, 700 mg) was dissolved in DCM (16 mL) and the 
solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed by methanesulfonamide 
(3.3 mmol, 314 mg) and DMAP (4.5 mmol, 550 mg). The reaction mixture was stirred at 0 °C for 15 
minutes and then room temperature for 16 hours. The mixture was quenched by the addition of 1M 
HCl (4.5 mL). The phases were separated, and the aqueous layer was further extracted with DCM (×2). 
The combined organic layers were washed with brine, dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography (5% MeOH/DCM) to give the title compound 
(667 mg, 71%) as a white solid. 
M.p. 158-159 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.38 (br. s, 1H, NH), 7.86 (d, J = 8.0 Hz, 1H, ArH), 
7.77 (s, 1H, ArH), 7.58 (t, J = 8.0 Hz, 1H, ArH), 7.46-7.42 (m, 1H, ArH), 5.72 (ddt, J = 17.0, 10.0, 7.5 Hz, 
1H, CH=CH2), 5.08-5.00 (m, 2H, CH=CH2), 3.78 (t, J = 7.5 Hz, NCH2), 3.44 (s, 3H, SO2CH3), 2.25 (q, J = 7.5 
Hz, 2H, CH2), 1.82 (s, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 170.7 (CO), 164.8 (CO), 143.6 (Cq), 134.9 




(SO2CH3), 32.2 (CH2), 23.1 (CH3); HRMS (ESI+): Calculated for C14H18N2O4S [M+H]+: 311.1060, found 
311.1059; IR νmax (neat)/cm-1: 3027 (br. NH), 2852 (CH), 1694 (C=O), 1625 (C=O), 1339 (S=O), 1162 
(S=O). 
Ethyl but-3-en-1-yl(3-((methylsulfonyl)carbamoyl)phenyl)carbamate 443e 
 
3-(But-3-en-1-yl(ethoxycarbonyl)amino)benzoic acid (3.0 mmol, 789 mg) was dissolved in DCM (18 
mL) and the solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed by 
methanesulfonamide (3.3 mmol, 314 mg) and DMAP (4.5 mmol, 550 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 16 hours. The mixture was quenched by 
the addition of 1M HCl (4.5 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated to yield the title compound (879 mg, 86%) as a white gum (analytically pure). The gum 
was dissolved in a minimum amount of DCM, hexane was added, and the solution was concentrated. 
This was repeated a further 2 times in order to transform the white gum into a white solid. 
M.p. 140-143 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.75-7.72 (m, 1H, ArH), 7.70-7.66 (m, 1H, ArH), 
7.46-7.39 (m, 2H, ArH), 5.78-5.66 (m, 1H, CH=CH2), 5.08-5.01 (m, 2H, CH=CH2), 4.19 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 3.76 (t, J = 7.5 Hz, 2H, NCH2), 3.40 (s, 3H, SO2CH3), 2.29 (q, J = 7.5 Hz, 2H, CH3), 1.30-1.21 
(m, 3H, OCH2CH3); 13C NMR (101 MHz, CDCl3): δ 165.6 (CO), 155.9 (CO), 142.4 (Cq), 134.7 (CH=CH2), 
132.5 (CH), 132.3 (Cq), 129.5 (CH), 127.4 (CH), 126.4 (CH), 117.3 (CH=CH2), 62.3 (OCH2), 49.5 (NCH2), 
41.7 (SO2CH3), 32.8 (CH2), 14.6 (CH3);  HRMS (ESI+): Calculated for C15H20N2O5S [M+H]+: 341.1166, 




3-(1-(But-3-en-1-yl)-3,3,-diethylureido)benzoic acid (3.0 mmol, 871 mg) was dissolved in DCM (18 mL) 
and the solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed by 




stirred at 0 °C for 15 minutes and then room temperature for 16 hours. The mixture was quenched by 
the addition of 1M HCl (4.5 mL). The phases were separated, and the aqueous layer was further 
extracted with DCM (×2). The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated to yield the title compound (380 mg, 34%) as a white gum (analytically pure). The gum 
was dissolved in a minimum amount of DCM, hexane was added, and the solution was concentrated. 
This was repeated a further 2 times in order to transform the white gum into a white solid. 
M.p. 114-116 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 9.76 (br. s, 1H, NH), 7.75 (t, J = 2.0 Hz, 1H, ArH), 
7.71 (d, J = 8.0 Hz, 1H, ArH), 7.44 (t, J = 8.0 Hz, 1H, ArH), 7.31 (dd, J = 8.0, 2.0 Hz, 1H, ArH), 5.76 (ddt, J 
= 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.06-4.96 (m, 2H, CH=CH2), 3.64 (dd, J = 8.5, 7.0 Hz, 2H, NCH2), 3.45 
(s, 3H, SO2CH3), 3.12 (q, J = 7.0 Hz, 4H, N(CH2CH3)2), 2.34 (q, J = 7.0 Hz, 2H CH2), 0.94 (t, J = 7.0 Hz, 6H, 
N(CH2CH3)2); 13C NMR (101 MHz, CDCl3): δ 165.4 (CO), 161.2 (CO), 147.0 (Cq), 135.6 (CH=CH2), 132.5 
(Cq), 130.1 (CH), 129.1 (CH), 124.2 (CH), 123.8 (CH), 116.9 (CH=CH2), 51.7 (NCH2), 41.9 (N(CH2CH3)2), 
41.9 (SO2CH3), 33.3 (CH2), 12.8 (N(CH2CH3)2); HRMS (ESI+): Calculated for C17H25N3O4S [M+H]+: 
368.1639, found 368.1634; IR νmax (neat)/cm-1: 3067-2936 (CH), 1689 (C=O), 1595 (C=O), 1339 (S=O), 
1153 (S=O). 
Methyl 3-((N-(but-3-en-1-yl)-4-methylphenyl)sulfonamido)benzoate 444a 
 
Synthesised using a modified literature procedure.231 
To a suspension of methyl 3-((4-methylphenyl)sulfonamido)benzoate (9.5 mmol, 2.90 g) and Cs2CO3 
(19.0 mmol, 6.19 g) in DMF (40 mL) was added 4-bromo-1-butene (19 mmol, 1.93 mL). The reaction 
mixture was stirred at room temperature for 18 hours. Water (40 mL) was added and the mixture was 
extracted with EtOAc (×3). The combined organic layers were washed with water (×2) and brine, dried 
over MgSO4 and concentrated. The crude material was purified by flash column chromatography (5-
10% EtOAc/petrol) to give the title compound (2.07 g, 61%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.98 (dt, J = 8.0, 1.5 Hz, 1H, ArH), 7.67 (t, J = 2.0 Hz, 1H, ArH), 7.47-7.44 
(m, 2H, ArH), 7.41 (t, J = 8.0 Hz, 1H, ArH),  7.32 (ddd, J = 8.0, 2.0, 1.0 Hz, 1H, ArH), 7.26-7.23 (m, 2H, 
ArH), 5.71 (ddt, J = 17.0, 10.5, 7.5 Hz, 1H, CH=CH2), 5.06-4.93 (m, 2H, CH=CH2), 3.90 (s, 3H, OCH3), 3.61 
(t, J = 7.5 Hz, 2H, NCH2), 2.42 (s, 3H, ArCH3), 2.17 (q, J = 7.5 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 
166.3 (CO), 143.8 (Cq), 139.6 (Cq), 135.2 (Cq), 134.4 (CH=CH2), 134.0 (CH), 131.3 (Cq), 129.6 (CH), 129.6 




(CH3); HRMS (ESI+): Calculated for C19H21NO4S [M+H]+: 360.1264, found 360.1261; IR νmax (neat)/cm-1: 
2952 (CH), 1723 (C=O), 1348 (S=O), 1165 (S=O). 
Methyl 3-(but-3-en-1-yl(methyl)amino)benzoate 444b 
 
To a solution of methyl 3-(but-3-en-1-ylamino)benzoate (6.0 mmol, 1.23 g) in DMF (6 mL) was added 
K2CO3 (15.0 mmol, 2.07 g) and MeI (7.2 mmol, 0.45 mL). The reaction mixture was stirred at room 
temperature for 20 hours and a subsequent portion of MeI was added (3.0 mmol, 0.19 mL). After 
stirring at room temperature for a further 18 hours the reaction mixture was diluted with water and 
extracted with EtOAc (×3). The combined organic extracts were washed with water (×2) and brine, 
dried over MgSO4 and concentrated. The crude material was purified by flash column chromatography 
(10% EtOAc/petrol) to give the title compound (493 mg, 37%) as a yellow oil.  
1H NMR (400 MHz, DMSO-d6): δ 7.34-7.26 (m, 1H, ArH), 7.24-7.18 (m, 2H, ArH), 7.01-6.93 (m, 1H, 
ArH), 5.84 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.11-5.05 (m, 1H, CH=CHH), 5.04-4.99 (m, 1H, 
CH=CHH), 3.82 (s, 3H, OCH3), 3.47-3.39 (m, 2H, NCH2), 2.29 (s, 3H, NCH3), 2.32-2.20 (m, 2H, CH2); 13C 
NMR (101 MHz, DMSO-d6): δ 167.4 (CO), 149.3 (Cq), 136.6 (CH=CH2), 130.9 (Cq), 129.9 (CH), 117.2 
(CH=CH2), 117.1 (CH), 116.7 (CH), 112.3 (CH), 52.5 (OCH3), 51.7 (NCH2), 38.5 (NCH3), 31.0 (CH2); HRMS 
(ESI+): Calculated for C13H17NO2 [M+H]+: 220.1332, found 220.1329; IR νmax (neat)/cm-1: 2949 (CH), 
1717 (C=O). 
Methyl 3-(N-(but-3-en-1-yl)acetamido)benzoate 444d 
 
To a solution of methyl 3-(but-3-en-1-ylamino)benzoate (6.0 mmol, 1.23 g) in DCM (30 mL) was added 
triethylamine (18.0 mmol, 2.39 mL), DMAP (1.2 mmol, 146 mg) and acetic anhydride (9.0 mmol, 918 
mg). The reaction mixture was stirred at room temperature for 16 hours. On completion the mixture 
was washed with water, 1M NaOH, 1M HCl and brine, dried over MgSO4 and concentrated. The crude 
material was purified by flash column chromatography (20% EtOAc/petrol) to give the title compound 




1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 8.0 Hz, 1H, ArH), 7.85 (t, J = 2.0 Hz, 1H, ArH), 7.50 (t, J = 8.0 
Hz, 1H, ArH), 7.36 (dt, J = 8.0, 1.5 Hz, 1H, ArH), 5.73 (ddt, J = 17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 5.08-4.98 
(m, 2H, CH=CH2), 3.93 (s, 3H, OCH3), 3.79 (t, J = 7.5 Hz, 2H, NCH2), 2.26 (q, J = 7.5 Hz, 2H, CH2), 1.81 (s, 
3H, CH3); 13C NMR (101 MHz, CDCl3): δ 170.0 (CO), 166.1 (CO), 143.3 (Cq), 135.1 (CH=CH2), 132.8 (CH), 
131.9 (Cq), 129.8 (CH), 129.3 (CH), 129.0 (CH), 116.8 (CH=CH2), 52.4 (OCH3), 48.2 (NCH2), 32.2 (CH2), 
22.9 (CH3); HRMS (ESI+): Calculated for C14H17NO3 [M+H]+: 248.1281, found 248.1284;  IR νmax 
(neat)/cm-1: 2951(CH), 1723 (C=O), 1661 (C=O). 
Methyl 3-(but-3-en-1-yl(ethoxycarbonyl)amino)benzoate 444e 
 
To a solution of methyl 3-(but-3-en-1-ylamino)benzoate (9.0 mmol, 1.85 g) in THF (50 mL) at 0 °C was 
added triethylamine (9.9 mmol, 1.31 mL) and ethyl chloroformate (27.0 mmol, 2.58 mL). The reaction 
mixture was then heated to 50 °C and stirred for 72 hours. The solvent was removed, and the residue 
was dissolved in DCM and 2 M NaOH. The phases were separated, and the aqueous portion was 
further extracted with DCM (×2). The combined organic layers were washed with brine, dried over 
MgSO4 and concentrated. The crude product was purified by flash column chromatography (2-10% 
EtOAc/petrol) to yield the title compound (1.90 g, 76%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.92 (dt, J = 7.0, 1.5 Hz, 1H, ArH), 7.88 (d, J = 2.0 Hz, 1H, ArH), 7.46-7.37 
(m, 2H, ArH), 5.74 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 5.08-5.00 (m, 2H, CH=CH2), 4.15 (q, J = 7.0 
Hz, OCH2CH3), 3.92 (s, 3H, OCH3), 3.79-3.74 (m, 2H, NCH2), 2.34-2.26 (m, 2H, CH2), 1.21 (t, J = 7.0 Hz, 
3H, OCH2CH3); 13C NMR (101 MHz, CDCl3): δ 166.5 (CO), 155.4 (CO), 1421. (Cq), 134.9 (CH=CH2), 132.1 
(CH), 131.1 (Cq), 128.9 (CH), 128.3 (CH), 127.6 (CH), 117.0 (CH=CH2), 61.7 (OCH2CH3), 52.3 (OCH3), 49.4 
(NCH2), 32.7 (CH2), 14.5 (OCH2CH3); HRMS (ESI+): Calculated for C15H19NO4 [M+H]+: 278.1387, found 
278.1383; IR νmax (neat)/cm-1: 2979 (CH), 1702 (C=O). 
Methyl 3-(1-(but-3-en-1-yl)-3,3-diethylureido)benzoate 444f 
 
Methyl 3-(but-3-en-1-ylamino)benzoate (9.0 mmol, 1.85 g), diethylcarbamoyl chloride (27.0 mmol, 




to reflux and stirred for 5 days. After cooling to room temperature, the mixture was washed with 1 M 
HCl and the aqueous layer was extracted with DCM (×2). The combined organic layers were washed 
with brine, dried over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography (4-20% EtOAc/petrol) to yield the title compound (2.00 g, 73%) as a yellow oil.  
1H NMR (400 MHz, CDCl3): δ 7.79-7.74 (m, 2H, ArH), 7.38 (t, J = 8.0 Hz, 1H, ArH), 7.26-7.22 (m, 1H, 
ArH), 5.80 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.08-4.99 (m, 2H, CH=CH2), 3.91 (s, 3H, OCH3), 3.68-
3.62 (m, 2H, NCH2), 3.10 (q, J = 7.0 Hz, 4H, N(CH2CH3)2), 2.39-2.29 (m, 2H, CH2), 0.92 (t, J = 7.0 Hz, 6H, 
N(CH2CH3); 13C NMR (101 MHz, CDCl3): δ 166.5 (CO), 160.8 (CO), 146.4 (Cq), 135.7 (CH=CH2), 131.4 
(Cq), 129.3 (CH), 128.6 (CH), 125.3 (CH), 125.1 (CH), 116.4 (CH=CH2), 52.2 (OCH3), 51.5 (NCH2), 41.7 
(N(CH2CH3)2), 33.1 (CH2), 12.7 (N(CH2CH3)2); HRMS (ESI+): Calculated for C17H24N2O3 [M+H]+: 305.1860, 
found 305.1855; IR νmax (neat)/cm-1: 2972 (CH), 1724 (C=O), 1649 (C=O). 
Methyl 3-(but-3-en-1-ylamino)benzoate 445 
     
To a solution of 3-methyl aminobenzoate (50.0 mmol, 7.56 g) in MeCN (150 mL) was added 4-bromo-
1-butene (75.0 mmol, 7.61 mL), K2CO3 (60.0 mmol, 8.29 g) and TBAI (5.0 mmol, 1.85 g). The reaction 
mixture was heated at reflux for 72 hours and was then filtered and concentrated. The crude material 
was purified by flash column chromatography (2-10% EtOAc/petrol) to give the biproduct (909 mg, 
7%) as a pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.40-7.33 (m, 1H, ArH), 7.31-7.26 (m, 1H, ArH), 6.78 (dd, J = 8.0, 2.5 Hz, 
1H, ArH), 5.86 (ddt, J = 17.0, 10.0, 7.0 Hz, 2H, 2 × CH=CH2), 5.18-5.06 (m, 2H, 2 × CH=CH2), 3.92 (s, 3H, 
OCH3), 3.45-3.39 (m, 2H, 2 × NCH2), 2.37 (q, J = 7.0 Hz, 2H, 2 × CH2); 13C NMR (101 MHz, CDCl3): δ 167.9 
(CO), 147.8 (Cq), 135.7 (CH=CH2), 131.2 (Cq), 129.3 (CH), 116.9 (CH), 116.8 (CH=CH2), 116.4 (CH), 112.9 
(CH), 52.2 (OCH3), 50.8 (NCH2), 31.7 (CH2); HRMS (ESI+): Calculated for C16H21NO2 [M+H]+: 260.1645, 
found 260.1643; IR νmax (neat)/cm-1: 2987 (CH), 1720 (C=O). 
Further elution afforded the desired title compound (4.93 g, 48%) as a pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.29 (dt, J = 7.5, 1.0 Hz, 1H, ArH), 7.21-7.18 (m, 1H, ArH), 7.14 (t, J = 8.0 
Hz, 1H, ArH), 6.72-6.68 (m, 1H, ArH), 5.75 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.11-5.02 (m, 2H, 
CH=CH2), 3.81 (s, 3H, OCH3), 3.15 (t, J = 6.5 Hz, 2H, NCH2), 2.32 (q, J = 6.5 Hz, 2H, CH2); 13C NMR (101 




117.4 (CH=CH2), 113.5 (CH), 52.1 (OCH3), 42.8 (NCH2), 33.6 (CH2); HRMS (ESI+): Calculated for C12H15NO2 
[M+H]+: 206.1176, found 206.1171; IR νmax (neat)/cm-1: 3394 (br. NH), 2949 (CH), 1711 (C=O). 
Methyl 3-((4-methylphenyl)sulfonamido)benzoate232 447 
 
To a solution of methyl 3-aminobenzoate (10.0 mmol, 1.51 g) in DCM (20 mL) was added N-
methylmorpholine (11.0 mmol, 1.21 mL) followed by tosyl chloride (11.0 mmol, 2.16 g). The reaction 
mixture was stirred at room temperature for 18 hours and then quenched with 1 M HCl (30 mL). The 
layers were separated, and the aqueous layer was extracted with DCM (×2). The combined organic 
layers were washed with brine, dried over MgSO4 and concentrated. This gave the title compound 
(2.93 g, 96%) as a pale-pink solid (analytically pure) which was used without further purification. 
M.p. 153-155 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.77 (dt, J = 7.5 Hz, 1H, ArH), 7.72-7.69 (m, 1H, 
ArH), 7.67 (d, J = 8.0 Hz, 2H, ArH), 7.42-7.38 (m, 1H, ArH), 7.33 (t, J = 8.0 Hz, 1H, ArH), 7.22 (d, J = 8.0 
Hz, 2H, ArH), 7.05 (br. s, 1H, NH), 3.90 (s, 3H, OCH3), 2.37 (s, 3H, ArCH3); 13C NMR (101 MHz, CDCl3): δ 
166.6 (CO), 144.3 (Cq), 137.2 (Cq), 136.0 (Cq), 131.4 (Cq), 129.9 (CH), 129.6 (CH), 127.4 (CH), 126.3 
(CH), 125.6 (CH), 122.2 (CH), 52.5 (OCH3), 21.7 (CH3); HRMS (ESI+): Calculated for C15H15NO4S [M+H]+: 
306.0795, found 306.0793; IR νmax (neat)/cm-1: 3227 (NH), 2960 (CH), 1703 (C=O), 1334 (S=O), 1156 
(S=O). 
3-((N-(But-3-en-1-yl)-4-methylphenyl)sulfonamido)benzoic acid 448a 
 
A solution of methyl 3-((N-(but-3-en-1-yl)-4-methylphenyl)sulfonamido)benzoate (5.5 mmol, 1.98 g) 
in THF (15 mL) and MeOH (15 mL) was treated with aqueous NaOH (6 M, 55.0 mmol, 9.0 mL). The 
mixture was stirred at reflux for 90 minutes and then allowed to cool to room temperature. The 
volatiles were removed, and the aqueous solution was acidified with 3 M HCl, extracted with EtOAc 
(×3), washed with brine, dried over MgSO4 and concentrated. This gave the title compound (1.877 g, 
99%) as a pale-yellow solid (analytically pure), which was used without further purification. 
M.p. 118-120 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.05 (d, J = 7.5 Hz, 1H, ArH), 7.74-7.66 (m, 1H, 
ArH), 7.52-7.38 (m, 4H, ArH), 7.32-7.22 (m, 2H, ArH), 5.72 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CH=CH2), 




CH2); 13C NMR (101 MHz, CDCl3): δ 171.3 (CO), 143.9 (Cq), 139.7 (Cq), 135.0 (Cq), 135.0 (CH), 134.3 
(CH=CH2), 130.4 (Cq), 130.0 (CH), 129.7 (CH), 129.7 (CH), 129.4 (CH), 127.7 (CH), 117.4 (CH=CH2), 49.9 
(NCH2), 32.8 (CH2), 21.7 (CH3); HRMS (ESI+): Calculated for C18H19NO4S [M+H]+: 346.1108, found 
346.1109; IR νmax (neat)/cm-1: 2922 (CH), 2551 (br. OH), 1694 (C=O), 1347 (S=O), 1163 (S=O). 
3-(But-3-en-1-yl(methyl)amino)benzoic acid 448b 
 
Methyl 3-(but-3-en-1-yl(methyl)amino)benzoate (2.0 mmol, 439 mg) was dissolved in MeOH (15 mL) 
and THF (15 mL). The Solution was treated with aqueous NaOH (1 M, 10.0 mmol, 10 mL) and was 
stirred at reflux for 30 minutes. The volatiles were removed, and the remaining aqueous solution was 
acidified with 3M HCl. The mixture was extracted with EtOAc (×3) and the combined organic layers 
were washed with brine, dried over MgSO4 and concentrated. This gave the title compound (362 mg, 
88%) as an off-white solid (analytically pure) which was used without further purification.  
M.p. 73-74 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.30-7.19 (m, 3H, ArH), 6.97-6.93 (m, 1H, ArH), 
5.84 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.12-5.00 (m, 2H, CH=CH2), 3.46-3.39 (m, 2H, NCH2), 2.92 
(s, 3H, NCH3), 2.26 (q, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 167.9 (CO), 148.6 (Cq), 
136.0 (CH=CH2), 131.5 (Cq), 129.2 (CH), 116.6 (CH), 166.6 (CH=CH2), 116.3 (CH), 112.2 (CH), 51.3 
(NCH2), 38.0 (NCH3), 30.4 (CH2); HRMS (ESI+): Calculated for C12H15NO2 [M+H]+: 206.1176, found 
206.1174; IR νmax (neat)/cm-1: 2883 (CH), 2657 (br. OH), 1677 (C=O). 
3-(Di(but-3-en-1-yl)amino)benzoic acid 448c 
 
Methyl 3-(di(but-3-en-1-yl)amino)benzoate (3.5 mmol, 908 mg) was dissolved in MeOH (20 mL) and 
THF (20 mL). The Solution was treated with aqueous NaOH (1M, 17.5 mmol, 17.5 mL) and was stirred 
at reflux for 30 minutes. The volatiles were removed, and the remaining aqueous solution was 
acidified with 3M HCl. The mixture was extracted with EtOAc (×3) and the combined organic layers 
were washed with brine, dried over MgSO4 and concentrated. This gave the title compound (940 mg, 
quantitative) as an off-white solid (analytically pure) which was used without further purification.  
M.p. 59-60 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.32-7.16 (m, 3H, ArH), 6.98-6.86 (m, 1H, ArH), 




2 × NCH2), 2.27 (q, J = 7.5 Hz, 4H, 2 × CH2); 13C NMR (101 MHz, DMSO-d6): δ 167.8 (CO), 135.8 (CH=CH2), 
131.6 (Cq), 129.3 (CH), 116.6 (CH=CH2), 49.8 (NCH2), 31.0 (CH2)*; HRMS (ESI+): Calculated for C15H19NO2 
[M+H]+: 246.1489, found 246.1489; IR νmax (neat)/cm-1: 2936 (CH), 2534 (br. OH), 1680 (C=O).  
*Some peaks missing from 13C NMR despite increased number of scans, increased relaxation time and 
increased temperature. 
3-(N-But-3-en-1-yl)acetamido)benzoic acid 448d 
 
Methyl 3-(N-(but-3-en-1-yl)acetamido)benzoate (5.0 mmol, 1.23 g) was dissolved in THF (7 mL) and 
MeOH (7 mL), and the resulting solution was treated with aqueous NaOH (1M, 5.0 mmol, 5 mL). The 
reaction mixture was stirred at 60 °C for 30 minutes. On completion the volatiles were removed, and 
the remaining aqueous solution was acidified with 3M HCl. The mixture was extracted with EtOAc (×3) 
and the combined organic extracts were washed with brine, dried over MgSO4 and concentrated. This 
gave the title compound (1.06 g, 90%) as a pale-yellow solid (analytically pure), which was used 
without further purification. 
M.p. 137-138 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.12 (d, J = 8.0 Hz, 1H, ArH), 7.97-7.93 (m, 1H, 
ArH), 7.56 (t, J = 8.0 Hz, 1H, ArH), 7.46-7.40 (m, 1H, ArH), 5.76 (ddt, J = 17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 
5.11-5.02 (m, 2H, CH=CH2), 3.83 (t, J = 7.5 Hz, 2H, NCH2), 2.29 (q, J = 7.5 Hz, 2H, CH2), 1.87 (s, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ 170.8 (CO), 169.8 (CO), 143.3 (CH), 135.1 (CH=CH2), 133.5 (CH), 131.7 
(Cq), 130.1 (CH), 129.9 (CH), 129.8 (CH), 117.1 (CH=CH2), 48.6 (NCH2), 32.2 (CH2), 22.9 (CH3); HRMS 
(ESI+): Calculated for C13H15NO3 [M+H]+: 234.1125, found 234.1123; IR νmax (neat)/cm-1: 2979 (CH), 
2597 (br. OH), 1717 (C=O), 1618 (C=O). 
3-(But-3-en-1-yl(ethoxycarbonyl)amino)benzoic acid 448e 
 
Methyl 3-(but-3-en-1-yl(ethoxycarbonyl)amino)benzoate (6.0 mmol, 1.66 g) was dissolved in MeOH 
(10 mL) and THF (10 mL) and treated with NaOH (1 M, 6.0 mmol, 6 mL). The reaction mixture was 




acidified with 3 M HCl and extracted with EtOAc (×3). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to give the title compound (1.62 g, quantitative) as a viscous 
yellow oil (analytically pure) which was used without further purification. 
1H NMR (400 MHz, CDCl3): δ 8.00 (td, J = 4.5, 1.5 Hz, 1H, ArH), 7.96 (q, J = 1.5 Hz, 1H, ArH), 7.49-7.45 
(m, 2H, ArH), 5.76 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H, CHCH2), 5.10-5.01 (m, 2H, CH=CH2), 4.17 (q, J = 7.0 
Hz, 2H, OCH2CH3), 3.84-3.75 (m, 2H, NCH2), 2.35-2.28 (m, 2H, CH2), 1.22 (t, J = 7.0 Hz, 3H, OCH2CH3); 
13C NMR (101 MHz, CDCl3): δ 171.3 (CO), 155.6 (CO), 142.4 (Cq), 135.0 (CH=CH2), 133.0 (CH), 130.5 
(Cq), 129.2 (CH), 129.0 (CH), 128.3 (CH), 117.2 (CH=CH2), 62.0 (OCH2CH3), 49.6 (NCH2), 32.9 (CH2), 14.6 
(OCH2CH3); HRMS (ESI+): Calculated for C14H17NO4 [M+H]+: 264.1230, found 264.1227; IR νmax 
(neat)/cm-1: 2980 (CH), 2600 (br. OH), 1697 (C=O). 
3-(1-(But-3-en-1-yl)-3,3,-diethylureido)benzoic acid 448f 
 
Methyl 3-(1-(but-3-en-1-yl)-3,3-diethylureido)benzoate (6.0 mmol, 1.83 g) was dissolved in MeOH (10 
mL) and THF (10 mL) and treated with NaOH (1 M, 6.0 mmol, 6 mL). The reaction mixture was heated 
at reflux for 6 hours and the volatiles were then removed. The remaining aqueous mixture was 
acidified with 3 M HCl and extracted with EtOAc (×3). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to give the title compound (1.62 g, 93%) as a viscous yellow 
oil (analytically pure) which was used without further purification. 
M.p. 85-87 °C (MeCN);  1H NMR (400 MHz, CDCl3): δ 7.88-7.82 (m, 2H, ArH), 7.41 (t, J = 8.0 Hz, 1H, 
ArH), 7.30 (ddd, J = 8.0, 2.5, 1.0 Hz, 1H, ArH), 5.81 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.07-4.98 
(m, 2H, CH=CH2), 3.71-3.65 (m, 2H, NCH2), 3.12 (q, J = 7.0 Hz, 4H, N(CH2CH3)2), 2.41-2.33 (m, 2H, CH2), 
0.94 (t, J = 7.0 Hz, 6H, N(CH2CH3)2); 13C NMR (101 MHz, CDCl3): δ 170.7 (CO), 161.1 (CO), 146.6 (Cq), 
135.9 (CH=CH2), 131.1 (Cq), 129.6 (CH), 129.4 (CH), 126.2 (CH), 125.8 (CH), 116.7 (CH=CH2), 51.8 
(N(CH2CH3)2), 42.0 (NCH2), 33.3 (CH2), 12.8 (N(CH2CH3)2); HRMS (ESI+): Calculated for C16H22N2O3 
[M+H]+: 291.1703, found 291.1702; IR νmax (neat)/cm-1: 2968 (CH), 2932 (CH), 2610 (br. OH), 1709 




Methyl 3-acetamidobenzoate233 452 
 
Methyl 3-aminobenzoate (10.0 mmol, 1.51 g) was dissolved in DCM (40 mL) and DIPEA (13.0 mmol, 
2.26 mL) and acetic anhydride (1.2 mmol, 1.13 mL) were added. DMAP (10.0 mmol, 1.22 g) was added 
and the reaction mixture was stirred at room temperature for 20 hours. Water was added and the 
layers were separated. The organic layer was washed with 1M NaOH, 1M HCl, water and brine, dried 
and concentrated. The crude material was purified by flash column chromatography (40-75% 
EtOAc/petrol) to yield the title compound (1.15 g, 59%) as a pale-orange solid.  
M.p. 132-135 °C (MeCN, lit = 136-137 °C); 1H NMR (400 MHz, CDCl3): δ 7.99 (d, J = 2.0 Hz, 1H, ArH), 
7.91 (d, J = 8.0 Hz, 1H, ArH), 7.78 (d, J = 7.5 Hz, 1H, ArH), 7.40 (t, J = 8.0 Hz, 1H, ArH), 3.91 (s, 3H, OCH3), 
2.20 (s, 3H, CH3); IR νmax (neat)/cm-1: 3295 (br. NH), 2952 (CH), 1736 (C=O), 1663 (C=O). Data are 
consistent with literature precedent.233 
Methyl 3-amino-5-methoxybenzoate234 457 
 
To a solution of 3-amino-5-methylbenzoic acid (29.9 mmol, 5.00 g) in MeOH (75 mL) at 0 °C was added 
thionyl chloride (180 mmol, 21.4 g) dropwise. The reaction mixture was stirred at room temperature 
for 5 hours and on completion was filtered and washed with Et2O. The filtrate was triturated with 
MeOH and Et2O, filtered and washed with Et2O. This trituration/filtreation was repeated a futher three 
times. The combined solids were suspended in DCM and basified with saturated NaHCO3 with vigorous 
stirring. The layers were separated, and the organic layer was washed with brine, dried over MgSO4 
and concentrated. This gave the title compound (4.71 g, 87%) as a pale-yellow solid.  
M.p. 80-83 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 6.98 (dq, J = 2.5, 1.5 Hz, 2H, ArH), 6.41 (t, J = 2.5 
Hz, 1H, ArH), 3.88 (s, 3H, OCH3), 3.80 (s, 3H, OCH3); IR νmax (neat)/cm-1: 3445 (br. NH), 3353 (br. NH), 




Methyl 3-(but-3-en-1-ylamino)5-methoxybenzoate 458 
 
To a solution of methyl 3-amino-5-methoxybenzoate (25.0 mmol, 4.53 g) in MeCN (75 mL) was added 
4-bromo-1-butene (25.0 mmol, 2.54 mL), K2CO3 (30.0 mmol, 4.15 g) and TBAI (2.5 mmol, 923 mg). The 
reaction mixture was heated at reflux for 5 days and was then filtered and concentrated. The crude 
material was purified by flash column chromatography (4-10% EtOAc/petrol) to give the title 
compound (2.11 g, 36%) as a white solid. 
M.p. 53-55 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 6.92 (s, 2H, ArH), 6.32 (s, 1H, ArH), 5.81 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.23-5.06 (m, 2H, CH=CH2), 3.88 (s, 3H, CO2CH3), 3.81 (s, 3H, OCH3), 
3.20 (t, J = 7.0 Hz, 2H, NCH2), 2.38 (q, J = 7.0 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 167.5 (CO), 
160.8 (Cq), 149.5 (Cq), 135.6 (CH=CH2), 132.0 (Cq), 117.5 (CH=CH2), 107.6 (CH), 103.6 (CH), 103.0 (CH), 
55.5 (OCH3), 52.2 (CO2CH3), 42.9 (NCH2), 33.6 (CH2); HRMS (ESI+): Calculated for C13H17NO3 [M+H]+: 
236.1281, found 236.1279; IR νmax (neat)/cm-1: 3397 (NH), 3010-2843 (CH), 1704 (C=O). 
Methyl 3-(N-(but-3-en-1-yl)acetamido)-5-methoxybenzoate 459 
 
To a solution of methyl 3-(but-3-en-1-ylamino)5-methoxybenzoate (8.5 mmol, 2.00 g) in DCM (40 mL) 
was added triethylamine (25.5 mmol, 3.55 mL), DMAP (1.7 mmol, 208 mg) and acetic anhydride (12.8 
mmol, 1.19 mL). The reaction mixture was stirred at room temperature for 20 hours. On completion 
the mixture was washed with water, 1M NaOH, 1M HCl and brine, dried over MgSO4 and concentrated. 
This gave the title compound (2.18 g, 92%) as a viscous colourless oil (analytically pure) which was 
used without further purification.  
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 2.5, 1.5 Hz, 1H, ArH), 7.44 (t, J = 1.5 Hz, 1H, ArH), 6.90 (t, J = 
2.0 Hz, 1H, ArH), 5.74 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.08-4.99 (m, 2H, CH=CH2), 3.93 (s, 3H, 
CO2CH3), 3.87 (s, 3H, OCH3), 3.81-3.73 (m, 2H, NCH2), 2.30-2.22 (m, 2H, CH2), 1.84 (s, 3H, CH3); 13C NMR 
(101 MHz, CDCl3): δ 170.1 (CO), 166.1 (CO), 160.6 (Cq), 144.3 (Cq), 135.3 (CH=CH2), 132.8 (Cq), 121.8 




(CH3); HRMS (ESI+): Calculated for C15H19NO4 [M+H]+: 278.1387, found 278.1384; IR νmax (neat)/cm-1: 
2950 (CH), 1722 (C=O), 1661 (C=O). 
3-(N-(But-3-en-1-yl)acetamido)-5-methoxybenzoic acid 460 
 
Methyl 3-(N-(but-3-en-1-yl)acetamido)-5-methoxybenzoate (7.5 mmol, 2.08 g) was dissolved in MeOH 
(10 mL) and THF (10 mL) and treated with NaOH (1 M, 15.0 mmol, 15 mL). The reaction mixture was 
heated at 60 °C for 3 hours and the volatiles were then removed. The remaining aqueous mixture was 
acidified with 3 M HCl and extracted with EtOAc (×3). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated to give the title compound (1.72 g, 97%) as an off-white 
solid (analytically pure) which was used without further purification. 
M.p. 98-100 °C (MeCN);  1H NMR (400 MHz, CDCl3): δ 7.63 (d, J = 2.5 Hz, 1H, ArH), 7.54 (t, J = 1.5 Hz, 
1H, ArH), 7.00-6.91 (m, 1H, ArH), 5.76 (ddt, J = 17.0, 10.0, 7.5 Hz, 1H, CH=CH2), 5.12-4.99 (m, 2H, 
CH=CH2), 3.89 (s, 3H, OCH3), 3.81 (t, J = 7.5 Hz, 2H, NCH2), 2.30 (q, J = 7.5 Hz, 2H, CH2), 1.90 (s, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ 170.7 (CO), 169.8 (CO), 160.7 (Cq), 144.2 (Cq), 135.2 (CH=CH2), 132.4 
(Cq), 122.3 (CH), 120.2 (CH), 117.1 (CH=CH2), 114.1 (CH), 56.0 (OCH3), 48.5 (NCH2), 32.3 (CH2), 22.9 
(CH3); HRMS (ESI+): Calculated for C14H17NO2 [M+H]+: 264.1230, found 264.1227; IR νmax (neat)/cm-1: 
2941 (CH), 2603 (br. OH), 1706 (C=O). 
3-(N-(but-3-en-1-yl)acetamide)-5-methoxy-N-(methylsulfonyl)benzamide 461 
 
3-(N-(But-3-en-1-yl)acetamido)-5-methoxybenzoic acid (3.0 mmol, 790 mg) was dissolved in DCM (18 
mL) and the solution was cooled to 0 °C. EDC.HCl (4.5 mmol, 863 mg) was added, followed by 
methanesulfonamide (3.3 mmol, 314 mg) and DMAP (4.5 mmol, 550 mg). The reaction mixture was 
stirred at 0 °C for 15 minutes and then room temperature for 18 hours. The mixture was quenched by 
the addition of 1M HCl (4.5 mL). The phases were separated, and the aqueous layer was further 




concentrated. The crude material was purified by flash column chromatography (3% MeOH/DCM) to 
give the title compound. 
M.p. 184-186 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 12.21 (br. s, 1H, NH), 7.48 (s, 1H, ArH), 7.44 
(s, 1H, ArH), 7.19 (s, 1H, ArH), 5.80-5.70 (m, 1H, CH=CH2), 5.09-4.98 (m, 2H, CH=CH2), 3.85 (s, 3H, OCH3), 
3.70 (t, J = 7.5 Hz, 2H, NCH2), 3.39 (s, 3H, SO2CH3), 2.17 (q, J = 7.5 Hz, 2H, CH2), 1.77 (s, 3H, CH3); 13C 
NMR (101 MHz, DMSO-d6): δ 168.8 (CO), 165.4 (CO), 160.0 (Cq), 143.9 (Cq), 135.6 (CH=CH2), 133.8 
(Cq), 120.4 (CH), 119.4 (CH), 116.6 (CH=CH2), 112.5 (CH), 55.8 (OCH3), 47.2 (NCH2), 41.3 (SO2CH3), 31.8 
(CH2), 22.6 (CH3); HRMS (ESI+): Calculated for C15H20N2O5S [M+H]+: 341.1166, found 341.1162; IR νmax 
(neat)/cm-1: 2987-2901 (CH), 1698 (C=O), 1595 (C=O), 1342 (S=O), 1153 (S=O). 
But-3-en-1-yl 4-methylbenzenesulfonate235 466 
 
To a solution of tosyl chloride (11.0 mmol, 2.10 g) and DMAP (1.5 mmol, 183 mg) in DCM (50 mL) was 
added triethylamine (20.0 mmol, 2.79 mL) and 3-buten-1-ol (10.0 mmol, 0.86 mL). The reaction 
mixture was stirred at room temperature for 3 hours and then quenched with water. The phases were 
separated, and the organic layer was washed with saturated aqueous NH4Cl (×2), washed with brine, 
dried over MgSO4 and concentrated. The crude product was purified by flash column chromatography 
(5-10% EtOAc/petrol) to give the title compound (1.87 g, 83%) as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ 7.79 (d, J = 8.0 Hz, 2H, ArH), 7.35 (d, J = 8.0 Hz, 2H, ArH), 5.67 (ddt, J = 
17.0, 10.5, 6.5 Hz, 1H, CH=CH2), 5.12-5.03 (m, 2H, CH=CH2), 4.06 (t, 7.0 Hz, 2H, OCH2), 2.45 (s, 3H, 
ArCH3), 2.43-2.37 (m, 2H, CH2); IR νmax (neat)/cm-1: 2982 (CH), 1357 (S=O), 1175 (S=O). Data are 
consistent with literature precedent.235 
N-(But-3-en-1-yl)-N-phenylacetamide177 467 
 
Synthesised using a modified literature procedure.177  
To a solution of acetanilide (6.0 mmol, 811 mg) in toluene (24 mL) was added K2CO3 (6.1 mmol, 845 
mg), tetrabutylammonium hydrogen sulfate (0.30 mmol, 102 mg) and NaOH (24.0 mmol, 960 mg). The 
resulting suspension was stirred for 1 hour at room temperature and then 80 °C for 15 minutes. But-
3-en-1-yl 4-methylbenzenesulfonate (7.3 mmol, 1.65 g) was added and the reaction mixture was 
stirred at 80 °C for a further 18 hours. The mixture was allowed to cool to room temperature and 1M 




combined organic extracts were washed with brine, dried over MgSO4 and concentrated. The crude 
product was purified by flash column chromatography (15-20% EtOAc/petrol) to give the title 
compound (860 mg, 76%) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.46-7.39 (m, 2H, ArH), 7.38-7.31 (m, 1H, ArH), 7.19-7.15 (m, 2H, ArH), 
5.76 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.10-4.97 (m, 2H, CH=CH2), 3.81-3.74 (m, 2H, NCH2), 
2.31-2.23 (m, 2H, CH2), 1.82 (s, 3H, CH3); IR νmax (neat)/cm-1: 2977 (CH), 2930 (CH), 1655 (C=O). Data 
are consistent with literature precedent.177 
N-(3-Methoxyphenyl)acetamide236 470 
 
Synthesised using a modified literature procedure.236 
To a solution of m-anidsidine (10.0 mmol, 1.23 g) and pyridine (6.0 mmol, 0.48 mL) in DCM (15 mL) at 
0 °C was added acetic anhydride (11.0 mmol, 1.04 mL) dropwise. The mixture was allowed to warm to 
room temperature and was stirred for 16 hours. Water was added and the layers were separated. The 
aqueous portion was extracted with DCM (×2) and the combined organic extracts were washed with 
saturates NaHCO3 and brine, dried over MgSO4 and concentrated. The crude material was purified by 
flash column chromatography (20-50% EtOAc/petrol) to give the title compound (1.54 g, 93%) as a 
pink solid.  
M.p. 78-80 °C (EtOAc/Hex, lit. = 81-83 °C236); 1H NMR (400 MHz, CDCl3): δ 7.41 (br. s, 1H, NH), 7.27 (t, 
J = 2.5 Hz, 1H, ArH), 7.20 (t, J = 8.0 Hz, 1H, ArH), 6.96 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 6.65 (dd, J = 8.5, 2.5 
Hz, 1H, ArH), 3.79 (s, 3H, OCH3), 2.16 (s, 3H, CH3); IR νmax (neat)/cm-1: 3257 (br. NH), 2973-2901 (CH), 
1662(C=O). Data are consistent with literature precedent.236 
N-(But-3-en-1-yl)-N-(3-methoxyphenyl)acetamide 471 
 
To a suspension of NaH (26.0 mmol, 1.04 g, 60% dispertion in mineral oil) in DMF (30 mL) at 0 °C was 
added N-(3-methoxyphenyl)acetamide (2.0 mmol, 330 mg) portionwise. The mixture was stirred at 
room temperature for 20 minutes and then recooled to 0 °C. 4-Bromo-1-butene (26.0 mmol, 2.64 mL) 




completion, the reaction mixture was quenched with water and then extracted with Et2O (×3). The 
combined organic portions were washed with water (×2) and brine, dried over MgSO4 and 
concentrated. The crude mixture was purified by flash column chromatography (15-40% EtOAc/petrol) 
to give the title compound (143 mg, 33%) as an orange oil. 
1H NMR (400 MHz, CDCl3): δ 7.31 (t, J = 8.0 Hz, 1H, ArH), 6.91-6.86 (m, 1H, ArH), 6.75 (ddd, J = 8.0, 2.0, 
1.0 Hz, 1H, ArH), 6.70 (t, J = 2.0 Hz, 1H, ArH), 5.75 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.08-4.99 
(m, 2H, CH=CH2), 3.81 (s, 3H, OCH3), 3.79-3.73 (m, 2H, NCH2), 2.31-2.24 (m, 2H, CH2), 1.84 (s, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ 170.3 (CO), 160.6 (Cq), 144.3 (Cq), 135.5 (CH=CH2), 130.4 (CH), 120.6 
(CH), 116.7 (CH=CH2), 114.3 (CH), 113.3 (CH), 55.5 (OCH3), 48.3 (NCH2), 32.4 (CH2), 22.9 (CH3); HRMS 




To a solution of aniline (12.0 mmol, 1.09 mL) and K2CO3 (20.0 mmol, 2.76 g) in DMF (30 mL) was added 
4-bromo-1-butene (10.0 mmol, 1.01 mL) dropwise. The reaction mixture was stirred at 110 °C for 6 
hours. On completion the mixture was allowed to cool to room temperature and water was added. 
The mixture was extracted with EtOAc (×3) and the combined organic layers were washed with water 
(×2) and brine, dried over MgSO4 and concentrated. The crude material was purified by flash column 
chromatography (0.25-1% EtOAc/petrol) to give the title compound (842 mg, 57%) as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ 7.22-7.14 (m, 2H, ArH), 6.71 (tt, J = 7.5, 1.0 Hz, 1H, ArH), 6.65-6.58 (m, 
2H, ArH), 5.83 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2), 5.19-5.08 (m, 2H, CH=CH2), 3.67 (br. s, 1H, NH), 
3.19 (t, J = 6.5 Hz, 2H, NCH2), 2.39 (app. qt, 2H, CH2); IR νmax (neat)/cm-1: 2979 (CH). Data are consistent 
with literature precedent.237 
1-(But-3-en-1-yl)-3-(tert-butyl)-1-phenylurea 484 
 
N-(But-3-en-1-yl)aniline (5.0 mmol, 736 mg) and tBu-isocyanate (15.0 mmol, 1.71 mL) were dissolved 
in toluene (10 mL) and stirred at 80 °C for 5 days. The reaction mixture was concentrated and purified 





M.p. 26 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 7.44-7.37 (m, 2H, ArH), 7.33-7.28 (m, 1H, ArH), 7.22-
7.17 (m, 2H, ArH), 5.76 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH=CH2), 5.07-4.95 (m, 2H, CH=CH2), 4.05 (br. 
s, 1H, NH), 3.75-3.68 (m, 2H, NCH2), 2.29-2.20 (m, 2H, CH2), 1.23 (s, 9H, C(CH3)3); 13C NMR (101 MHz, 
CDCl3): δ 156.3 (CO), 142.5 (Cq), 135.9 (CH=CH2), 130.1 (CH), 128.8 (CH), 127.5 (CH), 116.4 (CH=CH2), 
50.8 (C(CH3)3), 48.2 (CH2), 33.2 (CH2), 29.5 (C(CH3)3); HRMS (ESI+): Calculated for C15H27N2O [M+H]+: 
247.1805, found 247.1796; IR νmax (neat)/cm-1: 2964 (CH), 1654 (C=O). 
4.4 Cyclisation products 
4.4.1 General cyclisation procedure 
A flame-dried Schlenk tube under N2 was charged with indole substrate (1 equiv.), Pd(OAc)2 (10 mol%), 
Cu(OAc)2 (3 equiv.), K2CO3 (2 equiv.), and PivOH (30 mol%). Dioxane (0.1 M) was added and the 
reaction was heated to 100 °C and stirred for 16 hours. The reaction mixture was cooled to room 
temperature and filtered through Celite®. The filter-cake was washed with DCM and CHCl3, and the 
filtrate was then concentrated. The crude material was purified by flash column chromatography to 
give the product. 




A flame-dried Schlenk tube under N2 was charged with 1-(pent-4-en-1-yl)-N-tosyl-1H-indole-3-
carboxamide (0.30 mmol, 115 mg), Pd(TFA)2 (10 mol%, 10.0 mg), Cu(OAc)2 (0.75 mmol, 136 mg) and 
K2CO3 (0.75 mmol, 104 mg). Dioxane (3 mL) was added and the reaction was heated to 100 °C and 
stirred for 16 hours. The reaction mixture was cooled to room temperature and filtered through 
Celite®. The filter-cake was washed with DCM and CHCl3, and the filtrate was then concentrated. The 
crude material was purified by flash column chromatography (5% Et2O/30% petrol/CHCl3) to give the 
title compound (56 mg, 50%) as an off-white solid. 




9-Methylene-N-tosyl-6,7,8,9-tetrahydro[1,2-a]indole-10-carboxamide (0.30 mmol, 114 mg) was 
subjected to the general cyclization conditions described above. The crude material was purified by 
flash column chromatography to yield the title compound (101 mg, 83%) as an off-white solid. 
M.p. 250 °C, decomp. (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 8.5 Hz, 1H, ArH), 7.99 (d, J = 
8.5 Hz, 2H, ArH), 7.31 (d, J = 8.0 Hz, 2H, ArH), 7.27 (d, J = 4.0 Hz, 2H, ArH), 7.20 (dq, J = 8.0, 4.5 Hz, 1H, 
ArH), 6.08 (tt, J = 4.5 Hz, 1H, C=CH), 4.98 (app. q, 2H, SO2NCH2), 4.12 (t, J = 7.5 Hz, 2H, NCH2), 2.87-2.79 
(m, 2H, CH2), 2.41 (s, 3H, CH3); 13C NMR (126 MHz, CDCl3): δ 161.4 (CO), 144.3 (Cq), 140.2 (Cq), 137.9 
(Cq), 137.2 (Cq), 129.5 (CH), 128.5 (CH), 125.9 (Cq), 124.2 (CH), 122.7 (CH), 122.1 (Cq), 121.9 (CH), 
121.0 (C=CH), 109.6 (CH), 102.5 (Cq), 49.0 (SO2NCH2), 39.0  (NCH2), 24.8 (CH2), 21.8 (CH3); HRMS (ESI+): 
Calculated C21H18N2O3S for  [M+Na]+: 401.0930, found 401.0943; IR νmax (neat)/cm-1: 3056-2933 (CH), 
1673 (C=O), 1350 (S=O), 1159 (S=O). 
2-(Methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 202 
 
N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 92 mg) was subjected to 
the general cyclisation conditions described above. The crude material was purified by flash column 
chromatography to yield the title compound (61.4 mg, 68%) as an off-white solid. 
M.p. 185 °C, decomp. (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 7.5 Hz, 1H, ArH), 7.33-7.23 (m, 
3H, ArH), 6.05 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.88-4.79 (m, 2H, SO2NCH2), 4.14 (t, J = 7.5 Hz, 2H, NCH2), 
3.47 (s, 3H, SO2CH3), 2.89-2.81 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.6 (CO), 140.4 (Cq), 138.0 
(Cq), 125.8 (Cq), 124.4 (CH), 123.0 (CH), 121.7 (Cq), 121.7 (CH), 121.4 (CH=C), 109.8 (CH), 102.1 (Cq), 
48.0 (SO2NCH2), 42.6 (SO2CH3), 39.0 (NCH2), 24.8 (CH2); HRMS (ESI+): Calculated for C15H14N2O3S 




1-(Hex-4-en-1-yl)-N-(methylsulfonyl)-1H-indole-3-carboxamide (0.30 mmol, 96.1 mg) was subjected 




chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (50.1 mg, 53%) as a yellow 
solid.  
M.p. 150 °C, decomp. (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.38-8.27 (m, 1H, ArH), 7.43-7.29 (m, 3H, 
ArH), 6.26 (tt, J = 7.0, 1.5 Hz, 1H, CH=C), 4.26 (d, J = 6.5 Hz, 2H, SO2NCH2), 4.18 (t, J = 6.0 Hz, 2H, NCH2), 
3.45 (s, 3H, SO2CH3), 2.73-2.63 (m, 2H, CH2), 2.30-2.18 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 165.3 
(CO), 139.0 (Cq), 136.7 (Cq), 134.7 (Cq), 127.9 (Cq), 126.1 (CH), 124.5 (CH), 123.1 (CH), 122.9 (CH), 
109.6 (CH), 108.4 (Cq), 42.7 (SO2NCH2), 42.5 (NCH2), 42.5 (SO2CH3), 28.6 (CH2), 23.0 (CH2); HRMS (ESI+): 
Calculated for C16H16N2O3S [M+Na]+: 339.0774, found 339.0771; IR νmax (neat)/cm-1: 3018 (CH), 2931 
(CH), 2857 (CH), 1643 (CO), 1335 (S=O), 1160 (S=O). 
2-(Methylsulfonyl)-3-phenyl-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 246 
 
N-(Methylsulfonyl)-1-(5-phenylpent-4-en-yl)-1H-indole-3-carboxylate (0.30 mmol, 114.7 mg was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (5% Et2O/25% petrol/CHCl3) to yield the title compound (80.7 mg, 71%) 
as a pale-yellow solid. 
M.p. 238-240 °C (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.17 (dt, J = 7.5, 1.5 Hz, 1H, ArH), 7.42-7.27 (m, 
8H, ArH), 6.34 (s, 1H, CH), 6.11 (ddd, J = 6.0, 3.0, 1.0 Hz, 1H, CH=C), 4.31 (ddd, J = 12.5, 8.0, 2.5 Hz, 1H, 
NCHH), 3.88 (td, J = 12.5, 6.5 Hz, 1H, NCHH), 3.11 (s, 3H, SO2CH3), 2.99-2.87 (m, 1H, CHH), 2.76-2.68 
(m, 1H, CHH); 13C NMR (101 MHz, CDCl3): δ 162.5 (CO), 141.3 (Cq), 139.7 (Cq), 138.2 (Cq), 129.3 (CH), 
128.7 (CH), 126.0 (Cq), 126.0 (CH), 125.9 (Cq), 124.4 (CH=C), 123.1 (CH), 122.7 (CH), 121.9 (CH), 109.8 
(CH), 102.3 (Cq), 63.6 (CH), 43.3 (SO2CH3), 39.0 (NCH2), 25.0 (CH2); HRMS (ESI+): Calculated for 
C21H18N2O3S [M+H]+: 379.1111, found 379.1115; IR νmax (neat)/cm-1: 2980 (CH), 2906 (CH), 1667 (CO), 
1335 (S=O), 1149 (S=O). 
5-Methyl-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1Hindolo[3,2,1-ij][1,6]napthyridin-1-one 259 
 
1-(2-Methylpent-4-en-1-yl)-N-(methylsulfonyl)-1H-indole-3-carboxamide (0.30 mmol, 96.1 mg), was 




flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (60.2 mg, 
63%) as a yellow solid.  
M.p. 155 °C, decomp. (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.12-8.06 (m, 1H, ArH), 7.34-7.23 (m, 3H, 
ArH), 5.96 (dt, J = 4.0, 2.0 Hz, 1H, CH=C), 4.89-4.75 (m, 2H, SO2NCH2), 4.23 (dd, J = 12.5, 7.0 Hz, 1H, 
NCHH), 3.75 (dd, J = 12.5, 8.5 Hz, 1H, NCHH), 3.48 (s, 3H, SO2CH3), 3.13-3.02 (m, 1H, CH), 1.28 (d, J = 
7.0 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 162.2 (CO), 140.3 (Cq), 138.0 (Cq), 127.8 (CH=C), 126.0 
(Cq), 124.4 (CH), 123.0 (CH), 121.7 (CH), 120.8 (Cq), 109.8 (CH), 102.1 (Cq), 47.9 (SO2NCH2), 46.1 
(NCH2), 42.7 (SO2CH3), 31.1 (CH), 18.9 (CH3); HRMS (ESI+): Calculated for C16H16N2O3S [M+Na]+: 
339.0774, found 339.0789; IR νmax (neat)/cm-1: 2927 (CH), 1669 (CO), 1333 (S=O), 1149 (S=O). 
4-Methyl-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 266 
 
1-(3-Methylpent-4-en-yl)-N-indole-3-carboxamide (0.30 mmol, 96.1 mg was subjected to the general 
cyclisation conditions described above. The crude product was purified by flash column 
chromatography (6% Et2O/25% petrol/CHCl3) to yield the title compound (67.5 mg, 71%) as a yellow 
solid. 
M.p. decomp. 200 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.90-7.86 (m, 1H, ArH), 7.57-7.53 (m, 
1H, ArH), 7.32-7.25 (m, 1H, ArH), 7.23 (td, J = 7.5, 1.0 Hz, 1H, ArH), 4.84-4.80 (m, 2H, SO2NCH2), 4.22 
(t, J = 7.5 Hz, 2H, NCH2), 3.48 (s, 3H, SO2CH3), 2.82-2.75 (m, 2H, CH2), 1.99-1.95 (m, 2H, CH3); 13C NMR 
(101 MHz, DMSO-d6): δ 161.9 (CO), 141.5 (Cq), 137.3 (Cq), 133.7 (Cq), 125.4 (Cq), 123.3 (CH), 122.2 
(CH), 119.9 (CH), 114.0 (Cq), 110.6 (CH), 99.4 (Cq), 46.0 (SO2NCH2), 41.4 (SO2CH3), 38.9 (NCH2), 30.0 
(CH2), 18.2 (CH3); HRMS (ESI+): Calculated for C16H16N2O3S [M+H]+: 317.0954, found 317.0960; IR νmax 
(neat)/cm-1: 2931 (CH), 1660 (CO), 1334 (S=O), 1156 (S=O). 
4,4-Dimethyl-2-(methylsulfonyl)-2,4,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]napthyridin-1-one 273 
 
1-(3,3-Dimethylpent-4-en-1-yl)-N-(methylsulfonyl)-1H-indole-3-caboxamide (0.30 mmol, 100.3 mg) 
was subjected to the general cyclisation conditions described above. The crude product was purified 
by flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (18.1 mg, 




M.p. 136-138 °C, (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.29 (dq, J = 7.5 Hz, 1.0 Hz, 1H, ArH), 7.78 (s, 
1H, C=CH), 7.45-7.42 (m, 2H, ArH), 7.37 (dq, J = 8.0, 4.5 Hz, 1H, ArH), 4.28-4.18 (m, 2H, NCH2), 3.72 (s, 
3H, SO2CH3), 2.09-2.04 (m, 2H, CH2), 1.41 (s, 6H, C(CH3)2); 13C NMR (101 MHz, CDCl3): δ 158.3 (CO), 
142.9 (Cq), 138.2 (Cq), 124.8 (Cq), 124.8 (CH), 123.1 (CH), 122.7 (CH), 122.1 (CH), 116.2 (Cq), 109.4 
(CH), 104.9 (Cq), 42.8 (SO2CH3), 38.8 (NCH2), 37.0 (CH2), 31.0 (C(CH3)2), 28.1 (C(CH3)2); HRMS (ESI+): 
Calculated for C17H18N2O3S [M+H]+: 331.1111, found 331,1135; IR νmax (neat)/cm-1: 2962 (CH), 1678 
(C=O), 1347 (S=O), 1164 (S=O).  
2-(Methylsulfonyl)-3,5,6,7-tetrahydro-2,7a-diazacyclohepta[jk]fluoren-1(2H)-one 283 
 
1-(Hex-5-en-1-yl)-N-(methylsulfonyl)-1H-indole-3-carboxamide (0.30 mmol, 96.2 mg was subjected to 
the general cyclisation conditions described above. The crude product was purified by flash column 
chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (36.3 mg, 38%) as a yellow 
solid.  
M.p. 150 °C, decomp. (MeCN); 1H NMR (400 MHz, CDCl3): δ 8.30-8.18 (m, 1H, ArH), 7.38-7.27 (m, 3H, 
ArH), 6.22-6.15 (m, 1H, CH=C), 4.68 (d, J = 2.0 Hz, 2H, SO2NCH2), 4.33-4.28 (m, 2H, NCH2), 3.46 (s, 3H, 
SO2CH3), 2.73-2.64 (m, 2H, CH2), 2.20-2.13 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.9 (CO), 142.0 
(Cq), 138.2 (Cq), 132.1 (CH=C), 125.5 (Cq), 124.4 (CH), 123.0 (CH), 121.8 (CH), 121.6 (Cq), 109.7 (CH), 
106.3 (Cq), 51.3 (SO2NCH2), 46.0 (NCH2), 42.5 (SO2CH3), 31.1 (CH2), 25.7 (CH2); HRMS (ESI+): Calculated 
for C16H16N2O3S [M+Na]+: 339.0774, found 229.0780; IR νmax (neat)/cm-1: 2924 (CH), 1667 (CO), 1334 
(S=O), 1154 (S=O). 
10-Fluoro-2-(methylsulfonyl)-2,3,5,6-tetraheydro-1H-indolo[3,2,1-ij][1,6]napthiridin-1-one 312a 
 
5-Fluoro-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 97.3 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (58.7 mg, 
61%) as a pale-green solid. 
M.p. decomp. 247 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.63 (dd, J = 9.0, 4.5 Hz, 1H, ArH), 7.55 




4.83 (app. q, 2H, SO2NCH2), 4.22 (t, J = 7.5 Hz, 2H, NCH2), 3.47 (s, 3H, SO2CH3), 2.84-2.79 (m, 2H, CH2) ; 
13C NMR (101 MHz, DMSO-d6): δ 161.8 (CO), 158.6 (d, J = 236.5 Hz, CF), 142.0 (Cq), 134.3 (Cq), 125.6 
(Cq), 124.1 (CH=C), 120.4 (Cq), 112.2 (d, J = 10.0 Hz, CH), 111.6 (d, J = 26.0 Hz, CH), 105.2 (d, J = 25.0 
Hz, CH), 100.7 (Cq), 47.9 (SO2NCH2), 41.4 (SO2CH3), 38.8 (NCH2), 24.2 (CH2); HRMS (ESI+): Calculated 
for C15H13FN2O3S [M+H]+: 321.0704, found 321.0709; IR νmax (neat)/cm-1: 2924 (CH), 1655 (CO), 1334 




5-Cyano-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 99.4 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (2% MeOH/DCM) to yield the title compound (63.0 mg, 64%) as a pale-
yellow solid. 
M.p. decomp. 240 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 8.21 (dd, J = 1.5, 0.5 Hz, 1H, ArH), 7.80 
(dd, J = 8.5, 0.5 Hz, 1H, ArH), 7.72 (dd, J = 8.5, 1.5 Hz, 1H, ArH), 6.45 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.86 
(app. q, 2H, SO2NCH2), 4.29 (t, J = 7.5 Hz, 2H, NCH2), 3.48 (s, 3H, SO2CH3), 2.87-2.81 (m, 2H, CH2); 13C 
NMR (101 MHz, DMSO-d6): δ 162.0 (CO), 143.1 (Cq), 139.9 (Cq), 127.3 (CH), 126.2 (CH=C), 125.3 (Cq), 
124.9 (CH), 120.5 (Cq), 120.2 (Cq), 112.8 (CH), 104.9 (Cq), 101.3 (Cq), 48.4 (SO2NCH2), 41.8 (SO2CH3), 
39.3 (NCH2), 24.6 (CH2); HRMS (ESI+): Calculated for C16H13N3O3S [M+H]+: 328.0750, found 328.0745; 
IR νmax (neat)/cm-1: 2987-2901 (CH), 2221 (CN), 1669 (C=O), 1354 (S=O), 1159 (S=O). 
10-Methyl-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 312c 
 
5-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 96.1 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (5% Et2O/25% petrol/CHCl3) to yield the title compound (71.1 mg, 75%) 
as a pale-yellow solid. 
M.p. decomp. 221 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.70 (dd, J = 1.5, 1.0 Hz, 1H, ArH), 7.46 




SO2NCH2), 4.17 (t, J = 7.5 Hz, 2H, NCH2), 3.46 (s, 3H, SO2CH3), 2.84-2.74 (m, 2H, CH2), 2.42 (s, 3H, CH3); 
13C NMR (101 MHz, DMSO-d6): δ 162.0 (CO), 140.7 (Cq), 135.9 (Cq), 131.4 (Cq), 125.2 (Cq), 125.1 (CH), 
123.1 (CH=C), 120.6 (Cq), 119.9 (CH), 110.5 (CH), 100.2 (Cq), 47.8 (SO2NCH2), 41.4 (SO2CH3), 38.6 
(NCH2), 24.1 (CH2), 21.2 (CH3); HRMS (ESI+): Calculated for C16H16N2O3S [M+H]+: 317.0954, found 
317.0962; IR νmax (neat)/cm-1: 2923 (CH), 1666 (C=O), 1333 (S=O), 1151 (S=O). 
10-Methoxy-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]napthyridin-1-one 312d 
 
5-Methoxy-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 101 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (72.3 mg, 
73%) as a pale-yellow solid. 
M.p. decomp. 215 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.50 (d, J = 9.0 Hz, 1H, ArH), 7.38 (d, J 
= 2.5 Hz, 1H, ArH), 6.94 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 6.29 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.81 (app. q, 
2H, SO2NCH2), 4.17 (t, J = 7.5 Hz, 2H, NCH2), 3.80 (s, 3H, OCH3), 3.46 (s, 3H, SO2CH3), 2.83-2.75 (m, 2H, 
CH2); 13C NMR (101 MHz, DMSO-d6): δ 162.1 (CO), 155.7 (Cq), 140.8 (Cq), 132.5 (Cq), 125.9 (Cq), 122.9 
(CH=C), 120.6 (Cq), 113.2 (CH), 111.8 (CH), 102.1 (CH), 100.4 (Cq), 55.4 (OCH3), 47.9 (SO2NCH2), 41.4 
(SO2CH3), 36.7 (NCH2), 24.2 (CH2); HRMS (ESI+): Calculated for C16H16N2O4S [M+H]+: 333.0904, found 
333.0900; IR νmax (neat)/cm-1: 2921 (CH), 1662 (C=O), 1331 (S=O), 1159 (S=O). 
11-Methyl-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 312f 
 
4-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole (0.30 mmol, 96 mg) was subjected to the 
general cyclisation conditions described above. The crude product was purified by flash column 
chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (50.9 mg, 54%) as a pale-
yellow solid. 
M.p. decomp. 239 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.28 (d, J = 8.0 Hz, 1H, ArH), 7.21 (t, J 
= 7.5 Hz, 1H, ArH), 7.00 (d, J = 7.0 Hz, 1H, ArH), 6.35 (tt, J = 4.5 Hz, 2.0 Hz, 1H, CH=C), 4.79 (app. q, 2H, 
SO2NCH2), 4.17 (t, J = 7.5 Hz, 2H, NCH2), 3.46 (s, 3H, SO2CH3), 2.83 (s, 3H, CH3), 2.81-2.75 (m, 2H, CH2); 




124.5 (CH), 124.0 (CH), 121.4 (Cq), 108.5 (Cq), 102.4 (CH), 47.8 (SO2NCH2), 42.1 (SO2CH3), 39.0 (NCH2), 
24.3 (CH2), 22.6 (CH3); HRMS (ESI+): Calculated for C16H16N2O3S [M+H]+: 317.0954, found 317.0961; IR 
νmax (neat)/cm-1: 2988-2901 (CH), 1658 (C=O), 1334 (S=O), 1151 (S=O). 
11-Methoxy-2-(methylsulfonyl-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 312g 
 
4-Methoxy-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 101 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (67.3 mg, 
67%) as a pale-yellow solid. 
M.p. decomp. 188 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.26 (dd, J = 8.5, 1.0 Hz, 1H, ArH), 7.15 
(dd, J = 8.5, 1.0 Hz, 1H, ArH), 6.76 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 6.31 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.76 
(app. q, 2H, SO2NCH2), 4.16 (t, J = 7.5 Hz, 2H, NCH2), 3.86 (s, 3H, OCH3), 3.44 (s, 3H, SO2CH3), 2.81-2.73 
(m, 2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 160.7 (CO), 154.4 (Cq), 140.6 (Cq), 139.8 (Cq), 125.7 
(CH), 123.4 (CH), 121.3 (Cq), 115.4 (Cq), 104.4 (CH), 103.9 (CH), 102.0 (Cq), 56.1 (OCH3), 47.9 
(SO2NCH2), 42.0 (SO2CH3), 39.2 (NCH2), 24.3 (CH2); HRMS (ESI+): Calculated for C16H16N2O4S [M+H]+: 
333.0904, found 333.0917; IR νmax (neat)/cm-1: 2988-2901 (CH), 1677 (C=O), 1331 (S=O), 1153 (S=O). 
9-Chloro-2-(methylsulfonyl)-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 312h 
 
6-Chloro-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 102 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (10% Et2O/25% petrol/CHCl3) to yield the title compound (60.9 mg, 
60%) as a pale-yellow solid. 
M.p. decomp. 237 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 7.86-7.82 (m, 1H, ArH), 7.77-7.75 (m, 
1H, ArH), 7.26 (dd, J = 8.5, 2,0 Hz, 1H, ArH), 6.36 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.83 (app. q, 2H, 
SO2NCH2), 4.21 (t, J = 7.5 Hz, 2H, NCH2), 3.46 (s, 3H, SO2CH3), 2.80 (tdt, J = 7.5, 4.5, 2.5 Hz, 2H, CH2); 13C 
NMR (101 MHz, DMSO-d6): δ 161.7 (CO), 141.5 (Cq), 138.2 (Cq), 128.2 (Cq), 124.2 (CH=C), 123.8 (Cq), 




24.1 (CH2); HRMS (ESI+): Calculated for C15H1335ClN2O3S [M+Na]+: 359.0228, found 359.0242; IR νmax 
(neat)/cm-1: 2923 (CH), 1670 (C=O), 1347 (S=O), 1156 (S=O). 
2-(Methylsulfonyl)-8-nitro-2,3,5,6-tetrahydro-1H-indolo[3,2,1-ij][1,6]naphthyridin-1-one 312i 
 
N-(Methylsulfonyl)-7-nitro-1-(pent-4-en-1-yl)-1H-indole-3-carboxamide (0.30 mmol, 105 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (10% Et2O/CHCl3) to yield the title compound (23.3 mg, 22%) as a pale-
yellow solid. 
M.p. decomp. 236 °C (MeCN); 1H NMR (500 MHz, DMSO-d6): δ 8.31 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.99-
7.92 (m, 1H, ArH), 7.42 (td, J = 8.0, 0.5 Hz, 1H, ArH), 6.49 (tt, J = 4.5, 2.0 Hz, 1H, C=CH), 4.85 (app. q, 
2H, SO2NCH2), 4.27 (t, J = 7.5 Hz, 2H, NCH2), 3.49 (s, 3H, SO2CH3), 2.77 (tdt, J = 7.0, 4.5, 2.5 Hz, 2H, CH2); 
13C NMR (126 MHz, DMSO-d6): δ 161.7 (CO), 143.0 (Cq), 136.7 (Cq), 128.9 (Cq), 128.6 (Cq), 126.3 
(C=CH), 126.0 (CH), 121.9 (CH), 120.9 (CH), 120.4 (Cq), 101.6 (Cq), 47.8 (SO2NCH2), 42.7 (NCH3), 41.3 
(SO2CH3), 24.8 (CH2); HRMS (ESI+): Calculated for C15H13N3O5S [M+Na]+: 370.0468, found 370.0484; IR 




N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (0.30 mmol, 92.1 mg) 
was subjected to the general cyclisation conditions described above. The crude product was purified 
by flash column chromatography (2% MeOH/DCM) to yield the title compound (53.2 mg, 58%) as a 
pale-green solid. 
M.p. 235-237 °C (MeCN); 1H NMR (400 MHz, DMSO-d6): δ 8.36 (dd, J = 5.0 Hz, 1.5 Hz, 1H, ArH), 8.20 
(dd, J = 8.0, 1.5 Hz, 1H, ArH), 7.29 (dd, J = 8.0, 5.0 Hz, 1H, ArH), 6.44 (tt, J = 4.5, 2.0 Hz, 1H, C=CH), 4.85 
(app. q, 2H, SO2NCH2), 4.25 (t, J = 7.5 Hz, 2H, NCH2), 3.48 (s, 3H, SO2CH3), 2.83 (tdt, J = 7.5, 5.0, 2.5 Hz, 
2H, CH2); 13C NMR (101 MHz, DMSO-d6): δ 161.4 (CO), 148.5 (Cq), 144.3 (CH), 141.1 (Cq), 128.2 (CH), 




24.1 (CH2); HRMS (ESI+): Calculated for C14H13N3O3S [M+H]+: 304.0750, found 304.0755; IR νmax 
(neat)/cm-1: 2958 (CH), 1725 (C=O), 1334 (S=O), 1155 (S=O). 
2-(Methylsulfonyl)-1,2,7,8-tetrahydro-3H-pyrrolo[3,2,1-ij][1,6]naphthyridin-3-one 331a 
 
N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide (0.30 mmol, 76.8 mg) was subjected 
to the general cyclisation conditions described above. The crude product was purified by flash column 
chromatography (15% Et2O/ petrol 25%/ CHCl3) to yield the title compound (27 mg, 35%) as a pale-
yellow solid. 
M.p. 92-94 °C, (EtOAc); 1H NMR (400 MHz, CDCl3): δ 6.63 (d, J = 3.0 Hz, 1H, ArH), 6.55 (d, J = 3.0 Hz, 
1H, ArH), 5.76 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.76 (app. q, 2H, SO2NCH2), 3.99 (t, J = 7.5 Hz, 2H, NCH2), 
3.41 (s, 3H, SO2CH3), 2.68 (tdt, J = 7.0, 4.5, 2.5 Hz, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 162.7 (CO), 
135.0 (Cq), 123.6 (CH), 121.6 (Cq), 116.1 (CH=C), 110.2 (Cq), 107.9 (CH), 48.4 (SO2NCH2), 42.5 (NCH2), 
42.5 (SO2CH3), 25.0 (CH2); HRMS (ESI+): Calculated for C11H12N2O3S [M+H]+: 253.0641, found 253.0645; 
IR νmax (neat)/cm-1: 2928 (CH), 1673 (C=O), 1322 (S=O), 1156 (S=O). 
4-Methyl-2-(methylsulfonyl)-1,2,7,8-tetrahydro-3H-pyrrolo[3,2,1-ij][1,6]naphthyridin-3-one 331b 
 
4-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide (0.30 mmol, 81 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (5% Et2O/ CHCl3) to yield the title compound (40 mg, 50%) as a white 
solid.  
M.p. 165-166 °C, (EtOAc); 1H NMR (500 MHz, CDCl3): δ 6.39 (q, J = 1.0 Hz, 1H, ArH), 5.70 (tt, J = 4.5, 
2.0 Hz, 1H, CH=C), 4.72 (app. q, 2H, SO2NCH2), 3.90 (t, J = 7.5 Hz, 2H, NCH2), 3.41 (s, 3H, SO2CH3), 2.67-
2.60 (m, 2H, CH2), 2.27 (app. d, 3H, CH3); 13C NMR (126 MHz, CDCl3): δ 163.4 (CO), 135.0 (Cq), 121.7 
(Cq), 121.4 (CH), 121.3 (Cq), 115.5 (C=CH), 108.5 (Cq), 48.3 (SO2NCH2), 42.6 (SO2CH3), 42.2 (NCH2), 24.9 
(CH2), 11.0 (CH3); HRMS (ESI+): Calculated for C12H14N2O3S [M+H]+: 267.0798, found 267.0809; IR νmax 






N-(Methylsulfonyl)-1-(pent-4-en-1-yl)-4-phenyl-1H-pyrrole-3-carboxamide (0.30 mmol, 98 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (4% Et2O/ CHCl3) to yield the title compound (40 mg, 40%) as a white 
solid. 
M.p. 218 °C (EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.71-7.66 (m, 2H, ArH), 7.39-7.33 (m, 2H, ArH), 7.30-
7.27 (m, 1H, ArH), 6.78 (s, 1H, ArH), 5.82 (tt, J = 4.5, 2.0 Hz, 1H, CH=C), 4.79 (app. q, 2H, SO2NCH2), 4.02 
(t, J = 7.5 Hz, 2H, NCH2), 3.41 (s, 3H, SO2CH3), 2.71 (tdt, J = 7.5, 4.5, 2.5 Hz, 2H, CH2); 13C NMR (126 
MHz, CDCl3): δ 162.7 (CO), 136.0 (Cq), 133.1 (Cq), 128.5 (CH), 128.3 (CH), 127.2 (CH), 127.0 (Cq), 121.9 
(CH), 116.6 (C=CH), 106.9 (Cq), 48.0 (SO2NCH2), 42.8 (SO2CH3), 42.5 (NCH2), 24.8 (CH2); HRMS (ESI+): 
Calculated for C17H16N2O3S [M+Na]+: 351.0774, found 351.0774; IR νmax (neat)/cm-1: 2972 (CH), 1675 
(C=O), 1337 (S=O), 1157 (S=O). 
5-Methyl-2-(methylsulfonyl)-1,2,7,8-tetrahydro-3H-pyrrolo[3,2,1-ij][1,6]napthyridin-3-one 331d 
 
5-Methyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide (0.30 mmol, 81 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (3-5% Et2O/ CHCl3) to yield the title compound (31 mg, 39%) as a 
white solid. 
M.p. 147-148 °C, (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.44 (t, J = 1.5 Hz, 1H, ArH), 6.51-6.47 (m, 1H, 
CH=C), 3.95-3.90 (m, 2H, SO2NCH2), 3.62 (s, 3H, SO2CH3), 2.73 (ddd, J = 7.5, 5.0, 1.5 Hz, 2H, NCH2), 2.33 
(d, J = 1.0 Hz, 3H, CH3), 2.22-2.14 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3): δ 158.7 (CO), 138.0 (Cq), 
134.0 (Cq), 119.5 (CH), 112.3 (Cq), 107.3 (Cq), 103.6 (CH=C), 42.5 (SO2CH3), 41.6 (SO2NCH2), 23.2 (CH2), 
21.6 (NCH2), 11.8 (CH3); HRMS (ESI+): Calculated for C12H14N2O3S [M+H]+: 267.0798, found 267.0803; 






5-Acetyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide (0.30 mmol, 89.4 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (25% Et2O/ 25% petrol/ CHCl3) to yield the title compound (30.9 mg, 
35%) as a pale-yellow solid. 
M.p. decomp. 222 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.27 (s, 1H, ArH), 5.99 (tt, J = 4.0, 2.0 Hz, 
1H, CH=C), 4.76 (app. q, 2H, SO2NCH2), 4.50 (t, J = 8.0 Hz, 2H, NCH2), 3.42 (s, 3H, SO2CH3), 2.68 (tdt, J = 
7.5, 4.5, 2.5 Hz, 2H, CH2), 2.45 (s, 3H, CH3); 13C NMR (101 MHz, CDCl3): δ 189.6 (CO), 161.9 (CO), 138.7 
(Cq), 133.0 (Cq), 121.6 (CH), 120.8 (Cq), 117.4 (CH), 110.3 (Cq), 48.1 (SO2CH2), 42.5 (SO2CH3), 42.5 
(NCH2), 27.3 (CH3), 24.9 (CH2); HRMS (ESI+): Calculated for C13H14N2O4S [M+H]+: 295.0747, found 
295.0747; IR νmax (neat)/cm-1: 2988-2901 (CH), 1678 (C=O), 1651 (C=O), 1327 (S=O), 1157 (S=O). 
5-Benzoyl-2-(methylsulfonyl)-1,2,7,8-tetrahydro-3H-pyrrolo[3,2,1-ij][1,6]naphthyridin-3-one 331f 
 
5-Benzoyl-N-(methylsulfonyl)-1-(pent-4-en-1-yl)-1H-pyrrole-3-carboxamide (0.30 mmol, 108 mg) was 
subjected to the general cyclisation conditions described above. The crude product was purified by 
flash column chromatography (5% Et2O/ 25% petrol/ CHCl3) to yield the title compound (39.6 mg, 37%) 
as a pale-yellow solid. 
M.p. decomp. 192 °C (EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.84-7.77 (m, 2H, ArH), 7.71-7.63 (m, 1H, 
ArH), 7.60-7.50 (m, 2H, ArH), 6.92 (s, 1H, ArH), 6.27 (tt, J = 4.5, 2.5 Hz, 1H, CH=C), 4.80 (app. q, 2H, 
SO2NCH2), 4.47 (t, J = 8.0 Hz, 2H, NCH2), 3.43 (s, 3H, SO2CH3), 2.77-2.69 (m, 2H, CH2); 13C NMR (101 
MHz, CDCl3): δ 186.7 (CO), 162.0 (CO), 139.1 (Cq), 138.5 (Cq), 132.7 (CH), 132.6 (Cq), 129.3 (CH), 128.6 
(CH), 121.8 (CH), 120.9 (Cq), 120.1 (CH), 110.5 (Cq), 48.1 (SO2NCH2), 42.5 (SO2CH3), 42.3 (NCH2), 25.1 
(CH2); HRMS (ESI+): Calculated for C18H16N2O4S [M+H]+: 357.0904, found 357.0911; IR νmax (neat)/cm-
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1 100  0.0625 Pd(OAc)2 20 Cu(OAc)2 2 3 52 
2 80 0.025 [PdCl(allyl)]2 20 AgOAc 4 4 42 
3 80 0.025 Pd(TFA)2 10 Cu(OAc)2 2 2 52 
4 90 0.0625 Pd(TFA)2 15 Cu(OAc)2 3 3 59 
5 90 0.0625 Pd(TFA)2 15 Cu(OAc)2 3 3 54 
6 100 0.2 Pd(OAc)2 10 AgOAc 3 2 71 
7 80 0.0625 Pd(TFA)2 10 Cu(OAc)2 4 3 22 
8 80 0.0625 Pd(OAc)2 15 AgOAc 2 4 36 
9 100 0.0625 Pd(TFA)2 15 AgOAc 4 2 70 
10 80 0.0625 [PdCl(allyl)]2 20 Cu(OAc)2 3 2 36 
11 90 0.0625 Pd(TFA)2 15 Cu(OAc)2 3 3 54 
12 80 0.1 [PdCl(allyl)]2 10 AgOAc 2 3 3 
13 100 0.025 Pd(OAc)2 10 Cu(OAc)2 4 4 59 
14 100 0.1 [PdCl(allyl)]2 15 Cu(OAc)2 4 3 17 
15 100 0.1 Pd(TFA)2 20 Cu(OAc)2 2 4 49 
16 80 0.1 Pd(OAc)2 20 Cu(OAc)2 4 2 63 
17 80 0.025 Pd(OAc)2 15 Cu(OAc)2 3 3 46 
18 100 0.0625 [PdCl(allyl)]2 10 Cu(OAc)2 4 3 19 
19 100 0.025 [PdCl(allyl)]2 15 Cu(OAc)2 2 3 34 
20 100 0.025 Pd(TFA)2 20 AgOAc 3 2 60 
21 80 0.1 Pd(TFA)2 15 Cu(OAc)2 3 4 21 
22 100 0.025 Pd(OAc)2 20 AgOAc 4 2 75 
*As measured by 1H-NMR analysis with 1,4-dimethoxybenzene as a standard 
 
